PMID,Drug/metabilite name,Characteristics,Value,Unit,Summary Statistics,variation type,variation value,Interval type,Interval low,Interval high,Frequency,Route,Schedule,Subjects n,Population,Pregnancy Stage ,Gestational Age,P-value,Notes,_source_file,_source_folder,_source_sheet_original,_source_sheet_canonical,_row_index,_processed_at
20914,meperidine,dose,0.518,mmol,mean,SD,0.106,,,,,IV or IM,during labor,7.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,2,2025-12-02T15:56:54.560214
20914,meperidine,dose-delivery interval,3.3,h,mean,SD,1.68,,,,,,,7.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,3,2025-12-02T15:56:54.560214
47537,meperidine,dose,150,mg,,,,,,,once,intramuscular,,8.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,4,2025-12-02T15:56:54.560214
47537,Diamorphine,,10,,,,,,,,,,,8.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,5,2025-12-02T15:56:54.560214
47537,Cyclizine,,50,,,,,,,,,,,24.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,6,2025-12-02T15:56:54.560214
47537,Pentazocine,,60,,,,,,,,,,,8.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,7,2025-12-02T15:56:54.560214
47537,Metaclopromide,,10,,,,,,,,,,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,8,2025-12-02T15:56:54.560214
47537,Paracetamol,,1.5,grams (g),,,,,,,once,oral,,56.0,Maternal,Labor,,,also duringpostpartum period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,9,2025-12-02T15:56:54.560214
47537,Paracetamol,dose-delivery interval,10.6,hours (h),mean,SD,1.9,,,,,,,12.0,,,,,Paracetamol alone,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,10,2025-12-02T15:56:54.560214
47537,Paracetamol,,2.6,,,,0.6,,,,,,,8.0,,,,,Paracetamol after meperidine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,11,2025-12-02T15:56:54.560214
47537,Paracetamol,,4.2,,,,0.9,,,,,,,8.0,,,,,Paracetamol after diamorphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,12,2025-12-02T15:56:54.560214
47537,Paracetamol,,4.7,,,,1.1,,,,,,,8.0,,,,,Paracetamol after pentazocine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,13,2025-12-02T15:56:54.560214
47537,Paracetamol,,1.5,,,,0.4,,,,,,,5.0,,,,,Paracetamol after meperidine/metoclopramide,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,14,2025-12-02T15:56:54.560214
47537,Paracetamol,,6.7,,,,1.9,,,,,,,5.0,,,,,Paracetamol after diamorphine/metoclopramide,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,15,2025-12-02T15:56:54.560214
47537,,,,,Maternal,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,16,2025-12-02T15:56:54.560214
359109,butorphanol,dose,1 or 2,mg,,,,,,,1 or 2,IM,,6.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,17,2025-12-02T15:56:54.560214
359109,meperidine,dose,40,mg,,,,,,,1 or 2,IM,,6.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,18,2025-12-02T15:56:54.560214
434034,Meperidine,dose,50,mg,mean,,,,,,once,intravenous,,23.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,19,2025-12-02T15:56:54.560214
434034,Meperidine,dose-delivery interval,210,minutes (min),mean,,26.0,,,,,,,10.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,20,2025-12-02T15:56:54.560214
434035,Meperidine,dose,50,mg,median,,,,,,once,intravenous,,30.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,21,2025-12-02T15:56:54.560214
466928,morphine,dose,0.15,mg/kg,,,,,,,1,IV,as premedication before surgery,19.0,child,,,,group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,22,2025-12-02T15:56:54.560214
466928,morphine,dose,1.15,mg/kg,,,,,,,1,IV,as premedication before surgery,4.0,child,,,,group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,23,2025-12-02T15:56:54.560214
466928,morphine,dose,0.075,mg/kg,,,,,,,1,IV,at the beginning of the surgical operation,4.0,child,,,,group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,24,2025-12-02T15:56:54.560214
466928,morphine,dose,1.15,mg/kg,,,,,,,1,IV,as premedication before surgery,,child,,,,group C,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,25,2025-12-02T15:56:54.560214
466928,morphine,dose,0.075,mg/kg,,,,,,,multiple,IV,during the surgical procedure whenever the anesthesiologist considered it necessay to relieve pain,,child,,,,group C,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,26,2025-12-02T15:56:54.560214
656525,meperidine,dose,,,,,,,,,1,IV,,9.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,27,2025-12-02T15:56:54.560214
656525,,,,,,,,,,,1,IM,,4.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,28,2025-12-02T15:56:54.560214
656525,,,,,,,,,,,multiple,,,4.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,29,2025-12-02T15:56:54.560214
910821,methadone,,,,,,,,,,,,,22.0,maternal,pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,30,2025-12-02T15:56:54.560214
1163360,methadone,dose,38.1,mg/day,mean,SD,3.9,range,10.0,100.0,,,,29.0,maternal,pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,31,2025-12-02T15:56:54.560214
1218165,morphine hydrochloride,dose,0.2,mg/kg,,,,,,,once,intramuscular,,47.0,maternal,trimester 1,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,32,2025-12-02T15:56:54.560214
1218165,hyoscine bromide,dose,0.006,mg/kg,,,,,,,once,intramuscular,,47.0,maternal,trimester 1,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,33,2025-12-02T15:56:54.560214
1261164,Propoxyphene ,dose,1.5,mg/kg,,,,,,,1,oral,,23.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,34,2025-12-02T15:56:54.560214
1261164,propranolol,dose,,,,,,,,,,oral,6 hourly for at least 3 days,7.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,35,2025-12-02T15:56:54.560214
1271174,methadone,dose,38.1,mg/day,mean,SD,3.9,range,10.0,100.0,,,,28.0,maternal,pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,36,2025-12-02T15:56:54.560214
1424407,meperidine ,dose,1,mg/kg,,,,,,,single dose,IV,"after surgery, administered over a period of 1 minute",21.0,infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,37,2025-12-02T15:56:54.560214
1424407,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,38,2025-12-02T15:56:54.560214
1437393,Meperidine,dose,25,mg,,,,,,,bolus,intravenous,,8.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,39,2025-12-02T15:56:54.560214
1437393,,,25,mg/h,,,,,,,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,40,2025-12-02T15:56:54.560214
1437393,,,,mg,,,125.0,,,,,intravenous,for < 4 hours,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,41,2025-12-02T15:56:54.560214
1437393,,,1.18,mg/kg,mean,,0.43,,,,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,42,2025-12-02T15:56:54.560214
1437393,Meperidine,dose-delivery interval,5.5,hours (h),,,2.1,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,43,2025-12-02T15:56:54.560214
1437393,Bupivacaine 0.25%,dose,0.99,mg/kg,,,0.2,,,,,epidural,,,,,,,meperidine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,44,2025-12-02T15:56:54.560214
1437393,,,0.99,mg/kg,,CT/PK,0.26,,,,,epidural,,8.0,,,,,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,45,2025-12-02T15:56:54.560214
1437393,,,,,,CT/PK/PD,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,46,2025-12-02T15:56:54.560214
1467140,morphine,dose,,,,,,,,,,continuousinfusion,,12.0,neonate/infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,47,2025-12-02T15:56:54.560214
1467165,"meperidine, morphine, or codeine",Morphine-equivalent dose,32,ug/kg/h,mean,SD,20.0,,,,,IM or IV,every 3 or 4 hours,32.0,child,,,,"Group A: : meperidine, morphine, or codeine IM or IV bolus",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,48,2025-12-02T15:56:54.560214
1467165,"meperidine, morphine, or codeine",duration of opioid treatment,5.1,days,mean,SD,2.4,,,,,IM or IV,every 3 or 4 hours,32.0,child,,,,"Group A: : meperidine, morphine, or codeine IM or IV bolus",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,49,2025-12-02T15:56:54.560214
1467165,Morphine,dose,34,ug/kg/h,mean,SD,11.0,,,,,CIV,"a loading dose of 0.15 mg/kg of morphine sulfate was followed by CIV of morphine at an initial rate of 40 pg/kg/hr. When necessary, doses were increased every 8 hours in increments of 20 pg/kg/hr to a maximum rate of 100 pg/kg/hr. When effective analgesis (see below) had been achieved/maintained for at least 24 hours, the dose rate was decreased every 8 hours by steps of 20 pg/kg/hr. When serious side effects of morphine were observed (see below), CIV morphine dose rate was decreased or stopped",34.0,child,,,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,50,2025-12-02T15:56:54.560214
1467165,Morphine,duration of opioid treatment,4.7,days,mean,SD,2.8,,,,,CIV,"a loading dose of 0.15 mg/kg of morphine sulfate was followed by CIV of morphine at an initial rate of 40 pg/kg/hr. When necessary, doses were increased every 8 hours in increments of 20 pg/kg/hr to a maximum rate of 100 pg/kg/hr. When effective analgesis (see below) had been achieved/maintained for at least 24 hours, the dose rate was decreased every 8 hours by steps of 20 pg/kg/hr. When serious side effects of morphine were observed (see below), CIV morphine dose rate was decreased or stopped",34.0,child,,,,Group B: patients receiving CIV morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,51,2025-12-02T15:56:54.560214
1533168,sufentanil ,dose,4,ug/kg,,,,,,,,IV,given in the 15minute period before surgery. ,10.0,infant/child,,,,sufentanil monoanesthesia (SM) group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,52,2025-12-02T15:56:54.560214
1533168,sufentanil ,dose,4,ug/kg,,,,,,,,IV,given in the 15minute period before surgery. ,10.0,infant/child,,,,sufentanil/unitrazepam combination (SF) group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,53,2025-12-02T15:56:54.560214
1533168,flunitrazepam,dose,40,ug/kg,,,,,,,,IV,given in the 15minute period before surgery. ,10.0,infant/child,,,,sufentanil/unitrazepam combination (SF) group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,54,2025-12-02T15:56:54.560214
1540490,codeine phosphate,dose per suppository,4,mg,,,,,,,1,rectal,one suppository during elective surgery,9.0,infant/child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,55,2025-12-02T15:56:54.560214
1540490,codeine phosphate,dose per suppository,8,mg,,,,,,,5,rectal,"one suppository during elective surgery, in the latter, another suppository was administered every 6 th hour for a total of five doses",4.0,infant/child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,56,2025-12-02T15:56:54.560214
1551153,Fentanyl,dose,2,ug/kg,,,,,,,,IV,during either an elective Caesarean section or apostpartum tubal ligation,13.0,maternal,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,57,2025-12-02T15:56:54.560214
1551160,fentanyl,total dose,1025,ug,,,,range,0.1,0.2,,IV,"self-administered boluses of 25 txg of fentanyl with a lock-out interval often min. In addition, a concurrent fentanyl infusion of 25 I~g _x000C_9 hr -t was given.",1.0,maternal,delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,58,2025-12-02T15:56:54.560214
1567033,Bupivacaine,dose,12,mg,,,,,,,,intrathecal,,30.0,Maternal,Labor,,,1.6 ml of 0.75% solution,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,59,2025-12-02T15:56:54.560214
1567033,Morphine,dose,0.6,mg,,PK/PD,,,,,,intrathecal,,30.0,,,,,0.6 ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,60,2025-12-02T15:56:54.560214
1567033,Normal saline,dose,0.2,ml,,PK,,,,,,intrathecal,,15.0,,,,,"0.2 ml, 2.4 ml total",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,61,2025-12-02T15:56:54.560214
1567033,Epinephrine,dose,0.2,mg,,,,,,,,intrathecal,,15.0,,,,,"0.2 ml, 2.4 ml total",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,62,2025-12-02T15:56:54.560214
1567033,Ephedrine,dose,5,mg,,,,,,,,intravenous,,4.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,63,2025-12-02T15:56:54.560214
1567033,,,,,,PK/PD,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,64,2025-12-02T15:56:54.560214
1567033,,,,,,PK/PD,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,65,2025-12-02T15:56:54.560214
1578319,morphine ,dose,91.8,ug/kg,mean,SD,18.7,,,,1,IV,single dose,16.0,preterm newborn infant,,<32 weeks of gestational age,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,66,2025-12-02T15:56:54.560214
1632539,alfentanil,ug/kg,11.8,ug/kg,mean,,,range,9.0,15.0,,IV,single dose,20.0,neonates,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,67,2025-12-02T15:56:54.560214
1636668,morphine ,dose,20,ug/kg/hr,,,,,,,,IV,"an intravenous bolus followed by a continuous infusion, following surgery",,pediatric ,,younger than 1 year,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,68,2025-12-02T15:56:54.560214
1636668,,,30,ug/kg/hr,,,,,,,,IV,"an intravenous bolus followed by a continuous infusion, following surgery",,pediatric ,,older than 1 year,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,69,2025-12-02T15:56:54.560214
1683310,meperidine,dose,100,mg,,,,,,,,intramuscular,,40.0,Maternal,Labor,,,hours,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,70,2025-12-02T15:56:54.560214
1683310,levallophan,dose,1.2,mg,,,,,,,,intramuscular,,,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,71,2025-12-02T15:56:54.560214
1683310,promazine,dose,25,mg,,,,,,,,intramuscular,,,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,72,2025-12-02T15:56:54.560214
1765214,Fentanyl,dose,100,ug,,PK/PD,,,,,once,injection,,16.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,73,2025-12-02T15:56:54.560214
1765214,Bupivacaine,dose,85,mg,,PK,,,,,once,injection,,,,,,,dose at 0.5%,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,74,2025-12-02T15:56:54.560214
1765214,Etidocaine,dose,60,mg,,,,,,,once,injection,,,,,,,dose at 1%,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,75,2025-12-02T15:56:54.560214
1765214,Epinephrine,,,,,,,,,,once,injection,,,,,,,1:200000,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,76,2025-12-02T15:56:54.560214
1869598,morphine ,dose,,,,,,,,,6,oral,regular morphine sulphate tablets to be given every 4 h for 2-4 days until adequate pain relief was achieved,2.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,77,2025-12-02T15:56:54.560214
1869598,morphine ,dose,,,,,,,,,2,oral,controlled-release morphine sulphate tablets every 12 h for 2-4 days until adequate pain control was achieved,2.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,78,2025-12-02T15:56:54.560214
1883657,methadone ,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,79,2025-12-02T15:56:54.560214
1883657,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,80,2025-12-02T15:56:54.560214
1919898,fentanyl,infusion rate on day 1,9.2,ug/kg per hour,mean,SD,1.9,,,,,CIV,for each day of ECMO,8.0,neonatal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,81,2025-12-02T15:56:54.560214
1919898,fentanyl,infusion rate on day 6,21.9,ug/kg per hour,mean,SD,4.5,,,,,CIV,for each day of ECMO,8.0,neonatal,,,0.0024,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,82,2025-12-02T15:56:54.560214
1919898,Lorazepam ,dose,0.1-0.2,mg/kg,,,,,,,every 6 to 8 hours,,for each day of ECMO,8.0,neonatal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,83,2025-12-02T15:56:54.560214
1919898,midazolam ,,,,,,,,,,,,Midazolam was occasionally administered in individual doses together with fentanyl in response to inadequate sedation,8.0,neonatal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,84,2025-12-02T15:56:54.560214
1919898,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,85,2025-12-02T15:56:54.560214
1923912,alfentanil,dose,5.63,ug/kg/hr,mean,SD,1.88,,,,,IV,"a loading dose of 8 ug/kg intravenous alfentanil was infused over 10 minutes through a peripheral venous line. A maintenace infusion of 5 ug/kg/hour was started 20 minutes after the loading dose. At 6/12 hours into the maintenance infusion, dosing adjustment was allowed to occur in increments or decrements of 2.5 ug/kg/hour with a minimum dose of 1 ug/kg/hours. After the 12-hour dosing adjustment the dose was fixed for 15 hours/subsequently discontinued.",13.0,neonate ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,86,2025-12-02T15:56:54.560214
2012289,bupivacaine plain,dose,0.25,%,mean,,,,,,,caudal,single dose at induction of anesthesia,30.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,87,2025-12-02T15:56:54.560214
2012289,morphine,dose,0.05,mg/kg,,,,,,,,caudal,single dose at induction of anesthesia,15.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,88,2025-12-02T15:56:54.560214
2012289,nalbuphine,dose,0.3,mg/kg,,,,,,,,intramuscular,prn,11.0,chiildren,,,,bupivacaine alone group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,89,2025-12-02T15:56:54.560214
2012289,paracetamol ,dose,15,mg/kg,,,,,,,,oral,prn,8.0,children,,,,5 from the bupivacaine alone/3 from the bupivacaine/morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,90,2025-12-02T15:56:54.560214
2078976,alfentanil,dose,25,ug/kg,,,,,,,,IV,administered over 30s ,10.0,neonate ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,91,2025-12-02T15:56:54.560214
2097341,Morphine,dose,11.8,mg,mean,SD,1.9,,,,once,intramuscular,,9.0,Maternal,Labor,,,0.15 mg/kg,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,92,2025-12-02T15:56:54.560214
2097341,Morphine,dose,11,mg,,,2.0,,,,once,intravenous,,4.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,93,2025-12-02T15:56:54.560214
2097341,Morphine,dose-delivery interval,6.3,hours (h),,,4.4,range,1.4,15.5,,,,13.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,94,2025-12-02T15:56:54.560214
2097341,Morphine,dose,5.8,mg,,,2.1,,,,once,intravenous,,6.0,Adult,Nonpregnant,,,0.07-0.15 mg/kg,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,95,2025-12-02T15:56:54.560214
2097341,Morphine,dose,4.9,mg,,,0.25,,,,once,intramuscular,,4.0,Adult,Nonpregnant,,,2 weeks after iv dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,96,2025-12-02T15:56:54.560214
2231835,morphine ,dose,5,mg,,,,,,,4,oral,q 6 h over a 10 day period,1.0,maternal,lactation,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,97,2025-12-02T15:56:54.560214
2240676,meperidine,dose,1,mg/kg,,,,,,,,intravenous,,5.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,98,2025-12-02T15:56:54.560214
2240676,morphine,,0.1,mg/kg,,,,,,,,,,5.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,99,2025-12-02T15:56:54.560214
2240676,meperidine,,12.5,mg,,,,,,,,intravenous pump,,,maternal,delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,100,2025-12-02T15:56:54.560214
2240676,morphine,,,mg,,,,range,1.0,1.5,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,101,2025-12-02T15:56:54.560214
2240676,meperidine,,,mg,,,,,50.0,300.0,2-3 hours,oral,,,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,102,2025-12-02T15:56:54.560214
2240676,morphine,,,mg,,,,,5.0,30.0,2-3 hours,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,103,2025-12-02T15:56:54.560214
2240676,,PCA discontinutation ,,hours,,,,,20.0,43.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,104,2025-12-02T15:56:54.560214
2248393,fentanyl, peak infusion rate,33.1,ug/kg/h,mean,SD,22.5,,,,,CIV,during the ECMO therapy,37.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,105,2025-12-02T15:56:54.560214
2248393,, peak infusion rate,37.9,ug/kg/h,mean,SD,26.0,,,,,CIV,during the ECMO therapy,21.0,neonate with NAS,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,106,2025-12-02T15:56:54.560214
2248393,, peak infusion rate,26.9,ug/kg/h,mean,SD,15.5,,,,,CIV,during the ECMO therapy,16.0,non-NAS neonate  ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,107,2025-12-02T15:56:54.560214
2248393,,duration of ECMO therapy,5.2,days,mean,SD,1.7,,,,,CIV,during the ECMO therapy,37.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,108,2025-12-02T15:56:54.560214
2248393,,duration of ECMO therapy,6,days,mean,SD,1.4,,,,,CIV,during the ECMO therapy,21.0,neonate with NAS,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,109,2025-12-02T15:56:54.560214
2248393,,duration of ECMO therapy,4.2,days,mean,SD,1.7,,,,,CIV,during the ECMO therapy,16.0,non-NAS neonate  ,,,0.001,NAS vs. Non-NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,110,2025-12-02T15:56:54.560214
2248393,,total dose,3.4,mg/kg,mean,SD,2.5,,,,,CIV,during the ECMO therapy,21.0,neonate with NAS,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,111,2025-12-02T15:56:54.560214
2248393,,total dose,1.8,mg/kg,mean,SD,1.5,,,,,CIV,during the ECMO therapy,16.0,non-NAS neonate  ,,,0.03,NAS vs. Non-NAS,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,112,2025-12-02T15:56:54.560214
2248393,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,113,2025-12-02T15:56:54.560214
2262875,Morphine,dose,10,mg,median,,,range,8.0,15.0,once,intravenous,,5.0,Maternal,Trimester 3 (T3),26-34 wks,,one im route,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,114,2025-12-02T15:56:54.560214
2288836,morphine,,,,,,,,,,,CIV,,9.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,115,2025-12-02T15:56:54.560214
2288836,,,,,,,,,,,,CIV,,7.0,preterm neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,116,2025-12-02T15:56:54.560214
2288836,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,117,2025-12-02T15:56:54.560214
2288836,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,118,2025-12-02T15:56:54.560214
2288837,morphine,,,,,,,,,,,CIV,44 days,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,119,2025-12-02T15:56:54.560214
2288837,ketamine,,,,,,,,,,,CIV,32 days,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,120,2025-12-02T15:56:54.560214
2288837,midazolam,,,,,,,,,,,CIV,42 days,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,121,2025-12-02T15:56:54.560214
2288837,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,122,2025-12-02T15:56:54.560214
2354106,morphine,infusion rate,,mg/h,,,,range,2.0,10.0,,IV,started on day 1/discontinued 40 days after admission to ITU as analgesia,1.0,adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,123,2025-12-02T15:56:54.560214
2354106,midazolam,infusion rate,,mg/h,,,,range,5.0,15.0,,IV,"Sedation was provided initially by midazolam 5-15 mg/h, which subsequently was changed to propofol 100-250 mg/h",1.0,adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,124,2025-12-02T15:56:54.560214
2354106,propofol ,infusion rate,,mg/h,,,,range,100.0,250.0,,IV,"Sedation was provided initially by midazolam 5-15 mg/h, which subsequently was changed to propofol 100-250 mg/h,/stopped 40 days after admission to ITU",1.0,adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,125,2025-12-02T15:56:54.560214
2354106,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,126,2025-12-02T15:56:54.560214
2485290,Methadone,dose,30,mg,,,,,,,daily,oral,,1.0,Maternal,Trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,127,2025-12-02T15:56:54.560214
2568289,Meperidine,dose,50,mg,median,,,,,,bolus,intravenous,,11.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,128,2025-12-02T15:56:54.560214
2568289,,dose-delivery interval,,hours,,,,range,1.0,9.0,,,,11.0,Neonate,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,129,2025-12-02T15:56:54.560214
2590614,Morphine,dose,,ug/kg/h,,,,range,15.0,140.0,,IV,,12.0,pediatric,,child,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,130,2025-12-02T15:56:54.560214
2590614,,,,ug/kg/h,,,,range,10.0,40.0,,IV,,9.0,pediatric,,neonate ,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,131,2025-12-02T15:56:54.560214
2719905,morphine,,,,,,,,,,,IV,on the first/second postoperative days,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,132,2025-12-02T15:56:54.560214
2719905,diazepam,,,,,,,,,,,IV,on the first/second postoperative days,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,133,2025-12-02T15:56:54.560214
2719905,midazolam,,,,,,,,,,,IV,on the second postoperative day,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,134,2025-12-02T15:56:54.560214
2719905,naloxone,,,,,,,,,,,IV,started from day 3 to day 9,1.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,135,2025-12-02T15:56:54.560214
2719905,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,136,2025-12-02T15:56:54.560214
2729393,Meperidine,dose,50,mg,median,,,,,,,intravenous,,5.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,137,2025-12-02T15:56:54.560214
2729393,,dose,50,mg,median,,,,,,,intramuscular,,15.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,138,2025-12-02T15:56:54.560214
2729393,,dose,50,mg,median,,,,,,,intramuscular,,5.0,Adult,Nonpregnant,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,139,2025-12-02T15:56:54.560214
2744067,Meptazinol,dose,25,mg,mean,,,,,,once,intravenous,,10.0,Adult,Nonpregnant,,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,140,2025-12-02T15:56:54.560214
2744067,,dose,25,mg,,,,,,,once,intravenous,,9.0,Maternal,Trimester 3 (T3),,,single-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,141,2025-12-02T15:56:54.560214
2744067,,dose,10,mg,,,,,,,six,intravenous,every 30 mins for 2.5 hrs,9.0,Adult,Nonpregnant,,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,142,2025-12-02T15:56:54.560214
2744067,,dose,10,mg,,,,,,,six,intravenous,every 30 mins for 2.5 hrs,10.0,Maternal,Trimester 3 (T3),,,repeated-dose study,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,143,2025-12-02T15:56:54.560214
2800981,morphine ,dose,4,mg,,,,,,,,epidural blockade ,,2.0,maternal,lactation,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,144,2025-12-02T15:56:54.560214
2800981,morphine ,dose,5,mg,,,,,,,,IV,,4.0,maternal,lactation,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,145,2025-12-02T15:56:54.560214
2800981,morphine ,dose,5-10,mg,,,,,,,,IM,,4.0,maternal,lactation,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,146,2025-12-02T15:56:54.560214
2876662,Alfentanil,dose,30,ug/kg,,,,,,,bolus,intravenous,,5.0,Maternal,Term,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,147,2025-12-02T15:56:54.560214
2876662,,,30,ug/kg,,,,,,,bolus,epidural,,5.0,Maternal,Term,,,Group B,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,148,2025-12-02T15:56:54.560214
2876662,,,30,ug/kg/hr,,,,,,,,infusion,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,149,2025-12-02T15:56:54.560214
2876662,,,120,ug/kg,,,,,,,bolus,intravenous,,5.0,Adult,nonpregnant,,,Group C,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,150,2025-12-02T15:56:54.560214
2964213,sufentanil,dose,3-5,ug/kg,,,,,,,,,infused over 1 minute,,Adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,151,2025-12-02T15:56:54.560214
2979128,alfentanil,bolus dose,20,ug/kg,,,,,,,,intravenous,bolus,11.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,152,2025-12-02T15:56:54.560214
2979128,alfentanil,infusion dose,1,ug/kg/min,,,,,,,,intravenous,infusion,11.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,153,2025-12-02T15:56:54.560214
2979128,alfentanil,additonal bolus dose,5,ug/kg,,,,,,,,intravenous,prn,11.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,154,2025-12-02T15:56:54.560214
2979128,alfentanil,total dose,0.99,mg,mean,SD,0.26,,,,,intravenous,infusion,6.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,155,2025-12-02T15:56:54.560214
2979128,alfentanil,infusion duration,130,min,mean,SD,28.0,,,,,intravenous,infusion,6.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,156,2025-12-02T15:56:54.560214
2979128,alfentanil,time to extubation,34,min,mean,SD,9.0,,,,,,,6.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,157,2025-12-02T15:56:54.560214
2979128,alfentanil,time to first opioid in ICU,399,min,mean,SD,216.0,,,,,,,6.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,158,2025-12-02T15:56:54.560214
2979128,alfentanil,total dose,3.39,mg,mean,SD,1.14,,,,,intravenous,infusion,5.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,159,2025-12-02T15:56:54.560214
2979128,alfentanil,infusion duration,147,min,mean,SD,15.0,,,,,intravenous,infusion,5.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,160,2025-12-02T15:56:54.560214
2979128,alfentanil,time to extubation,33,min,mean,SD,6.0,,,,,,,5.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,161,2025-12-02T15:56:54.560214
2979128,alfentanil,time to first opioid in ICU,312,min,mean,SD,320.0,,,,,,,5.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,162,2025-12-02T15:56:54.560214
3098137,morphine ,dose,50,ug/kg,,,,,,,,epidural injection,after abdominal/urologic surgery,7.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,163,2025-12-02T15:56:54.560214
3120765,alfentanil,dose,20,ug/kg,,,,,,,,IV,single bolus,18.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,164,2025-12-02T15:56:54.560214
3120765,,dose,50,ug/kg,,,,,,,,IV,single bolus,2.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,165,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,<25,mg,,,,,,,,epidural,,43.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,166,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,26-50,mg,,,,,,,,,,35.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,167,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,51-75,mg,,,,,,,,,,13.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,168,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,76-100,mg,,,,,,,,,,6.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,169,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,101-125 ,mg,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,170,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,126-150 ,mg,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,171,2025-12-02T15:56:54.560214
3214378,Bupivacaine,dose,> 151 ,mg,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,172,2025-12-02T15:56:54.560214
3214378,Bupivacaine,total dose,40,mg,mean,SD,28.0,range,0.0,100.0,,,,48.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,173,2025-12-02T15:56:54.560214
3214378,meperidine,dose,<25,mg,,,,,,,,,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,174,2025-12-02T15:56:54.560214
3214378,meperidine,dose,26-50,mg,,,,,,,,,,42.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,175,2025-12-02T15:56:54.560214
3214378,meperidine,dose,51-75,mg,,,,,,,,,,22.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,176,2025-12-02T15:56:54.560214
3214378,meperidine,dose,76-100,mg,,,,,,,,,,14.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,177,2025-12-02T15:56:54.560214
3214378,meperidine,dose,101-125 ,mg,,,,,,,,,,4.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,178,2025-12-02T15:56:54.560214
3214378,meperidine,dose,126-150 ,mg,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,179,2025-12-02T15:56:54.560214
3214378,meperidine,total dose,75,mg,mean,SD,71.0,range,25.0,200.0,,,,48.0,,,,,3 patients were given the drug intramuscularly,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,180,2025-12-02T15:56:54.560214
3214378,Bupivacaine or bupivacaine+meperidine,dose-delivery interval,,hours,,,,range,0.13,12.1,,,,100.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,181,2025-12-02T15:56:54.560214
3214378,Bupivacaine alone,dose-delivery interval,3.9,hours,mean,,,,0.08,3.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,182,2025-12-02T15:56:54.560214
3377945,meperidine,dose,33.8,mg,mean,SD,8.0,,,,,IV,,10.0,Pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,183,2025-12-02T15:56:54.560214
3377945,,dose,30,mg,mean,SD,6.0,,,,,IM,,6.0,Pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,184,2025-12-02T15:56:54.560214
3377945,,dose,32,mg,mean,SD,9.0,,,,,Rectally,,9.0,Pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,185,2025-12-02T15:56:54.560214
3377945,,applied volume,3.3,ml,mean,SD,0.8,,,,,IV,,10.0,Pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,186,2025-12-02T15:56:54.560214
3377945,,applied volume,3,ml,mean,SD,0.6,,,,,IM,,6.0,Pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,187,2025-12-02T15:56:54.560214
3377945,,applied volume,3.2,ml,mean,SD,0.9,,,,,Rectally,,9.0,Pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,188,2025-12-02T15:56:54.560214
3535859,morphine ,dose,1,mg/kg,,,,,,,,IV,as part of the anaesthetic regimen before liver transplanation surgery,2.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,189,2025-12-02T15:56:54.560214
3609115,fentanyl,dose,,ug/kg,,,,range,30.0,50.0,bolus,intravenous,,18.0,children/adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,190,2025-12-02T15:56:54.560214
3609115,fentanyl,constant infusion dose,,ug/kg/min,,,,,0.15,0.3,infusion,intravenous,,18.0,children/adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,191,2025-12-02T15:56:54.560214
3609434,morphine chloride ,dose,1,mg,,,,,,,,intrathecal injection,during labor,13.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,192,2025-12-02T15:56:54.560214
3670879,morphine,infusion rate,0.11,mg/kg/h,median,,,range,0.03,0.29,infusion,intravenous,,10.0,pediatric,,,,mucositis pain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,193,2025-12-02T15:56:54.560214
3670879,morphine,infusion duration,8,days,median,,,range,4.0,19.0,,,,10.0,pediatric,,,,mucositis pain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,194,2025-12-02T15:56:54.560214
3670879,morphine,infusion rate,0.2,mg/kg/h,median,,,range,0.04,31.3,infusion,intravenous,,11.0,pediatric,,,,tumor-related pain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,195,2025-12-02T15:56:54.560214
3670879,morphine,infusion duration,17,days,median,,,range,5.0,154.0,,,,11.0,pediatric,,,,tumor-related pain group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,196,2025-12-02T15:56:54.560214
3709338,fentanyl,dose,50,ug/kg,mean,,,,,,bolus,intravenous,,10.0,infants/children/adolescents,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,197,2025-12-02T15:56:54.560214
3709338,fentanyl,dose,30,ug/kg,,,,,,,bolus,intravenous,,9.0,infants/children/adolescents,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,198,2025-12-02T15:56:54.560214
3709338,fentanyl,continuous dose,0.3,ug/kg/min,,,,,,,infusion,intravenous,,15.0,infants/children/adolescents,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,199,2025-12-02T15:56:54.560214
3709338,fentanyl,continuous dose,0.15,ug/kg/min,,,,,,,infusion,intravenous,,4.0,infants/children/adolescents,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,200,2025-12-02T15:56:54.560214
3813075,morphine ,infusion rate,38,ug/kg/h,mean,SD,,range,20.0,100.0,1,IV,,10.0,infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,201,2025-12-02T15:56:54.560214
3813075,morphine ,duration of infusion,2.8,days,mean,SD,,range,14.0,15.0,1,IV,,10.0,infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,202,2025-12-02T15:56:54.560214
3840338,Fentanyl,dose,30,ug/kg,median,,,,,,bolus,intravenous,,9.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,203,2025-12-02T15:56:54.560214
3954090,Fentanyl,preferred dose,25 or 50,ug/kg,,,,,,,,IV,"Approximately 5 min prior to surgcal incision/after 10 mlikg of fresh frozen plasma had been administered, fentanyl was infused over 1-3 min",14.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,204,2025-12-02T15:56:54.560214
3954090,Fentanyl,time from injection to end of surgery,109,min,mean,SD,13.0,range,50.0,170.0,,IV,"Approximately 5 min prior to surgcal incision/after 10 mlikg of fresh frozen plasma had been administered, fentanyl was infused over 1-3 min",14.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,205,2025-12-02T15:56:54.560214
3970110,Meperidine,dose,,mg,,,,range,25.0,50.0,prn,intravenous,,12.0,Maternal,Labor,,,"multiple doses ≤125 mg, given on an as needed basis",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,206,2025-12-02T15:56:54.560214
3970110,Meperidine,drug-delivery interval,242,minutes (min),mean,SD,77.0,,,,,,,12.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,207,2025-12-02T15:56:54.560214
3981450,Methadone,Absolute dose,30,mg,mean,SD,8.0,,,,once a day,oral,,8.0,Maternal,Timester 2,Phase 1 - 27 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,208,2025-12-02T15:56:54.560214
3981450,,,22,,,,9.0,,,,,,,9.0,,Trimester 3,Phase 2 - 37 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,209,2025-12-02T15:56:54.560214
3981450,,,28,,,,12.0,,,,,,,9.0,,Postpartum,Phase 3 - 2 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,210,2025-12-02T15:56:54.560214
3981450,,,36,,,,22.0,,,,,,,8.0,,Postpartum,Phase 4 - 8 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,211,2025-12-02T15:56:54.560214
3981450,Methadone, Weight adjusted dose,0.5,mg/kg,mean,SD,0.1,,,,,oral,,8.0,Maternal,Timester 2,Phase 1 - 27 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,212,2025-12-02T15:56:54.560214
3981450,,,0.4,,,,0.2,,,,,,,9.0,,Trimester 3,Phase 2 - 37 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,213,2025-12-02T15:56:54.560214
3981450,,,0.5,,,,0.3,,,,,,,9.0,,Postpartum,Phase 3 - 2 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,214,2025-12-02T15:56:54.560214
3981450,,,0.6,,,,0.4,,,,,,,8.0,,Postpartum,Phase 4 - 8 weeks gestation,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,215,2025-12-02T15:56:54.560214
4072588,Morphine,dose,0.15,mg/kg,median,,,,,,,rectal,,6.0,children,,,,Group 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,216,2025-12-02T15:56:54.560214
4072588,Diazepam,dose,0.5,mg/kg,median,,,,,,,rectal,,6.0,children,,,,Group 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,217,2025-12-02T15:56:54.560214
4072588,Morphine,dose,0.53,mg/kg,mean,SD,0.004,,,,,rectal,,11.0,children,,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,218,2025-12-02T15:56:54.560214
6670461,meperidine,dose,1.66,mg/kg,mean,SD,0.04,,,,once,intramuscular,,126.0,maternal,labor,,,15 minutes to 19.5 hours prior to delivery. ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,219,2025-12-02T15:56:54.560214
6670461,meperidine,dose,1.56,mg/kg,mean,SD,0.05,,,,,intramuscular,,85.0,neonates,,,,The meperidine dose-delivery interval in these cases ranged from 15 min to 5 h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,220,2025-12-02T15:56:54.560214
6670461,meperidine,dose,1.87,mg/kg,mean,SD,0.04,,,,,intramuscular,,41.0,neonates,,,,An additional 41 cases were included in which the meperidine dose-delivery interval exceeded 4 h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,221,2025-12-02T15:56:54.560214
6670461,naloxone,dose,,ug,,,,range,35.0,70.0,,intravenous,,35.0,newborn,,,, One minute after birth 35 of these newborn received 35 or 70 pg naloxone i.v. a,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,222,2025-12-02T15:56:54.560214
6670461,nalorphine,dose,0.5,mg,,,,,,,,intravenous,,18.0,newborn,,,,18 received 0.5 mg nalorphine i.v. The remainder did not receive a narcotic antagonist,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,223,2025-12-02T15:56:54.560214
6670461,meperidine,dose-delivery interval,2.13,hours,mean,SD,0.3,,,,,,,92.0,maternal,labor,,,given 100 mg meperidine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,224,2025-12-02T15:56:54.560214
6670461,meperidine,dose-delivery interval,5.56,hours,mean,SD,0.57,,,,,,,44.0,maternal,labor,,,given 150 mg meperidine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,225,2025-12-02T15:56:54.560214
6670461,meperidine,dose-delivery interval,3.33,hours,mean,SD,0.31,,,,,,,126.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,226,2025-12-02T15:56:54.560214
6713779,Propoxyphene,initial dose,130,mg,median,,,,,,once,oral,,6.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,227,2025-12-02T15:56:54.560214
6713779,Propoxyphene,dose,65,mg,median,,,,,,,oral,q4h,6.0,maternal,postpartum,,,Sixteen hours before dosing each subject was given two 65-mg P hydrochloride capsules/one capsule every 4 hr thereafter for a total of six capsules. The last capsule was always given at 8:00 A.M. the morning of the study to avoid influences of diurnal variation.,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,228,2025-12-02T15:56:54.560214
6713779,Propoxyphene,total dose,520,mg,median,,,,,,,oral,,6.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,229,2025-12-02T15:56:54.560214
6721986,meperidine,base dose,0.023,mg/ml,,,,,,,,in-vitro,,12.0,adults,,,,"2 subjects were pregnant, 6 were healthy volunteers/6 inlcuding the pregnant women were patients",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,230,2025-12-02T15:56:54.560214
6893898,morphine,dose,,mg,,,,range,4.0,6.0,,extradurally injected,during the first stage of labor,20.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,231,2025-12-02T15:56:54.560214
6893898,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,232,2025-12-02T15:56:54.560214
6896151,morphine,dose,0.02,mg/kg,mean,,,,,,,intrathecal injection,,25.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,233,2025-12-02T15:56:54.560214
6897154,Morphine,dose,4,mg,median,,,,,,,intramuscular,,12.0,maternal,delivery,,,Group A,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,234,2025-12-02T15:56:54.560214
6897154,Morphine,dose,4,mg,median,,,,,,,epidural,,23.0,maternal,delivery,,,Groups B/C,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,235,2025-12-02T15:56:54.560214
6897154,meperidine,dose,,mg,,,,range,50.0,100.0,prn,intramuscular,,35.0,maternal,delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,236,2025-12-02T15:56:54.560214
6927545,heroin,,,,,,,,,,,,,2.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,237,2025-12-02T15:56:54.560214
6927545,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,238,2025-12-02T15:56:54.560214
7059414,meperidine,dose,100,mg,,,,,,,,IV,when they requested analgesia,10.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,239,2025-12-02T15:56:54.560214
7059414,meperidine,dose,100,mg,,,,,,,,IM,when they requested analgesia,10.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,240,2025-12-02T15:56:54.560214
7059414,meperidine,dose,100,mg,,,,,,,,epidural injection,,10.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,241,2025-12-02T15:56:54.560214
7059414,meperidine,dose,100,mg,,,,,,,,epidural injection,,8.0,adult,Nonpregnant,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,242,2025-12-02T15:56:54.560214
7138758,Meptazinol,dose,50,mg,,,,,,,once,intramuscular,,4.0,Adult,Nonpregnant,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,243,2025-12-02T15:56:54.560214
7138758,,dose,50,mg,,,,,,,once,intramuscular,,3.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,244,2025-12-02T15:56:54.560214
7211235,meperidine ,dose,100,mg,,,,,,,,IM,during labor,28.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,245,2025-12-02T15:56:54.560214
7211235,,time interval between injection/delivery,,min,,,,range,26.0,180.0,,,,28.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,246,2025-12-02T15:56:54.560214
7211235,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,247,2025-12-02T15:56:54.560214
7214793,aspirin,dose per tablet,454,mg,,,,,,,,oral,2 tablets for analgestic preparation,2.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,248,2025-12-02T15:56:54.560214
7214793,phenacetin,dose per tablet,324,mg,,,,,,,,oral,3 tablets for analgestic preparation,2.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,249,2025-12-02T15:56:54.560214
7214793,caffeine,dose per tablet,64,mg,,,,,,,,oral,4 tablets for analgestic preparation,2.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,250,2025-12-02T15:56:54.560214
7214793,codeine,dose per tablet,60,mg,,,,,,,,oral,5 tablets for analgestic preparation,2.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,251,2025-12-02T15:56:54.560214
7214793,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,252,2025-12-02T15:56:54.560214
7225299,meperidine,total maternal dose,163.2,mg,mean,SD,12.0,,,,,IM,administered at the patient’s request/repeated as required during labor,12.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,253,2025-12-02T15:56:54.560214
7225299,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,254,2025-12-02T15:56:54.560214
7357807,Meperidine,dose,50,mg,,,,,,,prn,intravenous,,12.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,255,2025-12-02T15:56:54.560214
7357807,Meperidine,dose,50,mg,,,,,,,prn,intravenous,,7.0,Adult,Nonpregnant,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,256,2025-12-02T15:56:54.560214
7437369,meperidine,dose,100,mg,,,,,,,,IM,received meperidine from 25 minutes to 6 hours 45 minutes before delivery,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,257,2025-12-02T15:56:54.560214
7437369,promethazine,dose,25,mg,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,258,2025-12-02T15:56:54.560214
7437369,entonox,dose,,mg,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,259,2025-12-02T15:56:54.560214
7437369,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,260,2025-12-02T15:56:54.560214
7446613,butorphanol tatrate,,1 or 2,mg,,,,,,,once or twice,IM,between 1.4/6.3 hours before delivery,6.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,261,2025-12-02T15:56:54.560214
7446613,butorphanol tatrate,,2,mg,,,,,,,single,IM,received +- 20 hours after delivery,6.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,262,2025-12-02T15:56:54.560214
7446613,butorphanol tatrate,,8,mg,,,,,,,single,Oral,received 68+- 36 hours after delivery,6.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,263,2025-12-02T15:56:54.560214
7446613,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,264,2025-12-02T15:56:54.560214
7471613,Meperidine  ,plasma concentration,850,ng/ml,,,,,,,,,,9.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,265,2025-12-02T15:56:54.560214
7471613,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,266,2025-12-02T15:56:54.560214
7526750,alfentanil,dose,10,ng/mL,all,,,,,,,,,11.0,placentas,post-partum,post-partum,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,267,2025-12-02T15:56:54.560214
7545736,hydromorphone ,dose,,,,,,,,,2,,every 12 hr,2.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,268,2025-12-02T15:56:54.560214
7552591,morphine ,loading dose,50,mg/kg,,,,,,,,IV,over 30 minutes,13.0,newborn,,,,50 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,269,2025-12-02T15:56:54.560214
7552591,morphine ,loading dose,200,mg/kg,,,,,,,,IV,over 30 minutes,14.0,newborn,,,,200 mcg/kg loading dose group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,270,2025-12-02T15:56:54.560214
7552591,morphine ,dose,15,mg/kg/hour,,,,,,,,CIV,"After loading,",27.0,newborn,,,,both groups,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,271,2025-12-02T15:56:54.560214
7574018,Bupivacaine 0.25%,dose,10,ml,,,,,,,bolus,epidural,,28.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,272,2025-12-02T15:56:54.560214
7574018,Bupivacaine 0.125%,,10,ml/hr,,,,,,,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,273,2025-12-02T15:56:54.560214
7574018,Fentanyl,dose,2,ug/ml,,,,,,,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,274,2025-12-02T15:56:54.560214
7574018,Bupivacaine 0.125%,,12.5,mg/h,,,,,,,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,275,2025-12-02T15:56:54.560214
7574018,Fentanyl,,20,ug/h,,,,,,,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,276,2025-12-02T15:56:54.560214
7574018,Length of infusion time,,,hours,,,,range,1.17,15.0,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,277,2025-12-02T15:56:54.560214
7574018,Bupivacaine,total dose,,mg,,,,,27.0,200.0,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,278,2025-12-02T15:56:54.560214
7574018,Fentanyl,total dose,,ug,,,,,22.0,300.0,,infusion,,28.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,279,2025-12-02T15:56:54.560214
7631952,Bupivacaine,total dose,91,mg,mean,SD,9.4,,,,,epidural,,13.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,280,2025-12-02T15:56:54.560214
7631952,Bupivacaine,total dose,91,,,,12.9,,,,,epidural,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,281,2025-12-02T15:56:54.560214
7631952,Bupivacaine,total dose,90.2,,,,11.9,,,,,epidural,,14.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,282,2025-12-02T15:56:54.560214
7631952,Bupivacaine 0.25%,dose,12,ml,,,,,,,bolus,epidural,,13.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,283,2025-12-02T15:56:54.560214
7631952,Bupivacaine 0.125%,,10,ml/hr,,,,,,,,infusion,,36.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,284,2025-12-02T15:56:54.560214
7631952,Fentanyl,,75,ug,,,,,,,bolus,epidural,,14.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,285,2025-12-02T15:56:54.560214
7631952,Fentanyl,,1.5,ug/ml,,,,,,,,infusion,,14.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,286,2025-12-02T15:56:54.560214
7631952,Sufentanil,,15,ug,,,,,,,bolus,epidural,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,287,2025-12-02T15:56:54.560214
7631952,Sufentanil,,0.25,ug/ml,,,,,,,,infusion,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,288,2025-12-02T15:56:54.560214
7841696,Morphine  hydrochloride,dose,0.15,mg/kg,,,,,,,,IV,single dose,13.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,289,2025-12-02T15:56:54.560214
7869211,,dose rate,0.123,mg/kg/hr,mean,SD,0.042,range,0.035,0.206,,IV,continuous infusion,18.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,290,2025-12-02T15:56:54.560214
7869211,,dose rate,0.2,mg/kg,mean,,,range,0.15,0.2,,IV,"single dose Morphine sulfate was given into a free-flowing intravenous line for 30 seconds, between 9/10 AM in the morning, after an overnight fast.",6.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,291,2025-12-02T15:56:54.560214
7924762,morphine,dose,0.1,mg/kg,mean,,,,,,,intravenous,,27.0,neonates/infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,292,2025-12-02T15:56:54.560214
7948434,morphine ,loading dose,100,ug/kg/h,,,,,,,,IV,for 2 hours,11.0,premature neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,293,2025-12-02T15:56:54.560214
7948434,,maintenance dose,12.5,ug/kg/h,,,,,,,,IV,after the loading dose,11.0,premature neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,294,2025-12-02T15:56:54.560214
7948434,,loading dose,100,ug/kg/h,,,,,,,,IV,for 2 hours,12.0,premature neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,295,2025-12-02T15:56:54.560214
7948434,,maintenance dose,25,ug/kg/h,,,,,,,,IV,after the loading dose,12.0,premature neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,296,2025-12-02T15:56:54.560214
7948434,,loading dose,200,ug/kg/h,,,,,,,,IV,for 2 hours,8.0,premature neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,297,2025-12-02T15:56:54.560214
7948434,,maintenance dose,50,ug/kg/h,,,,,,,,IV,after the loading dose,8.0,premature neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,298,2025-12-02T15:56:54.560214
7999650,alfentanil,total dose,1.04,mg,mean,SD,0.41,,,,,epidural,,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,299,2025-12-02T15:56:54.560214
7999650,alfentanil,infusion rate,9.33,ml/hour,mean,SD,2.1,,,,,epidural,infusion,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,300,2025-12-02T15:56:54.560214
7999650,alfentanil,number of rate adjustments during continuous infusion,1.1,,mean,SD,1.1,,,,,epidural,,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,301,2025-12-02T15:56:54.560214
7999650,alfentanil,number of top-ups,0.5,,mean,SD,0.7,,,,,epidural,,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,302,2025-12-02T15:56:54.560214
7999650,fentanyl,total dose,0.106,mg,mean,SD,0.024,,,,,epidural,,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,303,2025-12-02T15:56:54.560214
7999650,fentanyl,infusion rate,9.6,ml/hour,mean,SD,1.7,,,,,epidural,infusion,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,304,2025-12-02T15:56:54.560214
7999650,fentanyl,number of rate adjustments during continuous infusion,0.9,,mean,SD,1.4,,,,,epidural,,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,305,2025-12-02T15:56:54.560214
7999650,fentanyl,number of top-ups,0.7,,mean,SD,0.7,,,,,epidural,,12.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,306,2025-12-02T15:56:54.560214
7999650,bupivacaine,total dose,58.9,mg,mean,SD,21.9,,,,,epidural,,12.0,maternal,labor,,,Group A - alfentanil group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,307,2025-12-02T15:56:54.560214
7999650,bupivacaine,total dose,59.5,mg,mean,SD,22.8,,,,,epidural,,12.0,maternal,labor,,,Group B - fentanyl group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,308,2025-12-02T15:56:54.560214
8026197,morphine,infusion rate,,ug/kg/hr,,,,range,20.0,40.0,,IV, during ECMO/after discontinuation of ECMO,7.0,infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,309,2025-12-02T15:56:54.560214
8213024,Morphine,dose,5,mg,median,,,,,,once,epidural,,30.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,310,2025-12-02T15:56:54.560214
8213024,Morphine,dose,5,mg,median,,,,,,once,epidural,,30.0,Maternal,Postpartum,,,24 hours after first dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,311,2025-12-02T15:56:54.560214
8260056,Codeine,dose,60,mg,median,,,,,,prn,oral,,7.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,312,2025-12-02T15:56:54.560214
8260056,,number of doses,4.1,count,mean,SD,3.0,range,1.0,12.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,313,2025-12-02T15:56:54.560214
8260056,meperidine,dose,50,mg,,,,,,,,intravenous,,3.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,314,2025-12-02T15:56:54.560214
8319480,Fentanyl,,5,ug/kg,,,,,,,,IV,a loading dose infused over 5 mins,19.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,315,2025-12-02T15:56:54.560214
8319480,Fentanyl,,3.6,ug/kg/hr,,,,range,0.47,10.3,,continuous infusion,administered immediately after the loading dose,19.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,316,2025-12-02T15:56:54.560214
8442811,morphine sulfate,loading infusion dose,50,ug/kg,,,,,,,,IV,over 20 minutes,20.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,317,2025-12-02T15:56:54.560214
8442811,,constant infusion dose,15,ug/kg/hr,,,,,,,,CIV,"after the loading dose, for at least 24 hours",20.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,318,2025-12-02T15:56:54.560214
8442811,,duration of continuous infusion,34,hours,mean,SD,15.0,range,12.0,66.0,,CIV,"after the loading dose, for at least 24 hours",20.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,319,2025-12-02T15:56:54.560214
8471411,Morphine,loading infusion dose,100,ug/kg/h,,,,,,,,IV, loading infusion for 2 h followed by constant rate infusions,4.0,premature neonate,,,,the low dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,320,2025-12-02T15:56:54.560214
8471411,,constant rate infusion dose,12.5,ug/kg/h,,,,,,,,CIV, loading infusion for 2 h followed by constant rate infusions,4.0,premature neonate,,,,the low dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,321,2025-12-02T15:56:54.560214
8471411,,loading infusion dose,200,ug/kg/h,,,,,,,,IV, loading infusion for 2 h followed by constant rate infusions,6.0,premature neonate,,,,the high dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,322,2025-12-02T15:56:54.560214
8471411,,constant rate infusion dose,50,ug/kg/h,,,,,,,,CIV, loading infusion for 2 h followed by constant rate infusions,6.0,premature neonate,,,,the high dose regimes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,323,2025-12-02T15:56:54.560214
8487566,fentanyl,dose,3.2,ug/kg/hr,mean,SD,1.7,,,,,intravenous,,9.0,neonates/infants,,,,survivors,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,324,2025-12-02T15:56:54.560214
8487566,fentanyl,dose,3.7,ug/kg/hr,mean,SD,1.6,,,,,intravenous,,3.0,neonates/infants,,,,lorazepam-survivor group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,325,2025-12-02T15:56:54.560214
8487566,fentanyl,dose,2.9,ug/kg/hr,mean,SD,1.7,,,,,intravenous,,6.0,neonates/infants,,,,no lorazepam-survivor group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,326,2025-12-02T15:56:54.560214
8487566,fentanyl,dose,3.6,ug/kg/hr,mean,SD,1.3,,,,,intravenous,,3.0,neonates/infants,,,,nonsurvivors,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,327,2025-12-02T15:56:54.560214
8487566,fentanyl,dose,2,ug/kg/hr,mean,SD,0.0,,,,,intravenous,,2.0,neonates/infants,,,,lorazepam-nonsurvivor group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,328,2025-12-02T15:56:54.560214
8487566,fentanyl,dose,4.4,ug/kg/hr,mean,SD,0.5,,,,,intravenous,,1.0,neonates/infants,,,<0.001,no lorazepam-nonsurvivor group; p for difference between +/- lorazepam nonsurvivors ,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,329,2025-12-02T15:56:54.560214
8487566,Lorazepam ,dose,0.1,mg/kg,,,,,,,every 30-60 mins,intravenous,prn,5.0,neonates/infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,330,2025-12-02T15:56:54.560214
8623970,Bupivacaine 0.125%,dose,10,ml,,,,,,,bolus,epidural,,28.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,331,2025-12-02T15:56:54.560214
8623970,Bupivacaine 0.125%,dose,10,ml/hr,,,,,,,,infusion,,28.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,332,2025-12-02T15:56:54.560214
8623970,Fentanyl,dose,50,ug,,,,,,,bolus,epidural,,14.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,333,2025-12-02T15:56:54.560214
8623970,Fentanyl 0.0002%,dose,10,ml/hr,,,,,,,,infusion,,14.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,334,2025-12-02T15:56:54.560214
8623970,Acetaminophen,dose,20,mg/kg,,,,,,,,oral,,28.0,Maternal,Labor,,,"in a suspension of 150 ml water, 2 hours after 1st dose of bupivacaine",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,335,2025-12-02T15:56:54.560214
8706774,Nalbuphine,total dose,0.28,mg/kg,mean,SD,0.03,range,0.25,0.32,,intramuscular,,5.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,336,2025-12-02T15:56:54.560214
8706774,Nalbuphine,total dose,0.1,,,,0.04,,0.05,0.22,,intravenous,,22.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,337,2025-12-02T15:56:54.560214
8706774,Nalbuphine,total dose,0.43,,,,,,,,,IM/IV,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,338,2025-12-02T15:56:54.560214
8738689,morphine,dose,0.2,mg/kg,,,,,,,1,IV,single dose before start of surgery,6.0,pediatric ,,,,intravenous administration of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,339,2025-12-02T15:56:54.560214
8738689,,,0.2,mg/kg,,,,,,,1,rectal,single dose before start of surgery,10.0,pediatric ,,,,rectal gel administration of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,340,2025-12-02T15:56:54.560214
8738689,,,0.2,mg/kg,,,,,,,1,rectal,single dose before start of surgery,9.0,pediatric ,,,,rectal solution administration of morphine,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,341,2025-12-02T15:56:54.560214
8827580,ketobemidone,dose,5,mg,median,,,range,5.0,10.0,,subcutaneously,,5.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,342,2025-12-02T15:56:54.560214
8839086,morphine ,dose,0.89,mg,mean,SD,0.24,,,,,PCA,,17.0,adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,343,2025-12-02T15:56:54.560214
8839086,,dose use Day1,0.045,mg/kg/h,mean,SD,0.02,range,0.01,0.08,,PCA,,17.0,adolescent,,,,"Day 1 indicates measurements made the morning after surgery,/Day 2 indicates measurements made the next day.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,344,2025-12-02T15:56:54.560214
8839086,,dose use Day2,0.047,mg/kg/h,mean,SD,0.014,range,0.013,0.063,,PCA,,13.0,adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,345,2025-12-02T15:56:54.560214
9024020,fentanyl,dose,125,ng/ml,,,,,,,,,,72.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,346,2025-12-02T15:56:54.560214
9024020,alfentanil,dose,125,ng/ml,,,,,,,,,,72.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,347,2025-12-02T15:56:54.560214
9034277,morphine ,loading dose,0.1,mg/kg,,,,,,,1 to 2,IV,1-2 boluse before infusion,11.0,infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,348,2025-12-02T15:56:54.560214
9034277,,constant infusion dose,10-20,ug/kg/h,,,,,,,,CIV,continuous intravenous infusions in ECMO,11.0,infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,349,2025-12-02T15:56:54.560214
9055894,meperidine ,dose,1.3,mg/kg,median,,,Q25-Q75,1.2,1.7,,IM,given during labor,7.0,child,,,,a “short DDI”  group (1.1-5.3 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,350,2025-12-02T15:56:54.560214
9055894,,dose,1.5,mg/kg,median,,,Q25-Q75,1.4,1.6,,IM,given during labor,6.0,child,,,,“long DDI”  group (8.1-9.9 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,351,2025-12-02T15:56:54.560214
9107559,nalbuphine ,dose,0.3,mg/kg,,,,,,,,intra-rectal route ,single dose administered on arrival in the operating room,10.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,352,2025-12-02T15:56:54.560214
9134513,fentanyl,final dosage,1.28,ug/kg/h,mean,SD,0.58,,,,,intravenous,,7.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,353,2025-12-02T15:56:54.560214
9134513,fentanyl,duration of infusion,111,hours,mean,SD,59.0,,,,,intravenous,infusion,7.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,354,2025-12-02T15:56:54.560214
9203876,fentanyl ,total dose,104.6,ug,mean,SD,60.8,range,,,,epidural ,,40.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,355,2025-12-02T15:56:54.560214
9203876,bupivacaine ,total dose,67.5,mg,mean,SD,42.0,range,15.0,185.0,,epidural ,,40.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,356,2025-12-02T15:56:54.560214
9203876,,First dose – delivery interval,385.4,min,mean,SD,189.6,range,85.0,899.0,,,,40.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,357,2025-12-02T15:56:54.560214
9203876,,Last dose – delivery interval,51.8,min,mean,SD,37.6,range,6.0,48.0,,,,40.0,maternal,labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,358,2025-12-02T15:56:54.560214
9305564,Sufentanil,dose,1,ng/ml,,,,,,,,perfusion,90 min,10.0,Maternal/Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,359,2025-12-02T15:56:54.560214
9305564,Sufentanil,dose,100,ng/ml,,,,,,,,perfusion,90 min,10.0,Maternal/Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,360,2025-12-02T15:56:54.560214
9305564,antipyrine,dose,100,mg/l,,,,,,,,perfusion,90 min,10.0,Maternal/Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,361,2025-12-02T15:56:54.560214
9305564,creatinine,dose,100,mg/l,,,,,,,,perfusion,90 min,10.0,Maternal/Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,362,2025-12-02T15:56:54.560214
9431829,methadone,dose,43.3,mg,mean,,,range,20.0,80.0,,oral,,12.0,pregnant,post-partum,post-partum,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,363,2025-12-02T15:56:54.560214
9485967,Fentanyl ,dose,0,ug,,,,,,,,,,14.0,maternal,labor,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (control) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,364,2025-12-02T15:56:54.560214
9485967,Fentanyl ,concentration,0,ng/ml,,,,,,,,,,14.0,maternal,labor,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (control) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,365,2025-12-02T15:56:54.560214
9485967,Fentanyl ,dose,74.6,ug,mean,SD,11.3,,,,,epidural ,,14.0,maternal,labor,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (fentanyl) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,366,2025-12-02T15:56:54.560214
9485967,Fentanyl ,concentration,0.091,ng/ml,mean,SD,0.061,,,,,epidural ,,14.0,maternal,labor,,," In study A, 28 women received an oral dose of paracetamol 1.5 g after 30 ml of the infusion solution (fentanyl) had been given (mean time 2.5 h after the start of the infusion).",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,367,2025-12-02T15:56:54.560214
9485967,Fentanyl ,dose,0,ug,,,,,,,,,,,maternal,labor,,,In study B a further 28  women  received  the same  dose  of  paracetamol  after 40–50 ml  of  the  infusion (control)  had  been  given  (mean  time 4.5 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,368,2025-12-02T15:56:54.560214
9485967,Fentanyl ,concentration,0,ng/ml,,,,,,,,,,,maternal,labor,,,In study B a further 28  women  received  the same  dose  of  paracetamol  after 40–50 ml  of  the  infusion (control)  had  been  given  (mean  time 4.5 h),Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,369,2025-12-02T15:56:54.560214
9485967,Fentanyl ,dose,113.2,ug,mean,SD,8.5,,,,,epidural ,,13.0,maternal,labor,,,"In study B a further 28  women  received  the same  dose  of  paracetamol  after40–50 ml  of  the  infusion  had  been  given  (mean  time4.5 h), equivalent to 100–125mg fentanyl in the fentanylgroup.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,370,2025-12-02T15:56:54.560214
9485967,Fentanyl ,concentration,0.201,ng/ml,mean,SD,0.237,,,,,epidural ,,4.0,maternal,labor,,,"In study B a further 28  women  received  the same  dose  of  paracetamol  after40–50 ml  of  the  infusion  had  been  given  (mean  time4.5 h), equivalent to 100–125mg fentanyl in the fentanylgroup.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,371,2025-12-02T15:56:54.560214
9485967,paracetamol,dose,1.5,g,,,,,,,,oral,,55.0,maternal,labor,,,for all groups,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,372,2025-12-02T15:56:54.560214
9585276,morphine,total dose,0.97,mg/kg,mean,SD,0.53,,,,,IV,continuous IV infusion after major noncardiac surgery,26.0,Infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,373,2025-12-02T15:56:54.560214
9585276,,infusion rate,11,ug/kg/h,,,,,,,,IV,continuous IV infusion after major noncardiac surgery,4.0,Infant,,1-7 days old,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,374,2025-12-02T15:56:54.560214
9585276,,,14,ug/kg/h,,,,,,,,IV,continuous IV infusion after major noncardiac surgery,0.0,Infant,,8-30 days old,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,375,2025-12-02T15:56:54.560214
9585276,,,19,ug/kg/h,,,,,,,,IV,continuous IV infusion after major noncardiac surgery,6.0,Infant,,1-3 mo old ,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,376,2025-12-02T15:56:54.560214
9585276,,,25,ug/kg/h,,,,,,,,IV,continuous IV infusion after major noncardiac surgery,6.0,Infant,,3-6 mo old ,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,377,2025-12-02T15:56:54.560214
9585276,,,35,ug/kg/h,,,,,,,,IV,continuous IV infusion after major noncardiac surgery,10.0,Infant,,6-12 mo old,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,378,2025-12-02T15:56:54.560214
9585276,,bolus dose,2,times,median,,,range,0.0,10.0,,IV,,26.0,Infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,379,2025-12-02T15:56:54.560214
9637638,Remifentanil,dose,0.1,ug/kg/min,,,,,,,,intravenous,,19.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,380,2025-12-02T15:56:54.560214
9637638,,total dose,286,ug,mean,SD,122.0,,,,,,,16.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,381,2025-12-02T15:56:54.560214
9637638,,total dose/kg,3.56,ug/kg,,,1.36,,,,,,,16.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,382,2025-12-02T15:56:54.560214
9637638,,bolus dose,16.7,ug/ml,,,,,,,prn,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,383,2025-12-02T15:56:54.560214
9637638,Lidocaine,dose,2,%,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,384,2025-12-02T15:56:54.560214
9637638,Epinephrine,dose,1:200000,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,385,2025-12-02T15:56:54.560214
9637638,Morphine,dose,,mg,,,,range,3.0,5.0,,epidural,,19.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,386,2025-12-02T15:56:54.560214
9667297,Bupivacaine,dose in controls,132,mg,mean,SD,53.0,,,,,epidural,,70.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,387,2025-12-02T15:56:54.560214
9667297,,dose in fentanyl group,99,mg,,,43.0,,,,,,,68.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,388,2025-12-02T15:56:54.560214
9667297,fentanyl,dose,183,ug,,,75.0,,,,,epidural,,68.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,389,2025-12-02T15:56:54.560214
9667297,,duration of infusion in controls,356,min,,,164.0,,,,,,,70.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,390,2025-12-02T15:56:54.560214
9667297,,duration of infusion in fentanyl group,380,min,,,199.0,,,,,,,68.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,391,2025-12-02T15:56:54.560214
9756318,Fentanyl,dose,1.5,ug/kg,,,,,,,once,intravenous,,42.0,Maternal,Trimester 1 (T1),6-16 weeks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,392,2025-12-02T15:56:54.560214
10064669,fentanyl,dose,,ug/h,,,,range,25.0,300.0,,transdermal,,13.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,393,2025-12-02T15:56:54.560214
10064669,,total treatment days,497,days,cumulative,,,,6.0,275.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,394,2025-12-02T15:56:54.560214
10064669,opioids,pre-fentanyl dose,,mg/day,,,,,45.0,1080.0,,oral,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,395,2025-12-02T15:56:54.560214
10064669,,number of rescue doses,,/day,,,,,0.0,3.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,396,2025-12-02T15:56:54.560214
10512263,remifentanil,prebypass dose,5,ug/kg,,,,,,,,intravenous,over 1 min,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,397,2025-12-02T15:56:54.560214
10512263,,postbypass dose,5,ug/kg,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,398,2025-12-02T15:56:54.560214
10512263,morphine,postop analgesia,75,ug/kg,,,,,,,prn,caudal,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,399,2025-12-02T15:56:54.560214
10518075,morphine,infusin rate for all,24,ug/kg/h,mean,SD,9.7,,,,,intravenous,,10.0,preterm,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,400,2025-12-02T15:56:54.560214
10518075,,,22.4,,,,5.9,,,,,,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,401,2025-12-02T15:56:54.560214
10518075,,,24.1,,,,5.3,,,,,,,14.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,402,2025-12-02T15:56:54.560214
10518075,,,30,,,,20.2,,,,,,,4.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,403,2025-12-02T15:56:54.560214
10518075,,infusion rate in those reaching Css,24.4,ug/kg/h,,,10.1,,,,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,404,2025-12-02T15:56:54.560214
10518075,,,22.9,,,,6.4,,,,,,,13.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,405,2025-12-02T15:56:54.560214
10518075,,,24.5,,,,5.4,,,,,,,13.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,406,2025-12-02T15:56:54.560214
10518075,,,33.3,,,,23.1,,,,,,,3.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,407,2025-12-02T15:56:54.560214
10518075,,loading dose,0.05,mg/kg,,,,,,,bolus,intravenous,,48.0,preterm,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,408,2025-12-02T15:56:54.560214
10518075,,infusion dose,,mg/kg/h,,,,range,0.02,0.03,infusion,intravenous,,48.0,preterm,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,409,2025-12-02T15:56:54.560214
10518075,,duration of infusion,80.4,hours,mean,SD,34.8,range,56.5,245.6,infusion,intravenous,,44.0,preterm,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,410,2025-12-02T15:56:54.560214
10562792,Fentanyl,dose,2,g/kg,mean,,,,,,once,intravenous,,38.0,Maternal,Trimester 1 (T1),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,411,2025-12-02T15:56:54.560214
10562792,Propofol,dose,,mg/kg,,,,range,2.0,3.5,once,intravenous,,38.0,Maternal,Trimester 1 (T1),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,412,2025-12-02T15:56:54.560214
10562792,Isoflurane,dose,,percent (%),,,,range,0.5,2.0,once,intranasal,,38.0,Maternal,Trimester 1 (T1),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,413,2025-12-02T15:56:54.560214
10562792,Nitrous oxide,dose,70,percent (%),,,,,,,once,intranasal,,38.0,Maternal,Trimester 1 (T1),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,414,2025-12-02T15:56:54.560214
10597891,Morphine,concentration,50,ng/ml,,,,,,,,perfusion,,9.0,Maternal,Delivery,Full term,,placental,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,415,2025-12-02T15:56:54.560214
10597891,Naloxone,concentration,100,ng/ml,,,,,,,,perfusion,,5.0,Maternal,Delivery,Full term,,placental,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,416,2025-12-02T15:56:54.560214
10631963,Methadone,dose,39,mg,mean,SD,20.0,,,,once a day,oral,,12.0,Maternal,Trimester 3 (T3),,,0.41,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,417,2025-12-02T15:56:54.560214
10631963,,,47,,,,18.0,,,,,,,11.0,Adult,Nonpregnant,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,418,2025-12-02T15:56:54.560214
10631963,,,44,,,,21.0,,,,,,,14.0,Adult,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,419,2025-12-02T15:56:54.560214
10631963,,,23,,,,12.0,,,,,,,9.0,Adult,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,420,2025-12-02T15:56:54.560214
10793594,tramadol,dose,2,mg/kg,,,,,,,once,intravenous,over 30 min,9.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,421,2025-12-02T15:56:54.560214
10793594,,,2,mg/kg,,,,,,,once,caudal,,5.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,422,2025-12-02T15:56:54.560214
10839874,fentanyl,loading dose,10.5,ug/kg,,,,,,,,intravenous,1 hours,38.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,423,2025-12-02T15:56:54.560214
10839874,,infusion dose,1.5,ug/kg/h,,,,,,,continuous,intravenous,24 hours,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,424,2025-12-02T15:56:54.560214
10839874,,duration of infusion,58,hours,,,,IQR,45.0,78.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,425,2025-12-02T15:56:54.560214
10839874,,rescue analgesic dose,1.5,ug/kg,,,,,,,bolus,intravenous,q4h,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,426,2025-12-02T15:56:54.560214
10942481,morphine,does,0.16,mg/kg,mean,SD,0.02,range,0.12,0.19,,intramuscular,,10.0,maternal,pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,427,2025-12-02T15:56:54.560214
10962165,morphine,loading dose,,ug/kg,,,,range,50.0,100.0,bolus,intravenous,,14.0,preterm,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,428,2025-12-02T15:56:54.560214
10962165,,infusion dose,,ug/kg/h,,,,,5.0,15.0,infusion,,,12.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,429,2025-12-02T15:56:54.560214
10962165,,loading dose,100,ug/kg,mean,,,,,,bolus,intravenous,,8.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,430,2025-12-02T15:56:54.560214
10962165,,infusion dose,10,ug/kg/h,mean,,,,,,infusion,,,8.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,431,2025-12-02T15:56:54.560214
10976547,morphine,loading dose,140,ug/kg,,,,,,,,intravenous,1 hours,31.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,432,2025-12-02T15:56:54.560214
10976547,,infusion dose,20,ug/kg/h,,,,,,,continuous,intravenous,24 hours,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,433,2025-12-02T15:56:54.560214
10976547,,duration of infusion,73,hours,,,,IQR,54.0,93.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,434,2025-12-02T15:56:54.560214
10976547,,rescue analgesic dose,20,ug/kg,,,,,,,bolus,intravenous,q4h,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,435,2025-12-02T15:56:54.560214
11064622,fentanyl,loading dose,1.5,ug/kg,mean,,,,,,bolus,epidural,,6.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,436,2025-12-02T15:56:54.560214
11064622,,infusion dose,5,ug/kg/day,,,,,,,infusion,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,437,2025-12-02T15:56:54.560214
11064622,,PCA dose,0.2,ug/kg,,,,,,,bolus,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,438,2025-12-02T15:56:54.560214
11064622,sufentanil,loading dose,0.6,,,,,,,,bolus,epidural,,6.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,439,2025-12-02T15:56:54.560214
11064622,,infusion dose,2,,,,,,,,infusion,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,440,2025-12-02T15:56:54.560214
11064622,,PCA dose,0.08,,,,,,,,bolus,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,441,2025-12-02T15:56:54.560214
11064622,bupivacaine,infusion dose,5,mg/kg/day,,,,,,,infusion,epidural,,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,442,2025-12-02T15:56:54.560214
11064622,,PCA dose,0.2,mg/kg,,,,,,,bolus,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,443,2025-12-02T15:56:54.560214
11064622,,number of PCA doses,8,,median,,,range,1.0,27.0,bolus,epidural,,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,444,2025-12-02T15:56:54.560214
11098103,morphine,bolus doses (n),5.6,,mean,SD,3.9,,,,,IV,,27.0,infant,,,,bolus group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,445,2025-12-02T15:56:54.560214
11098103,,dosage,0.05,mg/kg,,,,,,,every 1-2 h,IV,,27.0,infant,,,,bolus group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,446,2025-12-02T15:56:54.560214
11098103,,total dose,0.26,mg/kg,mean,SD,0.2,,,,,IV,,27.0,infant,,,,bolus group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,447,2025-12-02T15:56:54.560214
11098103,,bolus doses (n),3.2,,mean,SD,3.9,,,,,IV,,56.0,infant,,,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,448,2025-12-02T15:56:54.560214
11098103,,loading dose,0.05,mg/kg,,,,,,,,IV,Infants in the infusion group received at least one bolus morphine dose (0.05 mg kg21 ) at the beginning of the infusion,56.0,infant,,,<=0.01,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,449,2025-12-02T15:56:54.560214
11098103,,total dose,1.01,mg/kg,mean,SD,0.6,,,,,IV,,56.0,infant,,,<=0.01,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,450,2025-12-02T15:56:54.560214
11098103,,infusion rate,20.6,ug/kg/h,mean,SD,8.7,,,,,CIV,,56.0,infant,,,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,451,2025-12-02T15:56:54.560214
11098103,,duration of infusion,39,h,mean,SD,14.4,,,,,CIV,,56.0,infant,,,,infusion group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,452,2025-12-02T15:56:54.560214
11098103,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,453,2025-12-02T15:56:54.560214
11121932,fentanyl,calculated delivery rate,1.72,ug/kg/h,median,,,IQR,1.57,2.0,,transdermal,,8.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,454,2025-12-02T15:56:54.560214
11121932,,duration of anesthesia,263.8,min,mean,SD,117.0,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,455,2025-12-02T15:56:54.560214
11121932,,minimum dose,25,ug/h,,,,,,,,transdermal,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,456,2025-12-02T15:56:54.560214
11121932,,maximum duration of patch,72,hours,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,457,2025-12-02T15:56:54.560214
11121932,alfentanil,rescue analgesia,ug/kg,,,,,range,10.0,30.0,,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,458,2025-12-02T15:56:54.560214
11121932,naloxone,respiratory depression treatment,5,ug/kg,,,,,,,,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,459,2025-12-02T15:56:54.560214
11153342,Methadone,dose,102,mg/day,mean,SD,42.0,range,25.0,180.0,twice a day,oral,,8.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,460,2025-12-02T15:56:54.560214
11726413,remifentanil,dose,5,ug/kg,,,,,,,bolus,intravenous,,42.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,461,2025-12-02T15:56:54.560214
11752093,Buprenorphine,concentration,,ng/ml,,,,range,0.0,30.0,,perfusion,,5.0,,Delivery,,,"BUP to the maternal perfusate (referred to as transfusate) was added  to achieve the final concentrations of 0.5, 2.5, 10, 15,/30 ng/ml.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,462,2025-12-02T15:56:54.560214
11772825,Morphine,cumulative dose,0.58,mg/kg,mean,SD,0.07,range,0.33,0.92,,intravenous,,7.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,463,2025-12-02T15:56:54.560214
11772825,Morphine,cumulative dose,0.17,mg/kg,,,0.06,,0.01,0.48,,intravenous,,7.0,Maternal,Postpartum (PP),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,464,2025-12-02T15:56:54.560214
12535033,Morphine,bolus dose,0.1,mg/kg,median,,,IQR,0.09,0.21,,intravenous,,10.0,infants,,,,cyanotic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,465,2025-12-02T15:56:54.560214
12535033,,,0.11,,,,,,0.05,0.18,,,,10.0,infants,,,,acyanotic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,466,2025-12-02T15:56:54.560214
12535033,,infusion dose,0.28,,,,,,0.21,0.32,,,,,,,,,cyanotic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,467,2025-12-02T15:56:54.560214
12535033,,,0.38,,,,,,0.25,0.42,,,,,,,,0.045,acyanotic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,468,2025-12-02T15:56:54.560214
12535033,fentanyl,anesthetic dose,,ug/kg,,,,,10.0,25.0,,inhalation,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,469,2025-12-02T15:56:54.560214
12587803,Hydromorphone,dose,2,mg,,,,,,,,intranasal,,8.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,470,2025-12-02T15:56:54.560214
12676878,L-α-Acetylmethadol,concentration,35,ng/ml,all,,,,,,,,,4.0,placentas,post-partum,post-partum,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,471,2025-12-02T15:56:54.560214
12676878,L-α-Acetyl-N-normethadol,concentration,35,ng/ml,all,,,,,,,,,4.0,placentas,post-partum,post-partum,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,472,2025-12-02T15:56:54.560214
12779111,Tramadol,dose,1.5,mg/kg,,,,,,,,oral,,24.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,473,2025-12-02T15:56:54.560214
12779111,,duration of anesthesia,27.9,min,mean,SD,10.1,range,10.0,55.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,474,2025-12-02T15:56:54.560214
12873948,Tramadol,dose,100,mg,,,,,,,,intramuscular,,90.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,475,2025-12-02T15:56:54.560214
12873948,Diclofenac,dose,75,mg,,,,,,,,intramuscular,,60.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,476,2025-12-02T15:56:54.560214
12873948,Ampicillin,dose,2,g,,,,,,,once,intravenous,prophylactic,120.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,477,2025-12-02T15:56:54.560214
12873948,prochlorperazine,,12.5,mg,,,,,,,once,intravenous,prophylactic,120.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,478,2025-12-02T15:56:54.560214
12873948,Cimetidine,dose,400,mg,,,,,,,once,oral,prophylactic,120.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,479,2025-12-02T15:56:54.560214
12873948,Bupivacaine 0.5% ,,,ml,,,,range,1.8,2.0,,intrathecal,,120.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,480,2025-12-02T15:56:54.560214
12873948,morphine,,10,mg,,,,,,,prn,intravenous,q4h,120.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,481,2025-12-02T15:56:54.560214
12897995,morphine,infusion rate,10,ug/kg/hour,median,,,range,10.0,10.2,,CIV,administrated up to 24 h after surgery,20.0,neonate,,,,Age ≤7 days,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,482,2025-12-02T15:56:54.560214
12897995,,,10.8,ug/kg/hour,median,,,range,10.2,11.9,,CIV,administrated up to 24 h after surgery,10.0,neonate,,,<0.001,Age >7 days,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,483,2025-12-02T15:56:54.560214
12897995,,,10,ug/kg/hour,median,,,range,10.0,10.4,,intermittent IV,administrated up to 24 h after surgery,27.0,neonate,,,,Age ≤7 days,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,484,2025-12-02T15:56:54.560214
12897995,,,10,ug/kg/hour,median,,,range,10.0,11.2,,intermittent IV,administrated up to 24 h after surgery,5.0,neonate,,,,Age >7 days,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,485,2025-12-02T15:56:54.560214
12897995,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,486,2025-12-02T15:56:54.560214
15001964,Morphine,daily dose,4.2,mg/kd/day,mean,SD,1.0,,,,,oral,,4.0,children,,,,"oral morphine, PK subgroup",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,487,2025-12-02T15:56:54.560214
15001964,,number of rescue doses per day,1.9,,,,1.3,,,,,oral,,4.0,,,,,"oral morphine, PK subgroup",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,488,2025-12-02T15:56:54.560214
15001964,,daily dose,0.76,mg/kd/day,,,0.21,,,,continuous,intravenous,,11.0,,,,,"CIV morphine, PK subgroup",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,489,2025-12-02T15:56:54.560214
15001964,,number of rescue doses per day,0.8,,,,0.5,,,,,intravenous,,11.0,,,,,"CIV morphine, PK subgroup",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,490,2025-12-02T15:56:54.560214
15001964,,daily dose,3,mg/kd/day,,,0.8,,,,,oral,,24.0,,,,,oral morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,491,2025-12-02T15:56:54.560214
15001964,,mean loading dose,0.13,mg/kg,,,0.3,,,,bolus,intravenous,,24.0,,,,,oral morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,492,2025-12-02T15:56:54.560214
15001964,,mean prestudy IV rescue doses,0.02,mg/kg/h,,,0.03,,,,,oral,,24.0,,,,0.21,oral morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,493,2025-12-02T15:56:54.560214
15001964,,number of days requiring analgesia,3.7,days,,,1.8,,,,,oral,,24.0,,,,0.13,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,494,2025-12-02T15:56:54.560214
15001964,,number of rescue doses,0.63,,,,1.06,,,,,oral,,24.0,,,,0.52,oral morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,495,2025-12-02T15:56:54.560214
15001964,,number of rescue doses per day,0.7,,,,0.8,,,,,oral,,24.0,,,,,oral morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,496,2025-12-02T15:56:54.560214
15001964,,Oral dose,≥1.9,mg/kg/12h,,,,,,,,oral,,24.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,497,2025-12-02T15:56:54.560214
15001964,,CIV dose,≥0.04,mg/kg/h,,,,,,,,intravenous,,26.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,498,2025-12-02T15:56:54.560214
15001964,,daily dose,0.81,mg/kd/day,,,0.3,,,,,intravenous,,26.0,,,,,CIV morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,499,2025-12-02T15:56:54.560214
15001964,,mean loading dose,0.12,mg/kg,,,0.4,,,,bolus,intravenous,,26.0,,,,,CIV morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,500,2025-12-02T15:56:54.560214
15001964,,mean prestudy IV rescue doses,0.04,mg/kg/h,,,0.04,,,,,intravenous,,26.0,,,,,CIV morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,501,2025-12-02T15:56:54.560214
15001964,,number of days requiring analgesia,4.6,days,,,2.7,,,,continuous,intravenous,,26.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,502,2025-12-02T15:56:54.560214
15001964,,number of rescue doses,1,,,,1.15,,,,,intravenous,,26.0,,,,,CIV morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,503,2025-12-02T15:56:54.560214
15001964,,number of rescue doses per day,0.9,,,,0.7,,,,,intravenous,,26.0,,,,,CIV morphine group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,504,2025-12-02T15:56:54.560214
15001964,,loading dose,0.15,mg/kg,,,,,,,bolus,intravenous,,50.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,505,2025-12-02T15:56:54.560214
15001964,,infusion dose,0.04,mg/kg/h,,,,,,,infusion,intravenous,,50.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,506,2025-12-02T15:56:54.560214
15001964,,rescue analgesia,0.4,mg/kg,,,,,,,,oral,q3h,50.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,507,2025-12-02T15:56:54.560214
15001964,,rescue analgesia,0.1,mg/kg,,,,,,,bolus,intravenous,q3h,50.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,508,2025-12-02T15:56:54.560214
15217304,Oxycodone,dose,0.1,mg/kg,,,,,,,,intravenous,,9.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,509,2025-12-02T15:56:54.560214
15217304,,dose,0.1,mg/kg,,,,,,,,intramuscular,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,510,2025-12-02T15:56:54.560214
15217304,,dose,0.1,mg/kg,,,,,,,,buccal,,11.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,511,2025-12-02T15:56:54.560214
15217304,,dose,0.1,mg/kg,,,,,,,,gastric,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,512,2025-12-02T15:56:54.560214
15217304,fentanyl,rescue analgesia,1,ug/kg,,,,,,,,fentanyl,,23.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,513,2025-12-02T15:56:54.560214
15217304,midazolam,preinduction dose,0.375,mg/kg,,,,,,,,buccal,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,514,2025-12-02T15:56:54.560214
15217304,ketamine,preinduction dose,1.25,mg/kg,,,,,,,,buccal,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,515,2025-12-02T15:56:54.560214
15217304,thiopental,dose,5,mg/kg,,,,,,,,intravenous,,17.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,516,2025-12-02T15:56:54.560214
15217304,acetaminophen,initial dose,40,mg/kg,,,,,,,,intravenous,q8h,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,517,2025-12-02T15:56:54.560214
15217304,,maintenance dose,20,mg/kg,,,,,,,,intravenous,q8h,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,518,2025-12-02T15:56:54.560214
15217304,ketoprofen,postop pain dose,1,mg/kg,,,,,,,,intravenous,q8h,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,519,2025-12-02T15:56:54.560214
15217304,Levobupivacaine,,,,,,,,,,,epidural,,21.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,520,2025-12-02T15:56:54.560214
15321955,methadone,dose at delivery,55,mg,median,,,range,15.0,105.0,once,oral,daily,25.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,521,2025-12-02T15:56:54.560214
15321955,,time between last dose/delivery,14,hours,,,,,1.0,33.0,,,,25.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,522,2025-12-02T15:56:54.560214
15321955,,dose in NAS treated group,48,mg,,,,,15.0,100.0,once,oral,daily,12.0,maternal,,,0.14,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,523,2025-12-02T15:56:54.560214
15321955,,dose in NAS untreated group,65,mg,,,,,20.0,105.0,once,oral,daily,13.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,524,2025-12-02T15:56:54.560214
15448532,Sufentanil,dose,10,ug,,,,,,,,intrathecal,,91.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,525,2025-12-02T15:56:54.560214
15502029,Fentanyl,dose,13.9,ug/kg,mean,SD,1.41,range,9.4,15.1,,oral,,10.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,526,2025-12-02T15:56:54.560214
15502029,,mean anesthetic time,184,min,mean,SD,87.0,range,100.0,454.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,527,2025-12-02T15:56:54.560214
15502029,Ondansetron, dose,0.1,mg/kg,,,,,,,,intravenous,,5.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,528,2025-12-02T15:56:54.560214
15588727,methadone,concentration,100,ng/ml,all,,,,,,,,,,placentas,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,529,2025-12-02T15:56:54.560214
15588727,,,200,ng/ml,all,,,,,,,,,,placentas,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,530,2025-12-02T15:56:54.560214
15588727,,,400,ng/ml,all,,,,,,,,,,placentas,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,531,2025-12-02T15:56:54.560214
15876424,methadone,concentration,200,ng/ml,all,,,,,,,,,12.0,placentas,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,532,2025-12-02T15:56:54.560214
15960639,Oxycodone,dose,0.1,mg/kg,,,,,,,bolus,intravenous,,22.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,533,2025-12-02T15:56:54.560214
15960639,,time to oxycodone from end of surgery,125,min,median,,,range,70.0,885.0,,,,10.0,neonates,,<1 week,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,534,2025-12-02T15:56:54.560214
15960639,,,90,,,,,,45.0,180.0,,,,6.0,infants,,0.25-2 months,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,535,2025-12-02T15:56:54.560214
15960639,,,42,,,,,,30.0,270.0,,,,6.0,infants,,2-6 months,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,536,2025-12-02T15:56:54.560214
15960639,morphine,dose,0.1,mg/kg,,,,,,,prn,intravenous,,22.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,537,2025-12-02T15:56:54.560214
16007420,tramadol,dose,141,mg,mean,SD,45.0,range,100.0,250.0,,,,22.0,pregnant,during delivery,,,"Of these patients, 9 received only a single dose (100 mg), 10 required a second dose of 50 mg (given between 20 min/110 min after the first dose)/1 received a second dose of 100 mg (225 min after the first dose). The remaining 2 patients obtained three doses (250 mg in total, 310–340 min between first/last dose). The first injection was given 243±130 min (range: 104–532 min), the last dose 172±71 min (range: 87–360 min) before birth.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,538,2025-12-02T15:56:54.560214
16021436,Fentanyl,dose,0.05,mg/ml,,,,,,,,epidural,,10.0,Maternal,Labor,,,2 ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,539,2025-12-02T15:56:54.560214
16021436,Lidocaine 2%,dose,5,ml,,,,,,,,,,,,,,,for skin/subcutaneous blockade,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,540,2025-12-02T15:56:54.560214
16021436,Bupivacaine 0.5%,dose,15,ml,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,541,2025-12-02T15:56:54.560214
16021436,Epinephrine,dose,1:200000,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,542,2025-12-02T15:56:54.560214
16021436,Lidocaine 2%,dose,10,ml,,,,,,,,,,,,,,,peridural space,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,543,2025-12-02T15:56:54.560214
16130057,fentanyl,dose,30,ug/kg,,,,,,,bolus,intravenous,,15.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,544,2025-12-02T15:56:54.560214
16130057,,maintenance dose,0.3,ug/kg/min,,,,,,,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,545,2025-12-02T15:56:54.560214
16130057,,dose for inadequate analgesia,5,ug/kg,,,,,,,bolus,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,546,2025-12-02T15:56:54.560214
16130057,,increased infusion rate for inadequate analgesia,25,%,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,547,2025-12-02T15:56:54.560214
16261362,methadone,dose,40,mg,median,,,,,,,,,4.0,pregnant,1st trimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,548,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.72,mg/kg,median,,,,,,,,,4.0,pregnant,1st trimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,549,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.83,mg/kg,median,,,,,,,,,4.0,pregnant,1st trimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,550,2025-12-02T15:56:54.560214
16261362,methadone,dose,35,mg,median,,,,,,,,,4.0,pregnant,2nd trimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,551,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.4,mg/kg,median,,,,,,,,,4.0,pregnant,2nd trimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,552,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.62,mg/kg,median,,,,,,,,,4.0,pregnant,2nd trimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,553,2025-12-02T15:56:54.560214
16261362,methadone,dose,25,mg,median,,,,,,,,,8.0,pregnant,3rd rimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,554,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.28,mg/kg,median,,,,,,,,,8.0,pregnant,3rd rimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,555,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.44,mg/kg,median,,,,,,,,,8.0,pregnant,3rd rimmester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,556,2025-12-02T15:56:54.560214
16261362,methadone,dose,25,mg,median,,,,,,,,,3.0,post-partum,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,557,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.16,mg/kg,median,,,,,,,,,3.0,post-partum,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,558,2025-12-02T15:56:54.560214
16261362,methadone,dose/kg,0.45,mg/kg,median,,,,,,,,,3.0,post-partum,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,559,2025-12-02T15:56:54.560214
16261362,methadone,dose,39.7,mg,mean,,,,,,,oral,,4.0,Maternal,Trimester 1,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,560,2025-12-02T15:56:54.560214
16261362,methadone,dose,28.1,mg,mean,,,,,,,,,4.0,Maternal,Trimester 2,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,561,2025-12-02T15:56:54.560214
16261362,methadone,dose,22.9,mg,mean,,,,,,,,,8.0,Maternal,Trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,562,2025-12-02T15:56:54.560214
16261362,methadone,dose,17.3,mg,mean,,,,,,,,,3.0,Maternal,Postnatal,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,563,2025-12-02T15:56:54.560214
16261362,methadone,weight-adjusted dose,0.72,mg/kg,mean,,,,,,,oral,,4.0,Maternal,Trimester 1,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,564,2025-12-02T15:56:54.560214
16261362,methadone,weight-adjusted dose,0.4,mg/kg,mean,,,,,,,,,4.0,Maternal,Trimester 2,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,565,2025-12-02T15:56:54.560214
16261362,methadone,weight-adjusted dose,0.28,mg/kg,mean,,,,,,,,,8.0,Maternal,Trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,566,2025-12-02T15:56:54.560214
16261362,methadone,weight-adjusted dose,0.16,mg/kg,mean,,,,,,,,,3.0,Maternal,Postnatal,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,567,2025-12-02T15:56:54.560214
16283273,Tramadol,loading dose,2,mg/kg,,,,,,,infusion,intravenous,over 30 mins,29.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,568,2025-12-02T15:56:54.560214
16283273,,infusion dose,5,mg/kg/24h,,,,,,,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,569,2025-12-02T15:56:54.560214
16394684,Remifentanil,dose,1,ug/kg,,,,,,,bolus,intravenous,over 30s,20.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,570,2025-12-02T15:56:54.560214
16394684,Ranitidine,,150,mg,,,,,,,twice,oral,,40.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,571,2025-12-02T15:56:54.560214
16394684,Famotidine,,20,mg,,,,,,,twice,oral,,40.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,572,2025-12-02T15:56:54.560214
16394684,Thiopental,,4,mg/kg,,,,,,,,intravenous,,40.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,573,2025-12-02T15:56:54.560214
16394684,succinylcholine,,1.5,mg/kg,,,,,,,,intravenous,,40.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,574,2025-12-02T15:56:54.560214
16394684,Isoflurance,concentration,0.5,%,,,,,,,,nasal,,40.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,575,2025-12-02T15:56:54.560214
16394684,Morphine,dose,0.15,mg/kg,,,,,,,,intravenous,,40.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,576,2025-12-02T15:56:54.560214
16394684,Morphine,dose,1,mg,,,,max,,20.0,bolus,intravenous,,40.0,Maternal,Postpartum,,,"bolus 1 mg, lockout 5 min, 4-h limit 20 mg,/no background infusion",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,577,2025-12-02T15:56:54.560214
16394684,Morphine,total consumption,30.5,mg,mean,SD,19.5,,,,,intravenous,,,,,,0.64,Remifentanil group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,578,2025-12-02T15:56:54.560214
16394684,Morphine,total consumption,27.9,mg,mean,SD,16.3,,,,,intravenous,,,,,,,Control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,579,2025-12-02T15:56:54.560214
16433900,Tramadol,loading dose,2,mg/kg,,,,,,,infusion,intravenous,over 30 mins,25.0,neonates,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,580,2025-12-02T15:56:54.560214
16433900,,infusion dose,5,mg/kg/24h,,,,,,,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,581,2025-12-02T15:56:54.560214
16496200,Piritramide,dose,50,ug/kg,median,,,range,50.0,200.0,bolus,intravenous,,39.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,582,2025-12-02T15:56:54.560214
16496200,,,0.16,mg,median,SD,0.01,,,,bolus,intravenous,,8.0,newborn,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,583,2025-12-02T15:56:54.560214
16496200,,,0.3,,,,0.13,,,,bolus,intravenous,,7.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,584,2025-12-02T15:56:54.560214
16496200,,,0.54,,,,0.25,,,,bolus,intravenous,,14.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,585,2025-12-02T15:56:54.560214
16496200,,,0.96,,,,0.51,,,,bolus,intravenous,,10.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,586,2025-12-02T15:56:54.560214
16799915,Methadone,concentration,,uM,,,,range,50.0,1500.0,,,,36.0,Maternal,,17-40 wks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,587,2025-12-02T15:56:54.560214
16802855,Oxycodone,dose,0.2,mg/kg,,,,,,,single,buccal,,15.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,588,2025-12-02T15:56:54.560214
16802855,,,0.2,mg/kg,,,,,,,single,sublingual,,15.0,pediatric,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,589,2025-12-02T15:56:54.560214
16949720,diamorphine,dose,7.5,mg,all,,,,,,,,,100.0,pregnant,during delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,590,2025-12-02T15:56:54.560214
17478871,Methadone,dose,75.8,mg,mean,SD,22.1,range,40.0,110.0,,oral,q.d,12.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,591,2025-12-02T15:56:54.560214
17550483,oxycodone,dose,60,mg,mode,,,range,30.0,90.0,,,,50.0,pregnant,postpartum,,,0-24h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,592,2025-12-02T15:56:54.560214
17550483,,,40,mg,mode,,,range,0.0,90.0,,,,50.0,pregnant,postpartum,,,24-48h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,593,2025-12-02T15:56:54.560214
17550483,,,20,mg,mode,,,range,0.0,50.0,,,,50.0,pregnant,postpartum,,,48-72h,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,594,2025-12-02T15:56:54.560214
17564645,fentanyl,induction dose,1,ug/kg,,,,,,,,intravenous,bolus,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,595,2025-12-02T15:56:54.560214
17564645,fentanyl,infusion dose,,ug/kg,,,,range,1.0,3.0,,intravenous,infusion,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,596,2025-12-02T15:56:54.560214
17564645,sevoflurane,dose,,%,,,,range,5.0,7.0,,inhalation,induction,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,597,2025-12-02T15:56:54.560214
17564645,sevoflurane,dose,2.5,%,,,,,,,,inhalation,continuous infusion,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,598,2025-12-02T15:56:54.560214
17564645,midazolam,dose,0.3,mg/kg,,,,,,,,oral/rectal,single dose at induction of anesthesia,24.0,children,,,,premedication,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,599,2025-12-02T15:56:54.560214
17564645,rocuronium,dose,0.6,mg/kg,,,,,,,,intravenous,induction,24.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,600,2025-12-02T15:56:54.560214
17564645,rocuronium,infusion dose,8.74,ug/kg/min,mean,SD,2.49,,,,,intravenous,infusion,12.0,children,,,<0.00019,sevoflurance group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,601,2025-12-02T15:56:54.560214
17564645,rocuronium,infusion dose,16.68,ug/kg/min,mean,SD,5.62,,,,,intravenous,infusion,12.0,children,,,,fentanyl group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,602,2025-12-02T15:56:54.560214
17564645,rocuronium,duration of administration,84,min,mean,SD,41.0,range,52.0,177.0,,intravenous,,12.0,children,,,0.74,sevoflurance group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,603,2025-12-02T15:56:54.560214
17564645,rocuronium,duration of administration,79,min,mean,SD,31.0,range,49.0,144.0,,intravenous,,12.0,children,,,,fentanyl group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,604,2025-12-02T15:56:54.560214
17913403,Tramadol,loading dose,2,mg/kg,,,,,,,,infusion,over 30 min,59.0,neonates,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,605,2025-12-02T15:56:54.560214
17913403,,infusion dose,,mg/kg/24h,,,,range,5.0,8.0,,infusion,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,606,2025-12-02T15:56:54.560214
17921260,Buprenorphine,maintenance duration,21.1,weeks,mean,SD,4.8,range,14.0,30.0,,sublingual,,9.0,Maternal,Pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,607,2025-12-02T15:56:54.560214
17921260,,initial dose,8.2,mg/day,,,2.1,,4.0,12.0,,sublingual,,9.0,Maternal,Pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,608,2025-12-02T15:56:54.560214
17921260,,dose at delivery,18.7,mg/day,,,3.5,,14.0,24.0,,sublingual,,9.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,609,2025-12-02T15:56:54.560214
17934758,Piritramide,dose,66.7,ug/kg,mean,SD,27.0,,,,bolus,intravenous,,19.0,children,,,,ventilated patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,610,2025-12-02T15:56:54.560214
17934758,,,61.9,,,,21.8,,,,bolus,intravenous,,20.0,,,,,spontaneously breathing patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,611,2025-12-02T15:56:54.560214
17934758,,initial dose,50,ug/kg,,,,,,,bolus,intravenous,,39.0,,,,,all patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,612,2025-12-02T15:56:54.560214
17934758,,follow-up dose at 15 min intervals,15,ug/kg,,,,,,,prn,intravenous,,39.0,,,,,all patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,613,2025-12-02T15:56:54.560214
17934758,,additional boluses,5,count,,,,,,,,,,3.0,,,,,ventilated patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,614,2025-12-02T15:56:54.560214
17934758,,,1,,,,,,,,,,,1.0,,,,,spontaneously breathing patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,615,2025-12-02T15:56:54.560214
17934758,,time of additional analgesia after piritramide bolus,122,min,,,141.0,,,,,,,19.0,,,,,ventilated patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,616,2025-12-02T15:56:54.560214
17934758,,,159,,,,194.0,,,,,,,20.0,,,,,spontaneously breathing patients,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,617,2025-12-02T15:56:54.560214
18032310,morphine,dose,,mg,,,,range,10.0,30.0,,oral,,42.0,pediatric/adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,618,2025-12-02T15:56:54.560214
18032310,,dose equivalent concentration,50,ng/ml,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,619,2025-12-02T15:56:54.560214
18043481,Ketoprofen,dose,100,mg,,,,,,,bolus,intravenous,q12h,18.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,620,2025-12-02T15:56:54.560214
18043481,,average dose,2.69,mg/kg/day,mean,SD,0.45,,,,bolus,intravenous,q12h,18.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,621,2025-12-02T15:56:54.560214
18043481,Nalbuphine,dose,0.2,mg,,,,,,,bolus,intravenous,q4h,18.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,622,2025-12-02T15:56:54.560214
18043481,,average dose,25.5,mg/kg/day,mean,SD,34.5,,,,bolus,intravenous,q4h,18.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,623,2025-12-02T15:56:54.560214
18166326,Methadone,dose,200,ng/ml,,,,,,,,perfusion,,16.0,fetal,delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,624,2025-12-02T15:56:54.560214
18166563,Methadone,dose,70,mg,median,,,range,50.0,105.0,once a day,oral,,16.0,Maternal,Postpartum (PP),,,"evaluated on days 1, 14, 30; women continued to be medicated at 10:00 to
11:00 AM throughout the study period",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,625,2025-12-02T15:56:54.560214
18294329,Tramadol,dose,100,mg,mean,,,range,50.0,100.0,q.6h,oral,,75.0,Maternal,Postpartum (PP),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,626,2025-12-02T15:56:54.560214
18294329,Tramadol,dose,50,mg,mean,,,,,,,oral,,8.0,Maternal,Postpartum (PP),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,627,2025-12-02T15:56:54.560214
18294329,Tramadol,number of doses,4,count,median,,,range,3.0,9.0,,oral,,75.0,Maternal,Postpartum (PP),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,628,2025-12-02T15:56:54.560214
18294329,Tramadol,dose interval,6.2,hours (h),mean,,,95% CI,5.9,6.4,,oral,,75.0,Maternal,Postpartum (PP),,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,629,2025-12-02T15:56:54.560214
18317231,tramadol,loading dose,2,mg/kg,,,,,,,single dose,IV,as 30 min infusion,86.0,Neonate/Infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,630,2025-12-02T15:56:54.560214
18317231,,continuous infusion,5-8,mg/kg/24h,,,,,,,,CIV,,86.0,Neonate/Infant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,631,2025-12-02T15:56:54.560214
18317231,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,632,2025-12-02T15:56:54.560214
18381513,Morphine,loading dose,,ug/kg,,,,range,50.0,150.0,bolus,intravenous,once,16.0,neonates,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,633,2025-12-02T15:56:54.560214
18381513,,infusion dose,,ug/kg/h,,,,,5.0,30.0,infusion,intravenous,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,634,2025-12-02T15:56:54.560214
18381513,,cumulative dose,0.58,mg/kg/h,median,,,range,0.31,1.87,,,,10.0,,,,0.083,hypothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,635,2025-12-02T15:56:54.560214
18381513,,,0.6,,,,,,0.4,1.08,,,,6.0,,,,,normothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,636,2025-12-02T15:56:54.560214
18381513,,overall infusion rate,10,ug/kg/h,median,,,,4.0,30.0,,,,10.0,,,,0.56,hypothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,637,2025-12-02T15:56:54.560214
18381513,,,10,,,,,,5.0,20.0,,,,6.0,,,,,normothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,638,2025-12-02T15:56:54.560214
18381513,,infusion rate at 12 h,6.85,,,,,,0.0,30.0,,,,10.0,,,,,hypothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,639,2025-12-02T15:56:54.560214
18381513,,infusion rate at 24 h,7.29,,,,,,3.0,20.0,,,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,640,2025-12-02T15:56:54.560214
18381513,,infusion rate at 48 h,9.42,,,,,,3.0,20.0,,,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,641,2025-12-02T15:56:54.560214
18381513,,infusion rate at 72 h,10,,,,,,5.0,30.0,,,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,642,2025-12-02T15:56:54.560214
18381513,,infusion rate at 12 h,8.33,,,,,,1.0,15.0,,,,6.0,,,,,normothermic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,643,2025-12-02T15:56:54.560214
18381513,,infusion rate at 24 h,8.33,,,,,,1.0,15.0,,,,6.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,644,2025-12-02T15:56:54.560214
18381513,,infusion rate at 48 h,10,,,,,,5.5,20.0,,,,6.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,645,2025-12-02T15:56:54.560214
18381513,,infusion rate at 72 h,6.25,,,,,,4.0,10.0,,,,6.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,646,2025-12-02T15:56:54.560214
18381513,Phenobarbital,initiation dose,20,ug/kg,,,,,,,,intravenous,once,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,647,2025-12-02T15:56:54.560214
18381513,,maintenance dose,,mg/kg/day,,,,,5.0,10.0,prn,intravenous,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,648,2025-12-02T15:56:54.560214
18381513,Midazolam,dose,,mg/kg,,,,,0.1,0.2,,intravenous,once,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,649,2025-12-02T15:56:54.560214
18381513,dobutamine,dose,,ug/kg/min,,,,,5.0,20.0,prn,intravenous,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,650,2025-12-02T15:56:54.560214
18381513,dopamine,dose,,ug/kg/min,,,,,2.0,10.0,prn,intravenous,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,651,2025-12-02T15:56:54.560214
18381513,norepinephrine,dose,,ug/kg/min,,,,,0.1,0.3,prn,intravenous,,16.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,652,2025-12-02T15:56:54.560214
18454213,Fentanyl,dose,50,ug,,,,,,,,intravenous,,50.0,maternal,postpartum,,,Group 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,653,2025-12-02T15:56:54.560214
18454213,,dose,,,,,,range,100.0,150.0,,epidural,,50.0,maternal,postpartum,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,654,2025-12-02T15:56:54.560214
18454213,,infusion dose,2,ug/10 ml/h,,,,,,,infusion,epidural,,50.0,maternal,postpartum,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,655,2025-12-02T15:56:54.560214
18454213,Bupivacaine 0.5%,dose,,ml,,,,,3.0,4.0,,,,50.0,maternal,postpartum,,,Group 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,656,2025-12-02T15:56:54.560214
18454213,,initiation dose,20,ml,,,,,,,,epidural,,50.0,maternal,postpartum,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,657,2025-12-02T15:56:54.560214
18454213,Bupivacaine 0.25%,infusion dose,10,ml/h,,,,,,,infusion,epidural,,50.0,maternal,postpartum,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,658,2025-12-02T15:56:54.560214
18474065,Morphine,Initial dose,0.34,mg/kg/day,,,,,,,,oral,,38.0,infants,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,659,2025-12-02T15:56:54.560214
18474065,,dose at delivery,0.4,mg/ml,,,,,,,,oral,,58.0,infants,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,660,2025-12-02T15:56:54.560214
18474065,,dose on day 0,0.38,mg/kg/day,mean,SD,0.1,,,,,oral,,25.0,infants,postpartum,,0.042,among infants of smoking maternal,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,661,2025-12-02T15:56:54.560214
18474065,,dose on day 1,0.38,,,,0.1,,,,,oral,,25.0,infants,postpartum,,0.038,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,662,2025-12-02T15:56:54.560214
18474065,,dose on day 2,0.38,,,,0.1,,,,,oral,,25.0,infants,postpartum,,0.008,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,663,2025-12-02T15:56:54.560214
18474065,,dose on day 0,0.3,,,,0.1,,,,,oral,,33.0,infants,postpartum,,,among infants of non-smoking maternal,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,664,2025-12-02T15:56:54.560214
18474065,,dose on day 1,0.31,,,,0.1,,,,,oral,,33.0,infants,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,665,2025-12-02T15:56:54.560214
18474065,,dose on day 2,0.29,,,,0.1,,,,,oral,,33.0,infants,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,666,2025-12-02T15:56:54.560214
18474065,Buprenorphine,dose at delivery,5,mg,median,SD,4.0,,,,,oral,,21.0,maternal,delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,667,2025-12-02T15:56:54.560214
18701886,Buprenorphine,dose at delivery,18.7,mg/day,mean,SD,1.2,range,14.0,24.0,,oral,,9.0,maternal,Trimester 3/Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,668,2025-12-02T15:56:54.560214
18701886,,mean daily dose,15,mg/day,,,0.8,,11.0,18.3,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,669,2025-12-02T15:56:54.560214
18701886,,Average T3 daily dose,16.1,mg/day,,,1.2,,10.4,21.8,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,670,2025-12-02T15:56:54.560214
18701886,,Cumulative dose,1701.6,mg,,,107.2,,1330.0,2196.0,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,671,2025-12-02T15:56:54.560214
18701886,,Cumulative T3 dose,1205.6,mg,,,55.5,,888.0,1396.0,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,672,2025-12-02T15:56:54.560214
18806024,Remifentanil,dose,4,ug/kg,mean,,,,,,,intranasal,,95.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,673,2025-12-02T15:56:54.560214
18806024,Sevoflurance ,dose,8,%,,,,,,,,inhalation,,188.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,674,2025-12-02T15:56:54.560214
19136395,Buprenorphine,dose profile,0.32,mg/kg/day,median,,,,,,,,,7.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,675,2025-12-02T15:56:54.560214
19136395,,dose,0.29,mg/kg/day,,,,,,,,,,6.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,676,2025-12-02T15:56:54.560214
19136395,,gestational age at initiation,6,weeks,,,,,,,,,,7.0,,pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,677,2025-12-02T15:56:54.560214
19260034,Morphine,dose,,mg/kg/h,,,,range,0.15,0.28,,intravenous,,4.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,678,2025-12-02T15:56:54.560214
19260034,,dose,,mg,,,,,2.0,10.0,once,oral,,3.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,679,2025-12-02T15:56:54.560214
19260034,,standard dose,0.25,mg/kg/h,,,,,,,,intravenous,,4.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,680,2025-12-02T15:56:54.560214
19260034,,standard dose,0.174,mg/kg,,,,,,,,oral,,3.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,681,2025-12-02T15:56:54.560214
19286842,Fentanyl,dose,100,ug/h,,,,,,,,transdermal,q.o.d,1.0,Maternal,,Pregnancy,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,682,2025-12-02T15:56:54.560214
19286842,Fentanyl,dose,35,ug ,,,,,,,every 6 mins,intravenous,x12 hr,1.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,683,2025-12-02T15:56:54.560214
19286842,Fentanyl,dose,50,ug ,,,,,,,,intravenous,4x,1.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,684,2025-12-02T15:56:54.560214
19286842,Propofol,dose,200,mg,,,,,,,once,intravenous,,1.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,685,2025-12-02T15:56:54.560214
19286842,Midazolam,dose,2,mg,,,,,,,once,intravenous,,1.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,686,2025-12-02T15:56:54.560214
19286842,Fentanyl,dose,100,ug ,,,,,,,,intravenous,5x,1.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,687,2025-12-02T15:56:54.560214
19286842,Sevoflurane,,,,,,,,,,,inhaled,,1.0,Maternal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,688,2025-12-02T15:56:54.560214
19286842,Fentanyl,dose,125,ug/h,,,,,,,,transdermal,q.o.d,1.0,Maternal,Postpartum (PP),1-2 wks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,689,2025-12-02T15:56:54.560214
19286842,Hydrocodone,dose,10,mg,,,,,,,,p.o,q.4h,1.0,Maternal,Postpartum (PP),1-2 wks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,690,2025-12-02T15:56:54.560214
19286842,Acetaminophen,dose,1000,mg,,,,,,,,p.o,q.4h,1.0,Maternal,Postpartum (PP),1-2 wks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,691,2025-12-02T15:56:54.560214
19286842,Fentanyl,dose,100,ug/h,,,,,,,,transdermal,q.o.d,1.0,Maternal,Postpartum (PP),>2 wks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,692,2025-12-02T15:56:54.560214
19286842,Morphine,dose,0.08,mg,,,,,,,,p.o,q.4h,1.0,Neonate,Postpartum (PP),day 1,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,693,2025-12-02T15:56:54.560214
19286842,Morphine,dose,0.16,mg,,,,,,,,p.o,q.4h,1.0,Neonate,Postpartum (PP),day 2,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,694,2025-12-02T15:56:54.560214
19286842,Morphine,dose,0.16,mg,,,,,,,,p.o,q.3h,1.0,Neonate,Postpartum (PP),day 3,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,695,2025-12-02T15:56:54.560214
19286842,Morphine,dose,0.2,mg,,,,,,,,p.o,q.3h,1.0,Neonate,Postpartum (PP),day 4-29,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,696,2025-12-02T15:56:54.560214
19325013,Buprenorphine,overall dose during pregnancy,15.4,mg/day,mean,SD,5.5,,,,,sublingual,,9.0,maternal,pregnancy,,<0.05,2nd trimester < 3rd <postpartum,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,697,2025-12-02T15:56:54.560214
19325013,,T2 dose,12.8,,,,4.8,,,,,sublingual,,9.0,maternal,trimester 2,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,698,2025-12-02T15:56:54.560214
19325013,,T3 dose,15.8,,,,5.5,,,,,sublingual,,9.0,maternal,trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,699,2025-12-02T15:56:54.560214
19325013,,Postpartum dose,17.4,,,,5.1,,,,,sublingual,,9.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,700,2025-12-02T15:56:54.560214
19330322,Fentanyl,dose,0.05,mg/ml,mean,,,,,,once,epidural,,10.0,Maternal,Labor,,,2 ml dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,701,2025-12-02T15:56:54.560214
19330322,Bupivacaine,dose,0.5,%,mean,,,,,,once,epidural,,10.0,Maternal,Labor,,,15 ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,702,2025-12-02T15:56:54.560214
19330322,Epinephrine,dose,1:200000,,mean,,,,,,once,epidural,,10.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,703,2025-12-02T15:56:54.560214
19330322,Lidocaine,dose,2,%,mean,,,,,,once,epidural,,10.0,Maternal,Labor,,,10 ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,704,2025-12-02T15:56:54.560214
19519880,methadone,concentration,500,ng/ml,all,,,,,,,,,6.0,placentas,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,705,2025-12-02T15:56:54.560214
19519880,methadone plus cocaine,concentration,3,mg/l,all,,,,,,,,,6.0,placentas,,,,the methadone conc is 500 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,706,2025-12-02T15:56:54.560214
19519880,methadone plus heroin,concentration,150,ng/ml,all,,,,,,,,,6.0,placentas,,,,the methadone conc is 500 ng/ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,707,2025-12-02T15:56:54.560214
19544152,Buprenorphine,perfusion dose,10,ng/ml,,,,,,,,perfusion,,25.0,maternal,delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,708,2025-12-02T15:56:54.560214
19761699,midazolam,,,mg/kg,,,,,0.04,0.1,,intravenous,,8.0,children/adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,709,2025-12-02T15:56:54.560214
19761699,fentanyl,,,ug/kg,,,,,20.0,30.0,,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,710,2025-12-02T15:56:54.560214
19761699,propofol,,,mg/kg,,,,range,1.0,2.0,,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,711,2025-12-02T15:56:54.560214
19761699,vecuronium,,0.1,mg/kg,,,,,,,,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,712,2025-12-02T15:56:54.560214
19793724,Diamorphine,dose,3,mg,median,,,range,1.8,5.8,,intranasal,,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,713,2025-12-02T15:56:54.560214
19793724,,dose,3.3,mg,,,,,1.6,4.2,,intravenous,,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,714,2025-12-02T15:56:54.560214
19839946,ketobemidone,dose,0.05,mg/kg,,,,,,,bolus,intravenous,,5.0,0-90 days,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,715,2025-12-02T15:56:54.560214
19839946,,,0.1,mg/kg,,,,,,,,,,10.0,1-2.5 years,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,716,2025-12-02T15:56:54.560214
19839946,,,0.1,mg/kg,,,,,,,,,,9.0,7-10 years,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,717,2025-12-02T15:56:54.560214
19839946,sodium thiopental,dose,6,mg/kg,mean,,,range,4.0,9.0,,intravenous,,19.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,718,2025-12-02T15:56:54.560214
19839946,propfol,dose,6,mg/kg,,,,,,,,intravenous,,1.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,719,2025-12-02T15:56:54.560214
19996953,fentanyl,dose,50,ug,all,,,,,,,combined spinal epidural method,,52.0,pregnant,post-partum,post-partum,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,720,2025-12-02T15:56:54.560214
20216119,buprenorphine,dose at delivery,18.4,mg/day,mean,SD,1.6,,,,,oral,,5.0,maternal,labor/delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,721,2025-12-02T15:56:54.560214
20216119,,mean daily dose,15.2,,,,1.0,,,,,,,,,,,0.029,A statistically significant positive correlation was observed between maternal mean daily BUP dose throughout gestation/placenta BUP-Gluc concentration,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,722,2025-12-02T15:56:54.560214
20216119,,mean T3 daily dose,16.6,,,,1.5,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,723,2025-12-02T15:56:54.560214
20216119,,mean last month dail dose,18.4,,,,1.6,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,724,2025-12-02T15:56:54.560214
20216119,,cumulative dose,1712.8,mg,,,146.5,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,725,2025-12-02T15:56:54.560214
20216119,,cumulative T3 dose,1220.8,,,,60.3,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,726,2025-12-02T15:56:54.560214
20216119,,cumulative last month dose,560.4,,,,55.3,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,727,2025-12-02T15:56:54.560214
20592651,methadone,dose,66.1,mg,mean,SD,17.0,range,10.0,100.0,,,,29.0,pregnant,between 9–29 weeks EGA,,,Mean daily methadone dose,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,728,2025-12-02T15:56:54.560214
20592651,,,70,mg,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,729,2025-12-02T15:56:54.560214
20592651,,,457.5,mg,mean,SD,216.5,range,60.0,2150.0,,,,29.0,pregnant,between 9–29 weeks EGA,,,mean dose administered during the patch wear period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,730,2025-12-02T15:56:54.560214
20592651,,,455,mg,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,731,2025-12-02T15:56:54.560214
20607647,Buprenorphine,dose,10,ng/ml,median,,,,,,once,perfusion,,39.0,Maternal,Pregnancy,17-42 weeks,,8 mg dose equivalent,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,732,2025-12-02T15:56:54.560214
20854338,Methadone,weeks in treatment,18,weeks,mean,SD,8.5,,,,,oral,,18.0,maternal,pregnancy,,0.009,opioid positive meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,733,2025-12-02T15:56:54.560214
20854338,,weeks in treatment,24.1,,,,7.1,,,,,,,31.0,,,,,opioid negative meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,734,2025-12-02T15:56:54.560214
20854338,,dose at delivery,76.1,mg/day,,,17.5,,30.0,110.0,,,,18.0,,,,0.879,opioid positive meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,735,2025-12-02T15:56:54.560214
20854338,,dose at delivery,76.9,,,,18.5,,30.0,110.0,,,,31.0,,,,,opioid negative meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,736,2025-12-02T15:56:54.560214
20854338,,cumulative dose during enrollment,7734,mg,,,4472.0,,,,,,,18.0,,,,0.005,opioid positive meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,737,2025-12-02T15:56:54.560214
20854338,,cumulative dose during enrollment,12009,,,,5086.0,,,,,,,31.0,,,,,opioid negative meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,738,2025-12-02T15:56:54.560214
20854338,,cumulative dose T3,5049,mg,,,1603.0,,,,,,,18.0,,,,0.008,opioid positive meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,739,2025-12-02T15:56:54.560214
20854338,,cumulative dose T3,6464,,,,1670.0,,,,,,,31.0,,,,,opioid negative meconium,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,740,2025-12-02T15:56:54.560214
20854338,,Length of MMT,21.8,weeks,mean,SD,8.2,range,7.6,38.9,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,741,2025-12-02T15:56:54.560214
20854338,,cumulative dose during enrollment,10188,mg,median,,,IQR,6554.0,13178.0,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,742,2025-12-02T15:56:54.560214
20854338,,cumulative dose T3,6163,mg,median,,,IQR,4790.0,7224.0,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,743,2025-12-02T15:56:54.560214
20854338,,Pre-conception initiation,8.3,%,,,,,,,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,744,2025-12-02T15:56:54.560214
20854338,,T1 initiation,25,%,,,,,,,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,745,2025-12-02T15:56:54.560214
20854338,,T2 initiation,54.2,%,,,,,,,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,746,2025-12-02T15:56:54.560214
20854338,,T3 initiation,12.5,%,,,,,,,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,747,2025-12-02T15:56:54.560214
20854338,,Dose <50 mg/day,6.1,%,,,,,,,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,748,2025-12-02T15:56:54.560214
20854338,,Dose ≥100 mg/day,12.2,%,,,,,,,,,,49.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,749,2025-12-02T15:56:54.560214
21175445,Methadone,dose,35,mg/day,median,,,range,25.0,140.0,,,,15.0,maternal,trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,750,2025-12-02T15:56:54.560214
21175445,,time from stable dose to delivery,5.5,weeks,,,,,1.0,31.0,,,,15.0,,trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,751,2025-12-02T15:56:54.560214
21175445,,dose-delivery interval,6.25,h,,,,,1.0,23.0,,,,15.0,,labor/delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,752,2025-12-02T15:56:54.560214
21175445,Buprenorphine,dose,6,mg/day,,,,,2.0,20.0,,,,18.0,,trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,753,2025-12-02T15:56:54.560214
21175445,,time from stable dose to delivery,9.5,weeks,,,,,1.0,37.0,,,,18.0,,trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,754,2025-12-02T15:56:54.560214
21175445,,dose-delivery interval,10.25,h,,,,,0.25,34.0,,,,18.0,,labor/delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,755,2025-12-02T15:56:54.560214
21245372,methadone,initial dose,42.6,mg,mean,SD,15.9,,,,,oral,,19.0,maternal,Pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,756,2025-12-02T15:56:54.560214
21245372,,Dose at delivery,75.3,mg,,,19.0,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,757,2025-12-02T15:56:54.560214
21245372,,mean daily dose,68,mg/day,,,16.6,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,758,2025-12-02T15:56:54.560214
21245372,,Mean T3 daily dose,71.9,mg/day,,,19.0,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,759,2025-12-02T15:56:54.560214
21245372,,Cumuluative dose,7931.3,mg,,,3462.7,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,760,2025-12-02T15:56:54.560214
21245372,,Cumuluative T3 dose,5246.7,mg,,,2046.7,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,761,2025-12-02T15:56:54.560214
21258236,remifentanil,dose equivalent concentration,50,ug/l,,,,,,,,intravenous,,40.0,preterm/term,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,762,2025-12-02T15:56:54.560214
21343764,Hydrocodone,dose,175,ug/kg/d,mean,SD,94.0,,,,,oral,,30.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,763,2025-12-02T15:56:54.560214
21343764,,dose,145,ug/kg/d,median,,,range,44.3,423.2,,oral,,30.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,764,2025-12-02T15:56:54.560214
21348770,methadone,dose,102.1,dose/day,mean,SD,46.2,range,40.0,200.0,once a day,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,765,2025-12-02T15:56:54.560214
21398109,meperidine ,total dose,679,mg,median,,,IQR,346.0,818.0,,intravenous,,20.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,766,2025-12-02T15:56:54.560214
21398109,,PCEA,41,h,median,,,95CI,35.0,46.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,767,2025-12-02T15:56:54.560214
21398109,,meperidine infusion,15.9,mg/h,median,,,95CI,12.5,19.2,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,768,2025-12-02T15:56:54.560214
21398109,,weight adjusted maternal dose,4577,ug/kg/day,median,,,95CI,3583.0,5571.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,769,2025-12-02T15:56:54.560214
21398109,,,,,,,,,,,,,,20.0,pregnant,post-partum,post-partum,,"All were on daily methadone for at least a month prior to delivery,/most for longer. The meth- adone dose was not changed for at least 2 weeks prior to sample collection. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,770,2025-12-02T15:56:54.560214
21642610,Extended-release morphine,dose,8,mg,,,,,,,,epidural,,30.0,Maternal,Labor,,,1 hour after a combined spinal-epidural or an epidural anesthetic,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,771,2025-12-02T15:56:54.560214
21642610,Lidocaine 2%,dose,,ml,,,,range,20.0,35.0,,epidural,,15.0,Maternal,Labor,,,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,772,2025-12-02T15:56:54.560214
21642610,Fentanyl,dose,100,ug,,,,,,,,epidural,,,,,,,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,773,2025-12-02T15:56:54.560214
21642610,IV MME,total analgesic use,20,mg,mean,SD,19.0,,,,,,,,Maternal,Postpartum,,0.09,"Group E, all p-values are compared to Group SE",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,774,2025-12-02T15:56:54.560214
21642610,Oxycodone,dose from 0-24 h,9,mg,,,11.0,,,,,oral,,,,,,0.01,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,775,2025-12-02T15:56:54.560214
21642610,,dose from 24-48 h,14,mg,,,13.0,,,,,oral,,,,,,0.13,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,776,2025-12-02T15:56:54.560214
21642610,,dose from 48-72 h,21,mg,,,22.0,,,,,oral,,,,,,0.83,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,777,2025-12-02T15:56:54.560214
21642610,Opioid,time to first analgesic,24.5,h,,,27.0,,,,,,,,,,,0.43,Group E,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,778,2025-12-02T15:56:54.560214
21642610,Bupivacaine 0.75%,dose,12,mg,,,,,,,,intrathecal,,14.0,Maternal,Labor,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,779,2025-12-02T15:56:54.560214
21642610,Fentanyl,dose,20,ug,,,,,,,,intrathecal,,14.0,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,780,2025-12-02T15:56:54.560214
21642610,Epinephrine,dose,1:200000,,,,,,,,,intrathecal,,14.0,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,781,2025-12-02T15:56:54.560214
21642610,IV MME,total analgesic use,34,mg,mean,SD,26.0,,,,,,,,Maternal,Postpartum,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,782,2025-12-02T15:56:54.560214
21642610,Oxycodone,dose from 0-24 h,22,mg,,,15.0,,,,,oral,,,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,783,2025-12-02T15:56:54.560214
21642610,,dose from 24-48 h,24,mg,,,20.0,,,,,oral,,,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,784,2025-12-02T15:56:54.560214
21642610,,dose from 48-72 h,19,mg,,,21.0,,,,,oral,,,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,785,2025-12-02T15:56:54.560214
21642610,Opioid,time to first analgesic,16.3,h,,,29.0,,,,,,,,,,,,Group SE,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,786,2025-12-02T15:56:54.560214
21642610,Ibuprofen,dose,600,mg,,,,,,,q6h,oral,72 hours total,30.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,787,2025-12-02T15:56:54.560214
21743375,methadone,initial dose,42.6,mg,mean,SD,15.9,,,,,oral,,19.0,maternal,Pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,788,2025-12-02T15:56:54.560214
21743375,,Dose at delivery,75.3,mg,,,19.0,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,789,2025-12-02T15:56:54.560214
21743375,,mean daily dose,68,mg/day,,,16.6,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,790,2025-12-02T15:56:54.560214
21743375,,Mean T3 daily dose,71.9,mg/day,,,19.0,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,791,2025-12-02T15:56:54.560214
21743375,,Cumuluative dose,7931.3,mg,,,3462.7,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,792,2025-12-02T15:56:54.560214
21743375,,Cumuluative T3 dose,5246.7,mg,,,2046.7,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,793,2025-12-02T15:56:54.560214
21819795,Buprenorphine,dose at delivery,18,mg/day,median,,,,,,,oral,,4.0,Maternal,Trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,794,2025-12-02T15:56:54.560214
21819795,,mean daily dose,15.9,mg/day,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,795,2025-12-02T15:56:54.560214
21819795,,mean 3rd trimester daily dose,17,mg/day,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,796,2025-12-02T15:56:54.560214
21819795,,mean last month daily dose,18,mg/day,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,797,2025-12-02T15:56:54.560214
21819795,,cumulative dose,1805,mg,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,798,2025-12-02T15:56:54.560214
21819795,,cumulative 3rd trimester dose,1231,mg,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,799,2025-12-02T15:56:54.560214
21819795,,cumulative last month dose,540,mg,median,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,800,2025-12-02T15:56:54.560214
22011128,buprenorphine,dose,7,mg/day,median,,,range,2.4,24.0,,oral,daily,7.0,maternal,pregnancy,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,801,2025-12-02T15:56:54.560214
22025493,Fentanyl,dose,60,ug,median,,,range,45.0,65.0,once,intramuscular,,13.0,Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,802,2025-12-02T15:56:54.560214
22025493,Atropine,dose,20,ug/kg,mean,,,,,,once,intramuscular,,13.0,Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,803,2025-12-02T15:56:54.560214
22025493,Vecuronium,dose,0.2,mg/kg,mean,,,,,,once,intramuscular,,13.0,Fetal,Delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,804,2025-12-02T15:56:54.560214
22037641,Methadone,intraperative dose,6.1,mg,mean,SD,1.3,,,,,IV,Methadone administration occurred 27 _x0001_ 20 min after propofol induction across all dose groups,10.0,Adolescent,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,805,2025-12-02T15:56:54.560214
22037641,Methadone,intraperative dose,9.9,mg,mean,SD,1.4,,,,,IV,Methadone administration occurred 27 _x0001_ 20 min after propofol induction across all dose groups,10.0,Adolescent,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,806,2025-12-02T15:56:54.560214
22037641,Methadone,intraperative dose,17.4,mg,mean,SD,2.3,,,,,IV,Methadone administration occurred 27 _x0001_ 20 min after propofol induction across all dose groups,11.0,Adolescent,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,807,2025-12-02T15:56:54.560214
22037641,Methadone,Total intraperative nonmethadone opioid (morphine equivalents),61.7,mg,mean,SD,25.5,,,,,,,10.0,Adolescent,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,808,2025-12-02T15:56:54.560214
22037641,Methadone,Total intraperative nonmethadone opioid (morphine equivalents),76.6,mg,mean,SD,54.0,,,,,,,10.0,Adolescent,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,809,2025-12-02T15:56:54.560214
22037641,Methadone,Total intraperative nonmethadone opioid (morphine equivalents),64.6,mg,mean,SD,27.3,,,,,,,11.0,Adolescent,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,810,2025-12-02T15:56:54.560214
22037641,Methadone,Total intraoperative opioid (morphine equivalents),67.8,mg,mean,SD,25.5,,,,,,,10.0,Adolescent,,,,0.1 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,811,2025-12-02T15:56:54.560214
22037641,Methadone,Total intraoperative opioid (morphine equivalents),86.5,mg,mean,SD,54.7,,,,,,,10.0,Adolescent,,,,0.2 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,812,2025-12-02T15:56:54.560214
22037641,Methadone,Total intraoperative opioid (morphine equivalents),82,mg,mean,SD,26.6,,,,,,,11.0,Adolescent,,,,0.3 mg/kg group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,813,2025-12-02T15:56:54.560214
22037641,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,814,2025-12-02T15:56:54.560214
22428721,Buprenorphine,daily dose,12,mg,mean,,,95% CI,1.0,28.0,,,,10.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,815,2025-12-02T15:56:54.560214
22428721,,daily dose,8.5,mg,median,,,IQR,6.0,19.0,,,,10.0,maternal,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,816,2025-12-02T15:56:54.560214
22428721,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,817,2025-12-02T15:56:54.560214
22448718,Oxycodone,total dose,5,mg,,,,range,2.0,5.0,,intravenous,,15.0,Maternal,Labor,,,"Oxycodone (Oxanest®; Leiras Oy, Helsinki, Finland) dosing wasstarted when contraction pain was 5/10 or higher. Oxycodone hydro-chloride trihydrate was administered i.v. in 1-mg (corresponding to0.78 mg oxycodone) bolus doses up to 5 mg. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,818,2025-12-02T15:56:54.560214
22448718,,last dose-delivery interval,408,min,,,,,102.0,1619.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,819,2025-12-02T15:56:54.560214
22486937,morphine,dose,0.15,mg/kg,,,,,,,,IV,single dose at induction of anesthesia,68.0,child,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,820,2025-12-02T15:56:54.560214
22486937,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,821,2025-12-02T15:56:54.560214
22898875,Methadone,dose,39,ug,,,,,,,q6h,oral,initiated on hospital day 17,1.0,neonate,,24.5 weeks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,822,2025-12-02T15:56:54.560214
22898875,,dose on hospital day 20,7.8,mg,,,,,,,single dose,oral,,1.0,neonate,,24.5 weeks,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,823,2025-12-02T15:56:54.560214
22898875,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,824,2025-12-02T15:56:54.560214
22926004,Methadone,dose,102.6,mg/day,mean,SD,44.3,range,22.0,200.0,,oral,,25.0,pregnant,At delivery,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,825,2025-12-02T15:56:54.560214
22926004,Methadone,dose,105.9,mg/day,mean,SD,42.1,range,26.0,190.0,,oral,,22.0,pregnant,Latepostpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,826,2025-12-02T15:56:54.560214
23703421,Hydrocodone,total dose,80.6,mg,mean,SD,39.2,,,,every 4 hours,oral, starting 24 hours after surgery for postoperative pain control,131.0,maternal,,,, OPRM1 genotype AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,827,2025-12-02T15:56:54.560214
23703421,Hydrocodone,total dose,73.1,mg,mean,SD,30.0,,,,every 4 hours,oral, starting 24 hours after surgery for postoperative pain control,27.0,maternal,,,, OPRM1 genotype AG/GG,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,828,2025-12-02T15:56:54.560214
23703421,morphine,,,,,,,,,,,intrathecal,for the first 24 hours after surgery,158.0,maternal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,829,2025-12-02T15:56:54.560214
23703421,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,830,2025-12-02T15:56:54.560214
24269714,Hydrocodone,total dose,81.9,mg,mean,SD,46.9,,,,,,during Cesarean delivery,8.0,pregnant,post-partum,,,CYP2D6 UM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,831,2025-12-02T15:56:54.560214
24269714,Hydrocodone,total dose,72.7,mg,mean,SD,35.0,,,,,,during Cesarean delivery,97.0,pregnant,post-partum,,,CYP2D6 EM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,832,2025-12-02T15:56:54.560214
24269714,Hydrocodone,total dose,82.3,mg,mean,SD,36.7,,,,,,during Cesarean delivery,44.0,pregnant,post-partum,,,CYP2D6 IM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,833,2025-12-02T15:56:54.560214
24269714,Hydrocodone,total dose,102.1,mg,mean,SD,48.2,,,,,,during Cesarean delivery,7.0,pregnant,post-partum,,,CYP2D6 PM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,834,2025-12-02T15:56:54.560214
24269714,Hydrocodone,treatment duation,48.7,h,mean,SD,11.8,,,,,,during Cesarean delivery,8.0,pregnant,post-partum,,,CYP2D6 UM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,835,2025-12-02T15:56:54.560214
24269714,Hydrocodone,treatment duation,43.8,h,mean,SD,16.0,,,,,,during Cesarean delivery,97.0,pregnant,post-partum,,,CYP2D6 EM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,836,2025-12-02T15:56:54.560214
24269714,Hydrocodone,treatment duation,48.3,h,mean,SD,16.5,,,,,,during Cesarean delivery,44.0,pregnant,post-partum,,,CYP2D6 IM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,837,2025-12-02T15:56:54.560214
24269714,Hydrocodone,treatment duation,42.2,h,mean,SD,16.2,,,,,,during Cesarean delivery,7.0,pregnant,post-partum,,,CYP2D6 PM,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,838,2025-12-02T15:56:54.560214
24749886,morphine ,dose,8,ug/kg/h,,,,,,,,IV,continuously infused for the next 48 h after the surgery,34.0,pediatric ,,0-3 months,,with biliary atresia,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,839,2025-12-02T15:56:54.560214
24749886,morphine ,dose,8,ug/kg/h,,,,,,,,IV,continuously infused for the next 48 h after the surgery,16.0,pediatric ,,0-3 months,, without biliary atresia,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,840,2025-12-02T15:56:54.560214
24824135,midazolam,premedication dose,0.3,mg/kg,,,,,,,,oral,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,841,2025-12-02T15:56:54.560214
24824135,propofol,dose,3,mg/kg,,,,,,,,,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,842,2025-12-02T15:56:54.560214
24824135,vecuronium,dose,0.1,mg/kg,,,,,,,,,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,843,2025-12-02T15:56:54.560214
24824135,remifentanil,dose,,ug/kg/min,,,,range,0.25,1.0,infusion,intravenous,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,844,2025-12-02T15:56:54.560214
24824135,sufentanil,initial dose,0.2,ug/kg,,,,,,,bolus,epidural,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,845,2025-12-02T15:56:54.560214
24824135,,infusion dose,0.112,ug/kg/h,,,,,,,infusion,epidural,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,846,2025-12-02T15:56:54.560214
24824135,,postop dose,0.037,ug/kg/h,,,,,,,infusion,epidural,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,847,2025-12-02T15:56:54.560214
24824135,ropivacaine 0.2%,initial dose,0.5,ml/kg,,,,,,,bolus,epidural,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,848,2025-12-02T15:56:54.560214
24824135,,infusion dose,0.15,ml/kg/h,,,,,,,infusion,epidural,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,849,2025-12-02T15:56:54.560214
24824135,acetaminophen,dose,,mg/kg/day,,,,range,60.0,80.0,once,intravenous,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,850,2025-12-02T15:56:54.560214
24824135,morphine,rescue analgesia dose,0.1,mg/kg,,,,,,,prn,subcutaneous,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,851,2025-12-02T15:56:54.560214
24824135,,anesthesia time,4,h,median,,,range,1.0,8.0,,,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,852,2025-12-02T15:56:54.560214
24824135,,length of epidural infusion,39,h,median,,,range,18.0,62.0,infusion,epidural,,20.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,853,2025-12-02T15:56:54.560214
25080430,morphine ,dose,30,ug kg-1h-1,median,,,range,20.0,40.0,,,at each time point during post-cardiac surger,16.0, neonatal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,854,2025-12-02T15:56:54.560214
25080430,clonidine ,dose,3,ug kg-1,,,,,,,1,,"a single, nasogastric dose  at between 2/6 h after surgery.",16.0, neonatal,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,855,2025-12-02T15:56:54.560214
25196888,Hydrocodone 5 ml,dose,2.5,mg,mean,,,,,,,oral,,3.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,856,2025-12-02T15:56:54.560214
25196888,Hydrocodone 7.5 ml,,3.75,,,,,,,,,,,4.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,857,2025-12-02T15:56:54.560214
25196888,Hydrocodone 10 ml,,5,,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,858,2025-12-02T15:56:54.560214
25196888,Hydrocodone 15 ml,,7.5,,,,,,,,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,859,2025-12-02T15:56:54.560214
25196888,Acetaminophen 5 ml,,166.67,,,,,,,,,,,3.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,860,2025-12-02T15:56:54.560214
25196888,Acetaminophen 7.5 ml,,250,,,,,,,,,,,4.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,861,2025-12-02T15:56:54.560214
25196888,Acetaminophen 10 ml,,333.34,,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,862,2025-12-02T15:56:54.560214
25196888,Acetaminophen 15 ml,,500,,,,,,,,,,,9.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,863,2025-12-02T15:56:54.560214
25196888,hydrocodone,dose,5.59,mg,mean,SD,2.17,,,,,,,17.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,864,2025-12-02T15:56:54.560214
25196888,,,5,,,,,,,,,,,24.0,adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,865,2025-12-02T15:56:54.560214
25196888,,weight-adjusted dose,0.08,mg/kg,,,0.01,,,,,,,17.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,866,2025-12-02T15:56:54.560214
25196888,,,0.04,,,,0.01,,,,,,,24.0,adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,867,2025-12-02T15:56:54.560214
25196888,,BSA-adjusted dose,2.5,mg/m2,,,0.45,,,,,,,17.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,868,2025-12-02T15:56:54.560214
25196888,,,1.71,,,,0.19,,,,,,,24.0,adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,869,2025-12-02T15:56:54.560214
25340733,Morphine,total dose,295,ug,median,,,range,270.0,368.0,,injection/infusion,,6.0,Neonate,Postpartum,,,UGT2B7 - 842 GA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,870,2025-12-02T15:56:54.560214
25340733,,,250,,,,,,200.0,600.0,,injection/infusion,,7.0,Neonate,Postpartum,,,UGT2B7 - 842 AA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,871,2025-12-02T15:56:54.560214
25904383,midazolam,premedication dose,0.3,mg/kg,,,,,,,,oral,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,872,2025-12-02T15:56:54.560214
25904383,propofol,dose,3,mg/kg,,,,,,,,,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,873,2025-12-02T15:56:54.560214
25904383,vecuronium,dose,0.1,mg/kg,,,,,,,,,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,874,2025-12-02T15:56:54.560214
25904383,remifentanil,dose,,ug/kg/min,,,,range,0.25,1.0,infusion,intravenous,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,875,2025-12-02T15:56:54.560214
25904383,ropivacaine 0.2%,dose,0.5,ml/kg,,,,,,,bolus,epidural,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,876,2025-12-02T15:56:54.560214
25904383,fentanyl,dose,2,ug/kg,,,,,,,bolus,epidural,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,877,2025-12-02T15:56:54.560214
25904383,ropivacaine 0.2%,dose,0.15,ml/kg/h,,,,,,,infusion,epidural,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,878,2025-12-02T15:56:54.560214
25904383,fentanyl,dose,1.12,ug/kg/h,,,,,,,infusion,epidural,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,879,2025-12-02T15:56:54.560214
25904383,fentanyl,postop dose,0.375,ug/kg/h,,,,,,,infusion,epidural,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,880,2025-12-02T15:56:54.560214
25904383,acetaminophen,postop dose,,mg/kg/day,,,,range,45.0,80.0,,intravenous,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,881,2025-12-02T15:56:54.560214
25904383,morphine,rescue analgesia dose,0.1,mg/kg,,,,,,,prn,subcutaneous,,24.0,infants/children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,882,2025-12-02T15:56:54.560214
25904383,,anesthesia time,4.3,h,median,,,range,1.3,5.8,,,,13.0,infants/toddler,,,,Group 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,883,2025-12-02T15:56:54.560214
25904383,,,3.5,,,,,,1.0,8.5,,,,11.0,children,,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,884,2025-12-02T15:56:54.560214
25904383,,length of postop infusion,38,h,median,,,range,37.0,38.8,infusion,epidural,,13.0,infants/toddler,,,,Group 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,885,2025-12-02T15:56:54.560214
25904383,,,38,,,,,,35.5,39.0,infusion,epidural,,11.0,children,,,,Group 2,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,886,2025-12-02T15:56:54.560214
26385675,Fentanyl,dose,50,ug,,,,,,,every 15 mins,intranasal,1-5x,15.0,Maternal,Pregnancy,Term,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,887,2025-12-02T15:56:54.560214
26385675,,cumulative dose,250,ug,median,,,range,100.0,250.0,,,,10.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,888,2025-12-02T15:56:54.560214
26701799,Fentanyl,dose,2,ug/ml,,,,,,,,epidural,10ml/hour,1.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,889,2025-12-02T15:56:54.560214
26701799,,demand bolus dose,5,ml,,,,,,,6x,epidural,,,,,,,lockout time of 10 minutes,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,890,2025-12-02T15:56:54.560214
26701799,,cumuluative dose,280,ug,,,,,,,,epidural,over 11 hours,,,,,,140 ml,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,891,2025-12-02T15:56:54.560214
27082504,Fentanyl,loading dose,,ug/kg,,,,range,3.0,5.0,,intravenous,,50.0,infants,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,892,2025-12-02T15:56:54.560214
27082504,,infusion dose,3,ug/kg/h,,,,,,,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,893,2025-12-02T15:56:54.560214
27082504,Tramadol,loading dose,2,mg/kg,,,,,,,,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,894,2025-12-02T15:56:54.560214
27082504,,infusion dose,,mg/kg/24h,,,,,5.0,8.0,infusion,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,895,2025-12-02T15:56:54.560214
27082504,acetaminophen,dose,,mg/kg/24h,,,,,10.0,20.0,q4h,intravenous,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,896,2025-12-02T15:56:54.560214
27138295,Tramadol ,dose,2,mg/kg,,,,,,,1,oral,days 1,37.0,pediatric ,,7–11 Years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,897,2025-12-02T15:56:54.560214
27138295,,dose,2.7,mg/kg,,,,,,,1,oral,days 1 ,38.0,pediatric ,,12–17 Years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,898,2025-12-02T15:56:54.560214
27140798,Tramadol,dose for 20-25kg,25,mg,,,,,,,,oral,,24.0,children,,,,"In studies 1/2, participating children/adolescents received a single oral dose of tramadol IR tablets on day 1 of the study while those in study 3 received multiple oral doses of tramadol IR tablets every 6 hours for 3 days.",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,899,2025-12-02T15:56:54.560214
27140798,,dose for 25-40 kg,50,,,,,,,,,oral,,35.0,children/adolescent,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,900,2025-12-02T15:56:54.560214
27140798,,dose for 40-60 kg,75,,,,,,,,,oral,,81.0,adolescent/adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,901,2025-12-02T15:56:54.560214
27140798,,dose for >60 kg,100,,,,,,,,,oral,,86.0,adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,902,2025-12-02T15:56:54.560214
27563013,buprenorphine,dose,,mg,,,,range,2.0,22.0,1,oral,daily,10.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,903,2025-12-02T15:56:54.560214
27572136,methadone,initial dose,0.1,mg/kg,mean,,,,,,bolus,intravenous,,12.0,adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,904,2025-12-02T15:56:54.560214
27572136,,dose escalation,0.125,mg/kg,,,,,,,,,,1.0,adults,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,905,2025-12-02T15:56:54.560214
27572136,,initial dose,0.1,mg/kg,,,,,,,infusion,intravenous,,12.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,906,2025-12-02T15:56:54.560214
27572136,,dose escalation,0.125,mg/kg,,,,,,,,,,3.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,907,2025-12-02T15:56:54.560214
27687214,Buprenorphine,dose,8,mg,,SD,3.1,range,2.0,12.0,,sublingual,bd,7.0,Maternal,Trimester 2,,0.0276,p for comparison of pregnancy vspostpartum,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,908,2025-12-02T15:56:54.560214
27687214,Buprenorphine,dose,10,,,,3.7,,2.0,16.0,,,,11.0,,Trimester 3,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,909,2025-12-02T15:56:54.560214
27687214,Buprenorphine,dose,8,,,,0.0,,,,,,,10.0,,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,910,2025-12-02T15:56:54.560214
28238111,fentanyl ,total dose,138,ug,mean,SD,49.0,,,,,bolus dose,during bariatric surgery,6.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,911,2025-12-02T15:56:54.560214
28238111,,total dose,1,ug/kg,mean,SD,0.4,,,,,bolus dose,during bariatric surgery,6.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,912,2025-12-02T15:56:54.560214
28244808,oxycodone,dose,0.1,mg/kg,,,,,,,1,oral,single dose,5.0,pediatric ,,ages 2–6 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,913,2025-12-02T15:56:54.560214
28244808,,dose,0.08,mg/kg,,,,,,,1,oral,single dose,8.0,pediatric ,,ages 7–12 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,914,2025-12-02T15:56:54.560214
28244808,,dose,0.7,mg/kg,,,,,,,1,oral,single dose,17.0,pediatric ,,ages 13 –17 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,915,2025-12-02T15:56:54.560214
28320034,methadone,dose,55,mg,median,,,range,2.0,100.0,,,at delivery,21.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,916,2025-12-02T15:56:54.560214
28320034,,dose,65,mg,median,,,range,30.0,100.0,,,at delivery,22.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,917,2025-12-02T15:56:54.560214
28320034,,dose,54,mg,median,,,range,2.0,100.0,,,at delivery,23.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,918,2025-12-02T15:56:54.560214
28669739,Buprenorphine,BID dose,8,mg,mean,SD,3.1,range,2.0,12.0,,,,7.0,pregnant,2nd trimester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,919,2025-12-02T15:56:54.560214
28669739,,BID dose,10,mg,mean,SD,3.7,range,2.0,16.0,,,,11.0,pregnant,3rd trimester,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,920,2025-12-02T15:56:54.560214
28669739,,BID dose,8,mg,mean,SD,0.0,,,,,,,10.0,pregnant,postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,921,2025-12-02T15:56:54.560214
28805611,propofol,,1,mg/kg,,,,,,,,bolus dose,,40.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,922,2025-12-02T15:56:54.560214
28805611,remifentanil,,1,ug/kg,,,,,,,,bolus dose,,40.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,923,2025-12-02T15:56:54.560214
28805611,propofol,,3,mg/kg,,,,,,,,continuous infusion,Immediately after bolus administration,40.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,924,2025-12-02T15:56:54.560214
28805611,remifentanil,,7,ug/kg,,,,,,,,continuous infusion,Immediately after bolus administration,40.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,925,2025-12-02T15:56:54.560214
29389842,dihydrocodeine,,,,,,,,,,,oral,,,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,926,2025-12-02T15:56:54.560214
29521669,Methadone,dose,154,mg/day,mean,,,range,35.0,355.0,,oral,,23.0,Maternal,Pregnancy,,,"Most patients were on 3 to 4 times a day dosing at the time of delivery, although the regimen varied between 2/6 times daily",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,927,2025-12-02T15:56:54.560214
29521669,Methadone,dose,205,mg/day,mean,,,range,95.0,340.0,,oral,,23.0,Maternal,Postpartum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,928,2025-12-02T15:56:54.560214
29943508,Fentanyl ,dose,2,ug/mL,,,,,,,,ESI,During Childbirth,39.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,929,2025-12-02T15:56:54.560214
29943508,Adrenalin ,dose,2,ug/mL,,,,,,,,ESI,During Childbirth,19.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,930,2025-12-02T15:56:54.560214
30870164,remifentanil,infusion rate,0.05,ug/kg/min,,,,,,,,IV,infusion was started/maintained for 15min at a continuous rate ,5.0,child,,,,Non-OSA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,931,2025-12-02T15:56:54.560214
30870164,remifentanil,infusion rate,0.1,ug/kg/min,,,,,,,,IV,infusion was started/maintained for 15min at a continuous rate ,5.0,child,,,,Non-OSA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,932,2025-12-02T15:56:54.560214
30870164,remifentanil,infusion rate,0.15,ug/kg/min,,,,,,,,IV,infusion was started/maintained for 15min at a continuous rate ,5.0,child,,,,Non-OSA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,933,2025-12-02T15:56:54.560214
30870164,remifentanil,infusion rate,0.05,ug/kg/min,,,,,,,,IV,infusion was started/maintained for 15min at a continuous rate ,5.0,child,,,,OSA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,934,2025-12-02T15:56:54.560214
30870164,remifentanil,infusion rate,0.1,ug/kg/min,,,,,,,,IV,infusion was started/maintained for 15min at a continuous rate ,5.0,child,,,,OSA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,935,2025-12-02T15:56:54.560214
30870164,remifentanil,infusion rate,0.15,ug/kg/min,,,,,,,,IV,infusion was started/maintained for 15min at a continuous rate ,5.0,child,,,,OSA,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,936,2025-12-02T15:56:54.560214
30870164,,,,,,,,,,,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,937,2025-12-02T15:56:54.560214
31213888,tapentadol,,1,mg/kg,,,,,,,1,oral,single dose,66.0,pediatric ,,2-<18 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,938,2025-12-02T15:56:54.560214
31303784,tapentadol ,,1,mg/kg,,,,,,,1,oral,single dose,44.0,pediatric ,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,939,2025-12-02T15:56:54.560214
31688081,morphine,dose,0.05,mg/kg,mean,SD,0.001,,,,once,intravenous,,18.0,children,,,0.003,control group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,940,2025-12-02T15:56:54.560214
31688081,morphine,dose,0.05,mg/kg,mean,SD,0.001,,,,once,intravenous,,9.0,,,,,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,941,2025-12-02T15:56:54.560214
31688081,morphine,dose,0.04,mg/kg,mean,SD,0.005,,,,once,intravenous,,13.0,,,,,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,942,2025-12-02T15:56:54.560214
31688081,,anesthesia duration,426.4,minutes,mean,SD,253.0,,,,,,,,,,,0.001,"control group. Patients in the control group underwent short procedures including ENT procedures (mean anesthesia duration 73.1 minutes, SD = 36.1), as well as long procedures including bladder extrophy repair (mean anesthesia duration = 458.6 minutes, SD = 259.9). ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,943,2025-12-02T15:56:54.560214
31688081,,anesthesia duration,59.4,minutes,mean,SD,9.3,,,,,,,18.0,children,,,,OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,944,2025-12-02T15:56:54.560214
31688081,,anesthesia duration,80.5,minutes,mean,SD,44.4,,,,,,,9.0,,,,,Obese/OSAS group,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,945,2025-12-02T15:56:54.560214
31688081,,,,,,,,,,,,,,13.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,946,2025-12-02T15:56:54.560214
31929398,Buprenorphine,dose,,mg,,,,range,2.0,16.0,,oral,b.d,31.0,Maternal,Pregnancy/Postpartum,,,study 1,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,947,2025-12-02T15:56:54.560214
32044215,fentanyl ,total dose,750,ug,median,,,range,250.0,1200.0,,intranasal,,13.0,pregnant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,948,2025-12-02T15:56:54.560214
32044215,,total dose,250,ug,median,,,range,200.0,400.0,,SC,,17.0,pregnant,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,949,2025-12-02T15:56:54.560214
32052397,Methadone,dose,112,mg,median,,,range,60.0,180.0,,,,20.0,pregnant,post-partum,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,950,2025-12-02T15:56:54.560214
32363420,hydromorphone,dose,1.5,mg,,,,,,,once,epidural,,1.0,Maternal,Labor,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,951,2025-12-02T15:56:54.560214
32363420,,dose,0.75,,,,,,,,once,epidural,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,952,2025-12-02T15:56:54.560214
32363420,,dose,0.5,,,,,,,,once,epidural,,4.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,953,2025-12-02T15:56:54.560214
32363420,,dose-delivery interval,385,min,,,,range,229.0,552.0,,,,,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,954,2025-12-02T15:56:54.560214
32363420,Levobupivacaine,dose,1.25,mg/ml,,,,,,,prn,,,7.0,,,,,rescue medication,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,955,2025-12-02T15:56:54.560214
32363420,,first dose request after hydromorphone,163,min,,,,,19.0,303.0,,,,7.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,956,2025-12-02T15:56:54.560214
32591773,fentanyl ,,,μg/kg/h ,,,,,,,,IV,,2.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,957,2025-12-02T15:56:54.560214
32591773,midazolam,,,m/h,,,,,,,,IV,,1.0,neonate,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,958,2025-12-02T15:56:54.560214
33481403,medthadone,dose,0.18,mg/kg/day,median,,,range,0.17,0.19,,oral,q12h,38.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,959,2025-12-02T15:56:54.560214
33481403,oxycodone,dose,0.23,mg/kg/day,,,,,0.19,0.26,,oral,q6h,38.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,960,2025-12-02T15:56:54.560214
33481403,hydromorphone,dose,0.014,mg/kg/day,,,,,0.011,0.02,prn,intravenous,q3h,38.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,961,2025-12-02T15:56:54.560214
33481403,morphine,equivalent dose 0-72 hours,120.2,mg,,,,,98.5,131.8,,,,38.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,962,2025-12-02T15:56:54.560214
33481403,morphine,average equivalent dose,0.66,mg/kg/day,,,,,0.59,0.74,,,,38.0,children,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,963,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.75,mg/kg,,,,,,,1,oral, single dose post-operatively,8.0,pediatric patients ,aged 6 months to <2 years,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,964,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.6,mg/kg,,,,,,,1,oral, single dose post-operatively,6.0,pediatric patients ,aged 1 month to <2 years,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,965,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.5,mg/kg,,,,,,,1,oral, single dose post-operatively,5.0,pediatric patients ,Birth to <1 m,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,966,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.4,mg/kg,,,,,,,1,IV, single dose post-operatively,38.0,pediatric patients ,aged 6 months to <2 years,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,967,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.4,mg/kg,,,,,,,1,IV, single dose post-operatively,38.0,pediatric patients ,aged 1 month to <2 years,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,968,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.4,mg/kg,,,,,,,1,IV, single dose post-operatively,39.0,pediatric patients ,Birth to <1 m,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,969,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.3,mg/kg,,,,,,,1,IV, single dose post-operatively,40.0,pediatric patients ,Preterm Neonates,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,970,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,1.25,mg/kg,,,,,,,4,oral,every 4 hours for up to 72 hours,11.0,pediatric patients ,aged 6 months to <2 years,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,971,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.5,mg/kg,,,,,,,4,oral,every 4 hours for up to 72 hours,12.0,pediatric patients ,aged 30 days to <6 months,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,972,2025-12-02T15:56:54.560214
33542653,Tapentadol ,dose,0.1,mg/kg,,,,,,,4,oral,every 4 hours for up to 72 hours,13.0,pediatric patients ,Birth to <1 m,post-partum,,"All were on daily methadone for at least a month prior to delivery,/most for longer. The meth- adone dose was not changed for at least 2 weeks prior to sample collection. ",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,973,2025-12-02T15:56:54.560214
33864131,Buprenorphine,dose,13,mg/d,mean,,,,,,daily,,daily,11.0,pregnant,the first trimester,,,women required an increase in their BUP daily dose across the perinatal period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,974,2025-12-02T15:56:54.560214
33864131,,dose,12.2,mg/d,mean,,,,,,daily,,daily,11.0,pregnant,the secondt trimester,,,women required an increase in their BUP daily dose across the perinatal period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,975,2025-12-02T15:56:54.560214
33864131,,dose,15.8,mg/d,mean,,,,,,daily,,daily,11.0,pregnant,the third trimester,,,women required an increase in their BUP daily dose across the perinatal period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,976,2025-12-02T15:56:54.560214
33864131,,dose,18.9,mg/d,mean,,,,,,daily,,daily,11.0,pregnant,postpartum,,,women required an increase in their BUP daily dose across the perinatal period,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,977,2025-12-02T15:56:54.560214
33864131,,dose,16,mg/d,median,,,IQR,16.0,,daily,,daily,18.0,pregnant,,,,other participants,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,978,2025-12-02T15:56:54.560214
34784012,fentanyl,initial dose,0.5,mg,mean,,,,,,,patch,,1.0,pediatric,,2-5 years,,"number of patients in initial, last/maximum dose groups at a specific fentanyl patch dose",Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,979,2025-12-02T15:56:54.560214
34784012,,last dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,980,2025-12-02T15:56:54.560214
34784012,,maximum dose,,,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,981,2025-12-02T15:56:54.560214
34784012,,initial dose,1,mg,mean,,,,,,,patch,,1.0,pediatric,,2-5 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,982,2025-12-02T15:56:54.560214
34784012,,last dose,,,,,,,,,,,,0.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,983,2025-12-02T15:56:54.560214
34784012,,maximum dose,,,,,,,,,,,,1.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,984,2025-12-02T15:56:54.560214
34784012,,initial dose,2,mg,mean,,,,,,,patch,,2.0,pediatric,,2-5 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,985,2025-12-02T15:56:54.560214
34784012,,last dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,986,2025-12-02T15:56:54.560214
34784012,,maximum dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,987,2025-12-02T15:56:54.560214
34784012,,initial dose,0.5,mg,mean,,,,,,,patch,,3.0,adolescent,,6-19 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,988,2025-12-02T15:56:54.560214
34784012,,last dose,,,,,,,,,,,,3.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,989,2025-12-02T15:56:54.560214
34784012,,maximum dose,,,,,,,,,,,,3.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,990,2025-12-02T15:56:54.560214
34784012,,initial dose,1,mg,mean,,,,,,,patch,,2.0,adolescent,,6-19 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,991,2025-12-02T15:56:54.560214
34784012,,last dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,992,2025-12-02T15:56:54.560214
34784012,,maximum dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,993,2025-12-02T15:56:54.560214
34784012,,initial dose,2,mg,mean,,,,,,,patch,,2.0,adolescent,,6-19 years,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,994,2025-12-02T15:56:54.560214
34784012,,last dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,995,2025-12-02T15:56:54.560214
34784012,,maximum dose,,,,,,,,,,,,2.0,,,,,,Combined PK ONLY Opioids Data Curation 10.2023.xlsx,Aditi,Drug (summary data),Drug_summary,996,2025-12-02T15:56:54.560214
26723196,pravastatin,dose,10.0,mg/day,mean,,,,,,once,oral,daily,11.0,maternal,"trimester 2/3, postpartum",,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,2,2025-12-02T15:57:20.311669
2899094,dilevalol,dose,400.0,mg,mean,,,,,,once,oral,single,6.0,maternal,lactation,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,3,2025-12-02T15:57:20.311669
26635169,labetalol,total dose,330.0,mg/day,,,,,,,,oral,tid,4.0,maternal,"trimester 2/3, postpartum",,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,4,2025-12-02T15:57:20.311669
26635169,labetalol,total dose,400.0,mg/day,,,,,,,,oral,tid,11.0,maternal,pregnancy,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,5,2025-12-02T15:57:20.311669
26635169,labetalol,total dose,600.0,mg/day,,,,,,,,oral,tid,6.0,maternal,pregnancy,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,6,2025-12-02T15:57:20.311669
26635169,labetalol,total dose,700.0,mg/day,,,,,,,,oral,tid,2.0,maternal,pregnancy,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,7,2025-12-02T15:57:20.311669
26635169,labetalol,total dose,800.0,mg/day,,,,,,,,oral,tid,1.0,maternal,pregnancy,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,8,2025-12-02T15:57:20.311669
26635169,labetalol,total dose,1200.0,mg/day,,,,,,,,oral,tid,1.0,maternal,pregnancy,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,9,2025-12-02T15:57:20.311669
26635169,labetalol,treatment duration,,days,,,,range,6.0,84.0,,oral,tid,25.0,maternal,pregnancy,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,10,2025-12-02T15:57:20.311669
18507654,Domperidone 30mg,dose,410.0,µg/kg/day,Mean,,,95% CI,326.0,494.0,,oral,tid,6.0,maternal,lactation,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,11,2025-12-02T15:57:20.311669
18507654,Domperidone 60mg,dose,820.0,µg/kg/day,Mean,,,95% CI,652.0,988.0,,oral,tid,5.0,maternal,lactation,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,12,2025-12-02T15:57:20.311669
3882143,domperidone,dose,10.0,mg,,,,,,,2,oral,od,5.0,maternal,lactation,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,13,2025-12-02T15:57:20.311669
37565541,lemborexant,dose,10.0,mg,per patient,,,,,,single dose,oral,,8.0,maternal,lactation,,,,PRGLAC PK curations_AS.xlsx,Aditi,Drug (summary data),Drug_summary,14,2025-12-02T15:57:20.311669
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,23,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,24,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,25,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,26,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,27,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,28,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,29,2025-12-02T15:58:06.904430
19011433,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,30,2025-12-02T15:58:06.904430
8379562,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,31,2025-12-02T15:58:06.904430
8379562,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,32,2025-12-02T15:58:06.904430
8379562,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,33,2025-12-02T15:58:06.904430
8379562,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,34,2025-12-02T15:58:06.904430
8379562,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,35,2025-12-02T15:58:06.904430
8379562,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,36,2025-12-02T15:58:06.904430
8379562,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,37,2025-12-02T15:58:06.904430
8379562,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,38,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,63,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,64,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,65,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,66,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,67,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,68,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,69,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,70,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,71,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,72,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,73,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,74,2025-12-02T15:58:06.904430
26416100,clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,75,2025-12-02T15:58:06.904430
28129551,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,76,2025-12-02T15:58:06.904430
28129551,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,77,2025-12-02T15:58:06.904430
28129551,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,78,2025-12-02T15:58:06.904430
28129551,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,79,2025-12-02T15:58:06.904430
28129551,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,80,2025-12-02T15:58:06.904430
28129551,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,81,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,82,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,83,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,84,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,85,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,86,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,87,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,88,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,89,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,90,2025-12-02T15:58:06.904430
16271264,Nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,91,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,92,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,93,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,94,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,95,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,96,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,97,2025-12-02T15:58:06.904430
16271264,Clomipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,98,2025-12-02T15:58:06.904430
16390902.0,venlafaxine,dose,200,mg/day,mean,SD,35.4,,,,daily,oral,for more than 4 weeks before amniocentesis,4.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,45,2025-12-02T16:05:06.199640
16390902.0,venlafaxine,dose,200,mg/day,mean,SD,35.4,,,,daily,oral,for more than 4 weeks before amniocentesis,4.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,45,2025-12-02T16:05:11.478648
16390902,venlafaxine,dose,200,mg/day,mean,SD,35.4,,,,daily,oral,for more than 4 weeks before amniocentesis,4.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,44,2025-12-02T16:05:15.087972
16390902,venlafaxine,dose,200,mg/day,mean,SD,35.4,,,,daily,oral,for more than 4 weeks before amniocentesis,4.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,44,2025-12-02T16:05:21.408417
33751155.0,Sertraline,dose,25,mg/day,,,,minmax,,,1,oral,daily,10.0,maternal,pregnancy and postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,543,2025-12-02T16:03:32.268615
33751155.0,Sertraline,dose,50,mg/day,median,,,minmax,50,50.0,1,oral,daily,7.0,maternal,pregnancy,2nd trimester,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,544,2025-12-02T16:03:32.268615
33751155.0,Sertraline,dose,50,mg/day,median,,,minmax,50,75.0,1,oral,daily,9.0,maternal,pregnancy,3rd trimester,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,545,2025-12-02T16:03:32.268615
33751155.0,Sertraline,dose,75,mg/day,median,,,minmax,50,100.0,1,oral,daily,8.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,546,2025-12-02T16:03:32.268615
33751155.0,Sertraline,dose,75,mg/day,median,,,minmax,50,75.0,1,oral,daily,8.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,547,2025-12-02T16:03:32.268615
18426260.0,sertraline,dose,,mg/day,,,,minmax,50,200.0,daily,oral,,6.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,19,2025-12-02T16:05:06.199640
18426260.0,citalopram,dose,,mg/day,,,,minmax,20,40.0,daily,oral,,3.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,20,2025-12-02T16:05:06.199640
18426260.0,escitalopram,dose,,mg/day,,,,minmax,10,20.0,daily,oral,,2.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,21,2025-12-02T16:05:06.199640
18426260.0,sertraline,dose,,mg/day,,,,minmax,50,200.0,daily,oral,,6.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,19,2025-12-02T16:05:11.478648
18426260.0,citalopram,dose,,mg/day,,,,minmax,20,40.0,daily,oral,,3.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,20,2025-12-02T16:05:11.478648
18426260.0,escitalopram,dose,,mg/day,,,,minmax,10,20.0,daily,oral,,2.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,21,2025-12-02T16:05:11.478648
18426260,sertraline,dose,,mg/day,,,,minmax,50,200.0,daily,oral,,6.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,19,2025-12-02T16:05:15.087972
18426260,citalopram,dose,,mg/day,,,,minmax,20,40.0,daily,oral,,3.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,20,2025-12-02T16:05:15.087972
18426260,escitalopram,dose,,mg/day,,,,minmax,10,20.0,daily,oral,,2.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,21,2025-12-02T16:05:15.087972
18426260,sertraline,dose,,mg/day,,,,minmax,50,200.0,daily,oral,,6.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,19,2025-12-02T16:05:21.408417
18426260,citalopram,dose,,mg/day,,,,minmax,20,40.0,daily,oral,,3.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,20,2025-12-02T16:05:21.408417
18426260,escitalopram,dose,,mg/day,,,,minmax,10,20.0,daily,oral,,2.0,maternal,"pregnancy, delivery, postpartum",,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,21,2025-12-02T16:05:21.408417
30380149,citalopram,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,207,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,208,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,209,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,210,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,212,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,214,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,215,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,217,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,218,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,219,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,220,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,221,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,222,2025-12-02T15:58:06.904430
30380149,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,223,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,224,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,225,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,226,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,227,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,228,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,229,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,230,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,231,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,232,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,233,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,234,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,235,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,236,2025-12-02T15:58:06.904430
30380149,,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,237,2025-12-02T15:58:06.904430
30380149,morphine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,238,2025-12-02T15:58:06.904430
30380149,metoclopramide,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,239,2025-12-02T15:58:06.904430
30380149,oxazepam,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,240,2025-12-02T15:58:06.904430
30380149,paracetamol,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,241,2025-12-02T15:58:06.904430
30380149,sumatriptan,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,242,2025-12-02T15:58:06.904430
30380149,tramadol,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,243,2025-12-02T15:58:06.904430
30380149,zopiclone,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,244,2025-12-02T15:58:06.904430
30380149,no drugs ingested,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,245,2025-12-02T15:58:06.904430
30380149,no drugs ingested,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,246,2025-12-02T15:58:06.904430
1749054,clomipramine,,,,,,,,,,,,,,,,,,increased to 150 mg/day 10 days postpartum,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,247,2025-12-02T15:58:06.904430
32056930.0,venlafaxine,dose,75,mg/d,median,,,"Q1, Q3",75,150.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,40,2025-12-02T16:05:06.199640
32056930.0,venlafaxine,dose,,,,,,minmax,37.5,225.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,41,2025-12-02T16:05:06.199640
32056930.0,venlafaxine,dose,75,mg/d,median,,,"Q1, Q3",75,150.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,40,2025-12-02T16:05:11.478648
32056930.0,venlafaxine,dose,,,,,,minmax,37.5,225.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,41,2025-12-02T16:05:11.478648
32056930,venlafaxine,dose,75,mg/d,median,,,"Q1, Q3",75,150.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,39,2025-12-02T16:05:15.087972
32056930,venlafaxine,dose,,,,,,minmax,37.5,225.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,40,2025-12-02T16:05:15.087972
32056930,venlafaxine,dose,75,mg/d,median,,,"Q1, Q3",75,150.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,39,2025-12-02T16:05:21.408417
32056930,venlafaxine,dose,,,,,,minmax,37.5,225.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,40,2025-12-02T16:05:21.408417
28663113.0,citalopram,dose,20,mg/day,median,,,minmax,10,40.0,once daily,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,170,2025-12-02T16:05:06.199640
28663113.0,citalopram,dose,,mg/day,,,,"Q1, Q3",10,20.0,,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,171,2025-12-02T16:05:06.199640
28663113.0,citalopram,dose,20,mg/day,median,,,minmax,10,40.0,once daily,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,170,2025-12-02T16:05:11.478648
28663113.0,citalopram,dose,,mg/day,,,,"Q1, Q3",10,20.0,,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,171,2025-12-02T16:05:11.478648
28663113,citalopram,dose,20,mg/day,median,,,minmax,10,40.0,once daily,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,169,2025-12-02T16:05:15.087972
28663113,citalopram,dose,,mg/day,,,,"Q1, Q3",10,20.0,,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,170,2025-12-02T16:05:15.087972
28663113,citalopram,dose,20,mg/day,median,,,minmax,10,40.0,once daily,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,169,2025-12-02T16:05:21.408417
28663113,citalopram,dose,,mg/day,,,,"Q1, Q3",10,20.0,,,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,170,2025-12-02T16:05:21.408417
33253437.0,Sertraline,dose,75,mg/day,median,,,minmax,10,150.0,,,,24.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,548,2025-12-02T16:03:32.268615
33253437.0,Escitalopram,dose,10,mg/day,median,,,,,,daily,oral,,7.0,maternal,third trimester,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,601,2025-12-02T16:03:32.268615
33253437.0,venlafaxine,dose,75,mg/d,median,,,minmax,37.5,150.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,36,2025-12-02T16:05:06.199640
33253437.0,citalopram,dose,20,mg/d,,,,,,,daily,oral,,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,37,2025-12-02T16:05:06.199640
33253437.0,escitalopram,dose,10,mg/d,,,,,5,10.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,38,2025-12-02T16:05:06.199640
33253437.0,fluoxetine,dose,25,mg/d,,,,,20,30.0,daily,oral,,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,39,2025-12-02T16:05:06.199640
33253437.0,venlafaxine,dose,75,mg/d,median,,,minmax,37.5,150.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,36,2025-12-02T16:05:11.478648
33253437.0,citalopram,dose,20,mg/d,,,,,,,daily,oral,,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,37,2025-12-02T16:05:11.478648
33253437.0,escitalopram,dose,10,mg/d,,,,,5,10.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,38,2025-12-02T16:05:11.478648
33253437.0,fluoxetine,dose,25,mg/d,,,,,20,30.0,daily,oral,,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,39,2025-12-02T16:05:11.478648
33253437,venlafaxine,dose,75,mg/d,median,,,minmax,37.5,150.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,35,2025-12-02T16:05:15.087972
33253437,citalopram,dose,20,mg/d,,,,,,,daily,oral,,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,36,2025-12-02T16:05:15.087972
33253437,escitalopram,dose,10,mg/d,,,,,5,10.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,37,2025-12-02T16:05:15.087972
33253437,fluoxetine,dose,25,mg/d,,,,,20,30.0,daily,oral,,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,38,2025-12-02T16:05:15.087972
33253437,venlafaxine,dose,75,mg/d,median,,,minmax,37.5,150.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,35,2025-12-02T16:05:21.408417
33253437,citalopram,dose,20,mg/d,,,,,,,daily,oral,,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,36,2025-12-02T16:05:21.408417
33253437,escitalopram,dose,10,mg/d,,,,,5,10.0,daily,oral,,7.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,37,2025-12-02T16:05:21.408417
33253437,fluoxetine,dose,25,mg/d,,,,,20,30.0,daily,oral,,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,38,2025-12-02T16:05:21.408417
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,358,2025-12-02T15:58:06.904430
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,359,2025-12-02T15:58:06.904430
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,360,2025-12-02T15:58:06.904430
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,361,2025-12-02T15:58:06.904430
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,362,2025-12-02T15:58:06.904430
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,363,2025-12-02T15:58:06.904430
8834425,imipramine,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,364,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,365,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,366,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,367,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,368,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,369,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,370,2025-12-02T15:58:06.904430
8834425,nortriptyline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,371,2025-12-02T15:58:06.904430
20631556.0,fluoxetine,dose,,mg/day,,,,minmax,10,80.0,,,,17.0,maternal,pregnancy/delivery/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,163,2025-12-02T16:05:06.199640
20631556.0,fluoxetine,dose,,mg/day,,,,minmax,10,80.0,,,,17.0,maternal,pregnancy/delivery/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,163,2025-12-02T16:05:11.478648
20631556,fluoxetine,dose,,mg/day,,,,minmax,10,80.0,,,,17.0,maternal,pregnancy/delivery/postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,162,2025-12-02T16:05:15.087972
20631556,fluoxetine,dose,,mg/day,,,,minmax,10,80.0,,,,17.0,maternal,pregnancy/delivery/postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,162,2025-12-02T16:05:21.408417
14595087.0,fluoxetine,dose,27.3,mg/day,mean,SD,7.9,,,,,,,11.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,158,2025-12-02T16:05:06.199640
14595087.0,fluoxetine,dose,27.3,mg/day,mean,SD,7.9,,,,,,,11.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,158,2025-12-02T16:05:11.478648
14595087,fluoxetine,dose,27.3,mg/day,mean,SD,7.9,,,,,,,11.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,157,2025-12-02T16:05:15.087972
14595087,fluoxetine,dose,27.3,mg/day,mean,SD,7.9,,,,,,,11.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,157,2025-12-02T16:05:21.408417
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,400,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,401,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,402,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,403,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,404,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,405,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,406,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,407,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,408,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,409,2025-12-02T15:58:06.904430
9286185,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,410,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,411,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,412,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,413,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,414,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,415,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,416,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,417,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,418,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,419,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,420,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,421,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,422,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,423,2025-12-02T15:58:06.904430
11578995,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,424,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,450,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,451,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,452,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,453,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,454,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,455,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,456,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,457,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,458,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,459,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,460,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,461,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,462,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,463,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,464,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,465,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,466,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,467,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,468,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,469,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,470,2025-12-02T15:58:06.904430
12590627,sertraline,,,,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (individual data),Drug_summary,471,2025-12-02T15:58:06.904430
10485633.0,paroxetine,dose,,,,,,,,,once daily,oral,Each subject had been treated with a constant dose of paroxetine for at least 8 days prior to the study days. ,7.0,materanl,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,191,2025-12-02T16:05:06.199640
10485633.0,paroxetine,dose,,,,,,,,,once daily,oral,Each subject had been treated with a constant dose of paroxetine for at least 8 days prior to the study days. ,7.0,materanl,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,191,2025-12-02T16:05:11.478648
10485633,paroxetine,dose,,,,,,,,,once daily,oral,Each subject had been treated with a constant dose of paroxetine for at least 8 days prior to the study days. ,7.0,materanl,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,190,2025-12-02T16:05:15.087972
10485633,paroxetine,dose,,,,,,,,,once daily,oral,Each subject had been treated with a constant dose of paroxetine for at least 8 days prior to the study days. ,7.0,materanl,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,190,2025-12-02T16:05:21.408417
16433870.0,fluoxetine,dose,20,mg/day,mean,,,95% CI,16.7,23.2,,,for a minimum of 3 weeks prior to delivery,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,159,2025-12-02T16:05:06.199640
16433870.0,fluoxetine,dose,21,mg/day,mean,,,95% CI,18,24.0,,,for a minimum of 4 weeks,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,160,2025-12-02T16:05:06.199640
16433870.0,fluoxetine,duration of therapy,4,months,mean,,,95% CI,2,6.0,,,,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,161,2025-12-02T16:05:06.199640
16433870.0,fluoxetine,duration of therapy,6.8,months,mean,,,95% CI,2.7,10.9,,,,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,162,2025-12-02T16:05:06.199640
16433870.0,fluoxetine,dose,20,mg/day,mean,,,95% CI,16.7,23.2,,,for a minimum of 3 weeks prior to delivery,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,159,2025-12-02T16:05:11.478648
16433870.0,fluoxetine,dose,21,mg/day,mean,,,95% CI,18,24.0,,,for a minimum of 4 weeks,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,160,2025-12-02T16:05:11.478648
16433870.0,fluoxetine,duration of therapy,4,months,mean,,,95% CI,2,6.0,,,,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,161,2025-12-02T16:05:11.478648
16433870.0,fluoxetine,duration of therapy,6.8,months,mean,,,95% CI,2.7,10.9,,,,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,162,2025-12-02T16:05:11.478648
16433870,fluoxetine,dose,20,mg/day,mean,,,95% CI,16.7,23.2,,,for a minimum of 3 weeks prior to delivery,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,158,2025-12-02T16:05:15.087972
16433870,fluoxetine,dose,21,mg/day,mean,,,95% CI,18,24.0,,,for a minimum of 4 weeks,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,159,2025-12-02T16:05:15.087972
16433870,fluoxetine,duration of therapy,4,months,mean,,,95% CI,2,6.0,,,,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,160,2025-12-02T16:05:15.087972
16433870,fluoxetine,duration of therapy,6.8,months,mean,,,95% CI,2.7,10.9,,,,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,161,2025-12-02T16:05:15.087972
16433870,fluoxetine,dose,20,mg/day,mean,,,95% CI,16.7,23.2,,,for a minimum of 3 weeks prior to delivery,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,158,2025-12-02T16:05:21.408417
16433870,fluoxetine,dose,21,mg/day,mean,,,95% CI,18,24.0,,,for a minimum of 4 weeks,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,159,2025-12-02T16:05:21.408417
16433870,fluoxetine,duration of therapy,4,months,mean,,,95% CI,2,6.0,,,,9.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,160,2025-12-02T16:05:21.408417
16433870,fluoxetine,duration of therapy,6.8,months,mean,,,95% CI,2.7,10.9,,,,23.0,maternal,postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,161,2025-12-02T16:05:21.408417
20060670.0,venlafaxine,dose,,mg/day,,,,minmax,75,300.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,52,2025-12-02T16:05:06.199640
20060670.0,citalopram,dose,,mg/day,,,,minmax,30,60.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,4.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,53,2025-12-02T16:05:06.199640
20060670.0,fluoxetine,dose,30,mg/day,,,,,,,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,1.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,54,2025-12-02T16:05:06.199640
20060670.0,venlafaxine,dose,,mg/day,,,,minmax,75,300.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,52,2025-12-02T16:05:11.478648
20060670.0,citalopram,dose,,mg/day,,,,minmax,30,60.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,4.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,53,2025-12-02T16:05:11.478648
20060670.0,fluoxetine,dose,30,mg/day,,,,,,,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,1.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,54,2025-12-02T16:05:11.478648
20060670,venlafaxine,dose,,mg/day,,,,minmax,75,300.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,51,2025-12-02T16:05:15.087972
20060670,citalopram,dose,,mg/day,,,,minmax,30,60.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,4.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,52,2025-12-02T16:05:15.087972
20060670,fluoxetine,dose,30,mg/day,,,,,,,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,1.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,53,2025-12-02T16:05:15.087972
20060670,venlafaxine,dose,,mg/day,,,,minmax,75,300.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,51,2025-12-02T16:05:21.408417
20060670,citalopram,dose,,mg/day,,,,minmax,30,60.0,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,4.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,52,2025-12-02T16:05:21.408417
20060670,fluoxetine,dose,30,mg/day,,,,,,,daily,,in the first trimester of pregnancy (<=12 weeks) and followed throughout pregnancy and into the early postpartum period,1.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,53,2025-12-02T16:05:21.408417
7893588,nortripyline,dose,41.0,mg,mean,SD,,range,20.0,200.0,QD,,,283.0,women monotherapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,31,2025-12-02T15:58:19.325005
7893588,,,39.0,mg,mean,SD,,range,20.0,175.0,QD,,,80.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,32,2025-12-02T15:58:19.325005
7893588,,,42.0,mg,mean,SD,,range,20.0,225.0,QD,,,186.0,men monotherapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,33,2025-12-02T15:58:19.325005
7893588,,,40.0,mg,mean,SD,,range,30.0,225.0,QD,,,29.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,34,2025-12-02T15:58:19.325005
7893588,nortriptyline,dose,0.8,doses/day,mean,SD,,range,1.0,3.0,,,,283.0,women monotherapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,35,2025-12-02T15:58:19.325005
7893588,,dose,0.7,doses/day,mean,SD,,range,1.0,3.0,,,,80.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,36,2025-12-02T15:58:19.325005
7893588,,dose,0.8,doses/day,mean,SD,,range,1.0,3.0,,,,186.0,men monotherapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,37,2025-12-02T15:58:19.325005
7893588,,dose,0.7,doses/day,mean,SD,,range,1.0,3.0,,,,29.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,38,2025-12-02T15:58:19.325005
7893588,nortriptyline,time from last dose to sampling,3.3,hours,mean,SD,,range,1.0,24.0,,,,326.0,women monotherapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,39,2025-12-02T15:58:19.325005
7893588,,time from last dose to sampling,3.9,hours,mean,SD,,range,1.0,23.0,,,,93.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,40,2025-12-02T15:58:19.325005
7893588,,time from last dose to sampling,3.9,hours,mean,SD,,range,1.0,26.0,,,,220.0,men monotherapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,41,2025-12-02T15:58:19.325005
7893588,,time from last dose to sampling,1.2,hours,mean,SD,,range,8.5,15.0,,,,35.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,42,2025-12-02T15:58:19.325005
7893588,alimemazine,dose,17.0,mg,mean,SD,,range,5.0,60.0,QD,,,9.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,43,2025-12-02T15:58:19.325005
7893588,alimemazine,dose,,mg,mean,SD,,range,10.0,30.0,QD,,,2.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,44,2025-12-02T15:58:19.325005
7893588,chlorpromazine,dose,66.0,mg,mean,SD,,range,75.0,200.0,QD,,,3.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,45,2025-12-02T15:58:19.325005
7893588,chlorpromazine,dose,,mg,mean,SD,,range,25.0,100.0,QD,,,2.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,46,2025-12-02T15:58:19.325005
7893588,climipramine,dose,,mg,mean,SD,,range,,,QD,,,1.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,47,2025-12-02T15:58:19.325005
7893588,codeine,dose,,mg,mean,SD,,range,,,QD,,,1.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,48,2025-12-02T15:58:19.325005
7893588,d-prpoxyphene,dose,118.0,mg,mean,SD,,range,100.0,400.0,QD,,,10.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,49,2025-12-02T15:58:19.325005
7893588,d-prpoxyphene,dose,75.0,mg,mean,SD,,range,130.0,260.0,QD,,,3.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,50,2025-12-02T15:58:19.325005
7893588,dixyrazine,dose,32.0,mg,mean,SD,,range,25.0,100.0,QD,,,7.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,51,2025-12-02T15:58:19.325005
7893588,dixyrazine,dose,,mg,mean,SD,,range,,,QD,,,1.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,52,2025-12-02T15:58:19.325005
7893588,haloperidol,dose,2.0,mg,mean,SD,,range,0.5,8.0,QD,,,17.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,53,2025-12-02T15:58:19.325005
7893588,haloperidol,dose,0.6,mg,mean,SD,,range,1.0,2.0,QD,,,3.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,54,2025-12-02T15:58:19.325005
7893588,levomepromazine,dose,22.0,mg,mean,SD,,range,5.0,100.0,QD,,,20.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,55,2025-12-02T15:58:19.325005
7893588,levomepromazine,dose,8.0,mg,mean,SD,,range,10.0,25.0,QD,,,6.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,56,2025-12-02T15:58:19.325005
7893588,perphenazine,dose,6.0,mg,mean,SD,,range,2.0,24.0,QD,,,22.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,57,2025-12-02T15:58:19.325005
7893588,perphenazine,dose,5.0,mg,mean,SD,,range,6.0,16.0,QD,,,7.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,58,2025-12-02T15:58:19.325005
7893588,remoxipride,dose,,mg,mean,SD,,range,,,QD,,,1.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,59,2025-12-02T15:58:19.325005
7893588,terfluzine,dose,,mg,mean,SD,,range,,,QD,,,1.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,60,2025-12-02T15:58:19.325005
7893588,thioridazine,dose,88.0,mg,mean,SD,,range,10.0,300.0,QD,,,16.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,61,2025-12-02T15:58:19.325005
7893588,thioridazine,dose,66.0,mg,mean,SD,,range,25.0,200.0,QD,,,7.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,62,2025-12-02T15:58:19.325005
7893588,thiotixene,dose,,mg,mean,SD,,range,,,QD,,,1.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,63,2025-12-02T15:58:19.325005
7893588,zuclopenthixol,dose,,mg,mean,SD,,range,,,QD,,,1.0,women combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,64,2025-12-02T15:58:19.325005
7893588,zuclopenthixol,dose,,mg,mean,SD,,range,,,QD,,,1.0,men combination therapy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,65,2025-12-02T15:58:19.325005
15035694.0,venlafaxine,dose,150,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,26,2025-12-02T16:05:06.199640
15035694.0,paroxetine,dose,20,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,27,2025-12-02T16:05:06.199640
15035694.0,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,28,2025-12-02T16:05:06.199640
15035694.0,venlafaxine,dose,150,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,26,2025-12-02T16:05:11.478648
15035694.0,paroxetine,dose,20,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,27,2025-12-02T16:05:11.478648
15035694.0,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,28,2025-12-02T16:05:11.478648
15035694,venlafaxine,dose,150,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,26,2025-12-02T16:05:15.087972
15035694,paroxetine,dose,20,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,27,2025-12-02T16:05:15.087972
15035694,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,28,2025-12-02T16:05:15.087972
15035694,venlafaxine,dose,150,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,26,2025-12-02T16:05:21.408417
15035694,paroxetine,dose,20,mg/day,,,,,,,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,2.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,27,2025-12-02T16:05:21.408417
15035694,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,daily,oral,taking antidepressants in their third trimester for at least 4 wk before delivery ,4.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,28,2025-12-02T16:05:21.408417
28708853,escitalopram,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,70,2025-12-02T15:58:19.325005
28708853,citalopram,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,71,2025-12-02T15:58:19.325005
28708853,fluoxetine,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,72,2025-12-02T15:58:19.325005
28708853,sertraline,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,73,2025-12-02T15:58:19.325005
28708853,venlafaxine,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,74,2025-12-02T15:58:19.325005
28708853,paroxetine,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,75,2025-12-02T15:58:19.325005
28708853,fluvoxamine,defined daily dose,,mg,,,,,,,QD,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,76,2025-12-02T15:58:19.325005
19743889,paroxetine,dose,9.4,mg,mean,SD,,range,5.0,60.0,QD,,,54.0,16-20 wks,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,81,2025-12-02T15:58:19.325005
19743889,paroxetine,dose,9.5,mg,mean,SD,,range,5.0,60.0,QD,,,67.0,17-31 wks,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,82,2025-12-02T15:58:19.325005
19743889,paroxetine,dose,8.8,mg,mean,SD,,range,3.0,40.0,QD,,,70.0,36-40 wks,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,83,2025-12-02T15:58:19.325005
19452377.0,venlafaxine,dose,225,mg/day,median,,,IQR,150,300.0,daily,oral,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,46,2025-12-02T16:05:06.199640
19452377.0,citalopram,dose,20,mg/day,median,,,IQR,20,30.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,47,2025-12-02T16:05:06.199640
19452377.0,escitalopram,dose,20,mg/day,median,,,IQR,10,28.0,daily,oral,,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,48,2025-12-02T16:05:06.199640
19452377.0,fluoxetine,dose,30,mg/day,median,,,,,,daily,oral,,2.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,49,2025-12-02T16:05:06.199640
19452377.0,paroxetine,dose,30,mg/day,,,,,,,daily,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,50,2025-12-02T16:05:06.199640
19452377.0,venlafaxine,dose,225,mg/day,median,,,IQR,150,300.0,daily,oral,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,46,2025-12-02T16:05:11.478648
19452377.0,citalopram,dose,20,mg/day,median,,,IQR,20,30.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,47,2025-12-02T16:05:11.478648
19452377.0,escitalopram,dose,20,mg/day,median,,,IQR,10,28.0,daily,oral,,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,48,2025-12-02T16:05:11.478648
19452377.0,fluoxetine,dose,30,mg/day,median,,,,,,daily,oral,,2.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,49,2025-12-02T16:05:11.478648
19452377.0,paroxetine,dose,30,mg/day,,,,,,,daily,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,50,2025-12-02T16:05:11.478648
19452377,venlafaxine,dose,225,mg/day,median,,,IQR,150,300.0,daily,oral,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,45,2025-12-02T16:05:15.087972
19452377,citalopram,dose,20,mg/day,median,,,IQR,20,30.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,46,2025-12-02T16:05:15.087972
19452377,escitalopram,dose,20,mg/day,median,,,IQR,10,28.0,daily,oral,,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,47,2025-12-02T16:05:15.087972
19452377,fluoxetine,dose,30,mg/day,median,,,,,,daily,oral,,2.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,48,2025-12-02T16:05:15.087972
19452377,paroxetine,dose,30,mg/day,,,,,,,daily,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,49,2025-12-02T16:05:15.087972
19452377,venlafaxine,dose,225,mg/day,median,,,IQR,150,300.0,daily,oral,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,45,2025-12-02T16:05:21.408417
19452377,citalopram,dose,20,mg/day,median,,,IQR,20,30.0,daily,oral,,9.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,46,2025-12-02T16:05:21.408417
19452377,escitalopram,dose,20,mg/day,median,,,IQR,10,28.0,daily,oral,,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,47,2025-12-02T16:05:21.408417
19452377,fluoxetine,dose,30,mg/day,median,,,,,,daily,oral,,2.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,48,2025-12-02T16:05:21.408417
19452377,paroxetine,dose,30,mg/day,,,,,,,daily,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,49,2025-12-02T16:05:21.408417
12709723.0,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,157,2025-12-02T16:05:06.199640
12709723.0,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,157,2025-12-02T16:05:11.478648
12709723,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,156,2025-12-02T16:05:15.087972
12709723,fluoxetine,dose,20,mg/day,median,,,minmax,20,40.0,,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,156,2025-12-02T16:05:21.408417
27528039.0,Bupropion,dose,150,mg,,,,,,,bid,oral,,16.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,247,2025-12-02T16:05:06.199640
27528039.0,Bupropion,dose,150,mg,,,,,,,qd,oral,,5.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,248,2025-12-02T16:05:06.199640
27528039.0,Bupropion,dose,100,mg,,,,,,,tid,oral,,3.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,249,2025-12-02T16:05:06.199640
27528039.0,Bupropion,dose,300,mg,,,,,,,qd,oral,,2.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,250,2025-12-02T16:05:06.199640
27528039.0,Bupropion,dose,150,mg,,,,,,,bid,oral,,16.0,maternal,pregnancy/postpartum,,,BUP SR ,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,247,2025-12-02T16:05:11.478648
27528039.0,Bupropion,dose,150,mg,,,,,,,qd,oral,,5.0,maternal,pregnancy/postpartum,,,BUP SR,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,248,2025-12-02T16:05:11.478648
27528039.0,Bupropion,dose,100,mg,,,,,,,tid,oral,,3.0,maternal,pregnancy/postpartum,,,BUP immediate-release,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,249,2025-12-02T16:05:11.478648
27528039.0,Bupropion,dose,300,mg,,,,,,,qd,oral,,2.0,maternal,pregnancy/postpartum,,,BUP extended release,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,250,2025-12-02T16:05:11.478648
12860776,citalopram,dose,,mg,mean,,,range,20.0,40.0,QD,,,20.0,SSRI group,,,,During pregnancy 2 mothers received 30 mg/d and another 2 mothers received 40 mg/d of citalopram. All others received 20 mg/day,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,101,2025-12-02T15:58:19.325005
12860776,fluoxetine,dose,,mg,mean,,,range,20.0,40.0,QD,,,20.0,SSRI group,,,,1 mother received 40 mg/d of fluoxetine. All others received 20 mg/d,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,102,2025-12-02T15:58:19.325005
30346625.0,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,164,2025-12-02T16:05:06.199640
30346625.0,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,165,2025-12-02T16:05:06.199640
30346625.0,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,164,2025-12-02T16:05:11.478648
30346625.0,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,165,2025-12-02T16:05:11.478648
30346625,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,163,2025-12-02T16:05:15.087972
30346625,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,164,2025-12-02T16:05:15.087972
30346625,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,163,2025-12-02T16:05:21.408417
30346625,fluoxetine,dose,20,mg/day,,,,,,,single dose,oral,,9.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,164,2025-12-02T16:05:21.408417
12189365.0,citalopram,dose,20,mg/day,median,,,minmax,20,40.0,once daily,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,169,2025-12-02T16:05:06.199640
12189365.0,citalopram,dose,20,mg/day,median,,,minmax,20,40.0,once daily,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,169,2025-12-02T16:05:11.478648
12189365,citalopram,dose,20,mg/day,median,,,minmax,20,40.0,once daily,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,168,2025-12-02T16:05:15.087972
12189365,citalopram,dose,20,mg/day,median,,,minmax,20,40.0,once daily,,,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,168,2025-12-02T16:05:21.408417
36094046,sertraline,dose,,mg,mean,,,range,25.0,225.0,QD,,,,pregnancy,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,106,2025-12-02T15:58:19.325005
36094046,sertraline,dose,,mg,median,,,range,25.0,250.0,QD,,,,postpartum,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,107,2025-12-02T15:58:19.325005
37982307,sertraline,dose,36.52,mg,mean,SD,,range,25.0,200.0,QD,,,43.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,112,2025-12-02T15:58:19.325005
37982307,paroxetine,dose,4.08,mg,mean,SD,,range,10.0,25.0,QD,,,13.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,113,2025-12-02T15:58:19.325005
37982307,escitalopram,dose,5.42,mg,mean,SD,,range,5.0,20.0,QD,,,11.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,114,2025-12-02T15:58:19.325005
37982307,citalopram,dose,0.0,mg,mean,SD,,range,20.0,20.0,QD,,,3.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,115,2025-12-02T15:58:19.325005
37982307,fluoxetine,dose,5.0,mg,mean,SD,,range,20.0,30.0,QD,,,4.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,116,2025-12-02T15:58:19.325005
37982307,venlafaxine,dose,35.01,mg,mean,SD,,range,75.0,150.0,QD,,,11.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,117,2025-12-02T15:58:19.325005
37982307,duloxetine,dose,21.21,mg,mean,SD,,range,30.0,60.0,QD,,,2.0,,3rd tri,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,118,2025-12-02T15:58:19.325005
19658039,bupropion,dose,,ng/mL,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,120,2025-12-02T15:58:19.325005
19658039,bupropion,dose,,ng/mL,,,,,,,,,,,,,,,,PRGLAC Data Curation - Sara's Team (1).xlsx,IU team,Drug dosing (summary data),Drug_summary,121,2025-12-02T15:58:19.325005
30116895.0,Sertraline,daily dose,54.16,mg,mean,SD,24.57,,,,,,,6.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,549,2025-12-02T16:03:32.268615
30116895.0,Sertraline,daily dose,50,mg,median,,,minmax,25,100.0,,,,6.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,550,2025-12-02T16:03:32.268615
30116895.0,venlafaxine,daily dose,75,mg/day,median,,,minmax,37.5,150.0,,,,5.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,58,2025-12-02T16:05:06.199640
30116895.0,citalopram,daily dose,20,mg/day,median,,,minmax,10,30.0,,,,6.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,59,2025-12-02T16:05:06.199640
30116895.0,venlafaxine,daily dose,75,mg/day,median,,,minmax,37.5,150.0,,,,5.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,58,2025-12-02T16:05:11.478648
30116895.0,citalopram,daily dose,20,mg/day,median,,,minmax,10,30.0,,,,6.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,59,2025-12-02T16:05:11.478648
30116895,venlafaxine,daily dose,75,mg/day,median,,,minmax,37.5,150.0,,,,5.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,57,2025-12-02T16:05:15.087972
30116895,citalopram,daily dose,20,mg/day,median,,,minmax,10,30.0,,,,6.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,58,2025-12-02T16:05:15.087972
30116895,venlafaxine,daily dose,75,mg/day,median,,,minmax,37.5,150.0,,,,5.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,57,2025-12-02T16:05:21.408417
30116895,citalopram,daily dose,20,mg/day,median,,,minmax,10,30.0,,,,6.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,58,2025-12-02T16:05:21.408417
35880962.0,ketamine,dosage,0.5,mg/kg,,,,,,,1,IM,the first dose,4.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,2,2025-12-02T16:03:32.268615
35880962.0,ketamine,dosage,1,mg/kg,,,,,,,1,IM,5-14 days after the first dose,4.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,3,2025-12-02T16:03:32.268615
30825333.0,Ketamine,dose,2,mg/kg,,,,,,,1,IV,over 5 minutes in preparation for surgery.,19.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,9,2025-12-02T16:03:32.268615
16143486.0,racemic lorazepam,dose,2,mg,,,,,,,1,oral,2–9.2 h before delivery,10.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,38,2025-12-02T16:03:32.268615
16143486.0,Lorazepam,dose,2,mg,,,,,,,single dose,oral,2–9.2 h before delivery ,10.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,259,2025-12-02T16:05:06.199640
16143486.0,Lorazepam,dose,2,mg,,,,,,,single dose,oral,2–9.2 h before delivery ,10.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,259,2025-12-02T16:05:11.478648
6117307.0,lorazepam,dose,3-8,mg/day,,,,,,,,oral or IV,for some days before delivery,5.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,39,2025-12-02T16:03:32.268615
6117307.0,a-methyldopa,dose,0.75-2,g/day,,,,,,,,oral,for several weeks before delivery,3.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,40,2025-12-02T16:03:32.268615
6117307.0,Lorazepam,dose,,mg/day,,,,minmax,3,8.0,,oral or IV,some days before delivery,5.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,265,2025-12-02T16:05:06.199640
6117307.0,Lorazepam,dose,,mg/day,,,,minmax,3,8.0,,oral or IV,some days before delivery,5.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,265,2025-12-02T16:05:11.478648
6113019.0,lorazepam,dose,5.25,mg/day,mean,SD,1.9,,,,,oral,1 mg twice daily to 2-5 mg three times a day. After delivery lorazepam was continued for 48-72 hours,7.0,maternal,delivery,,,oral lorazepam given to their mothers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,41,2025-12-02T16:03:32.268615
6113019.0,lorazepam,dose,18,mg/day,mean,SD,8.0,,,,,IV,,9.0,maternal,delivery,,,IV lorazepam given to their mothers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,42,2025-12-02T16:03:32.268615
6113019.0,lorazepam,dose,11.1,mg/day,mean,SD,9.4,,,,,oral or IV,,16.0,maternal,delivery,,,all preterm infants given to their mothers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,43,2025-12-02T16:03:32.268615
6108045.0,lorazepam,dose,2,mg,,,,,,,1,IM,during the first stage of labour,13.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,44,2025-12-02T16:03:32.268615
6108045.0,lorazepam,dose,2.5,mg,,,,,,,1,oral,during the first stage of labour,10.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,45,2025-12-02T16:03:32.268615
6108045.0,Lorazepam,dose,2,mg,,,,,,,single dose,IM,during the first stage of labour ,13.0,maternal,delivery,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,263,2025-12-02T16:05:06.199640
6108045.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,oral,in the evening 1I to 15.5 (mean 12.5) hours before the operation ,10.0,maternal,delivery,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,264,2025-12-02T16:05:06.199640
6108045.0,Lorazepam,dose,2,mg,,,,,,,single dose,IM,during the first stage of labour ,13.0,maternal,delivery,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,263,2025-12-02T16:05:11.478648
6108045.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,oral,in the evening 1I to 15.5 (mean 12.5) hours before the operation ,10.0,maternal,delivery,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,264,2025-12-02T16:05:11.478648
42422.0,lorazepam,dose,2.5,mg,,,,,,,1,IV,over a period of 15s before surgical induction of labor,10.0,maternal,delivery,,,first stage group ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,46,2025-12-02T16:03:32.268615
42422.0,lorazepam,dose,2.5,mg,,,,,,,1,IV,over a period of 15s at the beginning of the second stage of labor,12.0,maternal,delivery,,,second stage group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,47,2025-12-02T16:03:32.268615
42422.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,IV,over a period of 15 sec,10.0,nonpregnant,,,,premedicant group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,260,2025-12-02T16:05:06.199640
42422.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,IV,over a period of 15 sec,10.0,maternal,delivery,,,first stage group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,261,2025-12-02T16:05:06.199640
42422.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,IV,over a period of 15 sec,12.0,maternal,delivery,,,second stage group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,262,2025-12-02T16:05:06.199640
42422.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,IV,over a period of 15 sec,10.0,nonpregnant,,,,premedicant group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,260,2025-12-02T16:05:11.478648
42422.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,IV,over a period of 15 sec,10.0,maternal,delivery,,,first stage group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,261,2025-12-02T16:05:11.478648
42422.0,Lorazepam,dose,2.5,mg,,,,,,,single dose,IV,over a period of 15 sec,12.0,maternal,delivery,,,second stage group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,262,2025-12-02T16:05:11.478648
8329793.0,lorazepam,total dose,1.5,mg/kg,,,,,,,5,IV,consecutive doses of lorazepam were administered for sedation per unit protocol until the patient demonstrated synchronous breathing with the ventilator,1.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,58,2025-12-02T16:03:32.268615
8329793.0,lorazepam,duration,27,hours,,,,,,,,,,1.0,pediatric,,infant,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,59,2025-12-02T16:03:32.268615
33813550.0,Dexmedetomidine ,infusion time,21.09,hr,mean,SD,13.1,,,,,IV,,61.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,81,2025-12-02T16:03:32.268615
33813550.0,Dexmedetomidine ,dose,0.726,ug/kg/hr,mean,SD,0.278,,,,,IV,,61.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,82,2025-12-02T16:03:32.268615
32158472.0,Dexmedetomidine ,duration of infustion,64.8,h,mean,SD,6.9,,,,,IV,"Given that all potential study candidates were outborn neonates, the window for enrollment was within the first 24h after TH was started. After study enrollment, dexmedetomidine infusion was started at 0.2 μg/kg/h, in- creased to 0.3μg/kg/h after one hour, then increased to 0.4 μg/kg/h after 2.5 h, and maintained at that dose until the neonate had completed the 6 h rewarming period following 72 h of TH. ",7.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,83,2025-12-02T16:03:32.268615
32158472.0,Dexmedetomidine ,maintenance infusion rate,0.4,ug/kg/h,,,,,,,,IV,"Given that all potential study candidates were outborn neonates, the window for enrollment was within the first 24h after TH was started. After study enrollment, dexmedetomidine infusion was started at 0.2 μg/kg/h, in- creased to 0.3μg/kg/h after one hour, then increased to 0.4 μg/kg/h after 2.5 h, and maintained at that dose until the neonate had completed the 6 h rewarming period following 72 h of TH. ",7.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,84,2025-12-02T16:03:32.268615
32158472.0,Dexmedetomidine ,nominal infused dose,21.8,ug/kg,mean,SD,3.9,,,,,IV,"Given that all potential study candidates were outborn neonates, the window for enrollment was within the first 24h after TH was started. After study enrollment, dexmedetomidine infusion was started at 0.2 μg/kg/h, in- creased to 0.3μg/kg/h after one hour, then increased to 0.4 μg/kg/h after 2.5 h, and maintained at that dose until the neonate had completed the 6 h rewarming period following 72 h of TH. ",7.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,85,2025-12-02T16:03:32.268615
32158472.0,Dexmedetomidine ,corrected infused dose,20.7,ug/kg,mean,SD,3.8,,,,,IV,"Given that all potential study candidates were outborn neonates, the window for enrollment was within the first 24h after TH was started. After study enrollment, dexmedetomidine infusion was started at 0.2 μg/kg/h, in- creased to 0.3μg/kg/h after one hour, then increased to 0.4 μg/kg/h after 2.5 h, and maintained at that dose until the neonate had completed the 6 h rewarming period following 72 h of TH. ",7.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,86,2025-12-02T16:03:32.268615
31333469.0,Dexmedetomidine ,dose,1,ug/kg,,,,,,,1,intranasally,Thirty minutes before the end of surgery ,13.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,87,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,dose,2.8,ug/kg,mean,SD,0.34,,,,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,50.0,pediatric,,child,0.45,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,88,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,Time from dose to discharge ,4,h,median,,,minmax,3.8,4.4,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,50.0,pediatric,,child,0.32,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,89,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,time from dose to thiopental ,72,min,median,,,minmax,53,92.0,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,50.0,pediatric,,child,0.35,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,90,2025-12-02T16:03:32.268615
31206433.0,thiopental,dose,2.4,mg/kg,median,,,minmax,1.5,4.9,,IV,"given as rescue medication to supplement sedation, if required. If rescue medica- tion was needed, effect parameters measured after the dosing were not analyzed. ",50.0,pediatric,,child,0.36,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,91,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,dose,2.7,ug/kg,mean,SD,0.35,minmax,,,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,8.0,pediatric,,child,,age 0-2 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,92,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,Time from dose to discharge ,3.9,h,median,,,minmax,3.7,4.4,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,8.0,pediatric,,child,,age 0-2 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,93,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,time from dose to thiopental ,68,min,median,,,minmax,39,96.0,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,8.0,pediatric,,child,,age 0-2 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,94,2025-12-02T16:03:32.268615
31206433.0,thiopental,dose,2.6,mg/kg,median,,,minmax,1.5,3.0,,IV,"given as rescue medication to supplement sedation, if required. If rescue medica- tion was needed, effect parameters measured after the dosing were not analyzed. ",8.0,pediatric,,child,,age 0-2 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,95,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,dose,2.9,ug/kg,mean,SD,0.33,,,,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,24.0,pediatric,,child,,age 2-6 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,96,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,Time from dose to discharge ,3.9,h,median,,,minmax,3.7,4.3,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,24.0,pediatric,,child,,age 2-6 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,97,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,time from dose to thiopental ,66,min,median,,,minmax,50,96.0,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,24.0,pediatric,,child,,age 2-6 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,98,2025-12-02T16:03:32.268615
31206433.0,thiopental,dose,2.6,mg/kg,median,,,minmax,1.5,3.9,,IV,"given as rescue medication to supplement sedation, if required. If rescue medica- tion was needed, effect parameters measured after the dosing were not analyzed. ",24.0,pediatric,,child,,age 2-6 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,99,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,dose,2.8,ug/kg,mean,SD,0.33,,,,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,18.0,pediatric,,child,,age 6-11 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,100,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,Time from dose to discharge ,4.2,h,median,,,minmax,3.9,4.8,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,18.0,pediatric,,child,,age 6-11 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,101,2025-12-02T16:03:32.268615
31206433.0,Dexmedetomidine ,time from dose to thiopental ,86,min,median,,,minmax,69,96.0,1,intranasally,approx-imately 45–60 minutes before the scheduled MRI proce- dure to achieve sufficient sedative effect ,18.0,pediatric,,child,,age 6-11 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,102,2025-12-02T16:03:32.268615
31206433.0,thiopental,dose,1.8,mg/kg,median,,,minmax,1,6.0,,IV,"given as rescue medication to supplement sedation, if required. If rescue medica- tion was needed, effect parameters measured after the dosing were not analyzed. ",18.0,pediatric,,child,,age 6-11 y,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,103,2025-12-02T16:03:32.268615
18288078.0,midazolam,dose,2,mg/day,,,,,,,once daily,oral,28-32 weeks gestation and repeated the studies 6-10 weeks postpartum,14.0,maternal,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,185,2025-12-02T16:03:32.268615
18288078.0,digoxin,dose,0.25,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,178,2025-12-02T16:05:06.199640
18288078.0,midazolam,dose,2,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,179,2025-12-02T16:05:06.199640
18288078.0,digoxin,dose,0.25,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,178,2025-12-02T16:05:11.478648
18288078.0,midazolam,dose,2,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,179,2025-12-02T16:05:11.478648
18288078,digoxin,dose,0.25,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,177,2025-12-02T16:05:15.087972
18288078,midazolam,dose,2,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,178,2025-12-02T16:05:15.087972
18288078,digoxin,dose,0.25,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,177,2025-12-02T16:05:21.408417
18288078,midazolam,dose,2,mg,,,,,,,,oral,received one oral dose of midazolam (2 mg) and digoxin (0.25 mg) 28–32 weeks gestation and repeated the studies 6–10 weeks postpartum.,13.0,maternal,3rd trimest,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,178,2025-12-02T16:05:21.408417
16765143.0,midazolam,dose,2,mg,,,,,,,1,IV,over 30 seconds,5.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,186,2025-12-02T16:03:32.268615
16765143.0,propofol,dose,180,mg,median,,,minmax,180,200.0,1,IV,over 30 seconds,5.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,187,2025-12-02T16:03:32.268615
16765143.0,fentanyl,dose,0.1,mg,,,,,,,1,IV,over 30 seconds,5.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,188,2025-12-02T16:03:32.268615
16765143.0,midazolam,dose,2,mg,,,,,,,,IV,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,175,2025-12-02T16:05:06.199640
16765143.0,fentanyl,dose,100,ug,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,176,2025-12-02T16:05:06.199640
16765143.0,propofol,dose,2.5,mg/kg,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,177,2025-12-02T16:05:06.199640
16765143.0,midazolam,dose,2,mg,,,,,,,,IV,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,175,2025-12-02T16:05:11.478648
16765143.0,fentanyl,dose,100,ug,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,176,2025-12-02T16:05:11.478648
16765143.0,propofol,dose,2.5,mg/kg,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,177,2025-12-02T16:05:11.478648
16765143,midazolam,dose,2,mg,,,,,,,,IV,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,174,2025-12-02T16:05:15.087972
16765143,fentanyl,dose,100,ug,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,175,2025-12-02T16:05:15.087972
16765143,propofol,dose,2.5,mg/kg,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,176,2025-12-02T16:05:15.087972
16765143,midazolam,dose,2,mg,,,,,,,,IV,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,174,2025-12-02T16:05:21.408417
16765143,fentanyl,dose,100,ug,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,175,2025-12-02T16:05:21.408417
16765143,propofol,dose,2.5,mg/kg,,,,,,,,,over 30 min,5.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,176,2025-12-02T16:05:21.408417
6711257.0,midazolam,dose,0.075,mg/kg,,,,,,,1,IV,"after delivery, lasting for about 2-3 h",11.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,189,2025-12-02T16:03:32.268615
6711257.0,Midazolam,dose,0.075,mg/kg,,,,,,,,IV,after delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,185,2025-12-02T16:05:06.199640
6711257.0,Midazolam,dose,0.075,mg/kg,,,,,,,,IV,after delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,185,2025-12-02T16:05:11.478648
6711257,Midazolam,dose,0.075,mg/kg,,,,,,,,IV,after delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,184,2025-12-02T16:05:15.087972
6711257,Midazolam,dose,0.075,mg/kg,,,,,,,,IV,after delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,184,2025-12-02T16:05:21.408417
36428856.0,midazolam,dose,200,ug/kg/h,median,,,minmax,50,1200.0,,CIV,,72.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,190,2025-12-02T16:03:32.268615
36388077.0,midazolam,cumulative dose,5,mg/kg,median,,,minmax,0,103.0,,IV,,54.0,pediatric,,child,,delirium (score >=9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,191,2025-12-02T16:03:32.268615
36388077.0,midazolam,cumulative dose,1.1,mg/kg,median,,,minmax,0,90.0,,IV,,7.0,pediatric,,child,0.01,not delirium (score <9),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,192,2025-12-02T16:03:32.268615
36388077.0,midazolam,exposure duration,2,days,median,,,minmax,1,14.0,,IV,,61.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,193,2025-12-02T16:03:32.268615
36036654.0,midazolam,dose,34.6,mcg/kg,mean,,,minmax,34.6,41.7,1,IV,,35.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,194,2025-12-02T16:03:32.268615
36036654.0,midazolam,duration,11.8,h,mean,,,minmax,0.25,372.0,1,IV,,54.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,195,2025-12-02T16:03:32.268615
36036654.0,midazolam,rate of infusion,129,mcg/kg/h,mean,,,minmax,8.33,760.0,1,CIV,,54.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,196,2025-12-02T16:03:32.268615
35488482.0,midazolam,dose,0.5,mg/kg,,,,,,,1,oral,administered 30min before the patients entered the OR,98.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,197,2025-12-02T16:03:32.268615
33638195.0,midazolam,dose,200,ug/kg/h,,,,,,,,CIV,,72.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,198,2025-12-02T16:03:32.268615
32403162.0,[14C]midazolam microtracer,dose,282.7,Bq,median,,,minmax,165,1080.0,,oral microtracer,,46.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,199,2025-12-02T16:03:32.268615
32403162.0,[14C]midazolam microtracer,dose,87.6,ng,median,,,minmax,51.15,334.8,,oral microtracer,,46.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,200,2025-12-02T16:03:32.268615
32354497.0,midazolam,infusion rate,,mg/kg/h,,,,minmax,0.15,0.3,,IV,for 48 hours after birth,1.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,201,2025-12-02T16:03:32.268615
31269280.0,[14C]midazolam,dose,37.6,ng/kg,,,,,,,1,IV,,9.0,pediatric,,child,,microdose,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,202,2025-12-02T16:03:32.268615
31269280.0,[14C]midazolam,dose,37.6,ng/kg,,,,,,,1,IV,,6.0,pediatric,,child,,microtracer,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,203,2025-12-02T16:03:32.268615
30472551.0,midazolam,initiated dose,0.15,mg/kg,,,,,,,1,IV,additional doses 0.1-0.3 mg/kg/dose were administered up to a maximum cumulative dose of 0.6 mg/kg until seizure cessation was achieved,19.0,pediatric,,child,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,204,2025-12-02T16:03:32.268615
30472551.0,midazolam,initiated infusion rate,0.1,mg/kg/h,,,,,,,,CIV,the dose was increased in increments of 0.05 to 0.1 mg/kg/h up to 0.4 mg/kg/h for 24 h,12.0,pediatric,,child,,"Patients who achieved seizure cessation but were deemed to have a higher risk of recurrence on the basis of past medical history, or those whose seizures were reduced after adminis- tration of bolus doses up to the maximum cumulative dose (0.6 mg/kg), were judged as eligible to receive Civ ",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,205,2025-12-02T16:03:32.268615
19838691.0,midazolam,dose,0.1,mg/kg,,,,,,,,IV,over a 30-min period,15.0,pediatric,,infant,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,212,2025-12-02T16:03:32.268615
19838691.0,midazolam,dose,0.1,mg/kg,,,,,,,,oral,,7.0,pediatric,,infant,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,213,2025-12-02T16:03:32.268615
11753268.0,midazolam,dose,0.1,mg/kg,,,,,,,1,IV,,24.0,pediatric,,infant,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,237,2025-12-02T16:03:32.268615
9323623.0,midazolam,dose,100,ug/kg,,,,,,,1,IV,over 2 min ,10.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,242,2025-12-02T16:03:32.268615
6851409.0,midazolam,dose,15,mg,,,,,,,1,oral,given  at between 9 and 10 pm the evening before the elective cesarean section,13.0,maternal,labor,,,Group 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,254,2025-12-02T16:03:32.268615
6851409.0,midazolam,dose,15,mg,,,,,,,1,oral,given 15-60 min befor elective cesarean section,11.0,maternal,labor,,,Group 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,255,2025-12-02T16:03:32.268615
6851409.0,midazolam,dose,0.05,mg/kg,,,,,,,1,IM,given 18 to 45 min before elective cesarean section,6.0,maternal,labor,,,Group 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,256,2025-12-02T16:03:32.268615
6851409.0,midazolam,dose,0.075,mg/kg,,,,,,,1,IV,after delivery of the child,8.0,maternal,labor,,,Group 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,257,2025-12-02T16:03:32.268615
6851409.0,Midazolam,dose,15,mg,,,,,,,,oral,at between 9 and 10 P.M. the evening before the elective cesarean section,13.0,maternal,delivery,,,Group 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,186,2025-12-02T16:05:06.199640
6851409.0,Midazolam,dose,15,mg,,,,,,,,oral,15 to 60 min before electi e cesarean section,11.0,maternal,delivery,,,Group 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,187,2025-12-02T16:05:06.199640
6851409.0,Midazolam,dose,0.05,mg/kg,,,,,,,,IM,18 to 45 min (mean 30.5) before elective cesarean section,6.0,maternal,delivery,,,Group 3,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,188,2025-12-02T16:05:06.199640
6851409.0,Midazolam,dose,15,mg,,,,,,,,oral,at between 9 and 10 P.M. the evening before the elective cesarean section,13.0,maternal,delivery,,,Group 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,186,2025-12-02T16:05:11.478648
6851409.0,Midazolam,dose,15,mg,,,,,,,,oral,15 to 60 min before electi e cesarean section,11.0,maternal,delivery,,,Group 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,187,2025-12-02T16:05:11.478648
6851409.0,Midazolam,dose,0.05,mg/kg,,,,,,,,IM,18 to 45 min (mean 30.5) before elective cesarean section,6.0,maternal,delivery,,,Group 3,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,188,2025-12-02T16:05:11.478648
6851409,Midazolam,dose,15,mg,,,,,,,,oral,at between 9 and 10 P.M. the evening before the elective cesarean section,13.0,maternal,delivery,,,Group 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,185,2025-12-02T16:05:15.087972
6851409,Midazolam,dose,15,mg,,,,,,,,oral,15 to 60 min before electi e cesarean section,11.0,maternal,delivery,,,Group 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,186,2025-12-02T16:05:15.087972
6851409,Midazolam,dose,0.05,mg/kg,,,,,,,,IM,18 to 45 min (mean 30.5) before elective cesarean section,6.0,maternal,delivery,,,Group 3,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,187,2025-12-02T16:05:15.087972
6851409,Midazolam,dose,15,mg,,,,,,,,oral,at between 9 and 10 P.M. the evening before the elective cesarean section,13.0,maternal,delivery,,,Group 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,185,2025-12-02T16:05:21.408417
6851409,Midazolam,dose,15,mg,,,,,,,,oral,15 to 60 min before electi e cesarean section,11.0,maternal,delivery,,,Group 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,186,2025-12-02T16:05:21.408417
6851409,Midazolam,dose,0.05,mg/kg,,,,,,,,IM,18 to 45 min (mean 30.5) before elective cesarean section,6.0,maternal,delivery,,,Group 3,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,187,2025-12-02T16:05:21.408417
3688386.0,midazolam,dose,5,mg,,,,,,,1,IV,over 10 seconds,12.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,266,2025-12-02T16:03:32.268615
3688386.0,midazolam,dose,5,mg,,,,,,,1,IV,given 5 min pre-operatively,8.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,267,2025-12-02T16:03:32.268615
3688386.0,midazolam,dose,5,mg,,,,,,,1,IV,given 3 h pre-operatively,10.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,268,2025-12-02T16:03:32.268615
3688386.0,midazolam,dose,5,mg,,,,,,,1,IV,,10.0,non-pregnant,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,269,2025-12-02T16:03:32.268615
3688386.0,midazolam,dose,5,mg,,,,,,,1,IV,,10.0,non-pregnant,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,270,2025-12-02T16:03:32.268615
3688386.0,Midazolam,dose,5,mg,,,,,,,,IV,given over 10 seconds,50.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,184,2025-12-02T16:05:06.199640
3688386.0,Midazolam,dose,5,mg,,,,,,,,IV,given over 10 seconds,50.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,184,2025-12-02T16:05:11.478648
3688386,Midazolam,dose,5,mg,,,,,,,,IV,given over 10 seconds,50.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,183,2025-12-02T16:05:15.087972
3688386,Midazolam,dose,5,mg,,,,,,,,IV,given over 10 seconds,50.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,183,2025-12-02T16:05:21.408417
2919760.0,midazolam,dose,0.3,mg/kg,,,,,,,,IV,,20.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,278,2025-12-02T16:03:32.268615
2919760.0,thiopental,dose,4,mg/kg,,,,,,,,IV,,20.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,279,2025-12-02T16:03:32.268615
2919760.0,thiopental,dose,4,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,thiopental,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,182,2025-12-02T16:05:06.199640
2919760.0,Midazolam,dose,0.3,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,Midazolam,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,183,2025-12-02T16:05:06.199640
2919760.0,thiopental,dose,4,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,thiopental,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,182,2025-12-02T16:05:11.478648
2919760.0,Midazolam,dose,0.3,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,Midazolam,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,183,2025-12-02T16:05:11.478648
2919760,thiopental,dose,4,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,thiopental,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,181,2025-12-02T16:05:15.087972
2919760,Midazolam,dose,0.3,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,Midazolam,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,182,2025-12-02T16:05:15.087972
2919760,thiopental,dose,4,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,thiopental,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,181,2025-12-02T16:05:21.408417
2919760,Midazolam,dose,0.3,mg/kg,,,,,,,,IV,,20.0,maternal,delivery,,,Midazolam,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,182,2025-12-02T16:05:21.408417
2288825.0,midazolam,dose,15,mg,,,,,,,1,oral,each night of the 5 day hospital period,12.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,286,2025-12-02T16:03:32.268615
2288825.0,Nitrazepam,dose,5,mg,,,,,,,daily,oral,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,180,2025-12-02T16:05:06.199640
2288825.0,Midazolam,dose,15,mg,,,,,,,daily,oral,,12.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,181,2025-12-02T16:05:06.199640
2288825.0,Nitrazepam,dose,5,mg,,,,,,,daily,oral,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,180,2025-12-02T16:05:11.478648
2288825.0,Midazolam,dose,15,mg,,,,,,,daily,oral,,12.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,181,2025-12-02T16:05:11.478648
2288825,Nitrazepam,dose,5,mg,,,,,,,daily,oral,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,179,2025-12-02T16:05:15.087972
2288825,Midazolam,dose,15,mg,,,,,,,daily,oral,,12.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,180,2025-12-02T16:05:15.087972
2288825,Nitrazepam,dose,5,mg,,,,,,,daily,oral,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,179,2025-12-02T16:05:21.408417
2288825,Midazolam,dose,15,mg,,,,,,,daily,oral,,12.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,180,2025-12-02T16:05:21.408417
1577053.0,midazolam,bolus dose,0.2,mg/kg,,,,,,,1,IV,over 2 to 5 min,15.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,300,2025-12-02T16:03:32.268615
1577053.0,midazolam,infusion rate,0.06,mg/kg/h,,,,,,,,CIV,administered after the bolus for as long as sedation was considered necessary,15.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,301,2025-12-02T16:03:32.268615
1577053.0,midazolam,duration,60,h,mean,23.3,,,,,,CIV,administered after the bolus for as long as sedation was considered necessary,15.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,302,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,4.0,,IV,,146.0,pediatric,,children,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,305,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,4.0,,IV,,118.0,pediatric,,children,,ABCC2 rs2273697 GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,306,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,3.5,,IV,,28.0,pediatric,,children,,ABCC2 rs2273697 GA+AA genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,307,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,4.0,,IV,,68.0,pediatric,,children,,ABCC2 rs2231142 GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,308,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,3.5,,IV,,78.0,pediatric,,children,,ABCC2 rs2231142 GT+TT genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,309,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,4.0,,IV,,53.0,pediatric,,children,,ABCB1 rs1128503 AA genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,310,2025-12-02T16:03:32.268615
36463535.0,Methotrexate,dose,2.5,g/m2,median,,,minmax,2,4.0,,IV,,93.0,pediatric,,children,,ABCB1 rs1128503 AG+GG genotype,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,311,2025-12-02T16:03:32.268615
36193736.0,Methotrexate,dose,2,g/m2,,,,,,,1,PI,"d1, d15, d29, d43",89.0,pediatric,,children,,low-risk group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,312,2025-12-02T16:03:32.268615
36193736.0,Methotrexate,dose,5,g/m2,,,,,,,1,PI,"d1, d15, d29, d43",212.0,pediatric,,children,,intermediate and high risk groups,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,313,2025-12-02T16:03:32.268615
34637107.0,Methotrexate,infusion rate,5,g/m2/24h,,,,,,,1,IV,24-h infusion,3.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,314,2025-12-02T16:03:32.268615
31867853.0,Methotrexate,dose,12,g/m2,,,,,,,,IV,over 4 hours,33.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,315,2025-12-02T16:03:32.268615
30835935.0,Methotrexate,dose,5,g/m2,,,,,,,1,IV,3 courses at three-week intervals,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,316,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,cycles given,54,,n,,,,,,,CIV,24-h continuous infusion,22.0,pediatric,,children,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,317,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,# of cycles per patient,2.5,,median,,,IQR,1,4.0,,CIV,24-h continuous infusion,22.0,pediatric,,children,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,318,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,cycles given,14,,n,,,,,,,CIV,24-h continuous infusion,8.0,pediatric,,children,,no dose adjustment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,319,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,# of cycles per patient,1.5,,median,,,IQR,1,4.0,,CIV,24-h continuous infusion,8.0,pediatric,,children,,no dose adjustment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,320,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,cycles given,40,,n,,,,,,,CIV,24-h continuous infusion,14.0,pediatric,,children,,dose adjustment group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,321,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,# of cycles per patient,3,,median,,,IQR,1,4.0,,CIV,24-h continuous infusion,14.0,pediatric,,children,,dose adjustment group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,322,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,initial dose per cycle,5,g/m2,median,,,IQR,,,,CIV,24-h continuous infusion,22.0,pediatric,,children,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,323,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,total dose,4.5,g/m2,median,,,IQR,4.2,5.0,,CIV,24-h continuous infusion,22.0,pediatric,,children,,54 subject-cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,324,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,total dose,5,g/m2,median,,,IQR,5,5.0,,CIV,24-h continuous infusion,8.0,pediatric,,children,,21no-dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,325,2025-12-02T16:03:32.268615
30488179.0,Methotrexate,total dose,4.3,g/m2,median,,,IQR,3.8,4.5,,CIV,24-h continuous infusion,14.0,pediatric,,children,<0.0001,33 dose-adjusted cycles,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,326,2025-12-02T16:03:32.268615
32612964.0,methotrexate,dose,2,g/m2,,,,,,,1,,,123.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,396,2025-12-02T16:03:32.268615
32612964.0,methotrexate,dose,5,g/m2,,,,,,,1,,,13.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,397,2025-12-02T16:03:32.268615
32612964.0,methotrexate,cycles given,478,,n,,,,,,,,,123.0,pediatric,,children,,MTX dose 2 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,398,2025-12-02T16:03:32.268615
32612964.0,methotrexate,cycles given,47,,n,,,,,,,,,13.0,pediatric,,children,,MTX dose 5 g/m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,399,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.3,mg,median,CV%,0.44,minmax,0.1,0.5,1,IV,,9.0,pediatric,,children,,group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,400,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.05,mg/kg,median,CV%,0.39,minmax,0.01,0.05,1,IV,,9.0,pediatric,,children,,group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,401,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.92,mg/m2,median,CV%,0.4,minmax,0.25,1.11,1,IV,,9.0,pediatric,,children,,group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,402,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.7,mg,median,CV%,0.3,minmax,0.2,1.1,1,IV,,36.0,pediatric,,children,,group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,403,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.05,mg/kg,median,CV%,0.28,minmax,0.02,0.11,1,IV,,36.0,pediatric,,children,,group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,404,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,1.23,mg/m2,median,CV%,0.27,minmax,0.45,2.21,1,IV,,36.0,pediatric,,children,,group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,405,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,1.22,mg,median,CV%,0.28,minmax,0.5,2.0,1,IV,,62.0,pediatric,,children,,group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,406,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.06,mg/kg,median,CV%,0.17,minmax,0.03,0.08,1,IV,,62.0,pediatric,,children,,group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,407,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,1.49,mg/m2,median,CV%,0.13,minmax,0.72,2.01,1,IV,,62.0,pediatric,,children,,group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,408,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,2,mg,median,CV%,0.17,minmax,1,2.8,1,IV,,25.0,pediatric,,children and adolescents,,group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,409,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,0.03,mg/kg,median,CV%,0.3,minmax,0.02,0.06,1,IV,,25.0,pediatric,,children and adolescents,,group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,410,2025-12-02T16:03:32.268615
34023919.0,Vincristine,dose,1.2,mg/m2,median,CV%,0.2,minmax,0.66,1.54,1,IV,,25.0,pediatric,,children and adolescents,,group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,411,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.2,mg,median,CV%,0.34,minmax,0.17,0.36,,,,4.0,pediatric,,children,,group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,412,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.03,mg/kg,median,CV%,0.34,minmax,0.02,0.03,,,,4.0,pediatric,,children,,group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,413,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.5,mg/m2,median,CV%,0.28,minmax,0.49,0.87,,,,4.0,pediatric,,children,,group1: <1 year,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,414,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.5,mg,median,CV%,0.29,minmax,0.2,0.9,,,,13.0,pediatric,,children,,group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,415,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.04,mg/kg,median,CV%,0.22,minmax,0.02,0.06,,,,13.0,pediatric,,children,,group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,416,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,1.01,mg/m2,median,CV%,0.22,minmax,0.48,1.51,,,,13.0,pediatric,,children,,group 2: >=1 to < 3 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,417,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.9,mg,median,CV%,0.45,minmax,0.56,2.5,,,,28.0,pediatric,,children,,group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,418,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.05,mg/kg,median,CV%,0.17,minmax,0.02,0.06,,,,28.0,pediatric,,children,,group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,419,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,1.14,mg/m2,median,CV%,0.18,minmax,0.54,1.6,,,,28.0,pediatric,,children,,group 3: >=3 to < 12 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,420,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,2.2,mg,median,CV%,0.17,minmax,1.5,2.5,,,,7.0,pediatric,,children and adolescents,,group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,421,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,0.04,mg/kg,median,CV%,0.31,minmax,0.01,0.05,,,,7.0,pediatric,,children and adolescents,,group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,422,2025-12-02T16:03:32.268615
34023919.0,Actinomycin-D,dose,1.45,mg/m2,median,CV%,0.23,minmax,0.61,1.55,,,,7.0,pediatric,,children and adolescents,,group 4: >=12 to < 17 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,423,2025-12-02T16:03:32.268615
33037681.0,Vincristine,dose,1.5,mg/m2,,,,,,,1,IV,received 15 min infusion at Day 0,74.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,424,2025-12-02T16:03:32.268615
33037681.0,Vincristine,dose,1.5,mg/m2,,,,,,,,IV,received 3 h infusion at Day 1,61.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,425,2025-12-02T16:03:32.268615
31958904.0,Risperidone,dose,1.5,mg/day,mean,SD,1.0,minmax,0.5,7.0,1,oral,daily,140.0,pediatric,,children and adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,426,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,3.9,mg/day,mean,SD,1.9,minmax,1,8.0,1,oral,daily,64.0,pediatric,,children and adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,427,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4,mg/day,median,,,IQR,2,5.4,1,oral,daily,64.0,pediatric,,children and adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,428,2025-12-02T16:03:32.268615
35303169.0,Risperidone,body weight-adjusted dose,0.02,mg/kg,mean,SD,0.01,minmax,0.009,0.043,1,oral,daily,64.0,pediatric,,children and adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,429,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4,mg/day,mean,SD,2.0,,,,1,oral,daily,45.0,pediatric,,children and adolescents,,boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,430,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4,mg/day,median,,,IQR,2,5.5,1,oral,daily,45.0,pediatric,,children and adolescents,,boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,431,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,3.6,mg/day,mean,SD,1.5,,,,1,oral,daily,19.0,pediatric,,children and adolescents,,girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,432,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,3,mg/day,median,,,IQR,2.5,4.5,1,oral,daily,19.0,pediatric,,children and adolescents,,girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,433,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4.2,mg/day,mean,SD,1.5,,,,1,oral,daily,13.0,pediatric,,children and adolescents,,mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,434,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4.5,mg/day,median,,,IQR,3,5.8,1,oral,daily,13.0,pediatric,,children and adolescents,,mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,435,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,3.7,mg/day,mean,SD,1.9,,,,1,oral,daily,50.0,pediatric,,children and adolescents,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,436,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,3.5,mg/day,median,,,IQR,2,5.0,1,oral,daily,50.0,pediatric,,children and adolescents,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,437,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,3.8,mg/day,mean,SD,2.0,,,,1,oral,daily,43.0,pediatric,,children and adolescents,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,438,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4,mg/day,median,,,IQR,2,5.0,1,oral,daily,43.0,pediatric,,children and adolescents,,Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,439,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4,mg/day,mean,SD,1.8,,,,1,oral,daily,16.0,pediatric,,children and adolescents,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,440,2025-12-02T16:03:32.268615
35303169.0,Risperidone,dose,4.5,mg/day,median,,,IQR,3,5.5,1,oral,daily,16.0,pediatric,,children and adolescents,,Non-Responders,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,441,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,11.5,mg/day,mean,SD,6.2,,,,1,oral,daily,130.0,pediatric,,children and adolescents,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,442,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,10,mg/day,median,,,IQR,5,15.0,1,oral,daily,130.0,pediatric,,children and adolescents,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,443,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,11,mg/day,mean,SD,6.1,,,,1,oral,daily,77.0,pediatric,,children and adolescents,,boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,444,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,10,mg/day,median,,,IQR,5,15.0,1,oral,daily,77.0,pediatric,,children and adolescents,,boys,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,445,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,12.2,mg/day,mean,SD,6.4,,,,1,oral,daily,53.0,pediatric,,children and adolescents,,girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,446,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,12.5,mg/day,median,,,IQR,6.3,15.0,1,oral,daily,53.0,pediatric,,children and adolescents,,girls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,447,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,8.5,mg/day,mean,SD,4.4,,,,1,oral,daily,37.0,pediatric,,children and adolescents,,Children < 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,448,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,5,mg/day,median,,,IQR,2.9,7.5,1,oral,daily,37.0,pediatric,,children and adolescents,,Children < 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,449,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,12.7,mg/day,mean,SD,6.4,,,,1,oral,daily,93.0,pediatric,,children and adolescents,,Children >= 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,450,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,7.5,mg/day,median,,,IQR,5,12.5,1,oral,daily,93.0,pediatric,,children and adolescents,,Children >= 14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,451,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,10.8,mg/day,mean,SD,5.5,,,,1,oral,daily,45.0,pediatric,,children and adolescents,,mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,452,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,10,mg/day,median,,,IQR,5,15.0,1,oral,daily,45.0,pediatric,,children and adolescents,,mono-therapy,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,453,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,11.8,mg/day,mean,SD,6.5,,,,1,oral,daily,85.0,pediatric,,children and adolescents,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,454,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,10,mg/day,median,,,IQR,5,10.0,1,oral,daily,85.0,pediatric,,children and adolescents,,Co-medication,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,455,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,15.1,mg/day,mean,SD,5.4,,,,1,oral,daily,57.0,pediatric,,children and adolescents,,Schizophrenia/psychotic disorders (ICD-10 F2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,456,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,15,mg/day,median,,,IQR,10,20.0,1,oral,daily,57.0,pediatric,,children and adolescents,,Schizophrenia/psychotic disorders (ICD-10 F2) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,457,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,10.4,mg/day,mean,SD,8.5,,,,1,oral,daily,13.0,pediatric,,children and adolescents,,Affective disorders (ICD-10 F3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,458,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,7.5,mg/day,median,,,IQR,3.8,17.5,1,oral,daily,13.0,pediatric,,children and adolescents,,Affective disorders (ICD-10 F3) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,459,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,7.2,mg/day,mean,SD,4.1,,,,1,oral,daily,31.0,pediatric,,children and adolescents,,Behavior and tic disorders (ICD-10 F9) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,460,2025-12-02T16:03:32.268615
32997183.0,Aripiprazole,dose,5,mg/day,median,,,IQR,5,10.5,1,oral,daily,31.0,pediatric,,children and adolescents,,Behavior and tic disorders (ICD-10 F9) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,461,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 4,16.25,mg/day,mean,SD,4.79,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 9 ",4.0,pediatric,,children and adolescents,,Poor metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,462,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 4,13.93,mg/day,mean,SD,6.56,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 10",17.0,pediatric,,children and adolescents,,Intermediate metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,463,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 4,15.48,mg/day,mean,SD,7.42,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 11",29.0,pediatric,,children and adolescents,,Normal metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,464,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 4,20,mg/day,mean,SD,,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 12",1.0,pediatric,,children and adolescents,0.785,Ultrarapid metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,465,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 12,12.5,mg/day,mean,SD,3.54,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 13",4.0,pediatric,,children and adolescents,,Poor metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,466,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 12,14.09,mg/day,mean,SD,9.17,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 14",17.0,pediatric,,children and adolescents,,Intermediate metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,467,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 12,15.69,mg/day,mean,SD,6.52,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 15",29.0,pediatric,,children and adolescents,,Normal metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,468,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 12,30,mg/day,mean,SD,,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 16",1.0,pediatric,,children and adolescents,0.241,Ultrarapid metabolizers,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,469,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 4,15.05,mg/day,mean,SD,6.7,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 17",51.0,pediatric,,children and adolescents,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,470,2025-12-02T16:03:32.268615
34735099.0,Aripiprazole,dose at Week 12,15.22,mg/day,mean,SD,7.5,,,,1,oral,"the initial dose was 2.5 mg/d, increasing every second day to 5, 10, 15, and finally 20 mg/d on day 18",51.0,pediatric,,children and adolescents,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,471,2025-12-02T16:03:32.268615
30681278.0,Levetiracetam,dose,625,mg/day,median,,,interquartile range ,500,813.0,1,oral,daily for 3–4 weeks,35.0,pediatric,,children,,LEV+LTG group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,472,2025-12-02T16:03:32.268615
30681278.0,Levetiracetam,dose,17.9,mg/kg/day,median,,,interquartile range ,13.2,29.2,1,oral,daily for 3–4 weeks,35.0,pediatric,,children,,LEV+LTG group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,473,2025-12-02T16:03:32.268615
30681278.0,Levetiracetam,dose,625,mg/day,median,,,interquartile range ,375,750.0,1,oral,daily for 3–4 weeks,35.0,pediatric,,children,,LEV+LTG+VPA  group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,474,2025-12-02T16:03:32.268615
30681278.0,Levetiracetam,dose,29.4,mg/kg/day,median,,,interquartile range ,19.7,33.7,1,oral,daily for 3–4 weeks,35.0,pediatric,,children,,LEV+LTG+VPA  group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,475,2025-12-02T16:03:32.268615
30681278.0,Topiramate,dose,125,mg/day,median,,,interquartile range ,88,200.0,,oral,,37.0,pediatric,,children,,TPM + LTG,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,476,2025-12-02T16:03:32.268615
30681278.0,Topiramate,dose,17.9,mg/kg/day,median,,,interquartile range ,13.2,29.2,,oral,,37.0,pediatric,,children,,TPM + LTG,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,477,2025-12-02T16:03:32.268615
30681278.0,Topiramate,dose,125,mg/day,median,,,interquartile range ,75,150.0,,oral,,32.0,pediatric,,children,,TPM + LTG+VPA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,478,2025-12-02T16:03:32.268615
30681278.0,Topiramate,dose,29.4,mg/kg/day,median,,,interquartile range ,19.7,33.7,,oral,,32.0,pediatric,,children,,TPM + LTG+VPA,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,479,2025-12-02T16:03:32.268615
32890316.0,Levetiracetam,dose,36.42,mg/kg/day,mean,SD,13.55,,,,1,oral,daily for 3–4 weeks,117.0,pediatric,,children,,Drug-resistant group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,480,2025-12-02T16:03:32.268615
32890316.0,Levetiracetam,dose,37.85,mg/kg/day,mean,SD,12.07,,,,1,oral,daily for 3–4 weeks,128.0,pediatric,,children,0.609,Drug-responsive group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,481,2025-12-02T16:03:32.268615
33336359.0,Levetiracetam,dose,,mg/day,,,,minmax,400,2250.0,1,IV,over 10 minutes,27.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,482,2025-12-02T16:03:32.268615
33336359.0,Valproic Acid,maintenance dose,,mg/day,,,,minmax,200,1050.0,,IV,,27.0,maternal,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,498,2025-12-02T16:03:32.268615
33336359.0,Valproic Acid,maintenance infusion rate,33.33,mg/ml,,,,,,,,IV,,27.0,maternal,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,499,2025-12-02T16:03:32.268615
33336359.0,Fosphenytoin ,dose,20,mg/kg,,,,,,,single dose,IV,over 10 minutes ,11.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,834,2025-12-02T16:03:32.268615
34114632.0,Levetiracetam,dose,,mg/kg/12 h,,,,minmax,5,15.0,bid,oral or NG/OG,,8.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,483,2025-12-02T16:03:32.268615
34114632.0,Levetiracetam,dose,,mg/kg/12 h,,,,minmax,15,25.0,bid,oral or NG/OG,,9.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,484,2025-12-02T16:03:32.268615
34114632.0,Levetiracetam,dose,,mg/kg/12 h,,,,minmax,25,35.0,bid,oral or NG/OG,,2.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,485,2025-12-02T16:03:32.268615
34131926.0,Levetiracetam,dose,2525,mg/day,mean,SD,663.0,minmax,1500,3750.0,1,oral,daily,20.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,486,2025-12-02T16:03:32.268615
34131926.0,Levetiracetam,dose per kg,39.2,mg/kg/day,mean,SD,10.7,minmax,20.3,57.9,1,oral,daily,20.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,487,2025-12-02T16:03:32.268615
31191874.0,Levetiracetam,total daily dose,2051.28,mg,mean,,,minmax,250,4000.0,,oral,daily,,maternal,pre-pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,488,2025-12-02T16:03:32.268615
31191874.0,Levetiracetam,total daily dose,2149.02,mg,mean,,,minmax,250,4000.0,,oral,daily,21.0,maternal,trimester 1,,0.486,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,489,2025-12-02T16:03:32.268615
31191874.0,Levetiracetam,total daily dose,2538.4,mg,mean,,,minmax,250,5000.0,,oral,daily,26.0,maternal,trimester 2,,0.003,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,490,2025-12-02T16:03:32.268615
31191874.0,Levetiracetam,total daily dose,2770.34,mg,mean,,,minmax,500,5000.0,,oral,daily,19.0,maternal,trimester 3,,<0.001,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,491,2025-12-02T16:03:32.268615
31191874.0,Levetiracetam,total daily dose,2703.13,mg,mean,,,minmax,1250,5000.0,,oral,daily,,maternal,post-partum,,0.017,compared to pre-oregnancy status,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,492,2025-12-02T16:03:32.268615
36260320.0,Levetiracetam,daily dose,1250,mg,median,,,minmax,250,3250.0,,oral,daily,37.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,493,2025-12-02T16:03:32.268615
35997547.0,Valproic Acid,daily dose,25.04,mg/kg/d,mean,SD,8.0,,,,,,,434.0,maternal,,children,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,494,2025-12-02T16:03:32.268615
35997547.0,Valproic Acid,daily dose,24.46,mg/kg/d,mean,SD,7.91,,,,,,,305.0,maternal,,children,,No comedication with ibuprofen,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,495,2025-12-02T16:03:32.268615
35997547.0,Valproic Acid,daily dose,26.01,mg/kg/d,mean,SD,8.07,,,,,,,151.0,maternal,,children,,Comedication with ibuprofen,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,496,2025-12-02T16:03:32.268615
34000957.0,Valproic Acid,daily dose,23.5,mg/kg/d,median,,,1st-3rd quartiles,19.05,28.6,,oral,,229.0,maternal,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,497,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.19,g,mean,SD,0.03,,,,,,,486.0,pediatric,, infants (0-12 month),,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,500,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.32,g,mean,SD,0.02,,,,,,,486.0,pediatric,,children (13-24 month),,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,501,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.42,g,mean,SD,0.01,,,,,,,486.0,pediatric,,children (2-5 years),,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,502,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.65,g,mean,SD,0.01,,,,,,,486.0,pediatric,,children (6-11 years),,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,503,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.75,g,mean,SD,0.04,,,,,,,486.0,pediatric,,adolescents (12-18 years),<0.001,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,504,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.16,g,mean,SD,,,,,,,,194.0,pediatric,, infants (0-12 month),,Controlled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,505,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.32,g,mean,SD,0.04,,,,,,,194.0,pediatric,,children (13-24 month),,Controlled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,506,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.42,g,mean,SD,0.01,,,,,,,194.0,pediatric,,children (2-5 years),,Controlled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,507,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.63,g,mean,SD,0.01,,,,,,,194.0,pediatric,,children (6-11 years),,Controlled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,508,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.67,g,mean,SD,0.05,,,,,,,194.0,pediatric,,adolescents (12-18 years),<0.001,Controlled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,509,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.29,g,mean,SD,0.04,,,,,,,186.0,pediatric,, infants (0-12 month),,Uncontrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,510,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.31,g,mean,SD,0.08,,,,,,,186.0,pediatric,,children (13-24 month),,Uncontrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,511,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.44,g,mean,SD,0.01,,,,,,,186.0,pediatric,,children (2-5 years),,Uncontrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,512,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.7,g,mean,SD,0.03,,,,,,,186.0,pediatric,,children (6-11 years),,Uncontrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,513,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.92,g,mean,SD,0.05,,,,,,,186.0,pediatric,,adolescents (12-18 years),<0.001,Uncontrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,514,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.55,g,mean,SD,0.01,,,,,,,486.0,pediatric,,,,Total: Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,515,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.5,g,mean,SD,0.01,,,,,,,486.0,pediatric,,,0.029,Total: Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,516,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.53,g,mean,SD,0.01,,,,,,,194.0,pediatric,,,,Controlled: Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,517,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.52,g,mean,SD,0.02,,,,,,,194.0,pediatric,,,0.48,Controlled: Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,518,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.57,g,mean,SD,0.02,,,,,,,186.0,pediatric,,,,Uncontrolled: Male,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,519,2025-12-02T16:03:32.268615
32276895.0,Valproic Acid,dose,0.48,g,mean,SD,0.02,,,,,,,186.0,pediatric,,,0.015,Uncontrolled: Female,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,520,2025-12-02T16:03:32.268615
32107351.0,Valproic Acid,maintenance dose,19.92,mg/kg,mean,SD,6.17,,,,,,,122.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,521,2025-12-02T16:03:32.268615
32776159.0,Methylphenidate,dose/weight,0.51,mg/kg,mean,SD,0.05,,,,1,oral,,5.0,pediatric,,children,,MPH-MLR 10 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,522,2025-12-02T16:03:32.268615
32776159.0,Methylphenidate,dose/weight,0.78,mg/kg,mean,SD,0.11,,,,1,oral,,3.0,pediatric,,children,,MPH-MLR 15 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,523,2025-12-02T16:03:32.268615
32776159.0,Methylphenidate,dose/weight,0.95,mg/kg,mean,SD,0.17,,,,1,oral,,2.0,pediatric,,children,,MPH-MLR 20 mg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,524,2025-12-02T16:03:32.268615
32776159.0,Methylphenidate,dose/weight,0.68,mg/kg,mean,SD,0.21,,,,1,oral,,10.0,pediatric,,children,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,525,2025-12-02T16:03:32.268615
34569533.0,Baclofen(oral),dose,10,mg,,,,,,,4,oral,daily,1.0,maternal,post-partum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,526,2025-12-02T16:03:32.268615
36006433.0,Oxcarbazepine,maintenance dose,13.64,mg/kg/day,median,,,P25–P75,10,19.47,,oral,,125.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,527,2025-12-02T16:03:32.268615
36006433.0,Oxcarbazepine,maintenance dose (more tha 1 month),13.64,mg/kg/day,median,,,P25-P75,10,19.7,,oral,,125.0,pediatrics,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,868,2025-12-02T16:03:32.268615
33848384.0,Furosemide,dose,1,mg/kg,mean,,,minmax,0.5,1.0,1,IV,in a 0.5-h infusion,10.0,pediatric,,neonate,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,528,2025-12-02T16:03:32.268615
32562572.0,Furosemide,dose,40,mg,,,,,,,1,oral,,12.0,maternal,the third trimester,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,529,2025-12-02T16:03:32.268615
35248877.0,Sertraline,daily dose,108.654,mg/day,mean,SD,49.809,minmax,25,250.0,,,,78.0,pediatric,,children and adolescents,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,540,2025-12-02T16:03:32.268615
35248877.0,Sertraline,daily dose,129.762,mg/day,mean,SD,56.8,minmax,50,250.0,,,,21.0,pediatric,,children and adolescents,,OCD,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,541,2025-12-02T16:03:32.268615
35248877.0,Sertraline,daily dose,99.306,mg/day,mean,SD,44.516,minmax,25,200.0,,,,36.0,pediatric,,children and adolescents,,Depression,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,542,2025-12-02T16:03:32.268615
31950485.0,Oxycodone,dose,8,mg,median,,,minmax,6,10.0,,S.C.,"in the latent phase, an initial dose of 0.1 mg/kg s.c. injection of oxycodone hydro-chloride with a maximum dose of 10 mg was administered, and four hours later, further doses of 0.05 mg/kg (maximum 5 mg) could be administered if required, no more frequently than every four hours",76.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,551,2025-12-02T16:03:32.268615
31950485.0,oxycodone,initial dose,0.1,mg/kg,,,,,,,,sc,,76.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,877,2025-12-02T16:03:32.268615
31950485.0,oxycodone,further dose,0.05,mg/kg,,,,,,,every 4 hours,sc,four hours after the initial dose if requred,76.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,878,2025-12-02T16:03:32.268615
31950485.0,oxycodone,initial dose,8,mg,median,,,minmax,6,10.0,,sc,,76.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,879,2025-12-02T16:03:32.268615
31950485.0,oxycodone,total dose,9,mg,median,,,minmax,6,43.0,,sc,,76.0,maternal,labor,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,880,2025-12-02T16:03:32.268615
33180318.0,Coffeine,loading dose,20,mg/kg/day,,,,,,,1,IV,over 30 min,112.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,552,2025-12-02T16:03:32.268615
33180318.0,Coffeine,maintenance dose,9.48,mg/kg/day,median,,,IQR,4.36,14.95,,IV,daily over 1 h,112.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,553,2025-12-02T16:03:32.268615
33180318.0,Coffeine,duration,33.6,days,mean,SD,17.0,,,,,,,112.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,554,2025-12-02T16:03:32.268615
33116005.0,Coffeine,loading dose,20,mg/kg,,,,,,,,IV,,23.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,555,2025-12-02T16:03:32.268615
33116005.0,Coffeine,maintenance dose,5 to 10,mg/kg/d,,,,,,,,IV or Oral,daily,23.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,556,2025-12-02T16:03:32.268615
31101409.0,Coffeine,loading dose d 1,20,mg/kg/d,median,,,IQR,19,22.0,,,,100.0,pediatric,,preterm,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,557,2025-12-02T16:03:32.268615
31101409.0,Coffeine,daily mantenance dose,9,mg/kg/d,median,,,IQR,8,10.0,,,daily,100.0,pediatric,,preterm,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,558,2025-12-02T16:03:32.268615
31101409.0,Coffeine,maximum daily dose,20,mg/kg/d,median,,,IQR,12,24.0,,,,100.0,pediatric,,preterm,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,559,2025-12-02T16:03:32.268615
31101409.0,Coffeine,cumulative dose,666,mg/kg,median,,,IQR,584,852.0,,,,100.0,pediatric,,preterm,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,560,2025-12-02T16:03:32.268615
31101409.0,Coffeine,duration of treatment,77,days,median,,,IQR,62,97.0,,,,100.0,pediatric,,preterm,,Site 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,561,2025-12-02T16:03:32.268615
31101409.0,Coffeine,loading dose d 1,17,mg/kg/d,median,,,IQR,13,25.0,,,,108.0,pediatric,,preterm,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,562,2025-12-02T16:03:32.268615
31101409.0,Coffeine,daily mantenance dose,7,mg/kg/d,median,,,IQR,5,10.0,,,daily,108.0,pediatric,,preterm,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,563,2025-12-02T16:03:32.268615
31101409.0,Coffeine,maximum daily dose,11,mg/kg/d,median,,,IQR,8,19.0,,,,108.0,pediatric,,preterm,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,564,2025-12-02T16:03:32.268615
31101409.0,Coffeine,cumulative dose,380,mg/kg,median,,,IQR,295,517.0,,,,108.0,pediatric,,preterm,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,565,2025-12-02T16:03:32.268615
31101409.0,Coffeine,duration of treatment,55,days,median,,,IQR,45,65.0,,,,108.0,pediatric,,preterm,,Site 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,566,2025-12-02T16:03:32.268615
31101409.0,Coffeine,loading dose d 1,20,mg/kg/d,median,,,IQR,20,25.0,,,,107.0,pediatric,,preterm,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,567,2025-12-02T16:03:32.268615
31101409.0,Coffeine,daily mantenance dose,5,mg/kg/d,median,,,IQR,5,6.0,,,daily,107.0,pediatric,,preterm,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,568,2025-12-02T16:03:32.268615
31101409.0,Coffeine,maximum daily dose,13,mg/kg/d,median,,,IQR,10,15.0,,,,107.0,pediatric,,preterm,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,569,2025-12-02T16:03:32.268615
31101409.0,Coffeine,cumulative dose,263,mg/kg,median,,,IQR,201,333.0,,,,107.0,pediatric,,preterm,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,570,2025-12-02T16:03:32.268615
31101409.0,Coffeine,duration of treatment,52,days,median,,,IQR,35,64.0,,,,107.0,pediatric,,preterm,,Site 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,571,2025-12-02T16:03:32.268615
31101409.0,Coffeine,loading dose d 1,20,mg/kg/d,median,,,IQR,20,20.0,,,,95.0,pediatric,,preterm,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,572,2025-12-02T16:03:32.268615
31101409.0,Coffeine,daily mantenance dose,9,mg/kg/d,median,,,IQR,8,10.0,,,daily,95.0,pediatric,,preterm,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,573,2025-12-02T16:03:32.268615
31101409.0,Coffeine,maximum daily dose,19,mg/kg/d,median,,,IQR,17,20.0,,,,95.0,pediatric,,preterm,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,574,2025-12-02T16:03:32.268615
31101409.0,Coffeine,cumulative dose,538,mg/kg,median,,,IQR,412,718.0,,,,95.0,pediatric,,preterm,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,575,2025-12-02T16:03:32.268615
31101409.0,Coffeine,duration of treatment,63,days,median,,,IQR,51,80.0,,,,95.0,pediatric,,preterm,,Site 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,576,2025-12-02T16:03:32.268615
31101409.0,Coffeine,loading dose d 1,20,mg/kg/d,median,,,IQR,19,23.0,,,,410.0,pediatric,,preterm,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,577,2025-12-02T16:03:32.268615
31101409.0,Coffeine,daily mantenance dose,8,mg/kg/d,median,,,IQR,5,10.0,,,daily,410.0,pediatric,,preterm,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,578,2025-12-02T16:03:32.268615
31101409.0,Coffeine,maximum daily dose,16,mg/kg/d,median,,,IQR,10,20.0,,,,410.0,pediatric,,preterm,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,579,2025-12-02T16:03:32.268615
31101409.0,Coffeine,cumulative dose,455,mg/kg,median,,,IQR,292,640.0,,,,410.0,pediatric,,preterm,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,580,2025-12-02T16:03:32.268615
31101409.0,Coffeine,duration of treatment,60,days,median,,,IQR,46,75.0,,,,410.0,pediatric,,preterm,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,581,2025-12-02T16:03:32.268615
35489632.0,meropenem ,overall duration,11,days,median,,,IQR,7,16.0,,,,72.0,pediatric,,,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,582,2025-12-02T16:03:32.268615
35489632.0,meropenem ,overall duration,12,days,median,,,IQR,7,16.0,,,,54.0,pediatric,,,,Extended infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,583,2025-12-02T16:03:32.268615
35489632.0,meropenem ,overall duration,11,days,median,,,IQR,8,16.0,,,,18.0,pediatric,,,0.89,Intermittent bolus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,584,2025-12-02T16:03:32.268615
35489632.0,meropenem ,dose,40,mg/kg,mean,,,minmax,38,40.0,every 8 hours,IV,0.5-1h infusion,54.0,pediatric,,,,Extended infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,585,2025-12-02T16:03:32.268615
35489632.0,meropenem ,dose,20,mg/kg,mean,,,minmax,20,21.0,every 8 hours,IV,3-h infusion,18.0,pediatric,,,,Intermittent bolus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,586,2025-12-02T16:03:32.268615
33476064.0,meropenem ,dose,20,mg/kg,,,,,,,every 8 hours,IV,at least 5 doses,27.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,587,2025-12-02T16:03:32.268615
34665470.0,Betamethasone acetate,dose,6,mg,,,,,,,every 24 hours,IM,2 doses,26.0,maternal,the third trimester of pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,588,2025-12-02T16:03:32.268615
34665470.0,Betamethasone sodium phosphate,dose,6,mg,,,,,,,every 24 hours,IM,3 doses,26.0,maternal,the third trimester of pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,589,2025-12-02T16:03:32.268615
34310083.0,Azithromycin,dose,1,g,,,,,,,1,oral,single dose,5.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,590,2025-12-02T16:03:32.268615
32168220.0,Tranexamic acid,dose,2,g,,,,,,,1,oral,1 hour after delivery,12.0,maternal,Postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,591,2025-12-02T16:03:32.268615
33248975.0,Tranexamic acid,dose,5,mg/kg,,,,,,,1,IV,over 15 min at the time of umbilical cord clamping after cesarean delivery,10.0,maternal,Delivery,,,Cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,592,2025-12-02T16:03:32.268615
33248975.0,Tranexamic acid,dose,10,mg/kg,,,,,,,1,IV,over 15 min at the time of umbilical cord clamping after cesarean delivery,10.0,maternal,Delivery,,,Cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,593,2025-12-02T16:03:32.268615
33248975.0,Tranexamic acid,dose,15,mg/kg,,,,,,,1,IV,over 15 min at the time of umbilical cord clamping after cesarean delivery,10.0,maternal,Delivery,,,Cohort 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,594,2025-12-02T16:03:32.268615
33248975.0,Tranexamic acid,dose,447.7,mg,mean,SD,87.1,,,,1,IV,over 15 min at the time of umbilical cord clamping after cesarean delivery,10.0,maternal,Delivery,,,Cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,595,2025-12-02T16:03:32.268615
33248975.0,Tranexamic acid,dose,831.8,mg,mean,SD,158.8,,,,1,IV,over 15 min at the time of umbilical cord clamping after cesarean delivery,10.0,maternal,Delivery,,,Cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,596,2025-12-02T16:03:32.268615
33248975.0,Tranexamic acid,dose,1000,mg,mean,SD,0.0,,,,1,IV,over 15 min at the time of umbilical cord clamping after cesarean delivery,10.0,maternal,Delivery,,,Cohort 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,597,2025-12-02T16:03:32.268615
32620262.0,Tranexamic acid,dose,50,mg/kg,,,,,,,1,IV,over 15 min LD followed by a maintenance infusion of 5 mg/kg/h until the end of surgery,32.0,pediatric,,children,,High-dose scheme,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,598,2025-12-02T16:03:32.268615
32620262.0,Tranexamic acid,dose,10,mg/kg,,,,,,,1,IV,over 15 min LD followed by a maintenance infusion of 5 mg/kg/h until the end of surgery,34.0,pediatric,,children,,Low-dose scheme,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,599,2025-12-02T16:03:32.268615
35679896.0,Tranexamic acid,dose,1,g,,,,,,,,IV,immediately after umbilical cord clamping over 10 minutes ,20.0,maternal,delivery,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,600,2025-12-02T16:03:32.268615
31980499.0,Metformin,dose,500,mg,,,,,,,BID,oral,,39.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,602,2025-12-02T16:03:32.268615
31980499.0,Metformin,dose,1000,mg,,,,,,,BID,oral,,15.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,603,2025-12-02T16:03:32.268615
31980499.0,Metformin,dose,500,mg,,,,,,,BID,oral,,14.0,nonpregnancy,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,604,2025-12-02T16:03:32.268615
31980499.0,Metformin,dose,1000,mg,,,,,,,BID,oral,,9.0,nonpregnancy,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,605,2025-12-02T16:03:32.268615
34964262.0,Metformin,dose,1000,mg,,,,,,,BID,oral,,38.0,maternal,pregnancy ,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,606,2025-12-02T16:03:32.268615
34964262.0,Metformin,dose,1000,mg,,,,,,,BID,oral,,37.0,maternal, post partum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,607,2025-12-02T16:03:32.268615
34602916.0,Metformin,dose,500,mg/d,,,,,,,qd,oral,daily,17.0,pediatric,,children ,,liquid formulation,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,608,2025-12-02T16:03:32.268615
34602916.0,Metformin,dose,500,mg/d,,,,,,,qd,oral,daily,17.0,pediatric,,children ,,tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,609,2025-12-02T16:03:32.268615
31106898.0,Hydroxyurea,starting dose,28,mg/kg/day,,,,,,,qd,oral,daily,50.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,610,2025-12-02T16:03:32.268615
31623213.0,Hydroxyurea,dose,19,mg/kg/day,mean,SD,4.0,,,,,oral,daily,9.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,611,2025-12-02T16:03:32.268615
31623213.0,Hydroxyurea,dose,20.4,mg/kg/day,median,,,minmax,12.9,24.6,,oral,daily,9.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,612,2025-12-02T16:03:32.268615
31623213.0,Hydroxyurea,time since introduction of HU,63.5,months,mean,SD,44.6,,,,,oral,daily,9.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,613,2025-12-02T16:03:32.268615
31623213.0,Hydroxyurea,time since introduction of HU,58.8,months,median,,,minmax,11.2,138.8,,oral,daily,9.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,614,2025-12-02T16:03:32.268615
33029796.0,Hydroxyurea,dose,800,mg,median,,,IQR,450,1000.0,,,Suggested hydroxyurea dosing started at 15-20 mg/kgdaily and was then titrated approximately every 2 weeksas platelets increased postoperatively to maintain agoal of platelets≤750×109/L. Hydroxyurea wasstopped once platelets were maintained below 500×109/L for 4 weeks. ,14.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,615,2025-12-02T16:03:32.268615
33029796.0,Hydroxyurea,weight-based dose,14,mg/kg,median,,,IQR,10,16.0,,,Suggested hydroxyurea dosing started at 15-20 mg/kgdaily and was then titrated approximately every 2 weeksas platelets increased postoperatively to maintain agoal of platelets≤750×109/L. Hydroxyurea wasstopped once platelets were maintained below 500×109/L for 4 weeks. ,14.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,616,2025-12-02T16:03:32.268615
33029796.0,Hydroxyurea,dose at PK1,1000,mg,median,,,IQR,500,1000.0,,suspension through the gastrojejunal tube,,11.0,pediatric,,,0.47,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,617,2025-12-02T16:03:32.268615
33029796.0,Hydroxyurea,weight-based dose at PK1,14,mg/kg,median,,,IQR,13,16.0,,suspension through the gastrojejunal tube,,11.0,pediatric,,,0.62,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,618,2025-12-02T16:03:32.268615
33029796.0,Hydroxyurea,dose at PK2,700,mg,median,,,IQR,313,1125.0,,oral,,9.0,pediatric,,,0.47,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,619,2025-12-02T16:03:32.268615
33029796.0,Hydroxyurea,weight-based dose at PK2,11,mg/kg,median,,,IQR,6.2,17.0,,oral,,9.0,pediatric,,,0.62,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,620,2025-12-02T16:03:32.268615
30257076.0,pantoprazole,dose,1.2,mg/kg,,,,,,,,oral,single dose after an overnight fast,57.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,621,2025-12-02T16:03:32.268615
35666852.0,budesonide ,total dose,0.35,mg/day,,,,,,,bid,oral,"placebo for morning, BOS dose of 0.35 mg  for evening",4.0,pediatric,,Children and Adolescents,,"BOS low dose group, 2-9 years",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,622,2025-12-02T16:03:32.268615
35666852.0,budesonide ,total dose,0.5,mg/day,,,,,,,bid,oral,"placebo for morning, BOS dose of 0.5 mg  for evening",5.0,pediatric,,Children and Adolescents,,"BOS low dose group, 10-18 years",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,623,2025-12-02T16:03:32.268615
35666852.0,budesonide ,total dose,1.4,mg/day,,,,,,,bid,oral,"placebo for morning, BOS dose of 1.4 mg  for evening",7.0,pediatric,,Children and Adolescents,,"BOS medium dose group, 2-9 years",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,624,2025-12-02T16:03:32.268615
35666852.0,budesonide ,total dose,2,mg/day,,,,,,,bid,oral,"placebo for morning, BOS dose of 2 mg  for evening",8.0,pediatric,,Children and Adolescents,,"BOS medium dose group, 10-18 years",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,625,2025-12-02T16:03:32.268615
35666852.0,budesonide ,total dose,2.8,mg/day,,,,,,,bid,oral,"morming dose is 1.4 mg, evening dose is 1.4 mg",8.0,pediatric,,Children and Adolescents,,"BOS high dose group, 2-9 years",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,626,2025-12-02T16:03:32.268615
35666852.0,budesonide ,total dose,4,mg/day,,,,,,,bid,oral,"morming dose is 2 mg, evening dose is 2 mg",5.0,pediatric,,Children and Adolescents,,"BOS high dose group, 10-18 years",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,627,2025-12-02T16:03:32.268615
32006953.0,budesonide ,doses given,3.9,,mean,,,minmax,2,5.0,,,,8.0,pediatric,,infants,,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,628,2025-12-02T16:03:32.268615
32006953.0,budesonide ,doses given,4.3,,mean,,,minmax,3,5.0,,,,8.0,pediatric,,infants,,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,629,2025-12-02T16:03:32.268615
32006953.0,budesonide ,doses given,3.9,,mean,,,minmax,2,5.0,,,,8.0,pediatric,,infants,,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,630,2025-12-02T16:03:32.268615
32006953.0,budesonide ,doses given,4,,mean,,,minmax,2,5.0,,,,24.0,pediatric,,infants,,All SASSIE patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,631,2025-12-02T16:03:32.268615
32006953.0,budesonide ,dose,0.025,mg/kg,,,,,,,qd,intratracheally,Infants were dosed every 24 h if still requiring ventilation and could receive up to five doses,8.0,pediatric,,infants,,0.025 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,632,2025-12-02T16:03:32.268615
32006953.0,budesonide ,dose,0.05,mg/kg,,,,,,,qd,intratracheally,Infants were dosed every 24 h if still requiring ventilation and could receive up to five doses,8.0,pediatric,,infants,,0.05 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,633,2025-12-02T16:03:32.268615
32006953.0,budesonide ,dose,0.1,mg/kg,,,,,,,qd,intratracheally,Infants were dosed every 24 h if still requiring ventilation and could receive up to five doses,8.0,pediatric,,infants,,0.1 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,634,2025-12-02T16:03:32.268615
32006953.0,budesonide ,dose,0,mg/kg,,,,,,,,,,48.0,pediatric,,infants,,TOLSURF controls,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,635,2025-12-02T16:03:32.268615
31561960.0,Atorvastatin ,dose,0.125,mg/kg/day,,,,,,,qd,oral,daily during six-week study period,6.0,pediatric,,children,,Dose 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,636,2025-12-02T16:03:32.268615
31561960.0,Atorvastatin ,dose,0.25,mg/kg/day,,,,,,,qd,oral,daily during six-week study period,7.0,pediatric,,children,,Dose 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,637,2025-12-02T16:03:32.268615
31561960.0,Atorvastatin ,dose,0.5,mg/kg/day,,,,,,,qd,oral,daily during six-week study period,3.0,pediatric,,children,,Dose 3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,638,2025-12-02T16:03:32.268615
31561960.0,Atorvastatin ,dose,0.75,mg/kg/day,,,,,,,qd,oral,daily during six-week study period,18.0,pediatric,,children,,Dose 4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,639,2025-12-02T16:03:32.268615
34033812.0,Pravastatin,dose,20,mg,,,,,,,qd,oral,daily,10.0,maternal,pregnancy and post partum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,640,2025-12-02T16:03:32.268615
34033812.0,Placebo,dose,20,mg,,,,,,,qd,oral,daily,10.0,maternal,pregnancy and post partum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,641,2025-12-02T16:03:32.268615
30549267.0,Pravastatin,dose,0.41,mg/kg,mean,SD,0.17,,,,,oral,single dose,15.0,pediatric,,children and adolescents ,0.764,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,642,2025-12-02T16:03:32.268615
30549267.0,Pravastatin,dose,0.42,mg/kg,mean,SD,0.13,,,,,oral,single dose,15.0,pediatric,,children and adolescents ,0.764,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,643,2025-12-02T16:03:32.268615
30549267.0,Pravastatin,dose,0.49,mg/kg,mean,SD,0.22,,,,,oral,single dose,2.0,pediatric,,children and adolescents ,0.764,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,644,2025-12-02T16:03:32.268615
31981411.0,Rosuvastatin ,dose,0.14,mg/kg,mean,SD,0.06,,,,,oral,single dose,13.0,pediatric,,children and adolescents ,0.402,SLCO1B1 521 TT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,645,2025-12-02T16:03:32.268615
31981411.0,Rosuvastatin ,dose,0.13,mg/kg,mean,SD,0.04,,,,,oral,single dose,13.0,pediatric,,children and adolescents ,0.402,SLCO1B1 521 TC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,646,2025-12-02T16:03:32.268615
31981411.0,Rosuvastatin ,dose,0.16,mg/kg,mean,SD,0.0,,,,,oral,single dose,2.0,pediatric,,children and adolescents ,0.402,SLCO1B1 521 CC,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,647,2025-12-02T16:03:32.268615
36087110.0,Rosuvastatin ,dose,5,mg,,,,,,,,oral,"fasted for 2 hours, a single dose received in the morning, at time 0",15.0,maternal,third trimester and post partum,,,Women living with HIV,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,648,2025-12-02T16:03:32.268615
36087110.0,Fexofenadine,dose,60,mg,,,,,,,,oral,"fasted for 2 hours, a single dose received in the morning, at time 1",15.0,maternal,third trimester and post partum,,,Women living with HIV,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,649,2025-12-02T16:03:32.268615
36087110.0,Rosuvastatin ,dose,5,mg,,,,,,,,oral,"fasted for 2 hours, a single dose received in the morning, at time 2",12.0,nonpregnancy,,,,healthy nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,650,2025-12-02T16:03:32.268615
36087110.0,Fexofenadine,dose,60,mg,,,,,,,,oral,"fasted for 2 hours, a single dose received in the morning, at time 3",12.0,nonpregnancy,,,,healthy nonpregnant women,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,651,2025-12-02T16:03:32.268615
31257615.0,Hydralazine,dose,13,mg,mean,SD,6.7,,,,4 times daily,oral,every 6 hours for the 3 days prior to the study,5.0,maternal,pregnancy,,,Mid-pregnancy (22-26 weeks) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,652,2025-12-02T16:03:32.268615
31257615.0,Hydralazine,dose,14.4,mg,mean,SD,9.0,,,,4 times daily,oral,every 6 hours for the 3 days prior to the study,8.0,maternal,pregnancy,,,Late pregnancy (30-38 weeks),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,653,2025-12-02T16:03:32.268615
31257615.0,Atenolol,dose,35,mg,mean,SD,14.0,,,,bid,oral,,5.0,maternal,pregnancy,,,Mid-pregnancy (22-26 weeks) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,654,2025-12-02T16:03:32.268615
31257615.0,Atenolol,dose,30,mg,mean,SD,30.0,,,,bid,oral,,8.0,maternal,pregnancy,,,Late pregnancy (30-38 weeks),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,655,2025-12-02T16:03:32.268615
32519032.0,6-mercaptopurine ,dose,50,mg/m2,median,,,minmax,33,109.0,qd,oral,6MP was administered after a 12 h fast on 2 study days,16.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,656,2025-12-02T16:03:32.268615
31415566.0,nifurtimox ,dose,540,mg/day,median,,,,,,tid,oral,for 30 days,10.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,657,2025-12-02T16:03:32.268615
31415566.0,nifurtimox ,weight-adjusted dose,9.75,mg/kg/day,median,,,IQR,9.45,10.0,tid,oral,for 30 days,10.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,658,2025-12-02T16:03:32.268615
35868608.0,isoniazid ,dose,25,mg/kg/week,median,,,minmax,21.7,26.8,,oral,"once weekly at the dose of 15 mg/kg for children who were ≥12 years old or 25 mg/kg for children who were 2-11 years old, with a maximum isoniazid dose of 900 mg. ",12.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,659,2025-12-02T16:03:32.268615
35868608.0,rifapentine ,dose,25.7,mg/kg/week,median,,,minmax,20.7,32.1,,oral,"once weekly with the dose based on the prespecified weight band: 300, 450, 600, 750, and 900 mg for 10- 14, 15-25, 26-32, 33-49.9, and ≥50 kg, respectively. ",12.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,660,2025-12-02T16:03:32.268615
35659902.0,isoniazid ,dose,6,mg/kg,median,,,IQR,4.6,7.0,,oral,,44.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,661,2025-12-02T16:03:32.268615
34674665.0,isoniazid ,duration during the first evaluations,54,days,median,,,IQR,33,95.0,,oral,,45.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,662,2025-12-02T16:03:32.268615
34674665.0,isoniazid ,duration during the second evaluations,85,days,median,,,IQR,19,64.0,,oral,,45.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,663,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,duration of treatment,6,weeks,median,,,IQR,5,8.0,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,664,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,duration of treatment,6,weeks,median,,,IQR,5,7.0,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,665,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,duration of treatment,14,weeks,median,,,IQR,7,20.0,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,666,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,duration of treatment,16,weeks,median,,,IQR,6,23.0,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,667,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,duration of treatment,14,weeks,median,,,IQR,5,14.0,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,668,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,duration of treatment,7,weeks,median,,,IQR,6,19.0,qd,oral,daily,77.0,pediatric,,children,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,669,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,dosage,7.1,mg/kg,median,,,IQR,6.5,8.1,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,670,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,dosage,10.9,mg/kg,median,,,IQR,9.8,11.5,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,671,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,dosage,10.7,mg/kg,median,,,IQR,10.3,11.7,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,672,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,dosage,10.6,mg/kg,median,,,IQR,9.6,11.8,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,673,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,dosage,5.1,mg/kg,median,,,IQR,4.4,5.3,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,674,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,dosage,9.7,mg/kg,median,,,IQR,6.5,11.1,qd,oral,daily,77.0,pediatric,,children,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,675,2025-12-02T16:03:32.268615
34420049.0,rifampicin,dosage,10.7,mg/kg,median,,,IQR,9.8,12.2,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,676,2025-12-02T16:03:32.268615
34420049.0,rifampicin,dosage,16.4,mg/kg,median,,,IQR,15.4,16.7,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,677,2025-12-02T16:03:32.268615
34420049.0,rifampicin,dosage,16.1,mg/kg,median,,,IQR,15.4,17.2,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,678,2025-12-02T16:03:32.268615
34420049.0,rifampicin,dosage,15.8,mg/kg,median,,,IQR,14.5,17.8,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,679,2025-12-02T16:03:32.268615
34420049.0,rifampicin,dosage,10.3,mg/kg,median,,,IQR,8.8,10.7,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,680,2025-12-02T16:03:32.268615
34420049.0,rifampicin,dosage,14.6,mg/kg,median,,,IQR,10.6,16.9,qd,oral,daily,77.0,pediatric,,children,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,681,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,dosage,21.4,mg/kg,median,,,IQR,19.5,23.4,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,682,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,dosage,32.3,mg/kg,median,,,IQR,26.8,33.7,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,683,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,dosage,31.7,mg/kg,median,,,IQR,31.3,32.4,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,684,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,dosage,35.1,mg/kg,median,,,IQR,26.2,36.1,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,685,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,dosage,28.2,mg/kg,median,,,IQR,23.4,28.3,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,686,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,dosage,28.2,mg/kg,median,,,IQR,22.7,32.3,qd,oral,daily,77.0,pediatric,,children,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,687,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,dosage,14.5,mg/kg,median,,,IQR,14.1,15.6,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,688,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,dosage,18.7,mg/kg,median,,,IQR,17,21.7,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,689,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,dosage,21,mg/kg,median,,,IQR,20,22.3,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,690,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,dosage,23.4,mg/kg,median,,,IQR,17.1,25.0,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,691,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,dosage,17.8,mg/kg,median,,,IQR,16.1,19.4,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,692,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,dosage,18.5,mg/kg,median,,,IQR,15.2,21.7,qd,oral,daily,77.0,pediatric,,children,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,693,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in intensive phase,50,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,694,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in intensive phase,100,mg/day,,,,,,,qd,oral,daily for 2 months,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,695,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in intensive phase,150,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,696,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in intensive phase,200,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,697,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in intensive phase,150,mg/day,,,,,,,qd,oral,daily for 2 months,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,698,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in intensive phase,75,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,699,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in intensive phase,150,mg/day,,,,,,,qd,oral,daily for 2 months,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,700,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in intensive phase,225,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,701,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in intensive phase,300,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,702,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in intensive phase,300,mg/day,,,,,,,qd,oral,daily for 2 months,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,703,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,daily doses in intensive phase,150,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,704,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,daily doses in intensive phase,300,mg/day,,,,,,,qd,oral,daily for 2 months,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,705,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,daily doses in intensive phase,450,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,706,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,daily doses in intensive phase,600,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,707,2025-12-02T16:03:32.268615
34420049.0,pyrazinamide,daily doses in intensive phase,800,mg/day,,,,,,,qd,oral,daily for 2 months,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,708,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,daily doses in intensive phase,100,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,709,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,daily doses in intensive phase,200,mg/day,,,,,,,qd,oral,daily for 2 months,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,710,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,daily doses in intensive phase,300,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,711,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,daily doses in intensive phase,400,mg/day,,,,,,,qd,oral,daily for 2 months,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,712,2025-12-02T16:03:32.268615
34420049.0,Ethambutol,daily doses in intensive phase,550,mg/day,,,,,,,qd,oral,daily for 2 months,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,713,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in continuation phase,50,mg/day,,,,,,,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,714,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in continuation phase,100,mg/day,,,,,,,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,715,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in continuation phase,150,mg/day,,,,,,,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,716,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in continuation phase,200,mg/day,,,,,,,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,717,2025-12-02T16:03:32.268615
34420049.0,isoniazid ,daily doses in continuation phase,150,mg/day,,,,,,,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,718,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in continuation phase,75,mg/day,,,,,,,qd,oral,daily,16.0,pediatric,,children,,weight band 4-7.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,719,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in continuation phase,150,mg/day,,,,,,,qd,oral,daily,14.0,pediatric,,children,,weight band 8-11.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,720,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in continuation phase,225,mg/day,,,,,,,qd,oral,daily,16.0,pediatric,,children,,weight band 12-15.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,721,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in continuation phase,300,mg/day,,,,,,,qd,oral,daily,16.0,pediatric,,children,,weight band 16-24.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,722,2025-12-02T16:03:32.268615
34420049.0,rifampicin,daily doses in continuation phase,300,mg/day,,,,,,,qd,oral,daily,15.0,pediatric,,children,,weight band 25-36.9 kg ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,723,2025-12-02T16:03:32.268615
34183327.0,isoniazid ,daily dose on PK1,8.9,mg/kg,median,,,IQR,7.7,11.0,qd,oral,daily,20.0,pediatric,,children and adolescents ,,first PK sampling assessments,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,724,2025-12-02T16:03:32.268615
34183327.0,rifampicin,daily dose on PK1,13.4,mg/kg,median,,,IQR,11.6,16.4,qd,oral,daily,20.0,pediatric,,children and adolescents ,,first PK sampling assessments,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,725,2025-12-02T16:03:32.268615
34183327.0,pyrazinamide,daily dose on PK1,26.7,mg/kg,median,,,IQR,23.1,32.9,qd,oral,daily,20.0,pediatric,,children and adolescents ,,first PK sampling assessments,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,726,2025-12-02T16:03:32.268615
34183327.0,Ethambutol,daily dose on PK1,20.5,mg/kg,median,,,IQR,19.1,21.6,qd,oral,daily,20.0,pediatric,,children and adolescents ,,first PK sampling assessments,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,727,2025-12-02T16:03:32.268615
31909887.0,isoniazid ,daily dose,5.36,mg/kg/day,mean,0.6,,,,,qd,oral,daily,12.0,pediatric,,children,,INH dose at 5 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,728,2025-12-02T16:03:32.268615
31909887.0,isoniazid ,daily dose,9.89,mg/kg/day,mean,1.03,,,,,qd,oral,daily,12.0,pediatric,,children,,INH dose at 10 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,729,2025-12-02T16:03:32.268615
34686231.0,isoniazid ,daily dose,20,mg/kg/day,,,,,,,qd,oral,daily,77.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,730,2025-12-02T16:03:32.268615
30572983.0,isoniazid ,daily dose,9.93,mg/kg/day,mean,SD,1.16,,,,qd,oral,daily,35.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,731,2025-12-02T16:03:32.268615
30395239.0,isoniazid ,daily dose,5,mg/kg ,,,,minmax,4,6.0,qd,oral,daily,47.0,pediatric,,children,,previous recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,732,2025-12-02T16:03:32.268615
30395239.0,isoniazid ,daily dose,10,mg/kg ,,,,minmax,10,15.0,qd,oral,daily,4.0,pediatric,,children,,revised recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,733,2025-12-02T16:03:32.268615
30395239.0,rifampicin,daily dose,10,mg/kg ,,,,,8,12.0,qd,oral,daily,35.0,pediatric,,children,,previous recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,734,2025-12-02T16:03:32.268615
30395239.0,rifampicin,daily dose,15,mg/kg ,,,,,10,20.0,qd,oral,daily,16.0,pediatric,,children,,revised recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,735,2025-12-02T16:03:32.268615
30395239.0,pyrazinamide,daily dose,25,mg/kg ,,,,,20,30.0,qd,oral,daily,16.0,pediatric,,children,,previous recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,736,2025-12-02T16:03:32.268615
30395239.0,pyrazinamide,daily dose,35,mg/kg ,,,,,30,40.0,qd,oral,daily,12.0,pediatric,,children,,revised recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,737,2025-12-02T16:03:32.268615
30395239.0,Ethambutol,daily dose,15,mg/kg ,,,,,15,20.0,qd,oral,daily,12.0,pediatric,,children,,previous recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,738,2025-12-02T16:03:32.268615
30395239.0,Ethambutol,daily dose,20,mg/kg ,,,,,15,25.0,qd,oral,daily,12.0,pediatric,,children,,revised recommendations ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,739,2025-12-02T16:03:32.268615
35083184.0,piperacillin,daily dose,336,mg/kg/day,mean,SD,127.0,minmax,94,625.0,qid,IV,intermittent short infusions (0.5h) four times a day during 23 treatment cycles,18.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,740,2025-12-02T16:03:32.268615
35083184.0,piperacillin,daily dose,416,mg/kg/day,mean,SD,104.0,minmax,132,541.0,qid,IV,continuous PIP infusions over six treatment cycles,3.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,741,2025-12-02T16:03:32.268615
34029707.0,piperacillin,first dose,100,mg,,,,,,,single dose,IV,in 30 min,90.0,pediatric,,children,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,742,2025-12-02T16:03:32.268615
34029707.0,piperacillin,subsequent doses,100,mg,,,,,,,tid,IV,over 4 h every 8 h ,45.0,pediatric,,children,,Extended infusion ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,743,2025-12-02T16:03:32.268615
34029707.0,piperacillin,subsequent doses,100,mg,,,,,,,tid,IV,over 30 min every 8 h ,45.0,pediatric,,children,,Intermittent bolus  ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,744,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,300,mg,,,,,,,q4w,subcutaneous,a treatment period of 16 weeks,42.0,pediatric,,adolescents,,< 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,745,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,600,mg,,,,,,,q4w,subcutaneous,a treatment period of 16 weeks,42.0,pediatric,,adolescents,,< 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,746,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,200,mg,,,,,,,q2w,subcutaneous,a treatment period of 16 weeks,43.0,pediatric,,adolescents,,< 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,747,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,400,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,43.0,pediatric,,adolescents,,< 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,748,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,300,mg,,,,,,,q2w,subcutaneous,a treatment period of 16 weeks,39.0,pediatric,,adolescents,,>= 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,749,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,600,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,39.0,pediatric,,adolescents,,>= 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,750,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,300,mg,,,,,,,q4w,subcutaneous,a treatment period of 16 weeks,42.0,pediatric,,adolescents,,>= 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,751,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,600,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,42.0,pediatric,,adolescents,,>= 60kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,752,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,100,mg,,,,,,,q2w,subcutaneous,a treatment period of 16 weeks,63.0,pediatric,,children,,< 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,753,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,200,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,63.0,pediatric,,children,,< 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,754,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,300,mg,,,,,,,q4w,subcutaneous,a treatment period of 16 weeks,61.0,pediatric,,children,,< 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,755,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,600,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,61.0,pediatric,,children,,< 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,756,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,200,mg,,,,,,,q2w,subcutaneous,a treatment period of 16 weeks,59.0,pediatric,,children,,>= 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,757,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,400,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,59.0,pediatric,,children,,>= 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,758,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,dosage,300,mg,,,,,,,q4w,subcutaneous,a treatment period of 16 weeks,61.0,pediatric,,children,,>= 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,759,2025-12-02T16:03:32.268615
34270797.0,Dupolumab,loading dose,600,mg,,,,,,,single dose,subcutaneous,a treatment period of 16 weeks,61.0,pediatric,,children,,>= 30kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,760,2025-12-02T16:03:32.268615
32969489.0,Dupolumab,duration between the last dose in the phase IIa study and the first dose in the OLE,118,days,mean,,,,,,,subcutaneous,,,pediatric,,children,,2 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,761,2025-12-02T16:03:32.268615
32969489.0,Dupolumab,duration between the last dose in the phase IIa study and the first dose in the OLE,97,days,mean,,,,,,,subcutaneous,,,pediatric,,children,,4 mg/kg group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,762,2025-12-02T16:03:32.268615
32969489.0,Dupolumab, dose in Part A,2,mg/kg,,,,,,,single dose,subcutaneous,with 8 weeks of follow-up,19.0,pediatric,,children,,Phase IIa study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,763,2025-12-02T16:03:32.268615
32969489.0,Dupolumab, dose in Part B,2,mg/kg,,,,,,,qw,subcutaneous,"day-1 visit of part B was the same visit as week-8 visit of part A, 4 weekly doses with an 8-week follow-up",19.0,pediatric,,children,,Phase IIa study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,764,2025-12-02T16:03:32.268615
32969489.0,Dupolumab, dose in Part A,4,mg/kg,,,,,,,single dose,subcutaneous,with 8 weeks of follow-up,18.0,pediatric,,children,,Phase IIa study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,765,2025-12-02T16:03:32.268615
32969489.0,Dupolumab, dose in Part B,4,mg/kg,,,,,,,qw,subcutaneous,"day-1 visit of part B was the same visit as week-8 visit of part A, 4 weekly doses with an 8-week follow-up",18.0,pediatric,,children,,Phase IIa study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,766,2025-12-02T16:03:32.268615
32969489.0,Dupolumab,dose in phase III OLE study,2,mg/kg,,,,,,,qw,subcutaneous,patients continued to receive their assignmed treatment regimen as in the phase IIa study. ,17.0,pediatric,,children,,Phase III OLE study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,767,2025-12-02T16:03:32.268615
32969489.0,Dupolumab,dose in phase III OLE study,4,mg/kg,,,,,,,qw,subcutaneous,patients continued to receive their assignmed treatment regimen as in the phase IIa study,16.0,pediatric,,children,,Phase III OLE study,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,768,2025-12-02T16:03:32.268615
32893393.0,Dupolumab,dose,3,mg/kg,,,,,,,single dose,subcutaneous,"single-dose treatment on day 1, followed by a 4 or 8 weeks of follow-up ",10.0,pediatric,,children,,">=2 to <6 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,769,2025-12-02T16:03:32.268615
32893393.0,Dupolumab,dose,6,mg/kg,,,,,,,single dose,subcutaneous,"single-dose treatment on day 1, followed by a 4 or 8 weeks of follow-up ",10.0,pediatric,,children,,">=2 to <6 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,770,2025-12-02T16:03:32.268615
32893393.0,Dupolumab,dose,3,mg/kg,,,,,,,single dose,subcutaneous,"single-dose treatment on day 1, followed by a 4 or 8 weeks of follow-up ",10.0,pediatric,,children,,">=6 months to <2 years of age, 3 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,771,2025-12-02T16:03:32.268615
32893393.0,Dupolumab,dose,6,mg/kg,,,,,,,single dose,subcutaneous,"single-dose treatment on day 1, followed by a 4 or 8 weeks of follow-up ",10.0,pediatric,,children,,">=6 months to <2 years of age, 6 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,772,2025-12-02T16:03:32.268615
32960980.0,Montelukast ,dose,30,mg,,,,,,,single dose,oral,,15.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,773,2025-12-02T16:03:32.268615
32960980.0,Montelukast ,dose,1,mg/kg,mean,SD,0.4,minmax,0.5,1.8,single dose,oral,,15.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,774,2025-12-02T16:03:32.268615
32960980.0,Montelukast ,dose,0.8,mg/kg,median,,,,,,single dose,oral,,15.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,775,2025-12-02T16:03:32.268615
31920289.0,Montelukast ,dose,5,mg,mean,SD,0.19,,,,qd,oral,,50.0,pediatric,,children,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,776,2025-12-02T16:03:32.268615
31920289.0,Montelukast ,dose,5,mg,median,,,minmax,4,5.0,qd,oral,,50.0,pediatric,,children,,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,777,2025-12-02T16:03:32.268615
31920289.0,Montelukast ,dose,4,mg,,,,,,,qd,oral,,2.0,pediatric,,children,0.17,SLCO2B1 c.935GG subjects ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,778,2025-12-02T16:03:32.268615
31920289.0,Montelukast ,dose,5,mg,,,,,,,qd,oral,,19.0,pediatric,,children,0.17,SLCO2B1 c.935GG subjects ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,779,2025-12-02T16:03:32.268615
31920289.0,Montelukast ,dose,4,mg,,,,,,,qd,oral,,0.0,pediatric,,children,0.17,SLCO2B1 c.935GA and c.935AA subjects ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,780,2025-12-02T16:03:32.268615
31920289.0,Montelukast ,dose,5,mg,,,,,,,qd,oral,,29.0,pediatric,,children,0.17,SLCO2B1 c.935GA and c.935AA subjects ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,781,2025-12-02T16:03:32.268615
35733414.0,beclometasone dipropionate,total dose,400,ug,,,,,,,single dose,inhalation,a single dose as four inhalations in 30-s intervals on Day 1,40.0,pediatric,,adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,782,2025-12-02T16:03:32.268615
35733414.0,formoterol fumarate ,total dose,24,ug,,,,,,,single dose,inhalation,a single dose as four inhalations in 30-s intervals on Day 1,40.0,pediatric,,adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,783,2025-12-02T16:03:32.268615
35733414.0,glycopyrronium bromide ,total dose,50,ug,,,,,,,single dose,inhalation,a single dose as four inhalations in 30-s intervals on Day 1,40.0,pediatric,,adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,784,2025-12-02T16:03:32.268615
35733414.0,beclometasone dipropionate,total dose,400,ug,,,,,,,single dose,inhalation,a single dose as four inhalations in 30-s intervals on Day 1,40.0,adults,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,785,2025-12-02T16:03:32.268615
35733414.0,formoterol fumarate ,total dose,24,ug,,,,,,,single dose,inhalation,a single dose as four inhalations in 30-s intervals on Day 1,40.0,adults,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,786,2025-12-02T16:03:32.268615
35733414.0,glycopyrronium bromide ,total dose,50,ug,,,,,,,single dose,inhalation,a single dose as four inhalations in 30-s intervals on Day 1,40.0,adults,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,787,2025-12-02T16:03:32.268615
30539740.0,amikacin,daily dose,14.1,mg/kg,mean,SD,2.6,,,,OD,IV,for 0.5-1h,20.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,788,2025-12-02T16:03:32.268615
30539740.0,amikacin,administration period,10.1,days,mean,SD,4.1,,,,OD,IV,for 0.5-1h,20.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,789,2025-12-02T16:03:32.268615
34035682.0,amikacin,dose,14,mg/kg,,,,,,,every 48 hr,IV,,,pediatric,,neonates,,"Postmenstrual age <=29 weeks, postnatal age of 0-7 days",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,790,2025-12-02T16:03:32.268615
34035682.0,amikacin,dose,12,mg/kg,,,,,,,every 36 hr,IV,,,pediatric,,neonates,,"Postmenstrual age <=29 weeks, postnatal age of 8-28 days",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,791,2025-12-02T16:03:32.268615
34035682.0,amikacin,dose,12,mg/kg,,,,,,,every 24 hr,IV,,,pediatric,,neonates,,"Postmenstrual age <=29 weeks, postnatal age >=29 days",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,792,2025-12-02T16:03:32.268615
34035682.0,amikacin,dose,12,mg/kg,,,,,,,every 36 hr,IV,,,pediatric,,neonates,,"Postmenstrual age 30-35 weeks, postnatal age of 0-7 days",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,793,2025-12-02T16:03:32.268615
34035682.0,amikacin,dose,12,mg/kg,,,,,,,every 24 hr,IV,,,pediatric,,neonates,,"Postmenstrual age 30-35 weeks, postnatal age >=8 days",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,794,2025-12-02T16:03:32.268615
34035682.0,amikacin,dose,12,mg/kg,,,,,,,every 24 hr,IV,,,pediatric,,neonates,,Postmenstrual age >=35 weeks,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,795,2025-12-02T16:03:32.268615
34142330.0,amikacin,dose,30,mg/kg/day,,,,minmax,29,33.0,OD,IV,over 30  min,30.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,796,2025-12-02T16:03:32.268615
34142330.0,amikacin,duration of treatment,2,days,,,,minmax,1,3.0,OD,IV,over 30  min,30.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,797,2025-12-02T16:03:32.268615
31306396.0,ceftazidime,,,,,,,,,,every 8 hours,IV,as a 2 hour  infusion for a minimum of 72 hours (9 doses),61.0,pediatric,,Infants and children,,dosage depends upon body weight and renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,798,2025-12-02T16:03:32.268615
31306396.0,avibactam,,,,,,,,,,every 8 hours,IV,as a 2 hour  infusion for a minimum of 72 hours (9 doses),61.0,pediatric,,Infants and children,,dosage depends upon body weight and renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,799,2025-12-02T16:03:32.268615
31306396.0,metronidazole,,,,,,,,,,every 8 hours,IV,"for a minimum of 72 hours (9 doses), administered ≤30 minutes after ceftazidime-avibactam as 20 to 30 minutes infusion ",61.0,pediatric,,Infants and children,,dosage depends upon body weight and renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,800,2025-12-02T16:03:32.268615
31306396.0,"ceftazidime, avibactam, metronidazole",duration of total therapy,12,days,median,,,minmax,2,17.0,every 8 hours,IV,as a 2 hour  infusion for a minimum of 72 hours (9 doses),61.0,pediatric,,Infants and children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,801,2025-12-02T16:03:32.268615
30113711.0,ceftazidime,dose,1,g,,,,,,,every 6 hours,IV,,10.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,802,2025-12-02T16:03:32.268615
35625789.0,Ciprofloxacin,dose,21.4,mg/kg,mean,SD,3.38,,,,single dose,oral,,8.0,pediatric,,,,2–6 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,803,2025-12-02T16:03:32.268615
35625789.0,Ciprofloxacin,dose,21.97,mg/kg,mean,SD,3.65,,,,single dose,oral,,14.0,pediatric,,,,6–12 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,804,2025-12-02T16:03:32.268615
35625789.0,Ciprofloxacin,dose,21.12,mg/kg,mean,SD,2.21,,,,single dose,oral,,11.0,pediatric,,,,12–18 Years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,805,2025-12-02T16:03:32.268615
35988360.0,Ciprofloxacin,dose,10.375,mg,mean,SD,0.3,,,,bid,,over 7 days,12.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,806,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,statim dose,1,mg/kg,,,,,,,single dose,IV,at the time of intubation or starting ventilator support ,100.0,pediatric,,neonates,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,807,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,dose,1,mg/kg/hour,,,,,,,continuous,IV,one hour after the stat dose,53.0,pediatric,,neonates,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,808,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,dose,1,mg/kg/dose,,,,,,,every 4 hours,IV,"after the stat dose, further doses were administered over 5 min, once every 4 hours",53.0,pediatric,,neonates,,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,809,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,12,hours,,,,,,,continuous,IV,one hour after the stat dose,53.0,pediatric,,neonates,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,810,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,24,hours,,,,,,,continuous,IV,one hour after the stat dose,53.0,pediatric,,neonates,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,811,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,36,hours,,,,,,,continuous,IV,one hour after the stat dose,53.0,pediatric,,neonates,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,812,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,48,hours,,,,,,,continuous,IV,one hour after the stat dose,53.0,pediatric,,neonates,,continuous infusion,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,813,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,12,hours,,,,,,,every 4 hours,IV,"after the stat dose, further doses were administered over 5 min, once every 4 hours",4.0,pediatric,,neonates,,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,814,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,24,hours,,,,,,,every 4 hours,IV,"after the stat dose, further doses were administered over 5 min, once every 4 hours",21.0,pediatric,,neonates,,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,815,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,36,hours,,,,,,,every 4 hours,IV,"after the stat dose, further doses were administered over 5 min, once every 4 hours",12.0,pediatric,,neonates,,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,816,2025-12-02T16:03:32.268615
30322973.0,fentanyl ,duration,48,hours,,,,,,,every 4 hours,IV,"after the stat dose, further doses were administered over 5 min, once every 4 hours",10.0,pediatric,,neonates,,intermittent bolus doses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,817,2025-12-02T16:03:32.268615
30721546.0,fentanyl ,dose,0.5,ug/kg,,,,,,,single dose,IV,injected during one minute,20.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,818,2025-12-02T16:03:32.268615
30721546.0,fentanyl ,dose,2,ug/kg,,,,,,,single dose,IV,administeredover5 minutes,8.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,819,2025-12-02T16:03:32.268615
31168770.0,fentanyl ,duration of infusion,90.7,hours,median,,,minmax,11,254.0,,,,66.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,820,2025-12-02T16:03:32.268615
31168770.0,fentanyl ,number of boluses per patient,25,,median,,,minmax,4,77.0,,,,66.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,821,2025-12-02T16:03:32.268615
31168770.0,fentanyl ,bolus dose,1,ug/kg,,,,,,,,IV,"administration of fentanyl began with a bolus dose (1 μg/kg), followed by initiation of an infusion (1 μg/kg/hr) 30 minutes afterwards. Two subsequent boluses (1 μg/kg) were also simulated, at 2 and 9 hours after initiation of the infusion, and the infusion rate (1 μg/kg/hr) remained constant and was continued for 48 hours after receipt of the second bolus, to simulate the steady state. ",66.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,822,2025-12-02T16:03:32.268615
31168770.0,fentanyl ,continuous infusion,1,ug/kg/h,,,,,,,,IV,"administration of fentanyl began with a bolus dose (1 μg/kg), followed by initiation of an infusion (1 μg/kg/hr) 30 minutes afterwards. Two subsequent boluses (1 μg/kg) were also simulated, at 2 and 9 hours after initiation of the infusion, and the infusion rate (1 μg/kg/hr) remained constant and was continued for 48 hours after receipt of the second bolus, to simulate the steady state. ",66.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,823,2025-12-02T16:03:32.268615
33855449.0,fosfomycin ,dose in IV phase ,100,mg/kg,,,,,,,bid,IV,minimum of 4 doses over 48 h at 12 h intervals,61.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,830,2025-12-02T16:03:32.268615
33855449.0,fosfomycin ,dose in oral phase,100,mg/kg,,,,,,,bid,oral,"after IV therapy, they converted to oral therapy for 48 h",61.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,831,2025-12-02T16:03:32.268615
33041716.0,Fosphenytoin ,loading dose,,mg/kg,,,,minmax,12.5,17.5,single dose,IV,,12.0,pediatric,,Infants and Neonates ,,15 mg/kg Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,832,2025-12-02T16:03:32.268615
33041716.0,Fosphenytoin ,loading dose,,mg/kg,,,,minmax,17.6,22.5,single dose,IV,,29.0,pediatric,,Infants and Neonates ,,20 mg/kg Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,833,2025-12-02T16:03:32.268615
35879140.0,Fosphenytoin ,loading dose,22.1,mg/kg,median,,,minmax,17.2,27.2,single dose,IV,,12.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,835,2025-12-02T16:03:32.268615
35879140.0,Fosphenytoin ,duration of treatment,4,days,median,,,minmax,1,15.0,qd,oral,,12.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,836,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,250,mg/day,median,,,IQR,250,250.0,qd,oral,,24.0,pediatric,,children,,all ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,837,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,250,mg/day,median,,,IQR,250,250.0,qd,oral,,13.0,pediatric,,children,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,838,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,250,mg/day,median,,,IQR,250,250.0,qd,oral,,11.0,pediatric,,children,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,839,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,12.8,mg/kg/day,median,,,IQR,9.5,18.5,qd,oral,,24.0,pediatric,,children,,all ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,840,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,17.9,mg/kg/day,median,,,IQR,13.9,21.7,qd,oral,,13.0,pediatric,,children,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,841,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,11.6,mg/kg/day,median,,,IQR,9.4,12.5,qd,oral,,11.0,pediatric,,children,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,842,2025-12-02T16:03:32.268615
30803975.0,Ethambutol,dose,300,mg/day,median,,,IQR,200,400.0,qd,oral,,17.0,pediatric,,children,,all ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,843,2025-12-02T16:03:32.268615
30803975.0,Ethambutol,dose,200,mg/day,median,,,IQR,200,300.0,qd,oral,,9.0,pediatric,,children,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,844,2025-12-02T16:03:32.268615
30803975.0,Ethambutol,dose,400,mg/day,median,,,IQR,350,400.0,qd,oral,,8.0,pediatric,,children,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,845,2025-12-02T16:03:32.268615
30803975.0,Ethionamide,dose,250,mg/day,median,,,IQR,250,250.0,qd,oral,,7.0,pediatric,,children,,all ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,846,2025-12-02T16:03:32.268615
30803975.0,Ethionamide,dose,250,mg/day,median,,,IQR,250,250.0,qd,oral,,4.0,pediatric,,children,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,847,2025-12-02T16:03:32.268615
30803975.0,Ethionamide,dose,250,mg/day,median,,,IQR,125,250.0,qd,oral,,3.0,pediatric,,children,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,848,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,17.9,mg/kg/day,median,,,minmax,7.8,35.7,qd,oral,,13.0,pediatric,,children,,2-5 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,849,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,11.6,mg/kg/day,median,,,minmax,7.6,13.2,qd,oral,,11.0,pediatric,,children,,6-10 yrs,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,850,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,17.9,mg/kg/day,median,,,minmax,16.3,19.2,qd,oral,,4.0,pediatric,,children,,"2-5 yrs, 15-20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,851,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,23.8,mg/kg/day,median,,,minmax,20.8,35.7,qd,oral,,5.0,pediatric,,children,,"2-5 yrs,  >20 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,852,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,9.3,mg/kg/day,median,,,minmax,7.6,9.6,qd,oral,,4.0,pediatric,,children,,"6-10 yrs, 7.5-10 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,853,2025-12-02T16:03:32.268615
30803975.0,Levofloxacin,dose,12.2,mg/kg/day,median,,,minmax,11.4,13.2,qd,oral,,7.0,pediatric,,children,,"6-10 yrs, 10-15 mg/kg",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,854,2025-12-02T16:03:32.268615
35842213.0,Levofloxacin,dose,18,mg/kg/day,median,,,IQR,17,18.0,qd,oral,,5.0,pediatric,,children,0.009,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,855,2025-12-02T16:03:32.268615
35842213.0,Levofloxacin,dose,25,mg/kg/day,median,,,IQR,24,26.0,qd,oral,,5.0,pediatric,,children,0.009,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,856,2025-12-02T16:03:32.268615
35842213.0,Levofloxacin,duration of the treatment,24,weeks,median,,,IQR,24,48.0,qd,oral,,5.0,pediatric,,children,,WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,857,2025-12-02T16:03:32.268615
35842213.0,Levofloxacin,duration of the treatment,12,weeks,median,,,IQR,8,24.0,qd,oral,,5.0,pediatric,,children,,Higher-than-WHO dosage group (15-20 mg/kg/day),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,858,2025-12-02T16:03:32.268615
34213821.0,Lidocaine,total dose,58.5,mg,mean,SD,23.94,,,,single dose,topical,,50.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,859,2025-12-02T16:03:32.268615
34213821.0,Lidocaine,dose,5,mg/kg,median,,,IQR,4.93,5.0,single dose,topical,,50.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,860,2025-12-02T16:03:32.268615
34213821.0,Lidocaine,Volume,2.94,ml,mean,SD,1.16,minmax,0.8,5.6,single dose,topical,,50.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,861,2025-12-02T16:03:32.268615
31646767.0,Methylprednisolone ,dose,30,mg/kg,,,,,,,single dose,IV,over 1 hour prior to CPB,29.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,862,2025-12-02T16:03:32.268615
31646767.0,Methylprednisolone ,dose,30,mg/kg,,,,,,,2 doses,IV,"besides a dose at the start of CPB, an additional dose approximately 10 hours before CPB",35.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,863,2025-12-02T16:03:32.268615
32768896.0,Methylprednisolone ,dose,1000,mg,,,,,,,qd,IV,infused for an 1 hour in the morning for 3 or 5 consecutive days as a relapse treatment,12.0,maternal,lactation,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,864,2025-12-02T16:03:32.268615
34513939.0,Methylprednisolone hemisuccinate,dose,30,mg/kg,,,,,,,,IV,"After induction of anesthesia, patients received MP–hemisuccinate (a prodrug of MP; Solumedrol, Pfizer BV, Capelle a/d IJssel, NL) 30 mg/kg with a maximum dose of 2 g as an intravenous bolus at the discretion of the attending anesthesiologist",36.0,pediatrics,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,865,2025-12-02T16:03:32.268615
30456415.0,Oxcarbazepine,daily dose,618.58,mg/day,mean,SD,208.23,minmax,120,1200.0,bid,oral,,141.0,pediatrics,,,,Model building set,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,866,2025-12-02T16:03:32.268615
30456415.0,Oxcarbazepine,daily dose,660,mg/day,mean,SD,197.08,minmax,300,900.0,bid,oral,,20.0,pediatrics,,,,Validation set,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,867,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,,mg/day,,,,minmax,,,,,,0.0,maternal,1st trimester,,,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,869,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,1025,mg/day,,,,minmax,600,1350.0,,,,6.0,maternal,1st trimester,,,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,870,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,675,mg/day,,,,minmax,600,975.0,,,,6.0,maternal,2nd trimester,,,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,871,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,900,mg/day,,,,minmax,750,1200.0,,,,6.0,maternal,2nd trimester,,,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,872,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,600,mg/day,,,,minmax,600,,,,,6.0,maternal,3rd trimester,,,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,873,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,1200,mg/day,,,,minmax,1200,1500.0,,,,6.0,maternal,3rd trimester,,,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,874,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,600,mg/day,,,,minmax,600,1050.0,,,,14.0,maternal,pregnancy,,,patients with seizures worsening,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,875,2025-12-02T16:03:32.268615
35037389.0,Oxcarbazepine,total daily dose,1200,mg/day,,,,minmax,900,1350.0,,,,14.0,maternal,pregnancy,,,patients without increased seizure frequency,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,876,2025-12-02T16:03:32.268615
31910460.0,ceftolozane/tazobactam,dose volume,8,mL,mean,,,,,,single dose,IV,,7.0,pediatric,,neonates and young infants (>32 weeks),,7 days postnatal to < 3 months ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,881,2025-12-02T16:03:32.268615
31910460.0,ceftolozane,,20,mg/kg,,,,,,,single dose,IV,,7.0,pediatric,,neonates and young infants (>32 weeks),,7 days postnatal to < 3 months ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,882,2025-12-02T16:03:32.268615
31910460.0,tazobactam,,10,mg/kg,,,,,,,single dose,IV,,7.0,pediatric,,neonates and young infants (>32 weeks),,7 days postnatal to < 3 months ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,883,2025-12-02T16:03:32.268615
31910460.0,ceftolozane/tazobactam,dose volume,4.2,mL,mean,,,,,,single dose,IV,,6.0,pediatric,,neonates and young infants (<= 32 weeks),,7 days postnatal to < 3 months ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,884,2025-12-02T16:03:32.268615
31910460.0,ceftolozane,,20,mg/kg,,,,,,,single dose,IV,,6.0,pediatric,,neonates and young infants (<= 32 weeks),,if eGFR >= 50 mg/min/1.73m2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,885,2025-12-02T16:03:32.268615
31910460.0,tazobactam,,10,mg/kg,,,,,,,single dose,IV,,6.0,pediatric,,neonates and young infants (<= 32 weeks),,if eGFR >= 50 mg/min/1.73m3,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,886,2025-12-02T16:03:32.268615
31910460.0,ceftolozane,,12,mg/kg,,,,,,,single dose,IV,,6.0,pediatric,,neonates and young infants (<= 32 weeks),,if eGFR <50 mg/min/1.73m4,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,887,2025-12-02T16:03:32.268615
31910460.0,tazobactam,,6,mg/kg,,,,,,,single dose,IV,,6.0,pediatric,,neonates and young infants (<= 32 weeks),,if eGFR <50 mg/min/1.73m5,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,888,2025-12-02T16:03:32.268615
36181377.0,rocuronium,dose,1,mg/kg,,,,,,,single dose,IV,after the start of the recording of train-of-four stimulation,40.0,pediatric,,children,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,889,2025-12-02T16:03:32.268615
36181377.0,sugammadex ,dose,2,mg/kg,,,,,,,single dose,IV,after neuromuscular blockade with 1 mg∙kg−1  of rocuronium,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,890,2025-12-02T16:03:32.268615
36181377.0,sugammadex ,dose,4,mg/kg,,,,,,,single dose,IV,after neuromuscular blockade with 1 mg∙kg−1  of rocuronium,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,891,2025-12-02T16:03:32.268615
36181377.0,sugammadex ,dose,8,mg/kg,,,,,,,single dose,IV,after neuromuscular blockade with 1 mg∙kg−1  of rocuronium,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,892,2025-12-02T16:03:32.268615
36181377.0,neostigmine ,dose,0.03,mg/kg,,,,,,,single dose,IV,after neuromuscular blockade with 1 mg∙kg−1  of rocuronium,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,893,2025-12-02T16:03:32.268615
31112621.0,tobramycin,daily dose,75,mg,,,,,,,bid,inhalation,Visit 1 was followed by a 28‐days home treatmentperiod during which patients inhaled tobramycin twice daily with theI‐neb,16.0,pediatric,,children,,nebulization with I‐neb,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,894,2025-12-02T16:03:32.268615
31112621.0,tobramycin,daily dose,300,mg,,,,,,,bid,inhalation,"The home treatment periodand study visit 2 was separated by a wash‐out period of 2 days forcomplete tobramycin clearance. Patients from treatment arm B startedwith a PARI‐LC Plus inhalation at visit 1, inhaled tobramycin twicedaily for 28 days with the PARI‐LC Plus and performed a supervisedtobramycin inhalation with the I‐neb at visit 2. ",6.0,pediatric,,children,,nebulization with PARI‐LC Plus,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,895,2025-12-02T16:03:32.268615
32507958.0,tobramycin,daily dose,4,mg/kg/dose,,,,,,,every 48 h,IV,,46.0,pediatric,,Preterm,,"Preterm < 32 weeks GA, < 7 days PNA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,896,2025-12-02T16:03:32.268615
32507958.0,tobramycin,daily dose,4,mg/kg/dose,,,,,,,every 36 h,IV,,28.0,pediatric,,Preterm,,"Preterm 32–37 weeks GA, < 7 days PNA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,897,2025-12-02T16:03:32.268615
32507958.0,tobramycin,daily dose,4,mg/kg/dose,,,,,,,every 36-48 h,IV,,71.0,pediatric,,Preterm,,"≥ 7 days PNA, before 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,898,2025-12-02T16:03:32.268615
32507958.0,tobramycin,daily dose,4,mg/kg/dose,,,,,,,every 24 h,IV,,71.0,pediatric,,Preterm,,"≥ 7 days PNA, after 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,899,2025-12-02T16:03:32.268615
32507958.0,tobramycin,daily dose,4,mg/kg/dose,,,,,,,every 24 h,IV,,76.0,pediatric,,neonates,,"Term, any PNA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,900,2025-12-02T16:03:32.268615
32507958.0,tobramycin,daily dose,5-7,mg/kg/dose,,,,,,,every 24 h,IV,,,pediatric,,children,,1 month-18 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,901,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,20,mg/kg/dose,,,,,,,every 12h,IV,,17.0,pediatric,,preterm,,"Preterm, <7 days PNA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,902,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,30,mg/kg/dose,,,,,,,every 8 h,IV,,65.0,pediatric,,preterm,,"Preterm, >=7 days PNA",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,903,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,20,mg/kg/dose,,,,,,,every 12h,IV,,10.0,pediatric,,neonates ,,"< 7 days PNA, before 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,904,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,32,mg/kg/dose,,,,,,,every 6 h,IV,,10.0,pediatric,,neonates ,,"< 7 days PNA, after 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,905,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,30,mg/kg/dose,,,,,,,every 8 h,IV,,,pediatric,,neonates ,,">= 7 days PNA, before 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,906,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,48,mg/kg/dose,,,,,,,every 6 h,IV,,,pediatric,,neonates ,,">= 7 days PNA, after  2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,907,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,40,mg/kg/dose,,,,,,,every 8 h,IV,,,pediatric,,children,,"1 month-18 years, before 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,908,2025-12-02T16:03:32.268615
32507958.0,vancomycin,daily dose,60,mg/kg/dose,,,,,,,every 6 h,IV,,,pediatric,,children,,"1 month-18 years, after 2015",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,909,2025-12-02T16:03:32.268615
32568427.0,tobramycin,dose,11.3,mg/kg,median,,,IQR,1.7,,,IV,before initiation ofCFTR modulator therap,34.0,pediatric,,children,0.06,Pre‐CFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,910,2025-12-02T16:03:32.268615
32568427.0,tobramycin,dose,10.55,mg/kg,median,,,IQR,2.1,,,IV,at least 2 weeks after beginningtreatment with a CFTR modulator,34.0,pediatric,,children,0.06,Post‐CFTRmodulator,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,911,2025-12-02T16:03:32.268615
35921575.0,tobramycin,dose,80,mg,,,,,,,every 8 hours,inhalation,,12.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,912,2025-12-02T16:03:32.268615
35921575.0,tobramycin,duration of treatment,7.9,days,mean,SD,2.6,,,,,,,12.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,913,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Final total daily dose,79.5,mg/kg/day,mean,SD,9.6,,,,,IIV,,17.0,pediatric,,infants/children (>31 days to <2 years),0.04,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,914,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Final total daily dose,79.1,mg/kg/day,mean,SD,8.5,,,,,IIV,,38.0,pediatric,,children/adolescents (2 to <8 years),0.04,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,915,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Final total daily dose,72.5,mg/kg/day,mean,SD,12.6,,,,,IIV,,21.0,pediatric,,children/adolescents (8 to <18 years),0.04,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,916,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Initial total daily dose,46.2,mg/kg/day,mean,SD,3.8,,,,,CIV,,17.0,pediatric,,infants/children (>31 days to <2 years),0.023,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,917,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Initial total daily dose,44.5,mg/kg/day,mean,SD,4.8,,,,,CIV,,38.0,pediatric,,children/adolescents (2 to <8 years),0.023,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,918,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Initial total daily dose,41.5,mg/kg/day,mean,SD,7.0,,,,,CIV,,21.0,pediatric,,children/adolescents (8 to <18 years),0.023,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,919,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of initial steady state serum vancomycin concentration,46.2,mg/kg/day,mean,SD,3.7,,,,,CIV,,13.0,pediatric,,infants/children (>31 days to <2 years),0.125,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,920,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of initial steady state serum vancomycin concentration,44.4,mg/kg/day,mean,SD,5.1,,,,,CIV,,28.0,pediatric,,children/adolescents (2 to <8 years),0.125,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,921,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of initial steady state serum vancomycin concentration,41.9,mg/kg/day,mean,SD,7.5,,,,,CIV,,18.0,pediatric,,children/adolescents (8 to <18 years),0.125,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,922,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of first therapeutic serum vancomycin concentration,48.4,mg/kg/day,mean,SD,4.6,,,,,CIV,,14.0,pediatric,,infants/children (>31 days to <2 years),<0.005,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,923,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of first therapeutic serum vancomycin concentration,45.6,mg/kg/day,mean,SD,5.5,,,,,CIV,,31.0,pediatric,,children/adolescents (2 to <8 years),<0.005,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,924,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of first therapeutic serum vancomycin concentration,39.4,mg/kg/day,mean,SD,7.3,,,,,CIV,,14.0,pediatric,,children/adolescents (8 to <18 years),<0.005,Goal SVC of 10-15 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,925,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Final total daily dose,77.9,mg/kg/day,mean,SD,12.4,,,,,IIV,,37.0,pediatric,,infants/children (>31 days to <2 years),0.023,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,926,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Final total daily dose,78.7,mg/kg/day,mean,SD,10.9,,,,,IIV,,56.0,pediatric,,children/adolescents (2 to <8 years),0.023,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,927,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Final total daily dose,72.9,mg/kg/day,mean,SD,13.8,,,,,IIV,,71.0,pediatric,,children/adolescents (8 to <18 years),0.023,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,928,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Initial total daily dose,47,mg/kg/day,mean,SD,5.0,,,,,CIV,,37.0,pediatric,,infants/children (>31 days to <2 years),0.002,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,929,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Initial total daily dose,45.6,mg/kg/day,mean,SD,4.2,,,,,CIV,,56.0,pediatric,,children/adolescents (2 to <8 years),0.002,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,930,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Initial total daily dose,43.1,mg/kg/day,mean,SD,7.1,,,,,CIV,,71.0,pediatric,,children/adolescents (8 to <18 years),0.002,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,931,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of initial steady state serum vancomycin concentration,47.7,mg/kg/day,mean,SD,5.4,,,,,CIV,,32.0,pediatric,,infants/children (>31 days to <2 years),0.008,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,932,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of initial steady state serum vancomycin concentration,46.8,mg/kg/day,mean,SD,5.4,,,,,CIV,,39.0,pediatric,,children/adolescents (2 to <8 years),0.008,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,933,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of initial steady state serum vancomycin concentration,43.6,mg/kg/day,mean,SD,5.4,,,,,CIV,,52.0,pediatric,,children/adolescents (8 to <18 years),0.008,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,934,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of first therapeutic serum vancomycin concentration,50.2,mg/kg/day,mean,SD,7.2,,,,,CIV,,19.0,pediatric,,infants/children (>31 days to <2 years),0.008,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,935,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of first therapeutic serum vancomycin concentration,50.6,mg/kg/day,mean,SD,6.3,,,,,CIV,,23.0,pediatric,,children/adolescents (2 to <8 years),0.008,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,936,2025-12-02T16:03:32.268615
29718415.0,Vancomycin ,Total daily dose at time of first therapeutic serum vancomycin concentration,44.7,mg/kg/day,mean,SD,10.2,,,,,CIV,,54.0,pediatric,,children/adolescents (8 to <18 years),0.008,Goal SVC of 15-20 ug/ml,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,937,2025-12-02T16:03:32.268615
29742643.0,Vancomycin ,Final daily dose,58,mg/kg/day,mean,SD,18.6,,,,,,,30.0,pediatric,,children/adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,938,2025-12-02T16:03:32.268615
29742643.0,Vancomycin ,Final dose,15.4,mg/kg/dose,mean,SD,4.3,,,,,,,30.0,pediatric,,children/adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,939,2025-12-02T16:03:32.268615
29742643.0,Vancomycin ,Final dosing interval,6.6,h,mean,SD,1.6,,,,,,,30.0,pediatric,,children/adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,940,2025-12-02T16:03:32.268615
29742643.0,Vancomycin ,dosing interval,,h,,,,,,,every 6 h,,,26.0,pediatric,,children/adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,941,2025-12-02T16:03:32.268615
29742643.0,Vancomycin ,dosing interval,,h,,,,,,,every 8 h,,,2.0,pediatric,,children/adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,942,2025-12-02T16:03:32.268615
29742643.0,Vancomycin ,dosing interval,,h,,,,,,,every 12 h,,,2.0,pediatric,,children/adolescents,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,943,2025-12-02T16:03:32.268615
30371946.0,Vancomycin ,dose,60.6,mg/kg/d,median,,,IQR,57.6,62.5,"every 6, 8, or 12 hours ",IV,for a period of at least 60 minutes,27.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,946,2025-12-02T16:03:32.268615
30785491.0,Vancomycin ,empirical dose,12.5,mg/kg,median,,,IQR,10,15.0,every 6 hours,,over 1 hour,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,947,2025-12-02T16:03:32.268615
30785491.0,Vancomycin ,,,,,,,minmax,8.4,20.0,,,,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,948,2025-12-02T16:03:32.268615
30785491.0,Vancomycin ,dose per hour,292.5,mg,median,,,IQR,75,372.8,every 6 hours,,over 1 hour,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,949,2025-12-02T16:03:32.268615
30785491.0,Vancomycin ,,,,,,,minmax,126,500.0,,,,10.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,950,2025-12-02T16:03:32.268615
30937470.0,Vancomycin ,dose,442,mg/dose,mean,SD,372.0,,,,,IV,over 1 hours,138.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,951,2025-12-02T16:03:32.268615
30937470.0,Vancomycin ,dose by weight,14.3,mg/kg/dose,mean,SD,1.6,,,,,IV,over 1 hours,138.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,952,2025-12-02T16:03:32.268615
30937470.0,Vancomycin ,dose by FFM,19.5,mg/kg/dose,mean,SD,3.0,,,,,IV,over 1 hours,138.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,953,2025-12-02T16:03:32.268615
30950674.0,Vancomycin ,daily maintenance dose,,mg/kg,,,,minmax,13,53.0,in 2-4 doses daily,IV,over 1 hours,22.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,954,2025-12-02T16:03:32.268615
30983533.0,Vancomycin ,daily maintenance dose,,mg/kg,,,,minmax,8.8,49.5,in 2-4 doses daily,IV,over 1 hours,40.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,955,2025-12-02T16:03:32.268615
31019403.0,Vancomycin ,dose,14.5,mg/kg/dose,mean,SD,1.7,,,,,IV,over 1 hours,261.0,pediatric,,pediatrics,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,956,2025-12-02T16:03:32.268615
31301023.0,Vancomycin ,dose,12.9,mg/kg,mean,SD,3.2,,,,"twice, thrice, or four times daily",IV,,20.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,957,2025-12-02T16:03:32.268615
31301023.0,Vancomycin ,dose,13.7,mg/kg,mean,SD,8.9,,,,"twice, thrice, or four times daily",IV,,63.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,958,2025-12-02T16:03:32.268615
31342543.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 6 hours,IV,over 1-2 hours,43.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,959,2025-12-02T16:03:32.268615
31342543.0,Vancomycin ,daily dose,63,mg/kg,mean,SD,11.0,,,,every 6 hours,IV,over 1-2 hours,43.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,960,2025-12-02T16:03:32.268615
31342543.0,Vancomycin ,duration of vancomycin therapy,6,days,median,,,minmax,1,20.0,every 6 hours,IV,over 1-2 hours,43.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,961,2025-12-02T16:03:32.268615
31403243.0,Vancomycin ,dose,519,mg/d,median,,,IQR,320,800.0,,IV,over 1 hour,201.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,962,2025-12-02T16:03:32.268615
31403243.0,Vancomycin ,dose,,,,,,minmax,45,3000.0,,IV,over 1 hour,201.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,963,2025-12-02T16:03:32.268615
31403243.0,Vancomycin ,dose,40,mg/kg,median,,,IQR,29,40.0,,IV,over 1 hour,201.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,964,2025-12-02T16:03:32.268615
31403243.0,Vancomycin ,dose,,,,,,minmax,9.6,60.0,,IV,over 1 hour,201.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,965,2025-12-02T16:03:32.268615
31403243.0,Vancomycin ,duration of vancomycin therapy,14,days,median,,,IQR,9,20.0,,IV,over 1 hour,201.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,966,2025-12-02T16:03:32.268615
31403243.0,Vancomycin ,duration of vancomycin therapy,,,,,,minmax,4,71.0,,IV,over 1 hour,201.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,967,2025-12-02T16:03:32.268615
31911739.0,Vancomycin ,dose,20,mg/kg,,,,,,,every 8 h,IV,over 1 hour,12.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,968,2025-12-02T16:03:32.268615
31935538.0,Vancomycin ,dose,15 or 20,mg/kg/dose,,,,,,,every 6 h,IV,over 1 hour,14.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,969,2025-12-02T16:03:32.268615
32296501.0,Vancomycin ,Duration of vancomycin therapy,18.96,days,mean,SD,9.17,minmax,4,38.0,,IV,over 1 hour,25.0,pediatric,,neonates,,with ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,970,2025-12-02T16:03:32.268615
32296501.0,Vancomycin ,Duration of vancomycin therapy,20.17,days,mean,SD,9.12,minmax,3,36.0,,IV,over 1 hour,25.0,pediatric,,neonates,,Non-ECMO support,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,971,2025-12-02T16:03:32.268615
32296501.0,Vancomycin ,dose,10,mg/kg,,,,,,,"every 6, 8, or 12 hours ",IV,over 1 hour,50.0,pediatric,,neonates,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,972,2025-12-02T16:03:32.268615
32296501.0,Vancomycin ,number of doeses received by each patient,40.5,,mean,SD,25.0,,,,"every 6, 8, or 12 hours ",IV,over 1 hour,50.0,pediatric,,neonates,,all,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,973,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Initial total daily dose,41,mg/kg/day,mean,SD,14.7,,,,,,,60.0,pediatric,,children,"<0.001, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,974,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Initial total daily dose,55.6,mg/kg/day,mean,SD,16.1,,,,,,,30.0,pediatric,,children,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,975,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Initial total daily dose,46.7,mg/kg/day,mean,SD,16.1,,,,,,,60.0,pediatric,,children,"0.01, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,976,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Final total daily dose,48,mg/kg/day,mean,SD,18.6,,,,,,,60.0,pediatric,,children,"0.67, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,977,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Final total daily dose,49.8,mg/kg/day,mean,SD,13.4,,,,,,,30.0,pediatric,,children,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,978,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Final total daily dose,50.9,mg/kg/day,mean,SD,16.0,,,,,,,60.0,pediatric,,children,"0.78, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,979,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Therapy duration,32.6,days,mean,SD,37.6,,,,,,,60.0,pediatric,,children,"0.01, Lower-Trough vs
High-Trough",Lower-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,980,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Therapy duration,14.6,days,mean,SD,9.9,,,,,,,30.0,pediatric,,children,,High-Trough cohort (reference),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,981,2025-12-02T16:03:32.268615
32636687.0,Vancomycin ,Therapy duration,19,days,mean,SD,12.1,,,,,,,60.0,pediatric,,children,"0.09, Low-Trough vs
High-Trough",Low-Trough cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,982,2025-12-02T16:03:32.268615
32641912.0,Vancomycin ,initial mantenance dose,55.7,mg/kg/day,mean,,,,,,,IV,,77.0,pediatric,,children,0.736,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,983,2025-12-02T16:03:32.268615
32641912.0,Vancomycin ,initial mantenance dose,57.5,mg/kg/day,mean,,,,,,,IV,,74.0,pediatric,,children,0.736,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,984,2025-12-02T16:03:32.268615
32641912.0,Vancomycin ,loading dose,23.4,mg/kg,mean,,,,,,,IV,,74.0,pediatric,,children,,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,985,2025-12-02T16:03:32.268615
32641912.0,Vancomycin ,loading dose,24.4,mg/kg,median,,,IQR,20,25.0,,IV,,74.0,pediatric,,children,,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,986,2025-12-02T16:03:32.268615
32641912.0,Vancomycin ,Duration of vancomycin use,79.9,h,mean,,,,,,,,,77.0,pediatric,,children,0.494,Standard dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,987,2025-12-02T16:03:32.268615
32641912.0,Vancomycin ,Duration of vancomycin use,80.1,h,mean,,,,,,,,,74.0,pediatric,,children,0.494,Loading dose cohort,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,988,2025-12-02T16:03:32.268615
32922785.0,Vancomycin ,dose,15,mg/kg/dose,,,,,,,every 6 hour,IV,,75.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,989,2025-12-02T16:03:32.268615
32984899.0,Vancomycin ,dose on post-operative day 1,12.8,mg/kg,mean,SD,2.5,,,,"every 8 h, for 72 h",IV,over 60 min,100.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,990,2025-12-02T16:03:32.268615
32984899.0,Vancomycin ,dose on post-operative day 2,9.4,mg/kg,mean,SD,5.4,,,,"every 8 h, for 72 h",IV,over 60 min,100.0,pediatric,,,"<0.001, compared to the POD1 dose",,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,991,2025-12-02T16:03:32.268615
32984899.0,Vancomycin ,dose on post-operative day 3,9.7,mg/kg,mean,SD,4.5,,,,"every 8 h, for 72 h",IV,over 60 min,100.0,pediatric,,,"<0.001, compared to the POD1 dose",,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,992,2025-12-02T16:03:32.268615
32984899.0,Vancomycin ,daily cumulative dose on POD2,31,mg/kg,mean,SD,11.0,,,,"every 8 h, for 72 h",IV,over 60 min,100.0,pediatric,,,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,993,2025-12-02T16:03:32.268615
32984899.0,Vancomycin ,daily cumulative dose on POD3,25,mg/kg,mean,SD,13.0,,,,"every 8 h, for 72 h",IV,over 60 min,100.0,pediatric,,,<0.001,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,994,2025-12-02T16:03:32.268615
33053028.0,Vancomycin ,dose,45,mg/kg/day,median,,,IQR,38,63.0,every 6 h,IV,over 1 h,11.0,pediatric,,<7 years,0.1002,G1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,995,2025-12-02T16:03:32.268615
33053028.0,Vancomycin ,dose,43,mg/kg/day,median,,,IQR,40,44.0,every 6 h,IV,over 1 h,11.0,pediatric,,>=7 years,0.1002,G2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,996,2025-12-02T16:03:32.268615
33068298.0,Vancomycin ,doses,6154,,N,,,,,,,IV,,350.0,pediatric,,,>0.1,model training population,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,997,2025-12-02T16:03:32.268615
33068298.0,Vancomycin ,doses,5249,,N,,,,,,,IV,,323.0,pediatric,,,>0.1,model evaluation population,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,998,2025-12-02T16:03:32.268615
33070357.0,Vancomycin ,daily dose,53.5,mg/kg,mean,SD,13.5,,,,2 to 4 times per day,IV,over 1 h,92.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,999,2025-12-02T16:03:32.268615
33070357.0,Vancomycin ,daily dose,52.1,mg/kg,median,,,minmax,24.4,95.1,,IV,,92.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1000,2025-12-02T16:03:32.268615
33189901.0,Vancomycin ,cocomitant dose,15,mg/kg,,,,,,,Babies who were < 29 weeks postmenstrual age received the subsequent doses at 24 hourly intervals and those who were 29-35 weeks postmenstrual age received the following doses at 12 hourly intervals.  ,IV,,6.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1001,2025-12-02T16:03:32.268615
33189901.0,Vancomycin ,dose,10,mg/ml,,,,,,,,Intraventricular ,"over 2 min, given at the end of the CSF drainage. Repeat intraventricular vancomycin dose was administered if the level dropped under the threshold of 10mg/L",8.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1002,2025-12-02T16:03:32.268615
33318009.0,Vancomycin ,dose,14.2,mg/kg/time,mean,SD,3.1,,,,bid,over 1h,,19.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1003,2025-12-02T16:03:32.268615
33318009.0,Vancomycin ,,14.03,mg/kg/time,median,,,minmax,5.7,20.9,,,,19.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1004,2025-12-02T16:03:32.268615
33318009.0,Vancomycin ,Volume of infusion,87.4,ml/day,mean,SD,60.5,,,,,,,19.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1005,2025-12-02T16:03:32.268615
33318009.0,Vancomycin ,,85.9,ml/day,median,,,minmax,7.7,222.6,,,,19.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1006,2025-12-02T16:03:32.268615
33708851.0,Vancomycin ,initial daily dose,40,mg/kg/day,median,,,IQR,40,47.0,every 6 h,IV,over 60 min,35.0,pediatric,,children,0.498,continuous venovenous hemofiltration Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1007,2025-12-02T16:03:32.268615
33708851.0,Vancomycin ,initial daily dose,40,mg/kg/day,median,,,IQR,40,50.0,every 6 h,IV,over 60 min,84.0,pediatric,,children,0.498,Non-continuous venovenous hemofiltration Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1008,2025-12-02T16:03:32.268615
33708851.0,Vancomycin ,duration of therapy,8,days,median,,,IQR,5,11.0,,,,35.0,pediatric,,children,0.481,continuous venovenous hemofiltration Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1009,2025-12-02T16:03:32.268615
33708851.0,Vancomycin ,duration of therapy,8.5,days,median,,,IQR,6,12.0,,,,84.0,pediatric,,children,0.481,Non-continuous venovenous hemofiltration Group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1010,2025-12-02T16:03:32.268615
33789546.0,Vancomycin ,dosage,144,ml/kg,median,,,interquartile range,44,1000.0,,IV,"an infusion over 60 min before skin incision,  and a bolus administered at CPB start",40.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1011,2025-12-02T16:03:32.268615
33793589.0,Vancomycin ,initial dose,40,mg/kg/d,median,,,interquartile range,40,55.0,,,,73.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1012,2025-12-02T16:03:32.268615
33830468.0,Vancomycin ,duration of therapy,9,days,median,,,IQR,7,10.0,,,,65.0,pediatric,,,0.67,"Pre-protocl, 2016",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1013,2025-12-02T16:03:32.268615
33830468.0,Vancomycin ,duration of therapy,10,days,median,,,IQR,7,11.5,,,,65.0,pediatric,,,0.67,"Post-protocl, 2018",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1014,2025-12-02T16:03:32.268615
33830468.0,Vancomycin ,initial dosage,15,mg/kg,,,,,,,every 6 h,,,130.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1015,2025-12-02T16:03:32.268615
33472817.0,Vancomycin ,daily dose,42.47,mg/kg/day,mean,,,minmax,30.37,45.11,"every 12 h, or 8 h",IV,over 1 h,40.0,pediatric,,neonates,0.253,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1016,2025-12-02T16:03:32.268615
33472817.0,Vancomycin ,daily dose,42.07,mg/kg/day,mean,,,minmax,29.97,44.93,"every 12 h, or 8 h",IV,over 1 h,32.0,pediatric,,neonates,0.253,Clinical cure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1017,2025-12-02T16:03:32.268615
33472817.0,Vancomycin ,daily dose,44.75,mg/kg/day,mean,,,minmax,31.15,56.44,"every 12 h, or 8 h",IV,over 1 h,8.0,pediatric,,neonates,0.253,Clinical failure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1018,2025-12-02T16:03:32.268615
33472817.0,Vancomycin ,course of vancomycin,16.5,days,mean,,,minmax,11.75,21.0,"every 12 h, or 8 h",IV,over 1 h,40.0,pediatric,,neonates,0.095,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1019,2025-12-02T16:03:32.268615
33472817.0,Vancomycin ,course of vancomycin,18.5,days,mean,,,minmax,14,21.0,"every 12 h, or 8 h",IV,over 1 h,32.0,pediatric,,neonates,0.095,Clinical cure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1020,2025-12-02T16:03:32.268615
33472817.0,Vancomycin ,course of vancomycin,12.6,days,mean,,,minmax,10,17.25,"every 12 h, or 8 h",IV,over 1 h,8.0,pediatric,,neonates,0.095,Clinical failure,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1021,2025-12-02T16:03:32.268615
33947475.0,Vancomycin ,daily dose,74.69,mg/day,mean,SD,44.95,,,,,,,94.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1022,2025-12-02T16:03:32.268615
33947475.0,Vancomycin ,daily dose,60,mg/day,median,,,minmax,20,200.0,,,,94.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1023,2025-12-02T16:03:32.268615
34197665.0,Vancomycin ,single initial dose,10,mg/kg,mean,SD,2.8,,,,"4 times, 3 times, twice or once daily",,,20.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1024,2025-12-02T16:03:32.268615
34197665.0,Vancomycin ,single maintenance,8.4,mg/kg,mean,SD,1.9,,,,"4 times, 3 times, twice or once daily",,,20.0,pediatric,,preterm,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1025,2025-12-02T16:03:32.268615
34289402.0,Vancomycin ,single dose,15,mg/kg,,,,,,,,IV,over 1 hour,9.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1026,2025-12-02T16:03:32.268615
34544677.0,Vancomycin ,dose,10.5,mg/kg,mean,SD,4.2,,,,every 6-12 h,IV,in a 90-min infusion,82.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1027,2025-12-02T16:03:32.268615
34612690.0,Vancomycin ,dose,15,mg/kg/dose,median,,,IQR,14,15.0,q6h in patients between the ages of 1 month and 12 years and q8h in patients between the ages of 13 and 17 years,IV,,270.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1028,2025-12-02T16:03:32.268615
34612690.0,Vancomycin ,dose,,mg/kg/dose,,,,minmax,4.3,37.0,q6h in patients between the ages of 1 month and 12 years and q8h in patients between the ages of 13 and 17 years,IV,,270.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1029,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,45,,N,,,,,,q6h,IV,,162.0,pediatric,,children,,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1030,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,183,,N,,,,,,q6h,IV,,599.0,pediatric,,children,,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1031,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,41,,N,,,,,,q6h,IV,,153.0,pediatric,,children,,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1032,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,39,,N,,,,,,q6h,IV,,185.0,pediatric,,children,,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1033,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,308,,N,,,,,,q6h,IV,,1099.0,pediatric,,children,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1034,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,110,,N,,,,,,q8h,IV,,162.0,pediatric,,children,,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1035,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,379,,N,,,,,,q8h,IV,,599.0,pediatric,,children,,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1036,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,95,,N,,,,,,q8h,IV,,153.0,pediatric,,children,,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1037,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,127,,N,,,,,,q8h,IV,,185.0,pediatric,,children,,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1038,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,711,,N,,,,,,q8h,IV,,1099.0,pediatric,,children,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1039,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,7,,N,,,,,,q12h,IV,,162.0,pediatric,,children,,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1040,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,37,,N,,,,,,q12h,IV,,599.0,pediatric,,children,,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1041,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,17,,N,,,,,,q12h,IV,,153.0,pediatric,,children,,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1042,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,19,,N,,,,,,q12h,IV,,185.0,pediatric,,children,,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1043,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dosing regimen,80,,N,,,,,,q12h,IV,,1099.0,pediatric,,children,,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1044,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by total body weight,50,mg/kg/d,mean,SD,11.0,,,,,IV,,162.0,pediatric,,children,<0.001,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1045,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by total body weight,48,mg/kg/d,mean,SD,11.0,,,,,IV,,599.0,pediatric,,children,<0.001,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1046,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by total body weight,45,mg/kg/d,mean,SD,10.0,,,,,IV,,153.0,pediatric,,children,<0.001,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1047,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by total body weight,42,mg/kg/d,mean,SD,12.0,,,,,IV,,185.0,pediatric,,children,<0.001,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1048,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by total body weight,48,mg/kg/d,mean,SD,11.0,,,,,IV,,1099.0,pediatric,,children,<0.001,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1049,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by ideal body weight,41,mg/kg/d,mean,SD,9.0,,,,,IV,,162.0,pediatric,,children,<0.001,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1050,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by ideal body weight,49,mg/kg/d,mean,SD,12.0,,,,,IV,,599.0,pediatric,,children,<0.001,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1051,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by ideal body weight,57,mg/kg/d,mean,SD,13.0,,,,,IV,,153.0,pediatric,,children,<0.001,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1052,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by ideal body weight,65,mg/kg/d,mean,SD,19.0,,,,,IV,,185.0,pediatric,,children,<0.001,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1053,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by ideal body weight,52,mg/kg/d,mean,SD,15.0,,,,,IV,,1099.0,pediatric,,children,<0.001,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1054,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by adjusted body weight,44,mg/kg/d,mean,SD,10.0,,,,,IV,,162.0,pediatric,,children,<0.001,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1055,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by adjusted body weight,49,mg/kg/d,mean,SD,11.0,,,,,IV,,599.0,pediatric,,children,<0.001,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1056,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by adjusted body weight,51,mg/kg/d,mean,SD,11.0,,,,,IV,,153.0,pediatric,,children,<0.001,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1057,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by adjusted body weight,53,mg/kg/d,mean,SD,14.0,,,,,IV,,185.0,pediatric,,children,<0.001,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1058,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by adjusted body weight,49,mg/kg/d,mean,SD,12.0,,,,,IV,,1099.0,pediatric,,children,<0.001,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1059,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by body surface area,1170,mg/kg/d,mean,SD,325.0,,,,,IV,,162.0,pediatric,,children,<0.001,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1060,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by body surface area,1317,mg/kg/d,mean,SD,351.0,,,,,IV,,599.0,pediatric,,children,<0.001,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1061,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by body surface area,1437,mg/kg/d,mean,SD,340.0,,,,,IV,,153.0,pediatric,,children,<0.001,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1062,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by body surface area,1483,mg/kg/d,mean,SD,378.0,,,,,IV,,185.0,pediatric,,children,<0.001,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1063,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,dose by body surface area,1341,mg/kg/d,mean,SD,363.0,,,,,IV,,1099.0,pediatric,,children,<0.001,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1064,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,"dose by allometric
weight",103,mg/kg/d,mean,SD,28.0,,,,,IV,,162.0,pediatric,,children,0.05,Underweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1065,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,"dose by allometric
weight",108,mg/kg/d,mean,SD,27.0,,,,,IV,,599.0,pediatric,,children,0.05,Normal weight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1066,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,"dose by allometric
weight",111,mg/kg/d,mean,SD,25.0,,,,,IV,,153.0,pediatric,,children,0.05,Overweight,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1067,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,"dose by allometric
weight",108,mg/kg/d,mean,SD,27.0,,,,,IV,,185.0,pediatric,,children,0.05,Obese,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1068,2025-12-02T16:03:32.268615
34645692.0,Vancomycin ,"dose by allometric
weight",107,mg/kg/d,mean,SD,27.0,,,,,IV,,1099.0,pediatric,,children,0.05,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1069,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,40,mg/kg/d,median,,,IQR,40,57.1,,IV,,470.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1070,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,10-15,mg/kg,,,,,,,4 times a day,IV,1 h infusion,263.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1071,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,10-15,mg/kg,,,,,,,4 times a day,IV,2-4 h infusion,70.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1072,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,10-20,mg/kg,,,,,,,3 times a day,IV,1 h infusion,110.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1073,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,10-15,mg/kg,,,,,,,3 times a day,IV,2-4 h infusion,18.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1074,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,10-20,mg/kg,,,,,,,bid,IV,1 h infusion,9.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1075,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,38.5,mg/kg/d,mean,SD,10.3,IQR,30.9,44.0,,,,20.0,pediatric,,neonates,0.023,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1076,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,45.4,mg/kg/d,mean,SD,9.4,IQR,40,55.8,,,,209.0,pediatric,,infant/chid,0.023,1-23 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1077,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,46.2,mg/kg/d,mean,SD,9.6,IQR,40,59.7,,,,122.0,pediatric,,children,0.023,2-5 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1078,2025-12-02T16:03:32.268615
34664790.0,Vancomycin ,dose,44,mg/kg/d,mean,SD,11.3,IQR,38.5,57.1,,,,105.0,pediatric,,children,0.023,6-14 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1079,2025-12-02T16:03:32.268615
35037934.0,Vancomycin ,dose,15,mg/kg,,,,,,,"every 6, 8, 12 or 24 h",IV,over 1 h,30.0,pediatric,,infant,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1080,2025-12-02T16:03:32.268615
35094368.0,Vancomycin ,,,,,,,,,,,,,1600.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1081,2025-12-02T16:03:32.268615
35049078.0,Vancomycin ,dose,48,mmg/kg/day,median,,,minmax,35,68.5,,IV,,47.0,pediatric,,infants,0.0856,Augmented renal clearance,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1082,2025-12-02T16:03:32.268615
35049078.0,Vancomycin ,dose,50,mmg/kg/day,mean,SD,10.8,,,,,IV,,47.0,pediatric,,infants,,Augmented renal clearance,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1083,2025-12-02T16:03:32.268615
35049078.0,Vancomycin ,dose,47,mmg/kg/day,median,,,minmax,23.7,71.1,,IV,,19.0,pediatric,,infants,0.0856,Normal renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1084,2025-12-02T16:03:32.268615
35049078.0,Vancomycin ,dose,45,mmg/kg/day,mean,SD,12.1,,,,,IV,,19.0,pediatric,,infants,,Normal renal function,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1085,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,amount of time the dosing and concentration history,409.7,h,mean,,,IQR,25.01,422.5,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1086,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,amount of time the dosing and concentration history,64,h,median,,,minmax,4.68,4165.97,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1087,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,No. of doses,12.6,,mean,,,IQR,4,14.0,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1088,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,No. of doses,6,,median,,,minmax,1,139.0,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1089,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,dose,50.4,mg,mean,,,IQR,27,70.0,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1090,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,dose,48,mg,median,,,minmax,5,175.0,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1091,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,dose,14.72,mg/kg,mean,,,IQR,13.79,15.28,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1092,2025-12-02T16:03:32.268615
35293782.0,Vancomycin ,dose,14.75,mg/kg,median,,,minmax,2.45,28.38,,IV,,934.0,pediatric,,neonates and infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1093,2025-12-02T16:03:32.268615
35465728.0,Vancomycin ,loading dose,7.1,mg/kg,median,,,25th-75th percentiles,7,7.1,,,,60.0,pediatric,,neonates,<0.001,before-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1094,2025-12-02T16:03:32.268615
35465728.0,Vancomycin ,loading dose,11.1,mg/kg,median,,,25th-75th percentiles,10.3,11.6,,,,59.0,pediatric,,neonates,<0.001,after-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1095,2025-12-02T16:03:32.268615
35465728.0,Vancomycin ,maintenance dose ,19.4,mg/kg,median,,,25th-75th percentiles,12.1,28.4,,,,60.0,pediatric,,neonates,<0.001,before-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1096,2025-12-02T16:03:32.268615
35465728.0,Vancomycin ,maintenance dose ,28.1,mg/kg,median,,,25th-75th percentiles,22.4,35.7,,,,59.0,pediatric,,neonates,<0.001,after-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1097,2025-12-02T16:03:32.268615
35465728.0,Vancomycin ,duration of vancomycin therapy,6,days,median,,,25th-75th percentiles,3,10.0,,,,60.0,pediatric,,neonates,0.089,before-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1098,2025-12-02T16:03:32.268615
35465728.0,Vancomycin ,duration of vancomycin therapy,5,days,median,,,25th-75th percentiles,2,9.0,,,,58.0,pediatric,,neonates,0.089,after-implementation group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1099,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,courses,129,,N,,,,,,,,,69.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1100,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 18 h,IV,over 1 h,28.0,pediatric,,"neonates (<=29 weeks of CGA, 0-14 days of PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1101,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 12 h,IV,over 1 h,16.0,pediatric,,"neonates (<=29 weeks of CGA, >14 days of PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1102,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 12 h,IV,over 1 h,24.0,pediatric,,"neonates (30-36 weeks of CGA, 0-14 days of PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1103,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 8 h,IV,over 1 h,49.0,pediatric,,"neonates (30-36 weeks of CGA, >14 days of PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1104,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 18 h,IV,over 1 h,0.0,pediatric,,"neonates (37-44 weeks of CGA, 0-14 days of PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1105,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 8 h,IV,over 1 h,12.0,pediatric,,"neonates (37-44 weeks of CGA, >14 days of PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1106,2025-12-02T16:03:32.268615
35383737.0,Vancomycin ,dose,15,mg/kg,,,,,,,every 6 h,IV,over 1 h,0.0,pediatric,,"neonates (>=45 weeks of CGA, all PNA)",,No. of courses,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1107,2025-12-02T16:03:32.268615
35255798.0,Vancomycin ,dose,55.83,mg/kg/day,mean,SD,,,,,,,,40.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1108,2025-12-02T16:03:32.268615
35255798.0,Vancomycin ,dose,3,,N,,,,,,,,,40.0,pediatric,,children,,<20 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1109,2025-12-02T16:03:32.268615
35255798.0,Vancomycin ,dose,7,,N,,,,,,,,,40.0,pediatric,,children,,20-40 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1110,2025-12-02T16:03:32.268615
35255798.0,Vancomycin ,dose,18,,N,,,,,,,,,40.0,pediatric,,children,,40-60 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1111,2025-12-02T16:03:32.268615
35255798.0,Vancomycin ,dose,12,,N,,,,,,,,,40.0,pediatric,,children,,>60 mg/kg/day,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1112,2025-12-02T16:03:32.268615
35581390.0,Vancomycin ,loading dose,15,mg/kg,median,,,IQR,10,15.0,,IV,over 60-min,70.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1113,2025-12-02T16:03:32.268615
35581390.0,Vancomycin ,maintenance dose,30,mg/kg,median,,,IQR,25,35.0,,CIV,started immediately after the loading dose infusion,70.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1114,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,initial dosage received,15.67,mg/kg,mean,SD,1.95,,,,,,,48.0,pediatric,,children,0.613,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1115,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,initial dosage received,15.75,mg/kg,mean,SD,1.73,,,,,,,36.0,pediatric,,children,0.613,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1116,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,initial dosage received,15.42,mg/kg,mean,SD,2.57,,,,,,,12.0,pediatric,,children,0.613,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1117,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,daily dose,61.51,mg/kg/day,mean,SD,12.7,,,,,,,48.0,pediatric,,children,0.92,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1118,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,daily dose,61.403,mg/kg/day,mean,SD,13.46,,,,,,,36.0,pediatric,,children,0.92,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1119,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,daily dose,61.83,mg/kg/day,mean,SD,10.63,,,,,,,12.0,pediatric,,children,0.92,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1120,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,adjusted dosage,19.82,mg/kg,mean,SD,3.38,,,,,,,48.0,pediatric,,children,0.214,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1121,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,adjusted dosage,20.73,mg/kg,mean,SD,2.5,,,,,,,36.0,pediatric,,children,0.214,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1122,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,adjusted dosage,18.91,mg/kg,mean,SD,3.99,,,,,,,12.0,pediatric,,children,0.214,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1123,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,Number of received doses,27.5,,median,,,IQR,21.25,,,,,48.0,pediatric,,children,0.229,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1124,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,Number of received doses,26,,median,,,IQR,22.75,,,,,36.0,pediatric,,children,0.229,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1125,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,Number of received doses,33,,median,,,IQR,"19,75",,,,,12.0,pediatric,,children,0.229,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1126,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,duration of treatment,7.12,days,median,,,IQR,5.563,,,,,48.0,pediatric,,children,0.512,Total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1127,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,duration of treatment,6.75,days,median,,,IQR,5.813,,,,,36.0,pediatric,,children,0.512,non-SCD patients ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1128,2025-12-02T16:03:32.268615
35688759.0,Vancomycin ,duration of treatment,8.25,days,median,,,IQR,2.688,,,,,12.0,pediatric,,children,0.512,sickle cell disease patients with  acute chest syndrome ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1129,2025-12-02T16:03:32.268615
35821590.0,Vancomycin ,initial dose,11.1,mg/kg/day,median,,,IQR,9.8,12.5,4 times a day,IV,over 1 h,17.0,pediatric,,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1130,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,40,mg/kg/day,median,,,IQR,40,58.71,,IV,for at least 60 min,110.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1131,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,40,mg/kg/day,median,,,IQR,40,57.06,,IV,for at least 60 min,76.0,pediatric,,children,0.054,effective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1132,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,40.61,mg/kg/day,median,,,IQR,40,60.0,,IV,for at least 60 min,34.0,pediatric,,children,0.054,ineffective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1133,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,length of vancomycin therapy,10,days,median,,,IQR,7,15.0,,IV,for at least 60 min,76.0,pediatric,,children,0.818,effective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1134,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,length of vancomycin therapy,10,days,median,,,IQR,6,18.0,,IV,for at least 60 min,34.0,pediatric,,children,0.818,ineffective group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1135,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,42.11,mg/kg/day,median,,,IQR,40,59.23,,IV,for at least 60 min,49.0,pediatric,,children,0.982,Pathogen-cleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1136,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,40,mg/kg/day,median,,,IQR,40,60.0,,IV,for at least 60 min,17.0,pediatric,,children,0.982,Pathogen-uncleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1137,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,length of vancomycin therapy,10,days,median,,,IQR,7,17.0,,IV,for at least 60 min,49.0,pediatric,,children,0.104,Pathogen-cleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1138,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,length of vancomycin therapy,13,days,median,,,IQR,5,22.0,,IV,for at least 60 min,17.0,pediatric,,children,0.104,Pathogen-uncleared group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1139,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,40,mg/kg/day,median,,,IQR,40,59.64,,IV,for at least 60 min,95.0,pediatric,,children,0.001,Non-nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1140,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state daily dose,40,mg/kg/day,median,,,IQR,28.57,40.0,,IV,for at least 60 min,15.0,pediatric,,children,0.001,Nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1141,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,length of vancomycin therapy,10,days,median,,,IQR,7,15.0,,IV,for at least 60 min,95.0,pediatric,,children,0.872,Non-nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1142,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,length of vancomycin therapy,10,days,median,,,IQR,7,14.0,,IV,for at least 60 min,15.0,pediatric,,children,0.872,Nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1143,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state single dose,10,mg/kg,median,,,IQR,10,14.91,,IV,for at least 60 min,95.0,pediatric,,children,0.001,Non-nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1144,2025-12-02T16:03:32.268615
35844752.0,Vancomycin ,steady-state single dose,10,mg/kg,median,,,IQR,7.14,10.0,,IV,for at least 60 min,15.0,pediatric,,children,0.001,Nephrotoxic group,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1145,2025-12-02T16:03:32.268615
36222533.0,Vancomycin ,initial dose,30,mg/kg,median,,,IQR,20,33.45,,intermittentIV,,25.0,pediatric,,neonates,0.34,favorable group according to early clinical evolution (ECE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1146,2025-12-02T16:03:32.268615
36222533.0,Vancomycin ,initial dose,21,mg/kg,median,,,IQR,20,31.5,,intermittentIV,,18.0,pediatric,,neonates,0.34,unfavorable group according to early clinical evolution (ECE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1147,2025-12-02T16:03:32.268615
36222533.0,Vancomycin ,adjusted dosage ,40,mg/kg,median,,,IQR,30,60.0,,intermittentIV,,13.0,pediatric,,neonates,0.841,favorable group according to late clinical evolution (LCE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1148,2025-12-02T16:03:32.268615
36222533.0,Vancomycin ,adjusted dosage,39,mg/kg,median,,,IQR,30,49.5,,intermittentIV,,5.0,pediatric,,neonates,0.841,unfavorable group according to late clinical evolution (LCE) ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1149,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,initial dose,36.7,mg/kg/d,mean,SD,6.6,,,,,IV,,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1150,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,duration of therapy,6.4,days,mean,SD,4.8,,,,,IV,,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1151,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,92,,N,,,,,,Q6,IV,,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1152,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,45,,N,,,,,,Q8,IV,,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1153,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,2,,N,,,,,,Q12,IV,,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1154,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,1,,N,,,,,,Q24,IV,,140.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1155,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,Total daily dose,42.5,mg/kg/day,mean,SD,3.5,,,,,,,3.0,pediatric,,children,"0.517, compared to patients with normal renal function",AKI after treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1156,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,Total daily dose,36.15,mg/kg/day,mean,SD,6.5,,,,,,,15.0,pediatric,,children,"0.878, compared to patients with normal renal function",Elevated Scr post-treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1157,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,Duration of therapy,7.67,days,mean,SD,2.8,,,,,,,3.0,pediatric,,children,"0.67, compared to patients with normal renal function",AKI after treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1158,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,Duration of therapy,7.2,days,mean,SD,5.96,,,,,,,15.0,pediatric,,children,"0.55, compared to patients with normal renal function",Elevated Scr post-treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1159,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,1,,N,,,,,,Q24,,,122.0,pediatric,,children, patients with normal renal function,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1160,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,1,,N,,,,,,Q12,,,122.0,pediatric,,children, patients with normal renal function,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1161,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,2,,N,,,,,,Q8,,,3.0,pediatric,,children,"0.26, compared to patients with normal renal function",AKI after treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1162,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,5,,N,,,,,,Q8,,,15.0,pediatric,,children,"0.65, compared to patients with normal renal function",Elevated Scr post-treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1163,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,1,,N,,,,,,Q6,,,3.0,pediatric,,children,"0.28, compared to patients with normal renal function",AKI after treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1164,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,10,,N,,,,,,Q6,,,15.0,pediatric,,children,"0.93, compared to patients with normal renal function",Elevated Scr post-treatment,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1165,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,37,,N,,,,,,Q8,,,122.0,pediatric,,children, patients with normal renal function,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1166,2025-12-02T16:03:32.268615
36254077.0,Vancomycin ,No. of patients,72,,N,,,,,,Q6,,,122.0,pediatric,,children, patients with normal renal function,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1167,2025-12-02T16:03:32.268615
34302760.0,bictegravir ,dose,50,mg,,,,,,,once daily,oral,,100.0,pediatric,,adolescents and children ,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1168,2025-12-02T16:03:32.268615
34302760.0,emtricitabine ,dose,200,mg,,,,,,,once daily,oral,,100.0,pediatric,,adolescents and children ,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1169,2025-12-02T16:03:32.268615
34302760.0,tenofovir alafenamide ,dose,25,mg,,,,,,,once daily,oral,,100.0,pediatric,,adolescents and children ,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1170,2025-12-02T16:03:32.268615
32330231.0,Elvitegravir,dose,150,mg,,,,,,,once daily,oral,,14.0,maternal,before the third trimester,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1171,2025-12-02T16:03:32.268615
32330231.0,cobicistat ,dose,150,mg,,,,,,,once daily,oral,,14.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1172,2025-12-02T16:03:32.268615
32015036.0,Fosamprenavir,dose,700,mg,,,,,,,bid,oral,,29.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1173,2025-12-02T16:03:32.268615
32015036.0,ritonavir,dose,100,mg,,,,,,,bid,oral,,29.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1174,2025-12-02T16:03:32.268615
30358179.0,Nelfinavir,dose,1250,mg,,,,,,,bid,oral,until 30 weeks of gestation ,2.0,maternal,second trimester,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1175,2025-12-02T16:03:32.268615
30358179.0,Nelfinavir,dose,1875,mg,,,,,,,bid,oral,from 30 weeks of gestation until 2–4 days postpartum ,18.0,maternal,third trimester,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1176,2025-12-02T16:03:32.268615
30358179.0,Nelfinavir,dose,1250,mg,,,,,,,bid,oral,from 2–4 days postpartum until 2–3 weeks postpartum. ,16.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1177,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,75,mg,,,,,,,bid,oral,,7.0,pediatric,,children ,,All enrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1178,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,75,mg,,,,,,,bid,oral,,0.0,pediatric,,children (1 to<6 years),,Cohort I ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1179,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,75,mg,,,,,,,bid,oral,,3.0,pediatric,,children (2 to <2 years),,Cohort II ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1180,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,100,mg,,,,,,,bid,oral,,16.0,pediatric,,children ,,All enrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1181,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,100,mg,,,,,,,bid,oral,,12.0,pediatric,,children (1 to<6 years),,Cohort I ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1182,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,100,mg,,,,,,,bid,oral,,3.0,pediatric,,children (2 to <2 years),,Cohort II ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1183,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,125,mg,,,,,,,bid,oral,,3.0,pediatric,,children ,,All enrolled,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1184,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,125,mg,,,,,,,bid,oral,,3.0,pediatric,,children (1 to<6 years),,Cohort I ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1185,2025-12-02T16:03:32.268615
33831904.0,Etravirine,dose,125,mg,,,,,,,bid,oral,,0.0,pediatric,,children (2 to <2 years),,Cohort II ,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1186,2025-12-02T16:03:32.268615
33252481.0,Maraviroc,dose,8,mg/kg,,,,,,,single dose,oral,single doses at Entry and Week 1 (7–14 days of life) ,15.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1187,2025-12-02T16:03:32.268615
33252481.0,Maraviroc,dose,8,mg/kg,,,,,,,bid,oral,from entry through Week 6 (35–42 days of life) ,32.0,pediatric,,infants,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1188,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,6.9,mg,mean,,,,,,once daily,oral,,13.0,pediatric,,infants,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1189,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,5,mg,median,,,minmax,5,10.0,once daily,oral,,13.0,pediatric,,infants,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1190,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.2,mg/kg,mean,,,,,,once daily,oral,,13.0,pediatric,,infants,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1191,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.1,mg/kg,median,,,minmax,0.9,1.7,once daily,oral,,13.0,pediatric,,infants,,>=4 weeks to <6 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1192,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,15.8,mg,mean,,,,,,once daily,oral,,13.0,pediatric,,infants and children,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1193,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,15,mg,median,,,minmax,10,25.0,once daily,oral,,13.0,pediatric,,infants and children,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1194,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.9,mg/kg,mean,,,,,,once daily,oral,,13.0,pediatric,,infants and children,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1195,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.9,mg/kg,median,,,minmax,1.6,2.2,once daily,oral,,13.0,pediatric,,infants and children,,>=6 months to <2 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1196,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,21.8,mg,mean,,,,,,once daily,oral,,17.0,pediatric,,children,,>=2 to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1197,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,20,mg,median,,,,,,once daily,oral,,17.0,pediatric,,children,,>=2 to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1198,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.7,mg/kg,mean,,,,,,once daily,oral,,17.0,pediatric,,children,,>=2 to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1199,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.7,mg/kg,median,,,minmax,1.4,2.0,once daily,oral,,17.0,pediatric,,children,,>=2 to <6 years,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1200,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,5,mg,,,,,,,once daily,oral,,8.0,pediatric,,infants and children,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1201,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.02,mg/kg,mean,,,,,,once daily,oral,,8.0,pediatric,,infants and children,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1202,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.03,mg/kg,median,,,minmax,0.88,1.22,once daily,oral,,8.0,pediatric,,infants and children,,weight band 3 to <6 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1203,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,15,mg,,,,,,,once daily,oral,,11.0,pediatric,,infants and children,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1204,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.86,mg/kg,mean,,,,,,once daily,oral,,11.0,pediatric,,infants and children,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1205,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.9,mg/kg,median,,,minmax,1.58,2.21,once daily,oral,,11.0,pediatric,,infants and children,,weight band 6 to <10 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1206,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,20,mg,,,,,,,once daily,oral,,10.0,pediatric,,infants and children,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1207,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.75,mg/kg,mean,,,,,,once daily,oral,,10.0,pediatric,,infants and children,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1208,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.72,mg/kg,median,,,minmax,1.54,2.0,once daily,oral,,10.0,pediatric,,infants and children,,weight band 10 to <14 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1209,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,25,mg,,,,,,,once daily,oral,,8.0,pediatric,,infants and children,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1210,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.66,mg/kg,mean,,,,,,once daily,oral,,8.0,pediatric,,infants and children,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1211,2025-12-02T16:03:32.268615
35489377.0,dolutegravir ,dose,1.71,mg/kg,median,,,minmax,1.43,1.77,once daily,oral,,8.0,pediatric,,infants and children,,weight band 14 to <20 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1212,2025-12-02T16:03:32.268615
35288747.0,dolutegravir ,dose,50,mg,,,,,,,once daily,oral,"4 weeks in sequence 1, and continuted  in sequence 2 and 3.",12.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1213,2025-12-02T16:03:32.268615
35288747.0,dihydroartemisinin/piperaquine ,,,,,,,,,,,,for three days in sequence 3,12.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1214,2025-12-02T16:03:32.268615
35868341.0,dolutegravir ,daily dose,3.4,mg/kg,,,,,,,bid,oral,,1.0,pediatric,,children,,25 mg dispersible tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1215,2025-12-02T16:03:32.268615
35868341.0,dolutegravir ,daily dose,1.8,mg/kg,,,,,,,once daily,oral,,1.0,pediatric,,children,,25 mg dispersible tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1216,2025-12-02T16:03:32.268615
35868341.0,dolutegravir ,daily dose,2,mg/kg,median,,,IQR,1.8,2.4,bid,oral,,5.0,pediatric,,children,,25 mg film-coated tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1217,2025-12-02T16:03:32.268615
35868341.0,dolutegravir ,daily dose,1,mg/kg,median,,,IQR,0.9,1.3,once daily,oral,,5.0,pediatric,,children,,25 mg film-coated tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1218,2025-12-02T16:03:32.268615
35868341.0,dolutegravir ,daily dose,3.1,mg/kg,median,,,IQR,2.3,3.2,bid,oral,,7.0,pediatric,,children,,50 mg film-coated tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1219,2025-12-02T16:03:32.268615
35868341.0,dolutegravir ,daily dose,1.5,mg/kg,median,,,IQR,1,1.6,once daily,oral,,7.0,pediatric,,children,,50 mg film-coated tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1220,2025-12-02T16:03:32.268615
35868341.0,Rifampicin ,daily dose,15.4,mg/kg,median,,,,,,bid,oral,,1.0,pediatric,,children,,25 mg dispersible tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1221,2025-12-02T16:03:32.268615
35868341.0,Rifampicin ,daily dose,12,mg/kg,median,,,IQR,11,14.6,bid,oral,,5.0,pediatric,,children,,25 mg film-coated tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1222,2025-12-02T16:03:32.268615
35868341.0,Rifampicin ,daily dose,14.1,mg/kg,median,,,IQR,9.6,16.0,bid,oral,,7.0,pediatric,,children,,50 mg film-coated tablet,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1223,2025-12-02T16:03:32.268615
35189082.0,dolutegravir ,dose,0.9,mg/kg,median,,,IQR,0.9,1.0,once daily,oral,,5.0,pediatric,,children <6 months,,"3 kg to <6 kg, receiving 5 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1224,2025-12-02T16:03:32.268615
35189082.0,dolutegravir ,dose,1.8,mg/kg,median,,,IQR,1.6,2.1,once daily,oral,,13.0,pediatric,,children,,"6 kg to <10 kg, receiving 15 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1225,2025-12-02T16:03:32.268615
35189082.0,dolutegravir ,dose,1.8,mg/kg,median,,,IQR,1.7,1.9,once daily,oral,,11.0,pediatric,,children,,"10 kg to <14 kg, receiving 20 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1226,2025-12-02T16:03:32.268615
35189082.0,dolutegravir ,dose,1.4,mg/kg,median,,,IQR,1.3,1.6,once daily,oral,,16.0,pediatric,,children,,"14 kg to <20 kg, receiving 25 mg dispersible tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1227,2025-12-02T16:03:32.268615
35189082.0,dolutegravir ,dose,1.5,mg/kg,median,,,IQR,1.3,1.6,once daily,oral,,19.0,pediatric,,children,,"14 kg to <20 kg, receiving 25 mg film-coated tablet",PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1228,2025-12-02T16:03:32.268615
36111542.0,dolutegravir ,dose,50,mg,,,,,,,once daily,oral,,20.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1229,2025-12-02T16:03:32.268615
32103260.0,dolutegravir ,dose,50,mg,,,,,,,once daily,oral,,17.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1230,2025-12-02T16:03:32.268615
32103260.0,dolutegravir ,Time on dolutegravir,59,weeks,median,,,minmax,1,97.0,once daily,oral,,17.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1231,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,1.1,mg/kg,median,,,IQR,1,1.1,once daily,oral,,14.0,pediatric,,children,,20 kg to <25 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1232,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,1.4,mg/kg,median,,,IQR,1.3,1.4,once daily,oral,,9.0,pediatric,,children,,20 kg to <25 kg with 30 mg DT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1233,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,2.3,mg/kg,median,,,IQR,2.2,2.4,once daily,oral,,9.0,pediatric,,children,,20 kg to <25 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1234,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,0.9,mg/kg,median,,,IQR,0.9,0.9,once daily,oral,,17.0,pediatric,,children,,25 kg to <30 kg with 25 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1235,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,1.8,mg/kg,median,,,IQR,1.7,1.9,once daily,oral,,16.0,pediatric,,children,,25 kg to <30 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1236,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,1.1,mg/kg,median,,,IQR,1,1.2,once daily,oral,,9.0,pediatric,,children,,35 kg to <40 kg with 35 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1237,2025-12-02T16:03:32.268615
32763217.0,dolutegravir ,dose,1.6,mg/kg,median,,,IQR,1.3,1.7,once daily,oral,,10.0,pediatric,,children,,35 kg to <40 kg with 50 mg FCT,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1238,2025-12-02T16:03:32.268615
31539371.0,dolutegravir ,dose,50,mg,,,,,,,once daily,oral,,29.0,maternal,pregnancy and postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1239,2025-12-02T16:03:32.268615
36177836.0,raltegravir,dose,400,mg,,,,,,,bid,oral,,3.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1240,2025-12-02T16:03:32.268615
36177836.0,rilpivirine,dose,25,mg,,,,,,,once daily,oral,,2.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1241,2025-12-02T16:03:32.268615
36177836.0,bictegravir,dose,50,mg,,,,,,,once daily,oral,,3.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1242,2025-12-02T16:03:32.268615
36177836.0,tenofovir alafenamide,dose,300,mg,,,,,,,once daily,oral,,24.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1243,2025-12-02T16:03:32.268615
36177836.0,dolutegravir ,dose,50,mg,,,,,,,once daily,oral,,6.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1244,2025-12-02T16:03:32.268615
36177836.0,raltegravir,dose,1200,mg,,,,,,,once daily,oral,,14.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1245,2025-12-02T16:03:32.268615
36177836.0,darunavir/ritonavir,dose,800/100,mg,,,,,,,once daily,oral,,4.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1246,2025-12-02T16:03:32.268615
32448902.0,raltegravir,dose,12,mg/kg,,,,,,,bid,oral,,13.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1247,2025-12-02T16:03:32.268615
32661003.0,raltegravir,dose,400,mg,,,,,,,bid,oral,,43.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1248,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,3,mg/kg,,,,,,,initial dose,oral,a single oral dose within 48 hours of birth followed by 3 mg/kg for the second dose at 7-10 days of life,6.0,pediatric,,neonates,,Cohort 1 RAL-naïve,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1249,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,2,mg/kg,,,,,,,initial dose,oral,a single oral dose within 48 hours of birth followed by 3 mg/kg for the second dose at 7-10 days of life,3.0,pediatric,,neonates,,Cohort 1 RAL-naïve,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1250,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,1.5,mg/kg,,,,,,,initial dose,oral,a single oral dose within 48 hours of birth followed by 3 mg/kg for the second dose at 7-10 days of life,6.0,pediatric,,neonates,,Cohort 1 RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1251,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,1.5,mg/kg,,,,,,,once daily,oral,started through day 7,25.0,pediatric,,neonates,,Cohort 2 RAL-naïve,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1252,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,1.5,mg/kg,,,,,,,once daily,oral,started through day 8,10.0,pediatric,,neonates,,Cohort 2 RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1253,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,3,mg/kg,,,,,,,bid,oral,from days 8 to 28 of life,24.0,pediatric,,neonates,,Cohort 2 RAL-naïve,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1254,2025-12-02T16:03:32.268615
31913995.0,raltegravir,dose,3,mg/kg,,,,,,,bid,oral,from days 8 to 28 of life,10.0,pediatric,,neonates,,Cohort 2 RAL-exposed,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1255,2025-12-02T16:03:32.268615
31689263.0,raltegravir,dose,12.3,mg/kg,geometric mean,CV%,0.102,,,,bid,oral,,12.0,pediatric,,children 2 to <6 yr,,cohort 1,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1256,2025-12-02T16:03:32.268615
31689263.0,raltegravir,dose,12.6,mg/kg,geometric mean,CV%,0.125,,,,bid,oral,,14.0,pediatric,,children 6 to <12 yr,,cohort 2,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1257,2025-12-02T16:03:32.268615
34076612.0,darunavir,dose,800,mg,,,,,,,once daily,oral,,29.0,maternal,"2T, 3T and postpartum",,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1258,2025-12-02T16:03:32.268615
34076612.0,cobicistat ,dose,150,mg,,,,,,,once daily,oral,,29.0,maternal,"2T, 3T and postpartum",,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1259,2025-12-02T16:03:32.268615
31923087.0,darunavir,dose,800,mg,,,,,,,bid,oral,,24.0,maternal,"2T, 3T ",,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1260,2025-12-02T16:03:32.268615
31923087.0,ritonavir,dose,100,mg,,,,,,,bid,oral,,24.0,maternal,"2T, 3T ",,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1261,2025-12-02T16:03:32.268615
31923087.0,darunavir,dose,600,mg,,,,,,,bid,oral,,24.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1262,2025-12-02T16:03:32.268615
31923087.0,ritonavir,dose,100,mg,,,,,,,bid,oral,,24.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1263,2025-12-02T16:03:32.268615
30873741.0,darunavir,dose,800,mg,,,,,,,once daily,oral,,7.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1264,2025-12-02T16:03:32.268615
30873741.0,cobicistat ,dose,150,mg,,,,,,,once daily,oral,,7.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1265,2025-12-02T16:03:32.268615
30728322.0,darunavir,dose,800,mg,,,,,,,once daily,oral,,33.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1266,2025-12-02T16:03:32.268615
30728322.0,ritonavir,dose,100,mg,,,,,,,once daily,oral,,33.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1267,2025-12-02T16:03:32.268615
34732682.0,Atazanavir ,dose,300,mg,,,,,,,once daily,oral,,11.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1268,2025-12-02T16:03:32.268615
34732682.0,Cobicistat ,dose,150,mg,,,,,,,once daily,oral,,11.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1269,2025-12-02T16:03:32.268615
34855626.0,abacavir ,dose,8.61,mg/kg,median,,,minmax,6.63,11.36,single dose,oral,,18.0,pediatric,,neonates,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1270,2025-12-02T16:03:32.268615
34855626.0,lamivudine ,dose,4.3,mg/kg,median,,,minmax,3.31,5.68,single dose,oral,,18.0,pediatric,,neonates,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1271,2025-12-02T16:03:32.268615
34855626.0,lopinavir ,dose,11.48,mg/kg,median,,,minmax,8.84,15.15,single dose,oral,,18.0,pediatric,,neonates,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1272,2025-12-02T16:03:32.268615
34855626.0,ritonavir ,dose,10,mg,,,,,,,single dose,oral,,18.0,pediatric,,neonates,,total,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1273,2025-12-02T16:03:32.268615
33464021.0,Zidovudine ,dose,,,,,,,,,bid,oral,,52.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1274,2025-12-02T16:03:32.268615
33464021.0,lamivudine ,dose,,,,,,,,,bid,oral,,52.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1275,2025-12-02T16:03:32.268615
33464021.0,lopinavir ,dose,,,,,,,,,bid,oral,,52.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1276,2025-12-02T16:03:32.268615
33464021.0,ritonavir ,dose,,,,,,,,,bid,oral,,52.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1277,2025-12-02T16:03:32.268615
31081020.0,lopinavir ,dose,21.5,mg/kg,median,,,IQR,20.3,22.4,8-hourly,oral,,11.0,pediatric,,children,0.06,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1278,2025-12-02T16:03:32.268615
31081020.0,lopinavir ,dose,22.2,mg/kg,median,,,IQR,21.5,22.6,8-hourly,oral,,7.0,pediatric,,children,0.06,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1279,2025-12-02T16:03:32.268615
31081020.0,lopinavir ,dose,20.3,mg/kg,median,,,IQR,20.2,20.8,8-hourly,oral,,4.0,pediatric,,children,0.06,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1280,2025-12-02T16:03:32.268615
31081020.0,rifampicin,dose,13.5,mg/kg,median,,,IQR,11.8,14.2,,,,11.0,pediatric,,children,0.45,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1281,2025-12-02T16:03:32.268615
31081020.0,rifampicin,dose,13.9,mg/kg,median,,,IQR,11.8,14.8,,,,7.0,pediatric,,children,0.45,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1282,2025-12-02T16:03:32.268615
31081020.0,rifampicin,dose,12.9,mg/kg,median,,,IQR,11.8,13.8,,,,4.0,pediatric,,children,0.45,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1283,2025-12-02T16:03:32.268615
31081020.0,ritonavir,dose,,,,,,,,,8-hourly,oral,8-hourly lopinavir/ritonavir-4:1,11.0,pediatric,,children,,all patients,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1284,2025-12-02T16:03:32.268615
31081020.0,ritonavir,dose,,,,,,,,,8-hourly,oral,8-hourly lopinavir/ritonavir-4:2,7.0,pediatric,,children,,Adequate lopinavir trough (Cmin>=1 mg/L) acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1285,2025-12-02T16:03:32.268615
31081020.0,ritonavir,dose,,,,,,,,,8-hourly,oral,8-hourly lopinavir/ritonavir-4:3,4.0,pediatric,,children,,Adequate lopinavir trough not acheived,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1286,2025-12-02T16:03:32.268615
32451952.0,ombitasvir ,dose,10,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",15.0,pediatric,,children,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1287,2025-12-02T16:03:32.268615
32451952.0,paritaprevir ,dose,50,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",15.0,pediatric,,children,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1288,2025-12-02T16:03:32.268615
32451952.0,Ritonavir ,dose,35,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",15.0,pediatric,,children,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1289,2025-12-02T16:03:32.268615
32451952.0,dasabuvir ,dose,100,mg,,,,,,,bid,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",15.0,pediatric,,children,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1290,2025-12-02T16:03:32.268615
32451952.0,ribavirin ,dose,40,mg/ml,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",15.0,pediatric,,children,,15-29 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1291,2025-12-02T16:03:32.268615
32451952.0,ombitasvir ,dose,15,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",9.0,pediatric,,children,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1292,2025-12-02T16:03:32.268615
32451952.0,paritaprevir ,dose,100,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",9.0,pediatric,,children,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1293,2025-12-02T16:03:32.268615
32451952.0,Ritonavir ,dose,70,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",9.0,pediatric,,children,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1294,2025-12-02T16:03:32.268615
32451952.0,dasabuvir ,dose,150,mg,,,,,,,bid,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",9.0,pediatric,,children,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1295,2025-12-02T16:03:32.268615
32451952.0,ribavirin ,dose,40,mg/ml,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",9.0,pediatric,,children,,30-44 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1296,2025-12-02T16:03:32.268615
32451952.0,ombitasvir ,dose,25,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",2.0,pediatric,,children,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1297,2025-12-02T16:03:32.268615
32451952.0,paritaprevir ,dose,150,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",2.0,pediatric,,children,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1298,2025-12-02T16:03:32.268615
32451952.0,Ritonavir ,dose,100,mg,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",2.0,pediatric,,children,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1299,2025-12-02T16:03:32.268615
32451952.0,dasabuvir ,dose,250,mg,,,,,,,bid,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",2.0,pediatric,,children,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1300,2025-12-02T16:03:32.268615
32451952.0,ribavirin ,dose,40,mg/ml,,,,,,,qd,oral,"receive 12 weeks of treatment with OBV, PTV, ritonavir, and DSV mini-tablet formulations ",2.0,pediatric,,children,,>=45 kg,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1301,2025-12-02T16:03:32.268615
32697327.0,Abacavir ,dose,8.1,mg/kg,median,,,minmax,8,8.4,single dose,oral,administered a single abacavir dose of 8 mg/kg before 15 days of life,,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1302,2025-12-02T16:03:32.268615
30767719.0,tenofovir diproxil fumarate,dose,,,,,,,,,qd,oral,,61.0,maternal,pregnancy/ postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1303,2025-12-02T16:03:32.268615
30767719.0,emtricitabine ,dose,,,,,,,,,qd,oral,,61.0,maternal,pregnancy/ postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1304,2025-12-02T16:03:32.268615
30767719.0,tenofovir diproxil fumarate and emtricitabine ,duration on regimen,27,months,median,,,minmax,1,48.0,qd,oral,,31.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1305,2025-12-02T16:03:32.268615
30767719.0,tenofovir diproxil fumarate and emtricitabine ,duration on regimen,13,months,median,,,minmax,2,36.0,qd,oral,,30.0,maternal,postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1306,2025-12-02T16:03:32.268615
35599363.0,Tenofovir alafenamide ,dose,25,mg,,,,,,,qd,oral,,8.0,maternal,third trimester or postpartum ,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1307,2025-12-02T16:03:32.268615
32960984.0,tenofovir disoproxil fumarate ,dose,,,,,,,,,,oral,,296.0,maternal,pregnancy/ postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1308,2025-12-02T16:03:32.268615
34254323.0,tenofovir disoproxil fumarate ,dose,300,mg,,,,,,,qd,oral,,44.0,maternal,pregnancy/ postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1309,2025-12-02T16:03:32.268615
34483946.0,Tenofovir alafenamide ,dose,25,mg,,,,,,,qd,oral,daily from 24 to 28weeks of gestation until the 4thweek postpartum ,12.0,maternal,pregnancy/ postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1310,2025-12-02T16:03:32.268615
34483946.0,tenofovir disoproxil fumarate ,dose,300,mg,,,,,,,qd,oral,daily from 24 to 28weeks of gestation until the 4thweek postpartum ,4.0,maternal,pregnancy/ postpartum,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1311,2025-12-02T16:03:32.268615
33242457.0,nevirapine ,daily dose,6,mg/kg/dose,,,,,,,bid,oral,initiated by 48 hours of age ,389.0,pediatric,,neonates,,>=37 weeks,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1312,2025-12-02T16:03:32.268615
33242457.0,nevirapine ,daily dose,4,mg/kg/dose,,,,,,,bid,oral,4 mg/kg/dose for the first week ,45.0,pediatric,,neonates,,34 to <37 weeks,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1313,2025-12-02T16:03:32.268615
33242457.0,nevirapine ,daily dose,6,mg/kg/dose,,,,,,,bid,oral,"after the first week, increased to 6 mg/kg/dose",45.0,pediatric,,neonates,,34 to <37 weeks,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1314,2025-12-02T16:03:32.268615
33710978.0,nevirapine ,dose,2,mg/kg/dose,,,,,,,,oral,only 3 NVP doses or daily doses were used in this study,11.0,pediatric,,neonates,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1315,2025-12-02T16:03:32.268615
33839311.0,nevirapine ,dose,10,mg/kg,median,,,minmax,7,14.0,,oral,200 mg/m2 once daily for 14 days then twice daily,53.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1316,2025-12-02T16:03:32.268615
31332062.0,nevirapine ,dose,10.1,mg/kg,median,,,IQR,9.6,11.0,,oral,dosed at 200 mg/m2 once daily for the first 14 days and then increased to 200 mg/m2 twice daily ,53.0,pediatric,,children,0.568,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1317,2025-12-02T16:03:32.268615
31332062.0,nevirapine ,dose,10,mg/kg,median,,,IQR,9.6,10.7,,oral,dosed at 200 mg/m2 once daily for the first 14 days and then increased to 200 mg/m2 twice daily ,30.0,pediatric,,children,0.568,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1318,2025-12-02T16:03:32.268615
31332062.0,nevirapine ,dose,10.3,mg/kg,median,,,IQR,9.2,11.3,,oral,dosed at 200 mg/m2 once daily for the first 14 days and then increased to 200 mg/m2 twice daily ,23.0,pediatric,,children,0.568,TB/HIV coinfected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1319,2025-12-02T16:03:32.268615
31332062.0,nevirapine ,dose,72,mg/m2,median,,,IQR,70,90.0,,oral,dosed at 200 mg/m2 once daily for the first 14 days and then increased to 200 mg/m2 twice daily ,53.0,pediatric,,children,0.281,All,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1320,2025-12-02T16:03:32.268615
31332062.0,nevirapine ,dose,77.5,mg/m2,median,,,IQR,6,94.0,,oral,dosed at 200 mg/m2 once daily for the first 14 days and then increased to 200 mg/m2 twice daily ,30.0,pediatric,,children,0.281,HIV infected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1321,2025-12-02T16:03:32.268615
31332062.0,nevirapine ,dose,72,mg/m2,median,,,IQR,70,70.0,,oral,dosed at 200 mg/m2 once daily for the first 14 days and then increased to 200 mg/m2 twice daily ,23.0,pediatric,,children,0.281,TB/HIV coinfected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1322,2025-12-02T16:03:32.268615
31332062.0,Isoniazid,dose,14.1,mg/kg,median,,,IQR,12.2,16.0,,,,23.0,pediatric,,children,,TB/HIV coinfected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1323,2025-12-02T16:03:32.268615
31332062.0,rifampin,dose,18.8,mg/kg,median,,,IQR,17.6,22.8,,,,23.0,pediatric,,children,,TB/HIV coinfected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1324,2025-12-02T16:03:32.268615
31332062.0,pyrazinamide,dose,25.8,mg/kg,median,,,IQR,23.1,32.3,,,,23.0,pediatric,,children,,TB/HIV coinfected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1325,2025-12-02T16:03:32.268615
31332062.0,ethambutol,dose,17.2,mg/kg,median,,,IQR,15.4,21.5,,,,23.0,pediatric,,children,,TB/HIV coinfected,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1326,2025-12-02T16:03:32.268615
34945777.0,Efavirenz ,dose,17,mg/kg,median,,,minmax,12,4.0,qd,oral,,111.0,pediatric,,children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1327,2025-12-02T16:03:32.268615
32811669.0,Efavirenz ,dose,600,mg/day,,,,,,,qd,oral,,19.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1328,2025-12-02T16:03:32.268615
30530925.0,Efavirenz ,dose,600,mg/day,,,,,,,qd,oral,,42.0,maternal,pregnancy,,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1329,2025-12-02T16:03:32.268615
31241542.0,Efavirenz ,dose,500,mg,median,,,IQR,450,500.0,qd,oral,,8.0,pediatric,,infants ,,3-<24 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1330,2025-12-02T16:03:32.268615
31241542.0,Efavirenz ,dose,500,mg,median,,,IQR,500,500.0,qd,oral,,5.0,pediatric,,children,,24-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1331,2025-12-02T16:03:32.268615
31241542.0,Efavirenz ,dose,500,mg,median,,,IQR,500,500.0,qd,oral,,13.0,pediatric,,infants and children,,3-36 months,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1332,2025-12-02T16:03:32.268615
31250045.0,nitroglycerin,infusion rate,7.8,ug/kg/min,mean,SD,2.1,,,,,IV,,9.0,pediatric,,infants,,ALDH2 gene polymorphism (−),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1333,2025-12-02T16:03:32.268615
31250045.0,nitroglycerin,infusion rate,7.6,ug/kg/min,mean,SD,2.4,,,,,IV,,9.0,pediatric,,infants,,ALDH2 gene polymorphism (+),PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1334,2025-12-02T16:03:32.268615
33604895.0,fentanyl ,duration,7,days,median,,,minmax,3,35.0,,,,17.0,pediatric,,infants and children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1335,2025-12-02T16:03:32.268615
33604895.0,fentanyl ,cumulative dose,59.1,ug/kg/day,median,,,IQR,59,69.7,,,,5.0,pediatric,,infants and children,0.57,Non-sedated,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1336,2025-12-02T16:03:32.268615
33604895.0,fentanyl ,cumulative dose,89,ug/kg/day,median,,,IQR,35.8,96.4,,,,7.0,pediatric,,infants and children,0.57,Sedated,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1337,2025-12-02T16:03:32.268615
33604895.0,fentanyl ,infusion rate,2,ug/kg/h,,,,,,,,,,17.0,pediatric,,infants and children,,,PK Curation_BPCA_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,1338,2025-12-02T16:03:32.268615
38145726.0,aspirin,dose,81,mg,,,,,,,daily,oral,,35.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,2,2025-12-02T16:05:06.199640
38145726.0,aspirin,dose,81,mg,,,,,,,daily,oral,,35.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,2,2025-12-02T16:05:11.478648
38145726,aspirin,dose,81,mg,,,,,,,daily,oral,,35.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,2,2025-12-02T16:05:15.087972
38145726,aspirin,dose,81,mg,,,,,,,daily,oral,,35.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,2,2025-12-02T16:05:21.408417
31051121.0,aspirin,dose,150,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,3,2025-12-02T16:05:06.199640
31051121.0,aspirin,dose,150,mg,,,,,,,daily,oral,evening dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,4,2025-12-02T16:05:06.199640
31051121.0,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,5,2025-12-02T16:05:06.199640
31051121.0,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,6,2025-12-02T16:05:06.199640
31051121.0,aspirin,dose,150 or 100,mg,,,,,,,daily,oral,used for all 4 subgroups in a crossover pattern with a washout period of at least 30 days between varying aspirin exposures,3.0,maternal,non-pregnant,,,non-enteric coated and enteric coated aspirin,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,7,2025-12-02T16:05:06.199640
31051121.0,aspirin,dose,150,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,3,2025-12-02T16:05:11.478648
31051121.0,aspirin,dose,150,mg,,,,,,,daily,oral,evening dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,4,2025-12-02T16:05:11.478648
31051121.0,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,5,2025-12-02T16:05:11.478648
31051121.0,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,6,2025-12-02T16:05:11.478648
31051121.0,aspirin,dose,150 or 100,mg,,,,,,,daily,oral,used for all 4 subgroups in a crossover pattern with a washout period of at least 30 days between varying aspirin exposures,3.0,maternal,non-pregnant,,,non-enteric coated and enteric coated aspirin,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,7,2025-12-02T16:05:11.478648
31051121,aspirin,dose,150,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,3,2025-12-02T16:05:15.087972
31051121,aspirin,dose,150,mg,,,,,,,daily,oral,evening dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,4,2025-12-02T16:05:15.087972
31051121,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,5,2025-12-02T16:05:15.087972
31051121,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,6,2025-12-02T16:05:15.087972
31051121,aspirin,dose,150 or 100,mg,,,,,,,daily,oral,used for all 4 subgroups in a crossover pattern with a washout period of at least 30 days between varying aspirin exposures,3.0,maternal,non-pregnant,,,non-enteric coated and enteric coated aspirin,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,7,2025-12-02T16:05:15.087972
31051121,aspirin,dose,150,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,3,2025-12-02T16:05:21.408417
31051121,aspirin,dose,150,mg,,,,,,,daily,oral,evening dosing,3.0,maternal,pregnancy,,,non-enteric coacted aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,4,2025-12-02T16:05:21.408417
31051121,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,5,2025-12-02T16:05:21.408417
31051121,aspirin,dose,100,mg,,,,,,,daily,oral,morning dosing,3.0,maternal,pregnancy,,,enteric coacted aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,6,2025-12-02T16:05:21.408417
31051121,aspirin,dose,150 or 100,mg,,,,,,,daily,oral,used for all 4 subgroups in a crossover pattern with a washout period of at least 30 days between varying aspirin exposures,3.0,maternal,non-pregnant,,,non-enteric coated and enteric coated aspirin,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,7,2025-12-02T16:05:21.408417
7823260.0,aspirin,dose,75,mg,,,,,,,single dose,oral,,20.0,maternal,trimester 2 and 3,,,Study 1,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,8,2025-12-02T16:05:06.199640
7823260.0,aspirin,dose,75,mg,,,,,,,single dose,oral,for 2 weeks,9.0,maternal,trimester 3,,,Study 2,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,9,2025-12-02T16:05:06.199640
7823260.0,aspirin,dose,75,mg,,,,,,,single dose,oral,,20.0,maternal,trimester 2 and 3,,,Study 1,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,8,2025-12-02T16:05:11.478648
7823260.0,aspirin,dose,75,mg,,,,,,,single dose,oral,for 2 weeks,9.0,maternal,trimester 3,,,Study 2,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,9,2025-12-02T16:05:11.478648
7823260,aspirin,dose,75,mg,,,,,,,single dose,oral,,20.0,maternal,trimester 2 and 3,,,Study 1,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,8,2025-12-02T16:05:15.087972
7823260,aspirin,dose,75,mg,,,,,,,single dose,oral,for 2 weeks,9.0,maternal,trimester 3,,,Study 2,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,9,2025-12-02T16:05:15.087972
7823260,aspirin,dose,75,mg,,,,,,,single dose,oral,,20.0,maternal,trimester 2 and 3,,,Study 1,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,8,2025-12-02T16:05:21.408417
7823260,aspirin,dose,75,mg,,,,,,,single dose,oral,for 2 weeks,9.0,maternal,trimester 3,,,Study 2,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,9,2025-12-02T16:05:21.408417
1951559.0,aspirin,dose,10^-5,mol/L,,,,,,,single dose,,added to maternal perfusate ,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,10,2025-12-02T16:05:06.199640
1951559.0,aspirin,dose,10^-5,mol/L,,,,,,,single dose,,added to maternal perfusate ,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,10,2025-12-02T16:05:11.478648
1951559,aspirin,dose,10^-5,mol/L,,,,,,,single dose,,added to maternal perfusate ,11.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,10,2025-12-02T16:05:15.087972
1951559,aspirin,dose,10^-5,mol/L,,,,,,,single dose,,added to maternal perfusate ,11.0,maternal,placentas,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,10,2025-12-02T16:05:21.408417
28418802.0,aspirin,dose,81,mg,,,,,,,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,11,2025-12-02T16:05:06.199640
28418802.0,aspirin,dose,81,mg,,,,,,,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,11,2025-12-02T16:05:11.478648
28418802,aspirin,dose,81,mg,,,,,,,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,11,2025-12-02T16:05:15.087972
28418802,aspirin,dose,81,mg,,,,,,,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,11,2025-12-02T16:05:21.408417
8329296.0,aspirin,dosing duration,18.6,weeks,mean,SD,5.8,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,12,2025-12-02T16:05:06.199640
8329296.0,aspirin,dose,100,mg,,,,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,13,2025-12-02T16:05:06.199640
8329296.0,aspirin,dosing duration,18.6,weeks,mean,SD,5.8,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,12,2025-12-02T16:05:11.478648
8329296.0,aspirin,dose,100,mg,,,,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,13,2025-12-02T16:05:11.478648
8329296,aspirin,dosing duration,18.6,weeks,mean,SD,5.8,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,12,2025-12-02T16:05:15.087972
8329296,aspirin,dose,100,mg,,,,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,13,2025-12-02T16:05:15.087972
8329296,aspirin,dosing duration,18.6,weeks,mean,SD,5.8,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,12,2025-12-02T16:05:21.408417
8329296,aspirin,dose,100,mg,,,,,,,daily,oral,daily in the morning after breakfast andtheycontinuedon thisregimenuntildelivery ,13.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,13,2025-12-02T16:05:21.408417
4093506.0,aspirin,dose,0.9,g,,,,,,,every 6 h,oral,for 4 days,25.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,14,2025-12-02T16:05:06.199640
4093506.0,aspirin,dose,0.9,g,,,,,,,every 6 h,oral,for 4 days,25.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,14,2025-12-02T16:05:11.478648
4093506,aspirin,dose,0.9,g,,,,,,,every 6 h,oral,for 4 days,25.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,14,2025-12-02T16:05:15.087972
4093506,aspirin,dose,0.9,g,,,,,,,every 6 h,oral,for 4 days,25.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,14,2025-12-02T16:05:21.408417
7165392.0,aspirin,infusion rate,,g/day,,,,minmax,4.8,8.6,daily,CIV,,10.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,15,2025-12-02T16:05:06.199640
7165392.0,aspirin,dose,1,g,,,,,,,single dose,IV,in late labour,9.0,maternal,late labour,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,16,2025-12-02T16:05:06.199640
7165392.0,aspirin,infusion rate,,g/day,,,,minmax,4.8,8.6,daily,CIV,,10.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,15,2025-12-02T16:05:11.478648
7165392.0,aspirin,dose,1,g,,,,,,,single dose,IV,in late labour,9.0,maternal,late labour,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,16,2025-12-02T16:05:11.478648
7165392,aspirin,infusion rate,,g/day,,,,minmax,4.8,8.6,daily,CIV,,10.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,15,2025-12-02T16:05:15.087972
7165392,aspirin,dose,1,g,,,,,,,single dose,IV,in late labour,9.0,maternal,late labour,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,16,2025-12-02T16:05:15.087972
7165392,aspirin,infusion rate,,g/day,,,,minmax,4.8,8.6,daily,CIV,,10.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,15,2025-12-02T16:05:21.408417
7165392,aspirin,dose,1,g,,,,,,,single dose,IV,in late labour,9.0,maternal,late labour,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,16,2025-12-02T16:05:21.408417
6662181.0,metoclopramide,dose,10,mg,,,,,,,tid,oral,Treatment for 2 weeks was started between the 3rd to 9th days after delivery,5.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,17,2025-12-02T16:05:06.199640
6662181.0,metoclopramide,dose,10,mg,,,,,,,tid,oral,treatment for two weeks was started between the 8th and 12th puerperal weeks,18.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,18,2025-12-02T16:05:06.199640
6662181.0,metoclopramide,dose,10,mg,,,,,,,tid,oral,Treatment for 2 weeks was started between the 3rd to 9th days after delivery,5.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,17,2025-12-02T16:05:11.478648
6662181.0,metoclopramide,dose,10,mg,,,,,,,tid,oral,treatment for two weeks was started between the 8th and 12th puerperal weeks,18.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,18,2025-12-02T16:05:11.478648
6662181,metoclopramide,dose,10,mg,,,,,,,tid,oral,Treatment for 2 weeks was started between the 3rd to 9th days after delivery,5.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,17,2025-12-02T16:05:15.087972
6662181,metoclopramide,dose,10,mg,,,,,,,tid,oral,treatment for two weeks was started between the 8th and 12th puerperal weeks,18.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,18,2025-12-02T16:05:15.087972
6662181,metoclopramide,dose,10,mg,,,,,,,tid,oral,Treatment for 2 weeks was started between the 3rd to 9th days after delivery,5.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,17,2025-12-02T16:05:21.408417
6662181,metoclopramide,dose,10,mg,,,,,,,tid,oral,treatment for two weeks was started between the 8th and 12th puerperal weeks,18.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,18,2025-12-02T16:05:21.408417
16855451.0,sertraline,dose,200,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",55.0,maternal,postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,22,2025-12-02T16:05:06.199640
16855451.0,nortriptyline,dose,150,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",54.0,maternal,postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,23,2025-12-02T16:05:06.199640
16855451.0,sertraline,dose,200,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",55.0,maternal,postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,22,2025-12-02T16:05:11.478648
16855451.0,nortriptyline,dose,150,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",54.0,maternal,postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,23,2025-12-02T16:05:11.478648
16855451,sertraline,dose,200,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",55.0,maternal,postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,22,2025-12-02T16:05:15.087972
16855451,nortriptyline,dose,150,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",54.0,maternal,postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,23,2025-12-02T16:05:15.087972
16855451,sertraline,dose,200,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",55.0,maternal,postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,22,2025-12-02T16:05:21.408417
16855451,nortriptyline,dose,150,mg/day,max,,,,,,bid,oral,"delivered in 2 doses, with breakfast and at bedtime ",54.0,maternal,postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,23,2025-12-02T16:05:21.408417
11849190.0,venlafaxine,dose,244,mg/day,median,,,minmax,225,300.0,bid,oral,"Patients 1–5 received Efexor® regular formulation twice daily (#1, 112.5 mg morning and night; #2, 150 mg morning and night; #3 and 4, 150 mg in the morning and 112.5 mg at night; #5, 150 mg in the morning and 75 mg at night), while patient 6 received Efexor-XR® extended release formulation 225 mg daily in the morning",6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,24,2025-12-02T16:05:06.199640
11849190.0,venlafaxine,therapy duration prior to the study day,111,days,mean,,,minmax,18,483.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,25,2025-12-02T16:05:06.199640
11849190.0,venlafaxine,dose,244,mg/day,median,,,minmax,225,300.0,bid,oral,"Patients 1–5 received Efexor® regular formulation twice daily (#1, 112.5 mg morning and night; #2, 150 mg morning and night; #3 and 4, 150 mg in the morning and 112.5 mg at night; #5, 150 mg in the morning and 75 mg at night), while patient 6 received Efexor-XR® extended release formulation 225 mg daily in the morning",6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,24,2025-12-02T16:05:11.478648
11849190.0,venlafaxine,therapy duration prior to the study day,111,days,mean,,,minmax,18,483.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,25,2025-12-02T16:05:11.478648
11849190,venlafaxine,dose,244,mg/day,median,,,minmax,225,300.0,bid,oral,"Patients 1–5 received Efexor® regular formulation twice daily (#1, 112.5 mg morning and night; #2, 150 mg morning and night; #3 and 4, 150 mg in the morning and 112.5 mg at night; #5, 150 mg in the morning and 75 mg at night), while patient 6 received Efexor-XR® extended release formulation 225 mg daily in the morning",6.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,24,2025-12-02T16:05:15.087972
11849190,venlafaxine,therapy duration prior to the study day,111,days,mean,,,minmax,18,483.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,25,2025-12-02T16:05:15.087972
11849190,venlafaxine,dose,244,mg/day,median,,,minmax,225,300.0,bid,oral,"Patients 1–5 received Efexor® regular formulation twice daily (#1, 112.5 mg morning and night; #2, 150 mg morning and night; #3 and 4, 150 mg in the morning and 112.5 mg at night; #5, 150 mg in the morning and 75 mg at night), while patient 6 received Efexor-XR® extended release formulation 225 mg daily in the morning",6.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,24,2025-12-02T16:05:21.408417
11849190,venlafaxine,therapy duration prior to the study day,111,days,mean,,,minmax,18,483.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,25,2025-12-02T16:05:21.408417
15367050.0,venlafaxine,dose,131,mg/day,mean,,,minmax,75,225.0,daily,oral,,3.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,29,2025-12-02T16:05:06.199640
15367050.0,citalopram,dose,24,mg/day,mean,,,minmax,20,50.0,daily,oral,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,30,2025-12-02T16:05:06.199640
15367050.0,paroxetine,dose,20,mg/day,mean,,,minmax,10,30.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,31,2025-12-02T16:05:06.199640
15367050.0,fluoxetine,dose,20,mg/day,mean,,,,,,daily,oral,,1.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,32,2025-12-02T16:05:06.199640
15367050.0,venlafaxine,dose,131,mg/day,mean,,,minmax,75,225.0,daily,oral,,3.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,29,2025-12-02T16:05:11.478648
15367050.0,citalopram,dose,24,mg/day,mean,,,minmax,20,50.0,daily,oral,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,30,2025-12-02T16:05:11.478648
15367050.0,paroxetine,dose,20,mg/day,mean,,,minmax,10,30.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,31,2025-12-02T16:05:11.478648
15367050.0,fluoxetine,dose,20,mg/day,mean,,,,,,daily,oral,,1.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,32,2025-12-02T16:05:11.478648
15367050,venlafaxine,dose,131,mg/day,mean,,,minmax,75,225.0,daily,oral,,3.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,29,2025-12-02T16:05:15.087972
15367050,citalopram,dose,24,mg/day,mean,,,minmax,20,50.0,daily,oral,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,30,2025-12-02T16:05:15.087972
15367050,paroxetine,dose,20,mg/day,mean,,,minmax,10,30.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,31,2025-12-02T16:05:15.087972
15367050,fluoxetine,dose,20,mg/day,mean,,,,,,daily,oral,,1.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,32,2025-12-02T16:05:15.087972
15367050,venlafaxine,dose,131,mg/day,mean,,,minmax,75,225.0,daily,oral,,3.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,29,2025-12-02T16:05:21.408417
15367050,citalopram,dose,24,mg/day,mean,,,minmax,20,50.0,daily,oral,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,30,2025-12-02T16:05:21.408417
15367050,paroxetine,dose,20,mg/day,mean,,,minmax,10,30.0,daily,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,31,2025-12-02T16:05:21.408417
15367050,fluoxetine,dose,20,mg/day,mean,,,,,,daily,oral,,1.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,32,2025-12-02T16:05:21.408417
19607765.0,venlafaxine,dose,183.3,mg,mean,,,95% CI,125.2,242.3,daily,oral,,13.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,42,2025-12-02T16:05:06.199640
19607765.0,venlafaxine,dose,194.3,mg,mean,,,95% CI,137.1,251.6,daily,oral,,11.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,43,2025-12-02T16:05:06.199640
19607765.0,venlafaxine,dose,206.3,mg,mean,,,95% CI,146.6,265.9,daily,oral,,6.0,maternal,lacation,,,infant-maternal paired plasma samples,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,44,2025-12-02T16:05:06.199640
19607765.0,venlafaxine,dose,183.3,mg,mean,,,95% CI,125.2,242.3,daily,oral,,13.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,42,2025-12-02T16:05:11.478648
19607765.0,venlafaxine,dose,194.3,mg,mean,,,95% CI,137.1,251.6,daily,oral,,11.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,43,2025-12-02T16:05:11.478648
19607765.0,venlafaxine,dose,206.3,mg,mean,,,95% CI,146.6,265.9,daily,oral,,6.0,maternal,lacation,,,infant-maternal paired plasma samples,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,44,2025-12-02T16:05:11.478648
19607765,venlafaxine,dose,183.3,mg,mean,,,95% CI,125.2,242.3,daily,oral,,13.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,41,2025-12-02T16:05:15.087972
19607765,venlafaxine,dose,194.3,mg,mean,,,95% CI,137.1,251.6,daily,oral,,11.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,42,2025-12-02T16:05:15.087972
19607765,venlafaxine,dose,206.3,mg,mean,,,95% CI,146.6,265.9,daily,oral,,6.0,maternal,lacation,,,infant-maternal paired plasma samples,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,43,2025-12-02T16:05:15.087972
19607765,venlafaxine,dose,183.3,mg,mean,,,95% CI,125.2,242.3,daily,oral,,13.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,41,2025-12-02T16:05:21.408417
19607765,venlafaxine,dose,194.3,mg,mean,,,95% CI,137.1,251.6,daily,oral,,11.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,42,2025-12-02T16:05:21.408417
19607765,venlafaxine,dose,206.3,mg,mean,,,95% CI,146.6,265.9,daily,oral,,6.0,maternal,lacation,,,infant-maternal paired plasma samples,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,43,2025-12-02T16:05:21.408417
19455083.0,venlafaxine,dose,75,mg/day,median,,,minmax,37.5,300.0,daily,,,7.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,51,2025-12-02T16:05:06.199640
19455083.0,venlafaxine,dose,75,mg/day,median,,,minmax,37.5,300.0,daily,,,7.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,51,2025-12-02T16:05:11.478648
19455083,venlafaxine,dose,75,mg/day,median,,,minmax,37.5,300.0,daily,,,7.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,50,2025-12-02T16:05:15.087972
19455083,venlafaxine,dose,75,mg/day,median,,,minmax,37.5,300.0,daily,,,7.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,50,2025-12-02T16:05:21.408417
20960017.0,desvenlafaxine ,dose,100,mg/day,mean,,,minmax,50,150.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,55,2025-12-02T16:05:06.199640
20960017.0,desvenlafaxine ,dose,1203,ug/kg/day,mean,,,95% CI,930,1476.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,56,2025-12-02T16:05:06.199640
20960017.0,desvenlafaxine ,duration of therapy,9,days,median,,,minmax,4,35.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,57,2025-12-02T16:05:06.199640
20960017.0,desvenlafaxine ,dose,100,mg/day,mean,,,minmax,50,150.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,55,2025-12-02T16:05:11.478648
20960017.0,desvenlafaxine ,dose,1203,ug/kg/day,mean,,,95% CI,930,1476.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,56,2025-12-02T16:05:11.478648
20960017.0,desvenlafaxine ,duration of therapy,9,days,median,,,minmax,4,35.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,57,2025-12-02T16:05:11.478648
20960017,desvenlafaxine ,dose,100,mg/day,mean,,,minmax,50,150.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,54,2025-12-02T16:05:15.087972
20960017,desvenlafaxine ,dose,1203,ug/kg/day,mean,,,95% CI,930,1476.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,55,2025-12-02T16:05:15.087972
20960017,desvenlafaxine ,duration of therapy,9,days,median,,,minmax,4,35.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,56,2025-12-02T16:05:15.087972
20960017,desvenlafaxine ,dose,100,mg/day,mean,,,minmax,50,150.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,54,2025-12-02T16:05:21.408417
20960017,desvenlafaxine ,dose,1203,ug/kg/day,mean,,,95% CI,930,1476.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,55,2025-12-02T16:05:21.408417
20960017,desvenlafaxine ,duration of therapy,9,days,median,,,minmax,4,35.0,,,,10.0,maternal,lacation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,56,2025-12-02T16:05:21.408417
31371035.0,venlafaxine,dosage,,mg/day,,,,minmax,75,150.0,,,at the time of delivery,3.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,60,2025-12-02T16:05:06.199640
31371035.0,sertraline,dosage,,mg/day,,,,minmax,25,125.0,,,at the time of delivery,20.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,61,2025-12-02T16:05:06.199640
31371035.0,paroxetine,dosage,,mg/day,,,,minmax,10,20.0,,,at the time of delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,62,2025-12-02T16:05:06.199640
31371035.0,fluoxetine,dosage,20,mg/day,,,,,,,,,at the time of delivery,2.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,63,2025-12-02T16:05:06.199640
31371035.0,citalopram,dosage,20,mg/day,,,,,,,,,at the time of delivery,1.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,64,2025-12-02T16:05:06.199640
31371035.0,venlafaxine,dosage,,mg/day,,,,minmax,75,150.0,,,at the time of delivery,3.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,60,2025-12-02T16:05:11.478648
31371035.0,sertraline,dosage,,mg/day,,,,minmax,25,125.0,,,at the time of delivery,20.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,61,2025-12-02T16:05:11.478648
31371035.0,paroxetine,dosage,,mg/day,,,,minmax,10,20.0,,,at the time of delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,62,2025-12-02T16:05:11.478648
31371035.0,fluoxetine,dosage,20,mg/day,,,,,,,,,at the time of delivery,2.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,63,2025-12-02T16:05:11.478648
31371035.0,citalopram,dosage,20,mg/day,,,,,,,,,at the time of delivery,1.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,64,2025-12-02T16:05:11.478648
31371035,venlafaxine,dosage,,mg/day,,,,minmax,75,150.0,,,at the time of delivery,3.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,59,2025-12-02T16:05:15.087972
31371035,sertraline,dosage,,mg/day,,,,minmax,25,125.0,,,at the time of delivery,20.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,60,2025-12-02T16:05:15.087972
31371035,paroxetine,dosage,,mg/day,,,,minmax,10,20.0,,,at the time of delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,61,2025-12-02T16:05:15.087972
31371035,fluoxetine,dosage,20,mg/day,,,,,,,,,at the time of delivery,2.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,62,2025-12-02T16:05:15.087972
31371035,citalopram,dosage,20,mg/day,,,,,,,,,at the time of delivery,1.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,63,2025-12-02T16:05:15.087972
31371035,venlafaxine,dosage,,mg/day,,,,minmax,75,150.0,,,at the time of delivery,3.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,59,2025-12-02T16:05:21.408417
31371035,sertraline,dosage,,mg/day,,,,minmax,25,125.0,,,at the time of delivery,20.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,60,2025-12-02T16:05:21.408417
31371035,paroxetine,dosage,,mg/day,,,,minmax,10,20.0,,,at the time of delivery,11.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,61,2025-12-02T16:05:21.408417
31371035,fluoxetine,dosage,20,mg/day,,,,,,,,,at the time of delivery,2.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,62,2025-12-02T16:05:21.408417
31371035,citalopram,dosage,20,mg/day,,,,,,,,,at the time of delivery,1.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,63,2025-12-02T16:05:21.408417
32153014.0,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,65,2025-12-02T16:05:06.199640
32153014.0,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,65,2025-12-02T16:05:11.478648
32153014,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,64,2025-12-02T16:05:15.087972
32153014,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,64,2025-12-02T16:05:21.408417
23103819.0,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,66,2025-12-02T16:05:06.199640
23103819.0,Infliximab,dose,5,mg/kg,,,,,,,every 6 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,67,2025-12-02T16:05:06.199640
23103819.0,Infliximab,dose,10,mg/kg,,,,,,,every 8 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,68,2025-12-02T16:05:06.199640
23103819.0,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,66,2025-12-02T16:05:11.478648
23103819.0,Infliximab,dose,5,mg/kg,,,,,,,every 6 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,67,2025-12-02T16:05:11.478648
23103819.0,Infliximab,dose,10,mg/kg,,,,,,,every 8 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,68,2025-12-02T16:05:11.478648
23103819,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,65,2025-12-02T16:05:15.087972
23103819,Infliximab,dose,5,mg/kg,,,,,,,every 6 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,66,2025-12-02T16:05:15.087972
23103819,Infliximab,dose,10,mg/kg,,,,,,,every 8 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,67,2025-12-02T16:05:15.087972
23103819,Infliximab,dose,5,mg/kg,,,,,,,every 8 weeks,infusion,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,65,2025-12-02T16:05:21.408417
23103819,Infliximab,dose,5,mg/kg,,,,,,,every 6 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,66,2025-12-02T16:05:21.408417
23103819,Infliximab,dose,10,mg/kg,,,,,,,every 8 weeks,infusion,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,67,2025-12-02T16:05:21.408417
34746508.0,Infliximab,duration,2.5,years,mean,SD,3.3,,,,,infusion,,4.0,materanl,second trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,69,2025-12-02T16:05:06.199640
34746508.0,Infliximab,duration,2.5,years,mean,SD,3.3,,,,,infusion,,4.0,materanl,second trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,69,2025-12-02T16:05:11.478648
34746508,Infliximab,duration,2.5,years,mean,SD,3.3,,,,,infusion,,4.0,materanl,second trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,68,2025-12-02T16:05:15.087972
34746508,Infliximab,duration,2.5,years,mean,SD,3.3,,,,,infusion,,4.0,materanl,second trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,68,2025-12-02T16:05:21.408417
23200982.0,Infliximab,time from last dose to delivery,35,days,median,,,minmax,2,91.0,,infusion,,11.0,materanl,1st to 3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,70,2025-12-02T16:05:06.199640
23200982.0,Infliximab,time from last dose to delivery,35,days,median,,,minmax,2,91.0,,infusion,,11.0,materanl,1st to 3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,70,2025-12-02T16:05:11.478648
23200982,Infliximab,time from last dose to delivery,35,days,median,,,minmax,2,91.0,,infusion,,11.0,materanl,1st to 3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,69,2025-12-02T16:05:15.087972
23200982,Infliximab,time from last dose to delivery,35,days,median,,,minmax,2,91.0,,infusion,,11.0,materanl,1st to 3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,69,2025-12-02T16:05:21.408417
29771301.0,Infliximab,Duration ,24,month,median,,,IQR,8,50.0,,infusion,,73.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,71,2025-12-02T16:05:06.199640
29771301.0,Infliximab,stop week,25,weeks,median,,,IQR,21,32.0,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,72,2025-12-02T16:05:06.199640
29771301.0,Infliximab,stop during pregnancy before gestational week 25,26,,N,%,50.0,,,,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,73,2025-12-02T16:05:06.199640
29771301.0,Infliximab,Duration ,24,month,median,,,IQR,8,50.0,,infusion,,73.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,71,2025-12-02T16:05:11.478648
29771301.0,Infliximab,stop week,25,weeks,median,,,IQR,21,32.0,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,72,2025-12-02T16:05:11.478648
29771301.0,Infliximab,stop during pregnancy before gestational week 25,26,,N,%,50.0,,,,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,73,2025-12-02T16:05:11.478648
29771301,Infliximab,Duration ,24,month,median,,,IQR,8,50.0,,infusion,,73.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,70,2025-12-02T16:05:15.087972
29771301,Infliximab,stop week,25,weeks,median,,,IQR,21,32.0,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,71,2025-12-02T16:05:15.087972
29771301,Infliximab,stop during pregnancy before gestational week 25,26,,N,%,50.0,,,,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,72,2025-12-02T16:05:15.087972
29771301,Infliximab,Duration ,24,month,median,,,IQR,8,50.0,,infusion,,73.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,70,2025-12-02T16:05:21.408417
29771301,Infliximab,stop week,25,weeks,median,,,IQR,21,32.0,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,71,2025-12-02T16:05:21.408417
29771301,Infliximab,stop during pregnancy before gestational week 25,26,,N,%,50.0,,,,,infusion,,52.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,72,2025-12-02T16:05:21.408417
32981127.0,Infliximab,dose,5,mg/kg,,,,,,,6-8 weekly,infusion,,21.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,74,2025-12-02T16:05:06.199640
32981127.0,Infliximab,dose,5,mg/kg,,,,,,,4-weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,75,2025-12-02T16:05:06.199640
32981127.0,Infliximab,dose,10,mg/kg,,,,,,,6-8 weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,76,2025-12-02T16:05:06.199640
32981127.0,Infliximab,dose,5,mg/kg,,,,,,,6-8 weekly,infusion,,21.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,74,2025-12-02T16:05:11.478648
32981127.0,Infliximab,dose,5,mg/kg,,,,,,,4-weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,75,2025-12-02T16:05:11.478648
32981127.0,Infliximab,dose,10,mg/kg,,,,,,,6-8 weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,76,2025-12-02T16:05:11.478648
32981127,Infliximab,dose,5,mg/kg,,,,,,,6-8 weekly,infusion,,21.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,73,2025-12-02T16:05:15.087972
32981127,Infliximab,dose,5,mg/kg,,,,,,,4-weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,74,2025-12-02T16:05:15.087972
32981127,Infliximab,dose,10,mg/kg,,,,,,,6-8 weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,75,2025-12-02T16:05:15.087972
32981127,Infliximab,dose,5,mg/kg,,,,,,,6-8 weekly,infusion,,21.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,73,2025-12-02T16:05:21.408417
32981127,Infliximab,dose,5,mg/kg,,,,,,,4-weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,74,2025-12-02T16:05:21.408417
32981127,Infliximab,dose,10,mg/kg,,,,,,,6-8 weekly,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,75,2025-12-02T16:05:21.408417
33079627.0,Infliximab,dose,5,mg/kg,,,,,,,q8w,infusion,,17.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,77,2025-12-02T16:05:06.199640
33079627.0,Infliximab,dose,5,mg/kg,,,,,,,q6w,infusion,,4.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,78,2025-12-02T16:05:06.199640
33079627.0,Infliximab,dose,5,mg/kg,,,,,,,q10w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,79,2025-12-02T16:05:06.199640
33079627.0,Infliximab,dose,10,mg/kg,,,,,,,q8w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,80,2025-12-02T16:05:06.199640
33079627.0,Infliximab,dose,5,mg/kg,,,,,,,q8w,infusion,,17.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,77,2025-12-02T16:05:11.478648
33079627.0,Infliximab,dose,5,mg/kg,,,,,,,q6w,infusion,,4.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,78,2025-12-02T16:05:11.478648
33079627.0,Infliximab,dose,5,mg/kg,,,,,,,q10w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,79,2025-12-02T16:05:11.478648
33079627.0,Infliximab,dose,10,mg/kg,,,,,,,q8w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,80,2025-12-02T16:05:11.478648
33079627,Infliximab,dose,5,mg/kg,,,,,,,q8w,infusion,,17.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,76,2025-12-02T16:05:15.087972
33079627,Infliximab,dose,5,mg/kg,,,,,,,q6w,infusion,,4.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,77,2025-12-02T16:05:15.087972
33079627,Infliximab,dose,5,mg/kg,,,,,,,q10w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,78,2025-12-02T16:05:15.087972
33079627,Infliximab,dose,10,mg/kg,,,,,,,q8w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,79,2025-12-02T16:05:15.087972
33079627,Infliximab,dose,5,mg/kg,,,,,,,q8w,infusion,,17.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,76,2025-12-02T16:05:21.408417
33079627,Infliximab,dose,5,mg/kg,,,,,,,q6w,infusion,,4.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,77,2025-12-02T16:05:21.408417
33079627,Infliximab,dose,5,mg/kg,,,,,,,q10w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,78,2025-12-02T16:05:21.408417
33079627,Infliximab,dose,10,mg/kg,,,,,,,q8w,infusion,,1.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,79,2025-12-02T16:05:21.408417
34493490.0,Infliximab,stop time point as recommended by EULAR-PtC,GA 20,weeks,median,,,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,81,2025-12-02T16:05:06.199640
34493490.0,Infliximab,gestational age at time of stopping TNFi,18.4,weeks,median,,,IQR,14,20.1,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,82,2025-12-02T16:05:06.199640
34493490.0,Infliximab,stopped before recommended GA,10,,N,%,71.4,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,83,2025-12-02T16:05:06.199640
34493490.0,Infliximab,stop time point as recommended by EULAR-PtC,GA 20,weeks,median,,,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,81,2025-12-02T16:05:11.478648
34493490.0,Infliximab,gestational age at time of stopping TNFi,18.4,weeks,median,,,IQR,14,20.1,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,82,2025-12-02T16:05:11.478648
34493490.0,Infliximab,stopped before recommended GA,10,,N,%,71.4,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,83,2025-12-02T16:05:11.478648
34493490,Infliximab,stop time point as recommended by EULAR-PtC,GA 20,weeks,median,,,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,80,2025-12-02T16:05:15.087972
34493490,Infliximab,gestational age at time of stopping TNFi,18.4,weeks,median,,,IQR,14,20.1,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,81,2025-12-02T16:05:15.087972
34493490,Infliximab,stopped before recommended GA,10,,N,%,71.4,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,82,2025-12-02T16:05:15.087972
34493490,Infliximab,stop time point as recommended by EULAR-PtC,GA 20,weeks,median,,,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,80,2025-12-02T16:05:21.408417
34493490,Infliximab,gestational age at time of stopping TNFi,18.4,weeks,median,,,IQR,14,20.1,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,81,2025-12-02T16:05:21.408417
34493490,Infliximab,stopped before recommended GA,10,,N,%,71.4,,,,,infusion,,14.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,82,2025-12-02T16:05:21.408417
36120653.0,Infliximab,discontinuation time,30,weeks,median,,,IQR,30-32,,,,,8.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,84,2025-12-02T16:05:06.199640
36120653.0,Infliximab,discontinuation time,30,weeks,median,,,IQR,30-32,,,,,8.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,84,2025-12-02T16:05:11.478648
36120653,Infliximab,discontinuation time,30,weeks,median,,,IQR,30-32,,,,,8.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,83,2025-12-02T16:05:15.087972
36120653,Infliximab,discontinuation time,30,weeks,median,,,IQR,30-32,,,,,8.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,83,2025-12-02T16:05:21.408417
25966992.0,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,27.0,materanl,pregnancy,,,Anti-TNF stop group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,85,2025-12-02T16:05:06.199640
25966992.0,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,21.0,materanl,pregnancy,,,Anti-TNF continue group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,86,2025-12-02T16:05:06.199640
25966992.0,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,27.0,materanl,pregnancy,,,Anti-TNF stop group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,85,2025-12-02T16:05:11.478648
25966992.0,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,21.0,materanl,pregnancy,,,Anti-TNF continue group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,86,2025-12-02T16:05:11.478648
25966992,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,27.0,materanl,pregnancy,,,Anti-TNF stop group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,84,2025-12-02T16:05:15.087972
25966992,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,21.0,materanl,pregnancy,,,Anti-TNF continue group,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,85,2025-12-02T16:05:15.087972
25966992,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,27.0,materanl,pregnancy,,,Anti-TNF stop group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,84,2025-12-02T16:05:21.408417
25966992,Infliximab,dose,5,mg/kg,median,,,,,,q8w,,,21.0,materanl,pregnancy,,,Anti-TNF continue group,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,85,2025-12-02T16:05:21.408417
22858514.0,Infliximab,dose,300,mg,,,,,,,,IV,,2.0,materanl,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,87,2025-12-02T16:05:06.199640
22858514.0,Infliximab,dose,300,mg,,,,,,,,IV,,2.0,materanl,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,87,2025-12-02T16:05:11.478648
22858514,Infliximab,dose,300,mg,,,,,,,,IV,,2.0,materanl,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,86,2025-12-02T16:05:15.087972
22858514,Infliximab,dose,300,mg,,,,,,,,IV,,2.0,materanl,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,86,2025-12-02T16:05:21.408417
27063728.0,Infliximab,last dose given during pregnancy (GW),30,weeks,median,,,minmax,8,37.0,,,,44.0,materanl,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,88,2025-12-02T16:05:06.199640
27063728.0,Infliximab,last dose given during pregnancy (GW),30,weeks,median,,,minmax,8,37.0,,,,44.0,materanl,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,88,2025-12-02T16:05:11.478648
27063728,Infliximab,last dose given during pregnancy (GW),30,weeks,median,,,minmax,8,37.0,,,,44.0,materanl,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,87,2025-12-02T16:05:15.087972
27063728,Infliximab,last dose given during pregnancy (GW),30,weeks,median,,,minmax,8,37.0,,,,44.0,materanl,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,87,2025-12-02T16:05:21.408417
28318043.0,Infliximab,dose,5.29,mg/kg,median,,,IQR,4.87,5.96,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,89,2025-12-02T16:05:06.199640
28318043.0,Infliximab,duration,7,weeks,median,,,IQR,6,8.0,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,90,2025-12-02T16:05:06.199640
28318043.0,Infliximab,dose,5.32,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,5.0,materanl,trimester 1,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,91,2025-12-02T16:05:06.199640
28318043.0,Infliximab,dose,5.48,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,15.0,materanl,trimester 2,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,92,2025-12-02T16:05:06.199640
28318043.0,Infliximab,dose,4.89,mg/kg,median,,,IQR,4.65,5.08,q6-8w,infusion,,16.0,materanl,trimester 3,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,93,2025-12-02T16:05:06.199640
28318043.0,Infliximab,last infusion (gestational weeks),29.3,weeks,median,,,IQR,25.4,31.2,,,,7.0,materanl,pregnancy,,,UC,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,94,2025-12-02T16:05:06.199640
28318043.0,Infliximab,last infusion (gestational weeks),30.3,weeks,median,,,IQR,28.4,30.8,,,,8.0,materanl,pregnancy,,,CD,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,95,2025-12-02T16:05:06.199640
28318043.0,Infliximab,interval,46.5,days,median,,,IQR,42,54.0,,,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,96,2025-12-02T16:05:06.199640
28318043.0,Infliximab,dose,5.29,mg/kg,median,,,IQR,4.87,5.96,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,89,2025-12-02T16:05:11.478648
28318043.0,Infliximab,duration,7,weeks,median,,,IQR,6,8.0,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,90,2025-12-02T16:05:11.478648
28318043.0,Infliximab,dose,5.32,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,5.0,materanl,trimester 1,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,91,2025-12-02T16:05:11.478648
28318043.0,Infliximab,dose,5.48,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,15.0,materanl,trimester 2,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,92,2025-12-02T16:05:11.478648
28318043.0,Infliximab,dose,4.89,mg/kg,median,,,IQR,4.65,5.08,q6-8w,infusion,,16.0,materanl,trimester 3,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,93,2025-12-02T16:05:11.478648
28318043.0,Infliximab,last infusion (gestational weeks),29.3,weeks,median,,,IQR,25.4,31.2,,,,7.0,materanl,pregnancy,,,UC,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,94,2025-12-02T16:05:11.478648
28318043.0,Infliximab,last infusion (gestational weeks),30.3,weeks,median,,,IQR,28.4,30.8,,,,8.0,materanl,pregnancy,,,CD,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,95,2025-12-02T16:05:11.478648
28318043.0,Infliximab,interval,46.5,days,median,,,IQR,42,54.0,,,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,96,2025-12-02T16:05:11.478648
28318043,Infliximab,dose,5.29,mg/kg,median,,,IQR,4.87,5.96,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,88,2025-12-02T16:05:15.087972
28318043,Infliximab,duration,7,weeks,median,,,IQR,6,8.0,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,89,2025-12-02T16:05:15.087972
28318043,Infliximab,dose,5.32,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,5.0,materanl,trimester 1,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,90,2025-12-02T16:05:15.087972
28318043,Infliximab,dose,5.48,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,15.0,materanl,trimester 2,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,91,2025-12-02T16:05:15.087972
28318043,Infliximab,dose,4.89,mg/kg,median,,,IQR,4.65,5.08,q6-8w,infusion,,16.0,materanl,trimester 3,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,92,2025-12-02T16:05:15.087972
28318043,Infliximab,last infusion (gestational weeks),29.3,weeks,median,,,IQR,25.4,31.2,,,,7.0,materanl,pregnancy,,,UC,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,93,2025-12-02T16:05:15.087972
28318043,Infliximab,last infusion (gestational weeks),30.3,weeks,median,,,IQR,28.4,30.8,,,,8.0,materanl,pregnancy,,,CD,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,94,2025-12-02T16:05:15.087972
28318043,Infliximab,interval,46.5,days,median,,,IQR,42,54.0,,,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,95,2025-12-02T16:05:15.087972
28318043,Infliximab,dose,5.29,mg/kg,median,,,IQR,4.87,5.96,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,88,2025-12-02T16:05:21.408417
28318043,Infliximab,duration,7,weeks,median,,,IQR,6,8.0,q6-8w,infusion,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,89,2025-12-02T16:05:21.408417
28318043,Infliximab,dose,5.32,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,5.0,materanl,trimester 1,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,90,2025-12-02T16:05:21.408417
28318043,Infliximab,dose,5.48,mg/kg,median,,,IQR,5.31,5.63,q6-8w,infusion,,15.0,materanl,trimester 2,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,91,2025-12-02T16:05:21.408417
28318043,Infliximab,dose,4.89,mg/kg,median,,,IQR,4.65,5.08,q6-8w,infusion,,16.0,materanl,trimester 3,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,92,2025-12-02T16:05:21.408417
28318043,Infliximab,last infusion (gestational weeks),29.3,weeks,median,,,IQR,25.4,31.2,,,,7.0,materanl,pregnancy,,,UC,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,93,2025-12-02T16:05:21.408417
28318043,Infliximab,last infusion (gestational weeks),30.3,weeks,median,,,IQR,28.4,30.8,,,,8.0,materanl,pregnancy,,,CD,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,94,2025-12-02T16:05:21.408417
28318043,Infliximab,interval,46.5,days,median,,,IQR,42,54.0,,,,15.0,materanl,pregnancy,,,all,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,95,2025-12-02T16:05:21.408417
20118196.0,metformin,dose,1000,mg/day,median,,,,,,every 12h,oral,,8.0,maternal,1st trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,97,2025-12-02T16:05:06.199640
20118196.0,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,18.0,maternal,2nd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,98,2025-12-02T16:05:06.199640
20118196.0,metformin,dose,2000,mg/day,median,,,,,,every 12h,oral,,14.0,maternal,3rd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,99,2025-12-02T16:05:06.199640
20118196.0,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,16.0,maternal, postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,100,2025-12-02T16:05:06.199640
20118196.0,metformin,dose,1000,mg/day,median,,,,,,every 12h,oral,,8.0,maternal,1st trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,97,2025-12-02T16:05:11.478648
20118196.0,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,18.0,maternal,2nd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,98,2025-12-02T16:05:11.478648
20118196.0,metformin,dose,2000,mg/day,median,,,,,,every 12h,oral,,14.0,maternal,3rd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,99,2025-12-02T16:05:11.478648
20118196.0,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,16.0,maternal, postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,100,2025-12-02T16:05:11.478648
20118196,metformin,dose,1000,mg/day,median,,,,,,every 12h,oral,,8.0,maternal,1st trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,96,2025-12-02T16:05:15.087972
20118196,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,18.0,maternal,2nd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,97,2025-12-02T16:05:15.087972
20118196,metformin,dose,2000,mg/day,median,,,,,,every 12h,oral,,14.0,maternal,3rd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,98,2025-12-02T16:05:15.087972
20118196,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,16.0,maternal, postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,99,2025-12-02T16:05:15.087972
20118196,metformin,dose,1000,mg/day,median,,,,,,every 12h,oral,,8.0,maternal,1st trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,96,2025-12-02T16:05:21.408417
20118196,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,18.0,maternal,2nd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,97,2025-12-02T16:05:21.408417
20118196,metformin,dose,2000,mg/day,median,,,,,,every 12h,oral,,14.0,maternal,3rd trimest,,N.S.,compared with postpartum,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,98,2025-12-02T16:05:21.408417
20118196,metformin,dose,1250,mg/day,median,,,,,,every 12h,oral,,16.0,maternal, postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,99,2025-12-02T16:05:21.408417
21538144.0,metformin,dose,850,mg,,,,,,,bid,oral,,8.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,101,2025-12-02T16:05:06.199640
21538144.0,metformin,dose,850,mg,,,,,,,bid,oral,,8.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,101,2025-12-02T16:05:11.478648
21538144,metformin,dose,850,mg,,,,,,,bid,oral,,8.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,100,2025-12-02T16:05:15.087972
21538144,metformin,dose,850,mg,,,,,,,bid,oral,,8.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,100,2025-12-02T16:05:21.408417
12436333.0,metformin,dose,500,mg,,,,,,,tid,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,102,2025-12-02T16:05:06.199640
12436333.0,metformin,dose,500,mg,,,,,,,once daily,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,1.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,103,2025-12-02T16:05:06.199640
12436333.0,metformin,dose,14,mg/kg/day,median,,,minmax,6.9,20.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,104,2025-12-02T16:05:06.199640
12436333.0,metformin,dose,500,mg,,,,,,,tid,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,102,2025-12-02T16:05:11.478648
12436333.0,metformin,dose,500,mg,,,,,,,once daily,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,1.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,103,2025-12-02T16:05:11.478648
12436333.0,metformin,dose,14,mg/kg/day,median,,,minmax,6.9,20.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,104,2025-12-02T16:05:11.478648
12436333,metformin,dose,500,mg,,,,,,,tid,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,6.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,101,2025-12-02T16:05:15.087972
12436333,metformin,dose,500,mg,,,,,,,once daily,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,1.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,102,2025-12-02T16:05:15.087972
12436333,metformin,dose,14,mg/kg/day,median,,,minmax,6.9,20.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,103,2025-12-02T16:05:15.087972
12436333,metformin,dose,500,mg,,,,,,,tid,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,6.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,101,2025-12-02T16:05:21.408417
12436333,metformin,dose,500,mg,,,,,,,once daily,oral,All had been on these dose regimens for at least 3 weeks at the time of the study,1.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,102,2025-12-02T16:05:21.408417
12436333,metformin,dose,14,mg/kg/day,median,,,minmax,6.9,20.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,103,2025-12-02T16:05:21.408417
15932841.0,metformin,dose,500,mg,,,,,,,every 12h,oral,started on metformin on postoperative day 1 ,7.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,105,2025-12-02T16:05:06.199640
15932841.0,metformin,dose,500,mg,,,,,,,every 12h,oral,started on metformin on postoperative day 1 ,7.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,105,2025-12-02T16:05:11.478648
15932841,metformin,dose,500,mg,,,,,,,every 12h,oral,started on metformin on postoperative day 1 ,7.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,104,2025-12-02T16:05:15.087972
15932841,metformin,dose,500,mg,,,,,,,every 12h,oral,started on metformin on postoperative day 1 ,7.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,104,2025-12-02T16:05:21.408417
23018469.0,metformin,dose,850,mg,,,,,,,every 12h,oral,throughout gestation after being diagosed with PCOS or T2DM before pregnancy,17.0,materanl,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,106,2025-12-02T16:05:06.199640
23018469.0,metformin,dose,850,mg,,,,,,,every 12h,oral,throughout gestation after being diagosed with PCOS or T2DM before pregnancy,17.0,materanl,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,106,2025-12-02T16:05:11.478648
23018469,metformin,dose,850,mg,,,,,,,every 12h,oral,throughout gestation after being diagosed with PCOS or T2DM before pregnancy,17.0,materanl,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,105,2025-12-02T16:05:15.087972
23018469,metformin,dose,850,mg,,,,,,,every 12h,oral,throughout gestation after being diagosed with PCOS or T2DM before pregnancy,17.0,materanl,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,105,2025-12-02T16:05:21.408417
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,12.0,,oral,,6.0,maternal,1st trimester,10-14 weeks gestation,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,107,2025-12-02T16:05:06.199640
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,15.0,maternal,2nd trimester,22-26 weeks gestation,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,108,2025-12-02T16:05:06.199640
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,13.0,maternal,3rd trimester,34-38 weeks gestation,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,109,2025-12-02T16:05:06.199640
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,14.0,maternal,postpartum,>=12 weeks,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,110,2025-12-02T16:05:06.199640
28069720.0,metformin,dose,,g/day,,,,minmax,0.5,3.0,,oral,,25.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,111,2025-12-02T16:05:06.199640
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,12.0,,oral,,6.0,maternal,1st trimester,10-14 weeks gestation,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,107,2025-12-02T16:05:11.478648
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,15.0,maternal,2nd trimester,22-26 weeks gestation,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,108,2025-12-02T16:05:11.478648
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,13.0,maternal,3rd trimester,34-38 weeks gestation,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,109,2025-12-02T16:05:11.478648
28069720.0,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,14.0,maternal,postpartum,>=12 weeks,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,110,2025-12-02T16:05:11.478648
28069720.0,metformin,dose,,g/day,,,,minmax,0.5,3.0,,oral,,25.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,111,2025-12-02T16:05:11.478648
28069720,metformin,dosing interval,12,h,median,,,minmax,8,12.0,,oral,,6.0,maternal,1st trimester,10-14 weeks gestation,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,106,2025-12-02T16:05:15.087972
28069720,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,15.0,maternal,2nd trimester,22-26 weeks gestation,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,107,2025-12-02T16:05:15.087972
28069720,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,13.0,maternal,3rd trimester,34-38 weeks gestation,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,108,2025-12-02T16:05:15.087972
28069720,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,14.0,maternal,postpartum,>=12 weeks,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,109,2025-12-02T16:05:15.087972
28069720,metformin,dose,,g/day,,,,minmax,0.5,3.0,,oral,,25.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,110,2025-12-02T16:05:15.087972
28069720,metformin,dosing interval,12,h,median,,,minmax,8,12.0,,oral,,6.0,maternal,1st trimester,10-14 weeks gestation,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,106,2025-12-02T16:05:21.408417
28069720,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,15.0,maternal,2nd trimester,22-26 weeks gestation,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,107,2025-12-02T16:05:21.408417
28069720,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,13.0,maternal,3rd trimester,34-38 weeks gestation,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,108,2025-12-02T16:05:21.408417
28069720,metformin,dosing interval,12,h,median,,,minmax,8,24.0,,oral,,14.0,maternal,postpartum,>=12 weeks,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,109,2025-12-02T16:05:21.408417
28069720,metformin,dose,,g/day,,,,minmax,0.5,3.0,,oral,,25.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,110,2025-12-02T16:05:21.408417
15866611.0,metformin,dose,850,mg,,,,,,,bid,oral,"started treatment between gestational weeks 5 and 12 (on average, at gestational week 8) and continued the medication until delivery",15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,112,2025-12-02T16:05:06.199640
15866611.0,metformin,treatment start gestational week,8,weeks,mean,,,minmax,5,12.0,,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,113,2025-12-02T16:05:06.199640
15866611.0,metformin,dose,850,mg,,,,,,,bid,oral,"started treatment between gestational weeks 5 and 12 (on average, at gestational week 8) and continued the medication until delivery",15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,112,2025-12-02T16:05:11.478648
15866611.0,metformin,treatment start gestational week,8,weeks,mean,,,minmax,5,12.0,,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,113,2025-12-02T16:05:11.478648
15866611,metformin,dose,850,mg,,,,,,,bid,oral,"started treatment between gestational weeks 5 and 12 (on average, at gestational week 8) and continued the medication until delivery",15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,111,2025-12-02T16:05:15.087972
15866611,metformin,treatment start gestational week,8,weeks,mean,,,minmax,5,12.0,,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,112,2025-12-02T16:05:15.087972
15866611,metformin,dose,850,mg,,,,,,,bid,oral,"started treatment between gestational weeks 5 and 12 (on average, at gestational week 8) and continued the medication until delivery",15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,111,2025-12-02T16:05:21.408417
15866611,metformin,treatment start gestational week,8,weeks,mean,,,minmax,5,12.0,,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,112,2025-12-02T16:05:21.408417
24633859.0,metformin,treatment start gestational week,30,weeks,mean,,,minmax,26,34.0,,oral,,86.0,maternal,3rd trimester,36 GW,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,114,2025-12-02T16:05:06.199640
24633859.0,metformin,dose,,g,,,,minmax,500,1000.0,bid,oral,"daily, started on average at
30 gw (range 26–34 gw)",86.0,maternal,3rd trimester,37 GW,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,115,2025-12-02T16:05:06.199640
24633859.0,metformin,treatment start gestational week,30,weeks,mean,,,minmax,26,34.0,,oral,,86.0,maternal,3rd trimester,36 GW,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,114,2025-12-02T16:05:11.478648
24633859.0,metformin,dose,,g,,,,minmax,500,1000.0,bid,oral,"daily, started on average at
30 gw (range 26–34 gw)",86.0,maternal,3rd trimester,37 GW,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,115,2025-12-02T16:05:11.478648
24633859,metformin,treatment start gestational week,30,weeks,mean,,,minmax,26,34.0,,oral,,86.0,maternal,3rd trimester,36 GW,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,113,2025-12-02T16:05:15.087972
24633859,metformin,dose,,g,,,,minmax,500,1000.0,bid,oral,"daily, started on average at
30 gw (range 26–34 gw)",86.0,maternal,3rd trimester,37 GW,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,114,2025-12-02T16:05:15.087972
24633859,metformin,treatment start gestational week,30,weeks,mean,,,minmax,26,34.0,,oral,,86.0,maternal,3rd trimester,36 GW,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,113,2025-12-02T16:05:21.408417
24633859,metformin,dose,,g,,,,minmax,500,1000.0,bid,oral,"daily, started on average at
30 gw (range 26–34 gw)",86.0,maternal,3rd trimester,37 GW,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,114,2025-12-02T16:05:21.408417
1608848.0,nifedipine,dose,10,mg,,,,,,,every 6 h,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,116,2025-12-02T16:05:06.199640
1608848.0,nifedipine,dose,10,mg,,,,,,,every 6 h,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,116,2025-12-02T16:05:11.478648
1608848,nifedipine,dose,10,mg,,,,,,,every 6 h,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,115,2025-12-02T16:05:15.087972
1608848,nifedipine,dose,10,mg,,,,,,,every 6 h,oral,,15.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,115,2025-12-02T16:05:21.408417
17464806.0,nifedipine,dose,60,mg,,,,,,,single dose,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,capsule,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,117,2025-12-02T16:05:06.199640
17464806.0,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,tablet,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,118,2025-12-02T16:05:06.199640
17464806.0,nifedipine,dose,60,mg,,,,,,,single dose,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,capsule,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,117,2025-12-02T16:05:11.478648
17464806.0,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,tablet,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,118,2025-12-02T16:05:11.478648
17464806,nifedipine,dose,60,mg,,,,,,,single dose,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,capsule,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,116,2025-12-02T16:05:15.087972
17464806,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,tablet,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,117,2025-12-02T16:05:15.087972
17464806,nifedipine,dose,60,mg,,,,,,,single dose,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,capsule,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,116,2025-12-02T16:05:21.408417
17464806,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,24.0,maternal,2nd and 3rd trimester,22-34 GW,,tablet,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,117,2025-12-02T16:05:21.408417
17667209.0,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,5.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,119,2025-12-02T16:05:06.199640
17667209.0,nifedipine,dose,20,mg,,,,,,,single dose,oral,administered 60 minutes after the last nifedipine capsule was given (t = 105 min) ,5.0,maternal,3rd trimester,,,slow release tablet,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,120,2025-12-02T16:05:06.199640
17667209.0,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,5.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,119,2025-12-02T16:05:11.478648
17667209.0,nifedipine,dose,20,mg,,,,,,,single dose,oral,administered 60 minutes after the last nifedipine capsule was given (t = 105 min) ,5.0,maternal,3rd trimester,,,slow release tablet,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,120,2025-12-02T16:05:11.478648
17667209,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,5.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,118,2025-12-02T16:05:15.087972
17667209,nifedipine,dose,20,mg,,,,,,,single dose,oral,administered 60 minutes after the last nifedipine capsule was given (t = 105 min) ,5.0,maternal,3rd trimester,,,slow release tablet,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,119,2025-12-02T16:05:15.087972
17667209,nifedipine,dose,10,mg,,,,,,,4 doses in 15 min intervals,oral,,5.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,118,2025-12-02T16:05:21.408417
17667209,nifedipine,dose,20,mg,,,,,,,single dose,oral,administered 60 minutes after the last nifedipine capsule was given (t = 105 min) ,5.0,maternal,3rd trimester,,,slow release tablet,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,119,2025-12-02T16:05:21.408417
18271884.0,nifedipine,dose,94.2,mg/day,mean,SE,7.2,minmax,30,150.0,,oral,,31.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,121,2025-12-02T16:05:06.199640
18271884.0,nifedipine,dose,81.9,mg/day,mean,SE,8.4,minmax,30,150.0,,oral,,21.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,122,2025-12-02T16:05:06.199640
18271884.0,nifedipine,dose,94.2,mg/day,mean,SE,7.2,minmax,30,150.0,"once daily, bid, or tid",oral,,31.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,121,2025-12-02T16:05:11.478648
18271884.0,nifedipine,dose,81.9,mg/day,mean,SE,8.4,minmax,30,150.0,"once daily, bid, or tid",oral,,21.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,122,2025-12-02T16:05:11.478648
18271884,nifedipine,dose,94.2,mg/day,mean,SE,7.2,minmax,30,150.0,,oral,,31.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,120,2025-12-02T16:05:15.087972
18271884,nifedipine,dose,81.9,mg/day,mean,SE,8.4,minmax,30,150.0,,oral,,21.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,121,2025-12-02T16:05:15.087972
18271884,nifedipine,dose,94.2,mg/day,mean,SE,7.2,minmax,30,150.0,,oral,,31.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,120,2025-12-02T16:05:21.408417
18271884,nifedipine,dose,81.9,mg/day,mean,SE,8.4,minmax,30,150.0,,oral,,21.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,121,2025-12-02T16:05:21.408417
18394772.0,nifedipine,loading dose,40,mg,,,,,,,,oral,over 1 h (four capsules 10 mg every 15 min),14.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,123,2025-12-02T16:05:06.199640
18394772.0,nifedipine,maintenance total dose,60,mg/day,,,,,,,,oral,20 mg slow-release tablets given all 8 h,7.0,maternal,3rd trimester,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,124,2025-12-02T16:05:06.199640
18394772.0,nifedipine,maintenance total dose,90,mg/day,,,,,,,every 12 h,oral,GITS given for at least 120 h,7.0,maternal,3rd trimester,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,125,2025-12-02T16:05:06.199640
18394772.0,nifedipine,loading dose,40,mg,,,,,,,,oral,over 1 h (four capsules 10 mg every 15 min),14.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,123,2025-12-02T16:05:11.478648
18394772.0,nifedipine,maintenance total dose,60,mg/day,,,,,,,,oral,20 mg slow-release tablets given all 8 h,7.0,maternal,3rd trimester,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,124,2025-12-02T16:05:11.478648
18394772.0,nifedipine,maintenance total dose,90,mg/day,,,,,,,every 12 h,oral,GITS given for at least 120 h,7.0,maternal,3rd trimester,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,125,2025-12-02T16:05:11.478648
18394772,nifedipine,loading dose,40,mg,,,,,,,,oral,over 1 h (four capsules 10 mg every 15 min),14.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,122,2025-12-02T16:05:15.087972
18394772,nifedipine,maintenance total dose,60,mg/day,,,,,,,,oral,20 mg slow-release tablets given all 8 h,7.0,maternal,3rd trimester,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,123,2025-12-02T16:05:15.087972
18394772,nifedipine,maintenance total dose,90,mg/day,,,,,,,every 12 h,oral,GITS given for at least 120 h,7.0,maternal,3rd trimester,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,124,2025-12-02T16:05:15.087972
18394772,nifedipine,loading dose,40,mg,,,,,,,,oral,over 1 h (four capsules 10 mg every 15 min),14.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,122,2025-12-02T16:05:21.408417
18394772,nifedipine,maintenance total dose,60,mg/day,,,,,,,,oral,20 mg slow-release tablets given all 8 h,7.0,maternal,3rd trimester,,,Group 1 nifedipine slow-release,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,123,2025-12-02T16:05:21.408417
18394772,nifedipine,maintenance total dose,90,mg/day,,,,,,,every 12 h,oral,GITS given for at least 120 h,7.0,maternal,3rd trimester,,,Group 2 nifedipine GITS,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,124,2025-12-02T16:05:21.408417
1951561.0,nifedipine,dose,10,mg,,,,,,,,oral,,8.0,maternal,postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,126,2025-12-02T16:05:06.199640
1951561.0,nifedipine,dose,10,mg,,,,,,,,oral,,8.0,maternal,postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,126,2025-12-02T16:05:11.478648
1951561,nifedipine,dose,10,mg,,,,,,,,oral,,8.0,maternal,postpartum,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,125,2025-12-02T16:05:15.087972
1951561,nifedipine,dose,10,mg,,,,,,,,oral,,8.0,maternal,postpartum,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,125,2025-12-02T16:05:21.408417
21644845.0,nifedipine,loading dose,30,mg,,,,,,,,oral,10 mg every 15 min up to three doses,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,127,2025-12-02T16:05:06.199640
21644845.0,nifedipine,study dose,10-20,mg,,,,,,,every 6 h,oral,12 h after the loading dose,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,128,2025-12-02T16:05:06.199640
21644845.0,nifedipine,loading dose,30,mg,,,,,,,,oral,10 mg every 15 min up to three doses,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,127,2025-12-02T16:05:11.478648
21644845.0,nifedipine,study dose,10-20,mg,,,,,,,every 6 h,oral,12 h after the loading dose,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,128,2025-12-02T16:05:11.478648
21644845,nifedipine,loading dose,30,mg,,,,,,,,oral,10 mg every 15 min up to three doses,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,126,2025-12-02T16:05:15.087972
21644845,nifedipine,study dose,10-20,mg,,,,,,,every 6 h,oral,12 h after the loading dose,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,127,2025-12-02T16:05:15.087972
21644845,nifedipine,loading dose,30,mg,,,,,,,,oral,10 mg every 15 min up to three doses,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,126,2025-12-02T16:05:21.408417
21644845,nifedipine,study dose,10-20,mg,,,,,,,every 6 h,oral,12 h after the loading dose,20.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,127,2025-12-02T16:05:21.408417
2216229.0,nifedipine,dose,20,mg,,,,,,,single dose,oral,,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,129,2025-12-02T16:05:06.199640
2216229.0,nifedipine,dose,20,mg,,,,,,,single dose,oral,,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,129,2025-12-02T16:05:11.478648
2216229,nifedipine,dose,20,mg,,,,,,,single dose,oral,,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,128,2025-12-02T16:05:15.087972
2216229,nifedipine,dose,20,mg,,,,,,,single dose,oral,,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,128,2025-12-02T16:05:21.408417
2256493.0,nifedipine,dose,45.1,mg/d,mean,SD,11.0,minmax,40,80.0,every 6 h,oral,,20.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,130,2025-12-02T16:05:06.199640
2256493.0,nifedipine,dose,45.1,mg/d,mean,SD,11.0,minmax,40,80.0,every 6 h,oral,,20.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,130,2025-12-02T16:05:11.478648
2256493,nifedipine,dose,45.1,mg/d,mean,SD,11.0,minmax,40,80.0,every 6 h,oral,,20.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,129,2025-12-02T16:05:15.087972
2256493,nifedipine,dose,45.1,mg/d,mean,SD,11.0,minmax,40,80.0,every 6 h,oral,,20.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,129,2025-12-02T16:05:21.408417
22875663.0,nifedipine,dose,10-20,mg,,,,,,,every 6 h,oral,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,131,2025-12-02T16:05:06.199640
22875663.0,nifedipine,dose,10-20,mg,,,,,,,every 8 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,132,2025-12-02T16:05:06.199640
22875663.0,nifedipine,dose,10-20,mg,,,,,,,every 4 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,133,2025-12-02T16:05:06.199640
22875663.0,nifedipine,dose,10-20,mg,,,,,,,every 6 h,oral,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,131,2025-12-02T16:05:11.478648
22875663.0,nifedipine,dose,10-20,mg,,,,,,,every 8 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,132,2025-12-02T16:05:11.478648
22875663.0,nifedipine,dose,10-20,mg,,,,,,,every 4 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,133,2025-12-02T16:05:11.478648
22875663,nifedipine,dose,10-20,mg,,,,,,,every 6 h,oral,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,130,2025-12-02T16:05:15.087972
22875663,nifedipine,dose,10-20,mg,,,,,,,every 8 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,131,2025-12-02T16:05:15.087972
22875663,nifedipine,dose,10-20,mg,,,,,,,every 4 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,132,2025-12-02T16:05:15.087972
22875663,nifedipine,dose,10-20,mg,,,,,,,every 6 h,oral,,12.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,130,2025-12-02T16:05:21.408417
22875663,nifedipine,dose,10-20,mg,,,,,,,every 8 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,131,2025-12-02T16:05:21.408417
22875663,nifedipine,dose,10-20,mg,,,,,,,every 4 h,oral,,1.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,132,2025-12-02T16:05:21.408417
2603904.0,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,134,2025-12-02T16:05:06.199640
2603904.0,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,134,2025-12-02T16:05:11.478648
2603904,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,133,2025-12-02T16:05:15.087972
2603904,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,,13.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,133,2025-12-02T16:05:21.408417
28042936.0,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 2 weeks,22.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,135,2025-12-02T16:05:06.199640
28042936.0,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 2 weeks,22.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,135,2025-12-02T16:05:11.478648
28042936,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 2 weeks,22.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,134,2025-12-02T16:05:15.087972
28042936,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 2 weeks,22.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,134,2025-12-02T16:05:21.408417
37987176.0,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,at the time of blood sampling,37.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,136,2025-12-02T16:05:06.199640
37987176.0,nifedipine,dose,40,mg,,,,,,,every 6 h,oral,at the time of blood sampling,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,137,2025-12-02T16:05:06.199640
37987176.0,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,at the time of blood sampling,37.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,136,2025-12-02T16:05:11.478648
37987176.0,nifedipine,dose,40,mg,,,,,,,every 6 h,oral,at the time of blood sampling,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,137,2025-12-02T16:05:11.478648
37987176,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,at the time of blood sampling,37.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,135,2025-12-02T16:05:15.087972
37987176,nifedipine,dose,40,mg,,,,,,,every 6 h,oral,at the time of blood sampling,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,136,2025-12-02T16:05:15.087972
37987176,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,at the time of blood sampling,37.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,135,2025-12-02T16:05:21.408417
37987176,nifedipine,dose,40,mg,,,,,,,every 6 h,oral,at the time of blood sampling,1.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,136,2025-12-02T16:05:21.408417
25407260.0,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,Study medication was phased out from day 10 (total daily dose of 60 mg) until day 12 (total daily dose of 20 mg) and discontinued on day 13. ,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,138,2025-12-02T16:05:06.199640
25407260.0,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,Study medication was phased out from day 10 (total daily dose of 60 mg) until day 12 (total daily dose of 20 mg) and discontinued on day 13. ,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,138,2025-12-02T16:05:11.478648
25407260,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,Study medication was phased out from day 10 (total daily dose of 60 mg) until day 12 (total daily dose of 20 mg) and discontinued on day 13. ,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,137,2025-12-02T16:05:15.087972
25407260,nifedipine,dose,20,mg,,,,,,,every 6 h,oral,Study medication was phased out from day 10 (total daily dose of 60 mg) until day 12 (total daily dose of 20 mg) and discontinued on day 13. ,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,137,2025-12-02T16:05:21.408417
30659932.0,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 15 days,19.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,139,2025-12-02T16:05:06.199640
30659932.0,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 15 days,19.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,139,2025-12-02T16:05:11.478648
30659932,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 15 days,19.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,138,2025-12-02T16:05:15.087972
30659932,nifedipine,dose,20,mg,,,,,,,every 12 h,oral,at least 15 days,19.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,138,2025-12-02T16:05:21.408417
10847234.0,azithromycin,dose,0.3,ug/ml,,,,,,,,,"after delivery, infused to the maternal inflow at a constant rate for 2 h",7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,140,2025-12-02T16:05:06.199640
10847234.0,azithromycin,dose,0.3,ug/ml,,,,,,,,,"after delivery, infused to the maternal inflow at a constant rate for 2 h",7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,140,2025-12-02T16:05:11.478648
10847234,azithromycin,dose,0.3,ug/ml,,,,,,,,,"after delivery, infused to the maternal inflow at a constant rate for 2 h",7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,139,2025-12-02T16:05:15.087972
10847234,azithromycin,dose,0.3,ug/ml,,,,,,,,,"after delivery, infused to the maternal inflow at a constant rate for 2 h",7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,139,2025-12-02T16:05:21.408417
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 6 hours before the cesarean operation,2.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,141,2025-12-02T16:05:06.199640
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at12 hours before the cesarean operation,7.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,142,2025-12-02T16:05:06.199640
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 24 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,143,2025-12-02T16:05:06.199640
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 72 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,144,2025-12-02T16:05:06.199640
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 168 hours before the cesarean operation,1.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,145,2025-12-02T16:05:06.199640
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 6 hours before the cesarean operation,2.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,141,2025-12-02T16:05:11.478648
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at12 hours before the cesarean operation,7.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,142,2025-12-02T16:05:11.478648
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 24 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,143,2025-12-02T16:05:11.478648
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 72 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,144,2025-12-02T16:05:11.478648
12634646.0,azithromycin,dose,1,g,,,,,,,,oral,at 168 hours before the cesarean operation,1.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,145,2025-12-02T16:05:11.478648
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 6 hours before the cesarean operation,2.0,maternal,labor,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,140,2025-12-02T16:05:15.087972
12634646,azithromycin,dose,1,g,,,,,,,,oral,at12 hours before the cesarean operation,7.0,maternal,labor,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,141,2025-12-02T16:05:15.087972
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 24 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,142,2025-12-02T16:05:15.087972
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 72 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,143,2025-12-02T16:05:15.087972
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 168 hours before the cesarean operation,1.0,maternal,labor,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,144,2025-12-02T16:05:15.087972
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 6 hours before the cesarean operation,2.0,maternal,labor,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,140,2025-12-02T16:05:21.408417
12634646,azithromycin,dose,1,g,,,,,,,,oral,at12 hours before the cesarean operation,7.0,maternal,labor,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,141,2025-12-02T16:05:21.408417
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 24 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,142,2025-12-02T16:05:21.408417
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 72 hours before the cesarean operation,5.0,maternal,labor,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,143,2025-12-02T16:05:21.408417
12634646,azithromycin,dose,1,g,,,,,,,,oral,at 168 hours before the cesarean operation,1.0,maternal,labor,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,144,2025-12-02T16:05:21.408417
25595580.0,azithromycin,dose timing,51,min,mean,,,minmax,10,219.0,,,,30.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,146,2025-12-02T16:05:06.199640
25595580.0,azithromycin,dose,500,mg,,,,,,,,IV,"initiated 15, 30, or 60 minutes prior to incision and infused over one hour.",30.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,147,2025-12-02T16:05:06.199640
25595580.0,azithromycin,dose timing,51,min,mean,,,minmax,10,219.0,,,,30.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,146,2025-12-02T16:05:11.478648
25595580.0,azithromycin,dose,500,mg,,,,,,,,IV,"initiated 15, 30, or 60 minutes prior to incision and infused over one hour.",30.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,147,2025-12-02T16:05:11.478648
25595580,azithromycin,dose timing,51,min,mean,,,minmax,10,219.0,,,,30.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,145,2025-12-02T16:05:15.087972
25595580,azithromycin,dose,500,mg,,,,,,,,IV,"initiated 15, 30, or 60 minutes prior to incision and infused over one hour.",30.0,maternal,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,146,2025-12-02T16:05:15.087972
25595580,azithromycin,dose timing,51,min,mean,,,minmax,10,219.0,,,,30.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,145,2025-12-02T16:05:21.408417
25595580,azithromycin,dose,500,mg,,,,,,,,IV,"initiated 15, 30, or 60 minutes prior to incision and infused over one hour.",30.0,maternal,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,146,2025-12-02T16:05:21.408417
27861509.0,azithromycin,dose,250,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,148,2025-12-02T16:05:06.199640
27861509.0,chloroquine,dose,155,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,149,2025-12-02T16:05:06.199640
27861509.0,azithromycin,dose,250,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,148,2025-12-02T16:05:11.478648
27861509.0,chloroquine,dose,155,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,149,2025-12-02T16:05:11.478648
27861509,azithromycin,dose,250,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,147,2025-12-02T16:05:15.087972
27861509,chloroquine,dose,155,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,148,2025-12-02T16:05:15.087972
27861509,azithromycin,dose,250,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,147,2025-12-02T16:05:21.408417
27861509,chloroquine,dose,155,mg,,,,,,,every day,oral,for 3 days,168.0,maternal,second or third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,148,2025-12-02T16:05:21.408417
1814844.0,nifedipine,dose,10,mg,,,,,,,thrice daily,oral,,11.0,maternal,third trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,150,2025-12-02T16:05:06.199640
1814844.0,nifedipine,dose,10,mg,,,,,,,thrice daily,oral,,11.0,maternal,third trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,150,2025-12-02T16:05:11.478648
1814844,nifedipine,dose,10,mg,,,,,,,thrice daily,oral,,11.0,maternal,third trimester,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,149,2025-12-02T16:05:15.087972
1814844,nifedipine,dose,10,mg,,,,,,,thrice daily,oral,,11.0,maternal,third trimester,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,149,2025-12-02T16:05:21.408417
38977063.0,azithromycin,dose,1,g,,,,,,,single dose,oral,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,151,2025-12-02T16:05:06.199640
38977063.0,azithromycin,dose,500,mg,,,,,,,daily,oral,for 7 days,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,152,2025-12-02T16:05:06.199640
38977063.0,azithromycin,dose,1,g,,,,,,,single dose,oral,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,151,2025-12-02T16:05:11.478648
38977063.0,azithromycin,dose,500,mg,,,,,,,daily,oral,for 7 days,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,152,2025-12-02T16:05:11.478648
38977063,azithromycin,dose,1,g,,,,,,,single dose,oral,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,150,2025-12-02T16:05:15.087972
38977063,azithromycin,dose,500,mg,,,,,,,daily,oral,for 7 days,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,151,2025-12-02T16:05:15.087972
38977063,azithromycin,dose,1,g,,,,,,,single dose,oral,,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,150,2025-12-02T16:05:21.408417
38977063,azithromycin,dose,500,mg,,,,,,,daily,oral,for 7 days,3.0,maternal,pregnancy,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,151,2025-12-02T16:05:21.408417
10583022.0,fluoxetine,dose,0.51,mg/kg/day,median,,,minmax,0.24,0.94,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,153,2025-12-02T16:05:06.199640
10583022.0,fluoxetine,absolute dose,,mg/day,,,,minmax,20,80.0,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,154,2025-12-02T16:05:06.199640
10583022.0,fluoxetine,dose,0.51,mg/kg/day,median,,,minmax,0.24,0.94,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,153,2025-12-02T16:05:11.478648
10583022.0,fluoxetine,absolute dose,,mg/day,,,,minmax,20,80.0,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,154,2025-12-02T16:05:11.478648
10583022,fluoxetine,dose,0.51,mg/kg/day,median,,,minmax,0.24,0.94,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,152,2025-12-02T16:05:15.087972
10583022,fluoxetine,absolute dose,,mg/day,,,,minmax,20,80.0,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,153,2025-12-02T16:05:15.087972
10583022,fluoxetine,dose,0.51,mg/kg/day,median,,,minmax,0.24,0.94,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,152,2025-12-02T16:05:21.408417
10583022,fluoxetine,absolute dose,,mg/day,,,,minmax,20,80.0,,,,14.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,153,2025-12-02T16:05:21.408417
11720696.0,fluoxetine,dose,,mg/day,,,,minmax,10,60.0,once daily,,,20.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,155,2025-12-02T16:05:06.199640
11720696.0,fluoxetine,dose,,mg/day,,,,minmax,10,60.0,once daily,,,20.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,155,2025-12-02T16:05:11.478648
11720696,fluoxetine,dose,,mg/day,,,,minmax,10,60.0,once daily,,,20.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,154,2025-12-02T16:05:15.087972
11720696,fluoxetine,dose,,mg/day,,,,minmax,10,60.0,once daily,,,20.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,154,2025-12-02T16:05:21.408417
12242061.0,fluoxetine,dose,34,mg/day,mean,SD,12.8,,,,,,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,156,2025-12-02T16:05:06.199640
12242061.0,fluoxetine,dose,34,mg/day,mean,SD,12.8,,,,,,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,156,2025-12-02T16:05:11.478648
12242061,fluoxetine,dose,34,mg/day,mean,SD,12.8,,,,,,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,155,2025-12-02T16:05:15.087972
12242061,fluoxetine,dose,34,mg/day,mean,SD,12.8,,,,,,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,155,2025-12-02T16:05:21.408417
8932542.0,fluoxetine,dose,0.39,mg/kg/day,mean,SD,0.21,minmax,0.17,0.85,,,for a minimum of 2 weeks before the study,10.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,166,2025-12-02T16:05:06.199640
8932542.0,fluoxetine,dose,0.39,mg/kg/day,mean,SD,0.21,minmax,0.17,0.85,,,for a minimum of 2 weeks before the study,10.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,166,2025-12-02T16:05:11.478648
8932542,fluoxetine,dose,0.39,mg/kg/day,mean,SD,0.21,minmax,0.17,0.85,,,for a minimum of 2 weeks before the study,10.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,165,2025-12-02T16:05:15.087972
8932542,fluoxetine,dose,0.39,mg/kg/day,mean,SD,0.21,minmax,0.17,0.85,,,for a minimum of 2 weeks before the study,10.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,165,2025-12-02T16:05:21.408417
10971311.0,citalopram,dose,0.36,mg/kg/day,mean,,,minmax,0.29,0.58,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,167,2025-12-02T16:05:06.199640
10971311.0,citalopram,duration of therapy,97,days,mean,,,minmax,49,183.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,168,2025-12-02T16:05:06.199640
10971311.0,citalopram,dose,0.36,mg/kg/day,mean,,,minmax,0.29,0.58,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,167,2025-12-02T16:05:11.478648
10971311.0,citalopram,duration of therapy,97,days,mean,,,minmax,49,183.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,168,2025-12-02T16:05:11.478648
10971311,citalopram,dose,0.36,mg/kg/day,mean,,,minmax,0.29,0.58,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,166,2025-12-02T16:05:15.087972
10971311,citalopram,duration of therapy,97,days,mean,,,minmax,49,183.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,167,2025-12-02T16:05:15.087972
10971311,citalopram,dose,0.36,mg/kg/day,mean,,,minmax,0.29,0.58,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,166,2025-12-02T16:05:21.408417
10971311,citalopram,duration of therapy,97,days,mean,,,minmax,49,183.0,,,,7.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,167,2025-12-02T16:05:21.408417
38841362.0,Sertraline,dose,83,mg/day,mean,,,minmax,50,200.0,,,,15.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,172,2025-12-02T16:05:06.199640
38841362.0,Citalopram,dose,21,mg/day,mean,,,minmax,10,40.0,,,,13.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,173,2025-12-02T16:05:06.199640
38841362.0,Paroxetine,dose,29,mg/day,mean,,,minmax,5,40.0,,,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,174,2025-12-02T16:05:06.199640
38841362.0,Sertraline,dose,83,mg/day,mean,,,minmax,50,200.0,,,,15.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,172,2025-12-02T16:05:11.478648
38841362.0,Citalopram,dose,21,mg/day,mean,,,minmax,10,40.0,,,,13.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,173,2025-12-02T16:05:11.478648
38841362.0,Paroxetine,dose,29,mg/day,mean,,,minmax,5,40.0,,,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,174,2025-12-02T16:05:11.478648
38841362,Sertraline,dose,83,mg/day,mean,,,minmax,50,200.0,,,,15.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,171,2025-12-02T16:05:15.087972
38841362,Citalopram,dose,21,mg/day,mean,,,minmax,10,40.0,,,,13.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,172,2025-12-02T16:05:15.087972
38841362,Paroxetine,dose,29,mg/day,mean,,,minmax,5,40.0,,,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,173,2025-12-02T16:05:15.087972
38841362,Sertraline,dose,83,mg/day,mean,,,minmax,50,200.0,,,,15.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,171,2025-12-02T16:05:21.408417
38841362,Citalopram,dose,21,mg/day,mean,,,minmax,10,40.0,,,,13.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,172,2025-12-02T16:05:21.408417
38841362,Paroxetine,dose,29,mg/day,mean,,,minmax,5,40.0,,,,9.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,173,2025-12-02T16:05:21.408417
21081764.0,Gabapentin,dose,600,mg,,,,,,,,oral,1 hour before the start of cesarean surgery,21.0,materanl,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,190,2025-12-02T16:05:06.199640
21081764.0,Gabapentin,dose,600,mg,,,,,,,,oral,1 hour before the start of cesarean surgery,21.0,materanl,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,190,2025-12-02T16:05:11.478648
21081764,Gabapentin,dose,600,mg,,,,,,,,oral,1 hour before the start of cesarean surgery,21.0,materanl,delivery,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,189,2025-12-02T16:05:15.087972
21081764,Gabapentin,dose,600,mg,,,,,,,,oral,1 hour before the start of cesarean surgery,21.0,materanl,delivery,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,189,2025-12-02T16:05:21.408417
10671385.0,paroxetine,dose,23.1,mg/day,mean,SD,12.0,minmax,10,50.0,once daily,oral,,16.0,materanl,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,192,2025-12-02T16:05:06.199640
10671385.0,paroxetine,dose,23.1,mg/day,mean,SD,12.0,minmax,10,50.0,once daily,oral,,16.0,materanl,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,192,2025-12-02T16:05:11.478648
10671385,paroxetine,dose,23.1,mg/day,mean,SD,12.0,minmax,10,50.0,once daily,oral,,16.0,materanl,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,191,2025-12-02T16:05:15.087972
10671385,paroxetine,dose,23.1,mg/day,mean,SD,12.0,minmax,10,50.0,once daily,oral,,16.0,materanl,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,191,2025-12-02T16:05:21.408417
11105735.0,paroxetine,daily dose,17.6,mg,mean,SD,9.7,,,,once daily,oral,every morning,25.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,193,2025-12-02T16:05:06.199640
11105735.0,paroxetine,daily dose,17.6,mg,mean,SD,9.7,,,,once daily,oral,every morning,25.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,193,2025-12-02T16:05:11.478648
11105735,paroxetine,daily dose,17.6,mg,mean,SD,9.7,,,,once daily,oral,every morning,25.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,192,2025-12-02T16:05:15.087972
11105735,paroxetine,daily dose,17.6,mg,mean,SD,9.7,,,,once daily,oral,every morning,25.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,192,2025-12-02T16:05:21.408417
11483479.0,Sertraline,,,,,,,,,,once daily,oral,,30.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,194,2025-12-02T16:05:06.199640
11483479.0,paroxetine,,,,,,,,,,once daily,oral,,16.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,195,2025-12-02T16:05:06.199640
11483479.0,fluvoxamine,,,,,,,,,,once daily,oral,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,196,2025-12-02T16:05:06.199640
11483479.0,Sertraline,,,,,,,,,,once daily,oral,,30.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,194,2025-12-02T16:05:11.478648
11483479.0,paroxetine,,,,,,,,,,once daily,oral,,16.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,195,2025-12-02T16:05:11.478648
11483479.0,fluvoxamine,,,,,,,,,,once daily,oral,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,196,2025-12-02T16:05:11.478648
11483479,Sertraline,,,,,,,,,,once daily,oral,,30.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,193,2025-12-02T16:05:15.087972
11483479,paroxetine,,,,,,,,,,once daily,oral,,16.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,194,2025-12-02T16:05:15.087972
11483479,fluvoxamine,,,,,,,,,,once daily,oral,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_Cleaned.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,195,2025-12-02T16:05:15.087972
11483479,Sertraline,,,,,,,,,,once daily,oral,,30.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,193,2025-12-02T16:05:21.408417
11483479,paroxetine,,,,,,,,,,once daily,oral,,16.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,194,2025-12-02T16:05:21.408417
11483479,fluvoxamine,,,,,,,,,,once daily,oral,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_SZ_By 91124.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,195,2025-12-02T16:05:21.408417
3239381.0,Diazepam,dose,10,mg,,,,,,,single dose,oral,1 hour before the surgery,8.0,maternal,1st trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,198,2025-12-02T16:05:06.199640
3239381.0,Diazepam,dose,10,mg,,,,,,,single dose,oral,2.5 h before the surgery,8.0,maternal,1st trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,199,2025-12-02T16:05:06.199640
3239381.0,Diazepam,dose,10,mg,,,,,,,single dose,oral,4h before the surgery,8.0,maternal,1st trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,200,2025-12-02T16:05:06.199640
3239381.0,Oxazepam,dose,25,mg,,,,,,,single dose,oral,,24.0,maternal,1st trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,201,2025-12-02T16:05:06.199640
3239381.0,Diazepam,dose,10,mg,,,,,,,single dose,oral,1 hour before the surgery,8.0,maternal,1st trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,198,2025-12-02T16:05:11.478648
3239381.0,Diazepam,dose,10,mg,,,,,,,single dose,oral,2.5 h before the surgery,8.0,maternal,1st trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,199,2025-12-02T16:05:11.478648
3239381.0,Diazepam,dose,10,mg,,,,,,,single dose,oral,4h before the surgery,8.0,maternal,1st trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,200,2025-12-02T16:05:11.478648
3239381.0,Oxazepam,dose,25,mg,,,,,,,single dose,oral,,24.0,maternal,1st trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,201,2025-12-02T16:05:11.478648
24134697.0,Diazepam,dose,0.063,mg/kg,mean,SD,0.0084,minmax,0.04,0.08,single dose,IM,,31.0,maternal,pregnant,,,control group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,202,2025-12-02T16:05:06.199640
24134697.0,Diazepam,dose,0.057,mg/kg,mean,SD,0.014,minmax,0.04,0.1,single dose,IM,,30.0,maternal,pregnant,,,hypertension group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,203,2025-12-02T16:05:06.199640
24134697.0,Diazepam,dose,0.061,mg/kg,mean,SD,0.014,minmax,0.04,0.08,single dose,IM,,14.0,maternal,pregnant,,,diabetes group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,204,2025-12-02T16:05:06.199640
24134697.0,Diazepam,dose,2.66,mg/m2,mean,SD,0.23,minmax,1.93,3.12,single dose,IM,,31.0,maternal,pregnant,,,control group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,205,2025-12-02T16:05:06.199640
24134697.0,Diazepam,dose,2.45,mg/m2,mean,SD,0.35,minmax,1.91,3.38,single dose,IM,,30.0,maternal,pregnant,,,hypertension group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,206,2025-12-02T16:05:06.199640
24134697.0,Diazepam,dose,2.58,mg/m2,mean,SD,0.36,minmax,2.04,3.11,single dose,IM,,14.0,maternal,pregnant,,,diabetes group,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,207,2025-12-02T16:05:06.199640
24134697.0,Diazepam,dose,0.063,mg/kg,mean,SD,0.0084,minmax,0.04,0.08,single dose,IM,,31.0,maternal,pregnant,,,control group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,202,2025-12-02T16:05:11.478648
24134697.0,Diazepam,dose,0.057,mg/kg,mean,SD,0.014,minmax,0.04,0.1,single dose,IM,,30.0,maternal,pregnant,,,hypertension group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,203,2025-12-02T16:05:11.478648
24134697.0,Diazepam,dose,0.061,mg/kg,mean,SD,0.014,minmax,0.04,0.08,single dose,IM,,14.0,maternal,pregnant,,,diabetes group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,204,2025-12-02T16:05:11.478648
24134697.0,Diazepam,dose,2.66,mg/m2,mean,SD,0.23,minmax,1.93,3.12,single dose,IM,,31.0,maternal,pregnant,,,control group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,205,2025-12-02T16:05:11.478648
24134697.0,Diazepam,dose,2.45,mg/m2,mean,SD,0.35,minmax,1.91,3.38,single dose,IM,,30.0,maternal,pregnant,,,hypertension group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,206,2025-12-02T16:05:11.478648
24134697.0,Diazepam,dose,2.58,mg/m2,mean,SD,0.36,minmax,2.04,3.11,single dose,IM,,14.0,maternal,pregnant,,,diabetes group,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,207,2025-12-02T16:05:11.478648
3114732.0,Diazepam,dose,5,mg,,,,,,,,oral,given on the night before surgery,3.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,208,2025-12-02T16:05:06.199640
3114732.0,Diazepam,dose,5,mg,,,,,,,,oral,in the morning before the operation,12.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,209,2025-12-02T16:05:06.199640
3114732.0,Diazepam,dose,5,mg,,,,,,,,oral,given on the night before surgery,3.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,208,2025-12-02T16:05:11.478648
3114732.0,Diazepam,dose,5,mg,,,,,,,,oral,in the morning before the operation,12.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,209,2025-12-02T16:05:11.478648
2721106.0,Diazepam,dose,6,mg,,,,,,,,IV,over 2 min approximately 1.5 to 3 hours before delivery,5.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,210,2025-12-02T16:05:06.199640
2721106.0,Diazepam,dose,6,mg,,,,,,,,IV,over 2 min approximately 1.5 to 3 hours before delivery,5.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,210,2025-12-02T16:05:11.478648
7397084.0,Diazepam,dose,20,mg,,,,,,,,IV,They were then given 20 mg of diazepam intravenously over a period of 15 seconds followed by a bolus injection of 50 to 100 mg of suxamethonium approximately 15 seconds later. ,30.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,211,2025-12-02T16:05:06.199640
7397084.0,Diazepam,dose,20,mg,,,,,,,,IV,They were then given 20 mg of diazepam intravenously over a period of 15 seconds followed by a bolus injection of 50 to 100 mg of suxamethonium approximately 15 seconds later. ,30.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,211,2025-12-02T16:05:11.478648
13006.0,Diazepam,dose,10,mg,,,,,,,,intraamniotically,injected into amniotic fluid during the amniocentesis after removing amniotic fluid,8.0,maternal,pregnant/abortion,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,212,2025-12-02T16:05:06.199640
13006.0,Diazepam,dose,10,mg,,,,,,,,intraamniotically,injected into amniotic fluid during the amniocentesis after removing amniotic fluid,8.0,maternal,pregnant/abortion,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,212,2025-12-02T16:05:11.478648
20359.0,Diazepam,total dose,30,mg,,,,,,,,IV,over a period of 15 sec,39.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,213,2025-12-02T16:05:06.199640
20359.0,Diazepam,total dose,30,mg,,,,,,,,IV,over a period of 15 sec,39.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,213,2025-12-02T16:05:11.478648
699483.0,Diazepam,dose,30,mg,,,,,,,,IV,over a period of 15 sec,30.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,214,2025-12-02T16:05:06.199640
699483.0,Diazepam,dose,30,mg,,,,,,,,IV,over a period of 15 sec,30.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,214,2025-12-02T16:05:11.478648
889746.0,Diazepam,dose,10,mg,,,,,,,,IV,over one minute,11.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,215,2025-12-02T16:05:06.199640
889746.0,Diazepam,dose,10,mg,,,,,,,,IV,over one minute,11.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,215,2025-12-02T16:05:11.478648
24101397.0,Diazepam,dose,7.6,mg/day,mean,SD,3.6,minmax,5,15.0,,,,47.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,216,2025-12-02T16:05:06.199640
24101397.0,Diazepam,period of administration,,months,,,,minmax,1,9.0,,,,47.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,217,2025-12-02T16:05:06.199640
24101397.0,Diazepam,length of dosing,2,months,mean,SD,0.9,,,,,,,6.0,maternal,I trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,218,2025-12-02T16:05:06.199640
24101397.0,Diazepam,length of dosing,2,months,mean,SD,1.0,,,,,,,14.0,maternal,II trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,219,2025-12-02T16:05:06.199640
24101397.0,Diazepam,length of dosing,2.5,months,mean,SD,0.7,,,,,,,26.0,maternal,III trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,220,2025-12-02T16:05:06.199640
24101397.0,Diazepam,dose,7.6,mg/day,mean,SD,3.6,minmax,5,15.0,,,,47.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,216,2025-12-02T16:05:11.478648
24101397.0,Diazepam,period of administration,,months,,,,minmax,1,9.0,,,,47.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,217,2025-12-02T16:05:11.478648
24101397.0,Diazepam,length of dosing,2,months,mean,SD,0.9,,,,,,,6.0,maternal,I trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,218,2025-12-02T16:05:11.478648
24101397.0,Diazepam,length of dosing,2,months,mean,SD,1.0,,,,,,,14.0,maternal,II trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,219,2025-12-02T16:05:11.478648
24101397.0,Diazepam,length of dosing,2.5,months,mean,SD,0.7,,,,,,,26.0,maternal,III trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,220,2025-12-02T16:05:11.478648
989345.0,Diazepam,dose,10,mg,,,,,,,daily,oral,beginning  the third day after delivery and continuing for the six following days,4.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,221,2025-12-02T16:05:06.199640
989345.0,Diazepam,dose,10,mg,,,,,,,daily,oral,beginning  the third day after delivery and continuing for the six following days,4.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,221,2025-12-02T16:05:11.478648
4441031.0,Diazepam,dose,10,mg,,,,,,,single dose,intraamniotically,given as premedication before legal abortion,14.0,maternal,pregnant/abortion,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,222,2025-12-02T16:05:06.199640
4441031.0,Diazepam,dose,10,mg,,,,,,,single dose,intraamniotically,given as premedication before legal abortion,14.0,maternal,pregnant/abortion,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,222,2025-12-02T16:05:11.478648
7318882.0,Diazepam,dose,0.3,mg/kg,,,,,,,single dose,IV,in 15 s,30.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,223,2025-12-02T16:05:06.199640
7318882.0,Diazepam,dose,0.3,mg/kg,,,,,,,single dose,IV,in 15 s,30.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,223,2025-12-02T16:05:11.478648
8244501.0,Diazepam,,,,,,,,,,,CIV and IV,,25.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,224,2025-12-02T16:05:06.199640
8244501.0,Diazepam,,,,,,,,,,,CIV and IV,,25.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,224,2025-12-02T16:05:11.478648
8671346.0,Diazepam,dose,0.1,mg/kg,,,,,,,,IV,in 15s,65.0,maternal,pregnant/abortion,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,225,2025-12-02T16:05:06.199640
8671346.0,Diazepam,dose,0.1,mg/kg,,,,,,,,IV,in 15s,65.0,maternal,pregnant/abortion,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,225,2025-12-02T16:05:11.478648
533212.0,Diazepam,dose,30,mg,,,,,,,,IV,in 15s,32.0,maternal,labor,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,226,2025-12-02T16:05:06.199640
533212.0,Diazepam,dose,30,mg,,,,,,,,IV,in 15s,32.0,maternal,labor,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,226,2025-12-02T16:05:11.478648
2119270.0,Flecainide,dose,3.2,mg/kg/day,mean,SD,0.4,,,,every 12 hours,oral,continued for 5.5 days,11.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,227,2025-12-02T16:05:06.199640
2119270.0,Flecainide,dose,3.2,mg/kg/day,mean,SD,0.4,,,,every 12 hours,oral,continued for 5.5 days,11.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,227,2025-12-02T16:05:11.478648
25068572.0,Flecainide,dose,100,mg,,,,,,,tid,oral,,33.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,228,2025-12-02T16:05:06.199640
25068572.0,Flecainide,dose,100,mg,,,,,,,tid,oral,,33.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,228,2025-12-02T16:05:11.478648
34026129.0,Flecainide,dose,100,mg,,,,,,,bid,oral,start at 30 weeks and 2 days of gestation until cesarean delivery,1.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,229,2025-12-02T16:05:06.199640
34026129.0,Flecainide,dose,100,mg,,,,,,,bid,oral,start at 30 weeks and 2 days of gestation until cesarean delivery,1.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,229,2025-12-02T16:05:11.478648
32488251.0,Rivaroxaban,dose,20,mg,,,,,,,single dose,oral,,2.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,230,2025-12-02T16:05:06.199640
32488251.0,Rivaroxaban,dose,20,mg,,,,,,,single dose,oral,,2.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,230,2025-12-02T16:05:11.478648
2206788.0,Zopiclone,dose,7.5,mg,,,,,,,single dose,oral,,12.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,231,2025-12-02T16:05:06.199640
2206788.0,Zopiclone,dose,7.5,mg,,,,,,,single dose,oral,,12.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,231,2025-12-02T16:05:11.478648
19657707.0,Zolpidem,dose @ delivery,9.17,mg/day,mean,SD,6.45,,,,,,,6.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,232,2025-12-02T16:05:06.199640
19657707.0,Zolpidem,length of use prior to delivery,18.2,weeks,mean,SD,16.7,,,,,,,6.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,233,2025-12-02T16:05:06.199640
19657707.0,Zolpidem,dose,8.8,mg/day,mean,SD,3.9,,,,,,,45.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,234,2025-12-02T16:05:06.199640
19657707.0,Zolpidem,duration,13.8,weeks,mean,SD,12.9,,,,,,,45.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,235,2025-12-02T16:05:06.199640
19657707.0,Zolpidem,dose @ delivery,9.17,mg/day,mean,SD,6.45,,,,single dose,,,6.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,232,2025-12-02T16:05:11.478648
19657707.0,Zolpidem,length of use prior to delivery,18.2,weeks,mean,SD,16.7,,,,,,,6.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,233,2025-12-02T16:05:11.478648
19657707.0,Zolpidem,dose,8.8,mg/day,mean,SD,3.9,,,,,,,45.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,234,2025-12-02T16:05:11.478648
19657707.0,Zolpidem,duration,13.8,weeks,mean,SD,12.9,,,,,,,45.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,235,2025-12-02T16:05:11.478648
2612539.0,Zolpidem,dose,20,mg,,,,,,,single dose,oral,study performed on Days 3 or 4 after delivery,5.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,236,2025-12-02T16:05:06.199640
2612539.0,Zolpidem,dose,20,mg,,,,,,,single dose,oral,study performed on Days 3 or 4 after delivery,5.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,236,2025-12-02T16:05:11.478648
18193916.0,Duloxetine,dose,40,mg,,,,,,,bid,oral,Duloxetine 40 mg (two 20-mg capsules) was given orally with food at 12-hour intervals for 3 days and once on the morning of the fourth day.,6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,237,2025-12-02T16:05:06.199640
18193916.0,Duloxetine,dose,40,mg,,,,,,,bid,oral,Duloxetine 40 mg (two 20-mg capsules) was given orally with food at 12-hour intervals for 3 days and once on the morning of the fourth day.,6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,237,2025-12-02T16:05:11.478648
20848091.0,Labetalol,dose,40,mg,,,,,,,single dose,IV,over a period of 1 min,14.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,238,2025-12-02T16:05:06.199640
20848091.0,Labetalol,dose,100,mg,,,,,,,single dose,Oral,,16.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,239,2025-12-02T16:05:06.199640
20848091.0,Labetalol,dose,40,mg,,,,,,,single dose,IV,over a period of 1 min,14.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,238,2025-12-02T16:05:11.478648
20848091.0,Labetalol,dose,100,mg,,,,,,,single dose,Oral,,16.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,239,2025-12-02T16:05:11.478648
2309815.0,Labetalol,dose,100,mg,,,,,,,every 8 hours,oral,,,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,240,2025-12-02T16:05:06.199640
2309815.0,Labetalol,dose,100,mg,,,,,,,every 8 hours,oral,,,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,240,2025-12-02T16:05:11.478648
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2400.0,,,,57.0,maternal,pregnant/postpartum,,,overall,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,241,2025-12-02T16:05:06.199640
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2000.0,,,,29.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,242,2025-12-02T16:05:06.199640
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2200.0,,,,47.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,243,2025-12-02T16:05:06.199640
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2400.0,,,,34.0,maternal,postmartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,244,2025-12-02T16:05:06.199640
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2400.0,,,,57.0,maternal,pregnant/postpartum,,,overall,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,241,2025-12-02T16:05:11.478648
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2000.0,,,,29.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,242,2025-12-02T16:05:11.478648
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2200.0,,,,47.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,243,2025-12-02T16:05:11.478648
24297680.0,Labetalol,dose,,mg/day,,,,minmax,50,2400.0,,,,34.0,maternal,postmartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,244,2025-12-02T16:05:11.478648
6849783.0,Labetalol,dose,50,mg,,,,,,,single dose,IV,over 2 min ,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,246,2025-12-02T16:05:06.199640
6849783.0,Labetalol,dose,50,mg,,,,,,,single dose,IV,over 2 min ,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,246,2025-12-02T16:05:11.478648
14985597.0,Bupropion,dose,150,mg,,,,,,,once a day,oral,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,251,2025-12-02T16:05:06.199640
14985597.0,Bupropion,dose,300,mg,,,,,,,once a day,oral,after three days,10.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,252,2025-12-02T16:05:06.199640
14985597.0,Bupropion,dose,150,mg,,,,,,,once a day,oral,,10.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,251,2025-12-02T16:05:11.478648
14985597.0,Bupropion,dose,300,mg,,,,,,,once a day,oral,after three days,10.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,252,2025-12-02T16:05:11.478648
8527284.0,Alprazolam,dose,0.5,mg,,,,,,,single dose,oral,,8.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,253,2025-12-02T16:05:06.199640
8527284.0,Alprazolam,dose,0.5,mg,,,,,,,single dose,oral,,8.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,253,2025-12-02T16:05:11.478648
19116263.0,Clonidine,dose,,mg/day,,,,minmax,0.15,0.3,,oral,,17.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,254,2025-12-02T16:05:06.199640
19116263.0,Clonidine,dose,,mg/day,,,,minmax,0.15,0.3,,oral,,17.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,254,2025-12-02T16:05:11.478648
7605757.0,Clonidine,accumulative dose administered,150,ug,mean,SD,22.0,,,,,,,12.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,255,2025-12-02T16:05:06.199640
7605757.0,Clonidine,accumulative dose administered,150,ug,mean,SD,22.0,,,,,,,12.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,255,2025-12-02T16:05:11.478648
20598025.0,Cefixime,dose,400,mg,,,,,,,single dose,oral,,6.0,maternal,pregnant,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,256,2025-12-02T16:05:06.199640
20598025.0,Cefixime,dose,400,mg,,,,,,,single dose,oral,,6.0,maternal,pregnant,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,256,2025-12-02T16:05:11.478648
17380592.0,dexamphetamine,dose,18,mg/day,median,,,minmax,15,45.0,,,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,257,2025-12-02T16:05:06.199640
17380592.0,dexamphetamine,dose,267,ug/kg/day,median,,,IQR,242,459.0,,,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,258,2025-12-02T16:05:06.199640
17380592.0,dexamphetamine,dose,18,mg/day,median,,,minmax,15,45.0,,,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,257,2025-12-02T16:05:11.478648
17380592.0,dexamphetamine,dose,267,ug/kg/day,median,,,IQR,242,459.0,,,,4.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,258,2025-12-02T16:05:11.478648
3768252.0,Trazodone,dose,50,mg,,,,,,,single dose,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,266,2025-12-02T16:05:06.199640
3768252.0,Trazodone,dose,50,mg,,,,,,,single dose,oral,,6.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,266,2025-12-02T16:05:11.478648
6117304.0,Nadolol,dose,80,mg,,,,,,,once a day,oral,for 5 days,12.0,maternal,lactation,,,normotensive lactating subjects,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,267,2025-12-02T16:05:06.199640
6117304.0,Nadolol,dose,80,mg,,,,,,,once a day,oral,for 13 days,7.0,adults,,,,hypertensive patients,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,268,2025-12-02T16:05:06.199640
6117304.0,Nadolol,dose,80,mg,,,,,,,once a day,oral,for 5 days,12.0,maternal,lactation,,,normotensive lactating subjects,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,267,2025-12-02T16:05:11.478648
6117304.0,Nadolol,dose,80,mg,,,,,,,once a day,oral,for 13 days,7.0,adults,,,,hypertensive patients,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,268,2025-12-02T16:05:11.478648
3608376.0,Propranolol,dose,10,mg,,,,,,,single dose,IV,over 10 min,12.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,269,2025-12-02T16:05:06.199640
3608376.0,Propranolol,dose,10,mg,,,,,,,single dose,IV,over 10 min,12.0,maternal,postmartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,270,2025-12-02T16:05:06.199640
3608376.0,Propranolol,dose,10,mg,,,,,,,single dose,IV,over 10 min,12.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,269,2025-12-02T16:05:11.478648
3608376.0,Propranolol,dose,10,mg,,,,,,,single dose,IV,over 10 min,12.0,maternal,postmartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,270,2025-12-02T16:05:11.478648
6519163.0,Propranolol,dose,120,mg,,,,,,,single dose,oral,,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,271,2025-12-02T16:05:06.199640
6519163.0,Propranolol,dose,10,mg,,,,,,,single dose,IV,over 10 min,5.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,272,2025-12-02T16:05:06.199640
6519163.0,Propranolol,dose,120,mg,,,,,,,single dose,oral,,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,271,2025-12-02T16:05:11.478648
6519163.0,Propranolol,dose,10,mg,,,,,,,single dose,IV,over 10 min,5.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,272,2025-12-02T16:05:11.478648
6653642.0,Propranolol,last dose,0.674,mg/kg,mean,SD,0.209,,,,,,,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,273,2025-12-02T16:05:06.199640
6653642.0,Propranolol,last dose,0.65,mg/kg,mean,SD,0.122,,,,,,,5.0,maternal,postmartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,274,2025-12-02T16:05:06.199640
6653642.0,Propranolol,last dose,0.606,mg/kg,mean,SD,0.088,,,,,,,3.0,maternal,1st trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,275,2025-12-02T16:05:06.199640
6653642.0,Propranolol,last dose,0.544,mg/kg,mean,SD,0.07,,,,,,,5.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,276,2025-12-02T16:05:06.199640
6653642.0,Propranolol,last dose,0.632,mg/kg,mean,SD,0.158,,,,,,,13.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,277,2025-12-02T16:05:06.199640
6653642.0,Propranolol,last dose,0.674,mg/kg,mean,SD,0.209,,,,,,,10.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,273,2025-12-02T16:05:11.478648
6653642.0,Propranolol,last dose,0.65,mg/kg,mean,SD,0.122,,,,,,,5.0,maternal,postmartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,274,2025-12-02T16:05:11.478648
6653642.0,Propranolol,last dose,0.606,mg/kg,mean,SD,0.088,,,,,,,3.0,maternal,1st trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,275,2025-12-02T16:05:11.478648
6653642.0,Propranolol,last dose,0.544,mg/kg,mean,SD,0.07,,,,,,,5.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,276,2025-12-02T16:05:11.478648
6653642.0,Propranolol,last dose,0.632,mg/kg,mean,SD,0.158,,,,,,,13.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,277,2025-12-02T16:05:11.478648
3427136.0,Propranolol,dose,25,mg,,,,,,,tid,oral,for 3 days,8.0,maternal,pregnancy,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,278,2025-12-02T16:05:06.199640
3427136.0,Propranolol,dose,25,mg,,,,,,,tid,oral,for 3 days,7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,279,2025-12-02T16:05:06.199640
3427136.0,Propranolol,dose,25,mg,,,,,,,tid,oral,for 3 days,9.0,nonpregnant,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,280,2025-12-02T16:05:06.199640
3427136.0,Propranolol,dose,50,mg,,,,,,,single dose,oral,on the day of investigation,8.0,maternal,pregnancy,,,Phenobarbital treated,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,281,2025-12-02T16:05:06.199640
3427136.0,Propranolol,dose,50,mg,,,,,,,single dose,oral,on the day of investigation,7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,282,2025-12-02T16:05:06.199640
3427136.0,Propranolol,dose,50,mg,,,,,,,single dose,oral,on the day of investigation,9.0,nonpregnant,,,,control,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,283,2025-12-02T16:05:06.199640
3427136.0,Propranolol,dose,25,mg,,,,,,,tid,oral,for 3 days,8.0,maternal,pregnancy,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,278,2025-12-02T16:05:11.478648
3427136.0,Propranolol,dose,25,mg,,,,,,,tid,oral,for 3 days,7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,279,2025-12-02T16:05:11.478648
3427136.0,Propranolol,dose,25,mg,,,,,,,tid,oral,for 3 days,9.0,nonpregnant,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,280,2025-12-02T16:05:11.478648
3427136.0,Propranolol,dose,50,mg,,,,,,,single dose,oral,on the day of investigation,8.0,maternal,pregnancy,,,Phenobarbital treated,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,281,2025-12-02T16:05:11.478648
3427136.0,Propranolol,dose,50,mg,,,,,,,single dose,oral,on the day of investigation,7.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,282,2025-12-02T16:05:11.478648
3427136.0,Propranolol,dose,50,mg,,,,,,,single dose,oral,on the day of investigation,9.0,nonpregnant,,,,control,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,283,2025-12-02T16:05:11.478648
7046334.0,Propranolol,dose,80,mg,,,,,,,single dose,oral,3 hours before operation,8.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,284,2025-12-02T16:05:06.199640
7046334.0,Sotalol,dose,80,mg,,,,,,,single dose,oral,3 hours before operation,8.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,291,2025-12-02T16:05:06.199640
7046334.0,Propranolol,dose,80,mg,,,,,,,single dose,oral,3 hours before operation,8.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,284,2025-12-02T16:05:11.478648
7046334.0,Sotalol,dose,80,mg,,,,,,,single dose,oral,3 hours before operation,8.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,291,2025-12-02T16:05:11.478648
12932617.0,Sotalol,initial dose,80,mg,,,,,,,bid,,,18.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,285,2025-12-02T16:05:06.199640
12932617.0,Sotalol,increased dose,160,mg,,,,,,,bid or tid,,,18.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,286,2025-12-02T16:05:06.199640
12932617.0,Sotalol,initial dose,80,mg,,,,,,,bid,,,18.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,285,2025-12-02T16:05:11.478648
12932617.0,Sotalol,increased dose,160,mg,,,,,,,bid or tid,,,18.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,286,2025-12-02T16:05:11.478648
36768172.0,Sotalol,starting dose,160,mg/day,,,,,,,,,,43.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,287,2025-12-02T16:05:06.199640
36768172.0,Sotalol,dose in the absence of a therapeutic effect,480,mg/day,,,,,,,,,,43.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,288,2025-12-02T16:05:06.199640
36768172.0,Sotalol,starting dose,160,mg/day,,,,,,,,,,43.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,287,2025-12-02T16:05:11.478648
36768172.0,Sotalol,dose in the absence of a therapeutic effect,480,mg/day,,,,,,,,,,43.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,288,2025-12-02T16:05:11.478648
6861867.0,Sotalol,dose,400,mg,,,,,,,,oral,,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,289,2025-12-02T16:05:06.199640
6861867.0,Sotalol,dose,100,mg,,,,,,,,IV,over 1 hour,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,290,2025-12-02T16:05:06.199640
6861867.0,Sotalol,dose,400,mg,,,,,,,,oral,,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,289,2025-12-02T16:05:11.478648
6861867.0,Sotalol,dose,100,mg,,,,,,,,IV,over 1 hour,6.0,maternal,pregnancy/postpartum,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,290,2025-12-02T16:05:11.478648
7426541.0,Sotalol,dose before delivery,433.3,mg/day,mean,SEM,54.1,minmax,200,800.0,,,,12.0,maternal,delivery,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,292,2025-12-02T16:05:06.199640
7426541.0,Sotalol,dose before delivery,433.3,mg/day,mean,SEM,54.1,minmax,200,800.0,,,,12.0,maternal,delivery,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,292,2025-12-02T16:05:11.478648
21030064.0,Octocrylene,,,,,,,,,,,,,23.0,maternal,lactation,,,reported use of UV filters in cosmetic products,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,293,2025-12-02T16:05:06.199640
21030064.0,Octocrylene,,,,,,,,,,,,,23.0,maternal,lactation,,,reported use of UV filters in cosmetic products,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,293,2025-12-02T16:05:11.478648
18709157.0,Oxybenzone,,,,,,,,,,,,,367.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,294,2025-12-02T16:05:06.199640
18709157.0,Oxybenzone,,,,,,,,,,,,,367.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,294,2025-12-02T16:05:11.478648
21900077.0,Oxybenzone,,,,,,,,,,,,,191.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,295,2025-12-02T16:05:06.199640
21900077.0,Oxybenzone,,,,,,,,,,,,,191.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,295,2025-12-02T16:05:11.478648
23469879.0,Oxybenzone,,,,,,,,,,,,,105.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,296,2025-12-02T16:05:06.199640
23469879.0,Oxybenzone,,,,,,,,,,,,,105.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,296,2025-12-02T16:05:11.478648
23562958.0,Oxybenzone,,,,,,,,,,,,,567.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,297,2025-12-02T16:05:06.199640
23562958.0,Oxybenzone,,,,,,,,,,,,,567.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,297,2025-12-02T16:05:11.478648
23712115.0,Oxybenzone,,,,,,,,,,,,,20.0,maternal,pregnancy,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,298,2025-12-02T16:05:06.199640
23712115.0,Oxybenzone,,,,,,,,,,,,,101.0,adults,,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,299,2025-12-02T16:05:06.199640
23712115.0,Oxybenzone,,,,,,,,,,,,,10.0,pediatric,children,,,,PRGLAC_PK_curation_051925.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,300,2025-12-02T16:05:06.199640
23712115.0,Oxybenzone,,,,,,,,,,,,,20.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,298,2025-12-02T16:05:11.478648
23712115.0,Oxybenzone,,,,,,,,,,,,,101.0,adults,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,299,2025-12-02T16:05:11.478648
23712115.0,Oxybenzone,,,,,,,,,,,,,10.0,pediatric,children,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,300,2025-12-02T16:05:11.478648
23714150.0,Oxybenzone,,,,,,,,,,,,,80.0,maternal,abortion,,,case,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,301,2025-12-02T16:05:11.478648
23714150.0,Oxybenzone,,,,,,,,,,,,,170.0,maternal,,,,control: had no history of spon- taneous abortion and had at least one living child,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,302,2025-12-02T16:05:11.478648
23714150.0,Oxybenzone,,,,,,,,,,,,,250.0,men,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,303,2025-12-02T16:05:11.478648
23942273.0,Oxybenzone,,,,,,,,,,,,,71.0,maternal,pregnancy,,,NCS,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,304,2025-12-02T16:05:11.478648
24529000.0,Oxybenzone,,,,,,,,,,,,,506.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,305,2025-12-02T16:05:11.478648
24529000.0,Oxybenzone,,,,,,,,,,,,,174.0,maternal,pregnant,,,NHANES 2005-2010,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,306,2025-12-02T16:05:11.478648
24529000.0,Oxybenzone,,,,,,,,,,,,,524.0,maternal,pregnant,,,NHANES 2009-2010,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,307,2025-12-02T16:05:11.478648
25435060.0,Oxybenzone,,,,,,,,,,,,,106.0,maternal,pregnant,,,"Women provided spot urine samples at three separate study visits (16-20, 20-24, and 24-28 weeks gestation) ",PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,308,2025-12-02T16:05:11.478648
25463527.0,Oxybenzone,,,,,,,,,,,,,34.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,309,2025-12-02T16:05:11.478648
25782115.0,Oxybenzone,,,,,,,,,,,,,45.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,310,2025-12-02T16:05:11.478648
26575635.0,Oxybenzone,,,,,,,,,,,,,220.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,311,2025-12-02T16:05:11.478648
26575635.0,Oxybenzone,,,,,,,,,,,,,220.0,paternal,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,312,2025-12-02T16:05:11.478648
27037776.0,Oxybenzone,,,,,,,,,,,,,404.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,313,2025-12-02T16:05:11.478648
29100749.0,Oxybenzone,,,,,,,,,,,,,200.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,314,2025-12-02T16:05:11.478648
29232646.0,Oxybenzone,,,,,,,,,,,,,79.0,maternal,lactation,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,315,2025-12-02T16:05:11.478648
29294443.0,Oxybenzone,,,,,,,,,,,,,476.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,316,2025-12-02T16:05:11.478648
29362228.0,Oxybenzone,,,,,,,,,,,,,183.0,maternal,2nd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,317,2025-12-02T16:05:11.478648
29366524.0,Oxybenzone,,,,,,,,,,,,,439.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,318,2025-12-02T16:05:11.478648
29458359.0,Oxybenzone,,,,,,,,,,,,,452.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,319,2025-12-02T16:05:11.478648
29477955.0,Oxybenzone,,,,,,,,,,,,,346.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,320,2025-12-02T16:05:11.478648
29477955.0,Oxybenzone,,,,,,,,,,,,,184.0,paternal,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,321,2025-12-02T16:05:11.478648
29550712.0,Oxybenzone,,,,,,,,,,,,,165.0,maternal,3rd trimester,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,322,2025-12-02T16:05:11.478648
29803919.0,Oxybenzone,,,,,,,,,,,,,452.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,323,2025-12-02T16:05:11.478648
30316544.0,Oxybenzone,,,,,,,,,,,,,1003.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,324,2025-12-02T16:05:11.478648
30412856.0,Oxybenzone,,,,,,,,,,,,,922.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,325,2025-12-02T16:05:11.478648
30517665.0,Oxybenzone,,,,,,,,,,,,,338.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,326,2025-12-02T16:05:11.478648
30557721.0,Oxybenzone,,,,,,,,,,,,,847.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,327,2025-12-02T16:05:11.478648
30624098.0,Oxybenzone,,,,,,,,,,,,,473.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,328,2025-12-02T16:05:11.478648
31077917.0,Oxybenzone,,,,,,,,,,,,,304.0,maternal,pre-pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,329,2025-12-02T16:05:11.478648
31081626.0,Oxybenzone,,,,,,,,,,,,,941.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,330,2025-12-02T16:05:11.478648
31288179.0,Oxybenzone,,,,,,,,,,,,,481.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,331,2025-12-02T16:05:11.478648
32120140.0,Oxybenzone,,,,,,,,,,,,,417.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,332,2025-12-02T16:05:11.478648
32120140.0,Oxybenzone,,,,,,,,,,,,,229.0,paternal,,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,333,2025-12-02T16:05:11.478648
32248023.0,Oxybenzone,,,,,,,,,,,,,479.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,334,2025-12-02T16:05:11.478648
32279061.0,Oxybenzone,,,,,,,,,,,,,8.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,335,2025-12-02T16:05:11.478648
32320878.0,Oxybenzone,,,,,,,,,,,,,97.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,336,2025-12-02T16:05:11.478648
32345324.0,Oxybenzone,,,,,,,,,,,,,217.0,maternal,preconception/pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,337,2025-12-02T16:05:11.478648
32653713.0,Oxybenzone,,,,,,,,,,,,,386.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,338,2025-12-02T16:05:11.478648
34952328.0,Oxybenzone,,,,,,,,,,,,,416.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,339,2025-12-02T16:05:11.478648
35421480.0,Oxybenzone,,,,,,,,,,,,,175.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,340,2025-12-02T16:05:11.478648
35700189.0,Oxybenzone,,,,,,,,,,,,,478.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,341,2025-12-02T16:05:11.478648
35839910.0,Oxybenzone,,,,,,,,,,,,,301.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,342,2025-12-02T16:05:11.478648
36227336.0,Oxybenzone,,,,,,,,,,,,,333.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,343,2025-12-02T16:05:11.478648
36346334.0,Oxybenzone,,,,,,,,,,,,,221.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,344,2025-12-02T16:05:11.478648
36525700.0,Oxybenzone,,,,,,,,,,,,,223.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,345,2025-12-02T16:05:11.478648
36568115.0,Oxybenzone,,,,,,,,,,,,,100.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,346,2025-12-02T16:05:11.478648
36701050.0,Oxybenzone,,,,,,,,,,,,,450.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,347,2025-12-02T16:05:11.478648
36857904.0,Oxybenzone,,,,,,,,,,,,,442.0,maternal,pregnancy,,,,PRGLAC_PK_curation_06232025.xlsx,PK curation_Shijun,Drug (summary data),Drug_summary,348,2025-12-02T16:05:11.478648
